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Neuropsychiatric disorders are on the rise and many are subject to memory and cognitive deficits, which 
have poor treatment options, generating a great need to better understand the underlying mechanisms 
to aid future therapeutics. Schizophrenia and drug abuse are neuropsychiatric disorders that are 
characterised by symptoms of cognitive and behavioural deficits. As with many psychiatric disorders 
they are the result of genetic and environmental influences that converge on altered behaviour and 
cognitive processing. Two cognitive domains frequently found to be disrupted in neuropsychiatric 
disorders are working memory and cognitive flexibility. 
Zebrafish are growing in use as a model of complex neuropsychiatric disorders. High genetic homology 
to humans and ease of genetic manipulation have resulted in a number of zebrafish lines characteristic 
of many human neuropsychiatric conditions, including schizophrenia and substance abuse. The primary 
aim of this thesis is the development and validation of a new cross-species task of cognitive assessment. 
Here I describe the first uses of the Free-Movement Pattern (FMP) Y-maze, a robust and reliable test of 
cognitive function with both preclinical and clinical applications. The work of this thesis has provided 
the foundation of future cognitive assessments in zebrafish and paved the way to increased 
translatability of therapeutic strategies targeting cognitive function from zebrafish models to humans 
and have been the first to describe comparative deficits in working memory in healthy ageing in 
zebrafish and humans. I have described the first longitudinal study of cognitive and neuroendocrine 
development from larvae to young adult and found several biomarkers that could be used to identify 
critical periods of increased susceptibility to the development of neuropsychiatric disorders. I have also 
described the first model of cognitive sensitization in zebrafish. Additionally, through the design of a 
new model of schizophrenia-like phenotypes, I have described a possible genetic link between 
schizophrenia and nicotine addiction. Finally, this is the first description of cognitive deficits in a 




Declaration by author 
I, Madeleine E. Cleal, hereby certify that this thesis, which is approximately 71,000 words in length, has 
been written by me, and that it is the record of work carried out by me, or principally by myself in 
collaboration with others as acknowledged. Whilst registered as a candidate for this degree, I have not 
been registered for any other research award and the results have not been submitted for any other 
academic award. I was admitted as a research student in September 2016, for the degree of Doctor of 
Philosophy; the higher study for which this is a record, was carried out in the University of Portsmouth 
between 2016 and 2020. 
 
Signature of Candidate:  
Name of Candidate:  Madeleine E. Cleal  













Publications during candidature 
Peer-reviewed papers (published)  
Cleal, M., Fontana, B. D., Ranson, D. C., McBride, S. D., Swinny, J. D., Redhead, E. S., & Parker, M. O. (2020). 
The Free-movement pattern Y-maze: A cross-species measure of working memory and executive 
function. Behavior Research Methods, 1–22. https://doi.org/10.3758/s13428-020-01452-x 
Cleal, M., Gibbon, A., Fontana, B. D., & Parker, M. O. (2020). The importance of pH: How aquarium 
water is affecting behavioural responses to drug exposure in larval zebrafish. Pharmacology 
Biochemistry and Behavior, 199, 173066. https://doi.org/10.1016/j.pbb.2020.173066 
Cleal, M., & Parker, M. O. (2018). Moderate developmental alcohol exposure reduces repetitive 
alternation in a zebrafish model of fetal alcohol spectrum disorders. Neurotoxicology and 
Teratology. https://doi.org/10.1016/j.ntt.2018.09.001 
 
Peer-reviewed papers (submitted, under review) 
Madeleine Cleal, Barbara D. Fontana, Molly Double, Roxana Mezabrovschi, Leah Parcell, Edward 
Redhead, Matthew O. Parker. Dopaminergic Modulation of WM and Cognitive Flexibility in a Zebrafish 
Model of Aging-Related Cognitive Decline  
 
Madeleine Cleal, Barbara. D. Fontana, Matthew. O. Parker. The Cognitive and Behavioural Effects of D-
Amphetamine and Nicotine Sensitization in Adult Zebrafish 
 
Collaborative publications 
Demin, K. A., Lakstygal, A. M., Volgin, A. D., de Abreu, M. S., Genario, R., Alpyshov, E. T., Serikuly, N., 
Wang, D., Wang, J., Yan, D., Wang, M., Yang, L. E., Hu, G., Bytov, M., Zabegalov, K. N., Zhdanov, A., 
Harvey, B. H., Costa, F., Rosemberg, D. B., … Kalueff, A. V. (2020). Cross-species Analyses of Intra-




Fontana, B.D., Cleal, M., Clay, J. M., & Parker, M. O. (2019). Zebrafish (Danio rerio) behavioral laterality 
predicts increased short-term avoidance memory but not stress-reactivity responses. Animal 
Cognition, 22(6). https://doi.org/10.1007/s10071-019-01296-9 
Fontana, Barbara D., Cleal, M., Clay, J. M., & Parker, M. O. (2019). Zebrafish (Danio rerio) behavioral 
laterality predicts increased short-term avoidance memory but not stress-reactivity responses. 
Animal Cognition, 22(6), 1051–1061. https://doi.org/10.1007/s10071-019-01296-9 
Fontana, Barbara D., Cleal, M., & Parker, M. O. (2019). Female adult zebrafish (Danio rerio) show higher 
levels of anxiety-like behavior than males, but do not differ in learning and memory capacity. 
European Journal of Neuroscience, ejn.14588. https://doi.org/10.1111/ejn.14588 
Gutiérrez, H. C., Vacca, I., Schoenmacker, G., Cleal, M., Tochwin, A., O’Connor, B., Young, A. M. J. J., 
Vasquez, A. A., Winter, M. J., Parker, M. O., & Norton, W. H. J. J. (2020). Screening for drugs to 
reduce zebrafish aggression identifies caffeine and sildenafil. European 
Neuropsychopharmacology, 30, 17–29. https://doi.org/10.1016/j.euroneuro.2019.10.005 
Mancuso, R., Fryatt, G., Cleal, M., Obst, J., Pipi, E., Monzón-Sandoval, J., Ribe, E., Winchester, L., Webber, 
C., Nevado, A., Jacobs, T., Austin, N., Theunis, C., Grauwen, K., Daniela Ruiz, E., Mudher, A., 
Vicente-Rodriguez, M., Parker, C. A., Simmons, C., … Perry, V. H. (2019). CSF1R inhibitor JNJ-
40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain. 
https://doi.org/10.1093/brain/awz241 
Zabegalov, K. N., Khatsko, S. L., Lakstygal, A. M., Demin, K. A., Cleal, M., Fontana, B. D., McBride, S. D., 
Harvey, B. H., de Abreu, M. S., Parker, M. O., & Kalueff, A. V. (2019). Abnormal repetitive 
behaviors in zebrafish and their relevance to human brain disorders. In Behavioural Brain 
Research. https://doi.org/10.1016/j.bbr.2019.03.044 
 






Cleal, M., Fontana, B. D., Ranson, D. C., McBride, S. D., Swinny, J. D., Redhead, E. S., & Parker, M. O. (2020). 
The Free-movement pattern Y-maze: A cross-species measure of working memory and executive 




Dopaminergic Modulation of WM and Cognitive Flexibility in a Zebrafish Model of Aging-Related 
Cognitive Decline  
Madeleine Cleal, Barbara D. Fontana, Molly Double, Roxana Mezabrovschi, Leah Parcell, Edward 




Cleal, M., Gibbon, A., Fontana, B. D., & Parker, M. O. (2020). The importance of pH: How aquarium 
water is affecting behavioural responses to drug exposure in larval zebrafish. Pharmacology 
Biochemistry and Behavior, 199, 173066. https://doi.org/10.1016/j.pbb.2020.173066 
Chapter 3 
Cleal, M., & Parker, M. O. (2018). Moderate developmental alcohol exposure reduces repetitive 




The Cognitive and Behavioural Effects of D-Amphetamine and Nicotine Sensitization in Adult 
Zebrafish 
Madeleine Cleal, Barbara. D. Fontana, Matthew. O. Parker 
 
 
List of Figures 
 
Part 1  
Figure 1.1. The cortico-striatal-thalamo-cortical loop…………….…………………………………………………...………..7 
Figure 1.2. Parasagittal schematic overview of the dopaminergic projection in humans, rodents and 
zebrafish………………………………………………………………………………………………………………………………………………..12 
Figure 3.2. FMP Y-maze behavioural equipment-zebrafish….……..……………………………………………………….39 
Figure 3.3. Frequency distribution of wild type adult zebrafish………..……..…………………………………………..45 
Figure 3.4. Time series analysis of wild type adult zebrafish…………..……………………………………….……….….47 
Figure 3.5. Percentage use of alternations and repetitions by wild type adult zebrafish..….……………….51 
Figure 3.6. Comparison of total alternations and repetitions in pharmacologically treated zebrafish..52 
Figure 3.7. Frequency distribution of pharmacologically treated zebrafish….……………………………………..54 
Figure 3.8. Autocorrelation function plot wild type and pharmacologically treated zebrafish….…..…....55 
Figure 3.9. FMP Y-maze behavioural equipment-Drosophila and rodents………..………………………………...37 
Figure 3.10. Comparison of frequency distributions in Drosophila, zebrafish and rodents…..…………….57 
Figure 3.11. Time series analysis Drosophila and rodent…………….………..……………………………………………...59 
Figure 3.12. Human virtual FMP Y-maze schematic…..……..………………..………………………………………………..62 
Figure 3.13. Frequency distribution of humans…………..….………….………………………………………………………..65 
Figure 4.1. FMP Y-maze schematic for larvae, juvenile and adult zebrafish……….…………………………...…..75 
Figure 4.2. Frequency distribution through development………………….…………………………………………….....83 
Figure 4.3. Age comparison of alternations and repetitions…..………….………………………………………………..84 
Figure 4.4. Frequency distribution per 10 min time bin across development………….………………………….85 
Figure 4.5. Effect of time on alternation use across development……………………………………..………………..86 
Figure 4.6. Locomotor activity across development……….…………………………………………………………………...87 
Figure 4.7. Whole-body cortisol and gr mRNA expression across development……….…………………….....89 
Figure 5.1A. FMP Y-maze movement strategies….….……………………………………………………………………..….104 
Figure 5.1B. Virtual Human FMP Y-maze………..…………………………..………………………………………………..……106 
 
 
Figure 5.2. Global search strategy adults v ageing……….…………………………………………………………………...112 
Figure 5.3. Effect D1/D5 agonist on adults and aged adults…………………………….……………………………....114 
Figure 5.4. Frequency distribution per 10 min time bin….……….……………………………………………………......117 
Figure 5.5. Percentage use of alternations over time for 6 v 24-month old zebrafish + SKF-38393…119 
Figure 5.6. Locomotion, weight and oxygen consumption 6 v 24-month old zebrafish + SKF-
38393………………………………………………………………………………………………………………………………………………….121 
Figure 5.7. QPCR dopaminergic gene expression 6 v 24-month old zebrafish..……………………………….122 
Figure 5.8. QPCR dopaminergic gene expression 6 v 24-month old zebrafish + SKF-38393.…….…….124 
Figure 5.9. Frequency distribution young v old aged humans……………………...………………………………….125 
Figure 6.1. Frequency distribution wild type v APP/PS1 mice………….……………………………………………….142 
 
Part 2 
Figure 2.1. Survival curve and locomotion of pH treated larvae…………..……………………………………………166 
Figure 2.2. Effect of pH on survival of drug exposed larvae………..…………………………………………………….168 
Figure 2.3. Effect of pH on locomotor activity of drug exposed larvae………….………………………………….169 
Figure 3.1. Behavioural testing equipment for appetitive learning task……………...….…………………………182 
Figure 3.2. Behavioural testing equipment for Pavlovian fear conditioning.....………………………………….184 
Figure 3.3. Behavioural testing equipment for FMP Y-maze………….………………………………………………….185 
Figure 3.4. Effect of developmental ethanol exposure on appetitive learning...…….………………………….190 
Figure 3.5. Effect of developmental ethanol exposure on Pavlovian fear conditioning..……………..…….191 
Figure 3.6. Frequency distribution of tetragrams of developmentally exposed to ethanol v control..192 
Figure 4.1. Schematic of FMP Y-maze equipment for adult zebrafish…….………..……………………………….204 
Figure 4.2. Schematic of treatment phase and cognitive assessment plan for drug sensitization…….205 







Figure 1.1. Brain divisions of the telencephalon and diencephalic regions in adult humans, rodents 
and zebrafish……….……………………………………………………………..……………………………………………………………….223 
Figure 2.1. Schematic and identification of slit-3 mutation in adult zebrafish...……….……………………….241 
Figure 2.2. Effect of slit-3 mutation of exploration strategy in the FMP Y-maze and tank diving …….243 
Figure 2.3. Effect of acute stress on control and slit-3 transgenic fish……………..…….………………………….245 
Figure 2.4. Effect of slit-3 mutation on whole-body cortisol and mRNA expression of bdnf and gr...246 
Figure 2.5. Effect of nicotine on exploration strategy of slit-3 mutants in the FMP Y-maze and tank 
diving response………………………………………………………………………………………………………………….……………….247 
Figure 2.6. Effect of ethanol on CPP and tank diving response in slit-3 mutants…….…….………………….249 
Figure 3.1. Schematic of disc1 mutation and effect on tank diving response in juvenile zebrafish…...268 
Figure 3.2. Effect of disc1 mutation on global search strategy in the FMP Y-maze………..………………….270 

















List of Tables 
 
Part 1  
Table 3.1. Tetragram sequences used for analysing exploration strategy in the FMP Y-maze…...……..40 
Table 4.1. Primer sets used for qPCR……………………………………………………………………………………………….....78 
Table 4.2. Tetragram sequences used for analysing exploration strategy in the FMP Y-maze…………..81 
Table 4.3. Table of significance of the effect of age group on locomotor activity…………………………..…88 
Table 5.1. Primer sets used for qPCR………………………………………………………………………………………………..108 
 
Part 2 
Table 2.1. Systematic review of zebrafish behaviour research articles reporting pH………………………..164 
 
Part 3 
Table 3.1. Primer sets used for HRM analysis…………………………………………………………………………………...235 
Table 3.2. Primer sets used for PCR genotyping...…………………………………………………………………………….236 
Table 3.3. Primer sets used for qPCR………………………………………………………………………………………………..238 

















Anterior limb of the internal capsule 
ASD 
 















Disrupted in schizophrenia 1 
DRD1 
 
Dopamine receptor D1 
DRD2 
 
Dopamine receptor D2 
DRD3 
 
Dopamine receptor D3 
DRD4 
 
Dopamine receptor D4 
DRD5 
 
Dopamine receptor D5 
DS/VS 
 
Dorsal striatum/ventral striatum 
FMP Y-maze                 Free-Movement Pattern Y-maze 
HPA axis                 Hypothalamic-pituitary-adrenal axis 
HPI axis                Hypothalamic-pituitary-interrenal axis 
LTP  
 
Long term potentiation 
MD 
 
Medial dorsal aspect of the thalamus 
MDD 
 
































































The work described in the first part of this thesis uses a combination of Drosophila, zebrafish, rodents and 
humans to characterise and validate a new protocol for the assessment of cognitive function, particularly, 
working memory and cognitive flexibility, in a test designed for preclinical and clinical applications. The 
aim of this work is to bridge the gap to successfully translate findings affecting cognition, from animal 
models to humans. Healthy, pharmacological and transgenic models have been utilised to validate this 
newly developed cognitive test and demonstrate its applicability to the field of neuroscience. The following 
sections describe molecular mechanisms and integrated neural networks and pathways that are critical to 
cognitive processing and executive function. Particular attention is paid to neural mechanisms 
underpinning working memory and cognitive flexibility and the evolutionarily conserved orthologues and 
homologues that have been identified in two commonly used model organisms: the rodent and the 
zebrafish. A description of current methods of cognitive assessments in animal models and their 
translational relevance to clinical assessments are outlined. Subsequent chapters in the first part of this 
thesis will focus on experimental validation of the Free-Movement Pattern (FMP) Y-maze both as a highly 
sensitive test for detecting changes in cognitive function and as a clinically and preclinically relevant task, 
with high translational pertinence. 
2 
 




Neuropsychiatric disorders are a global burden that can affect anyone, regardless of socioeconomic 
status, country of origin, ethnic background, gender or age. It is riff in everyday society and, despite 
decades of research, is on the rise with an estimated 970 million people globally suffering from mental 
or behavioural disorders (Vigo et al., 2016; World Health Organisation, 2016). Although there are many 
identifiable conditions, such as schizophrenia, substance abuse, attention deficit hyperactivity disorder 
(ADHD), obsessive compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorder, 
depression, anxiety, etc, there is significant overlap in symptoms, such as dysfunctional cognitive 
processing (Goldberg, 2017; Gould, 2010; Hammar & Årdal, 2009; Kim & Silvestri, 2015; Rǎdulescu et 
al., 2017), and triggers, such as stress (Hall et al., 2015; Homberg et al., 2016; Musazzi et al., 2017, 2018). 
Since the beginning of 2020 the world has been in the grasp of a global pandemic, SARS-CoV-2 (Covid-
19), which has caused significant shifts in everyday norms and the way people live their lives (A. Spinelli 
& Pellino, 2020). This impact is not limited to a single population but affects everyone from the very 
young to the very old (Daoust, 2020; Götzinger et al., 2020). Covid-19 has brought about unprecedented 
social isolation, future uncertainty, grave health issues and death. For those with the predisposition to 
develop neuropsychiatric disorders, any one of these environmental factors could be a trigger for 
illness-onset (Clay & Parker, 2020; Panchal et al., 2020; Rogers et al., 2020; Steardo et al., 2020). However, 
combined, there is little doubt of the huge impact that this event will have on the short and long-term 
mental health of the global population (Nalleballe et al., 2020; Pfefferbaum & North, 2020; Rajkumar, 
2020; Troyer et al., 2020). Questions are already being raised as to the steps that can be taken to prevent, 
reduce or reverse the impact of neuropsychiatric disorders on patients and the society that surrounds 
them (Tandon, 2020; Torales et al., 2020; Xiong et al., 2020; Zimmer et al., 2020). Understanding the 
3 
 
molecular and neurophysiological mechanisms of neuropsychiatric disorders is critical. Furthermore, 
having reliable tests that can detect changes in cognitive processing and associated behaviours, that 
are not only suitable to all age groups, but can robustly translate findings from animal models to 
humans is going to prove imperative to the future effort of restoring balance to the world’s mental 
health.    
Neuropsychiatric disorders are common and complex and often characterised by aberrant 
cognitive processing which results in altered behaviour (Barnett et al., 2006; Mega & Cummings, 1994; 
Rao et al., 2019; Sahakian et al., 2015; Sampath et al., 2017). Working memory (WM) deficits are one of 
the most regularly reported symptoms of many psychiatric conditions and has been reliably found in 
humans and animal models (Abi-Dargham, 2003; Cargiulo, 2007; Chai et al., 2018; Chamberlain et al., 
2006; Chang et al., 2020; Green et al., 2009; Moores et al., 2008; Rapport et al., 2008; Salloway et al., 
1994; Schweinsburg et al., 2005; Soraggi-Frez et al., 2017). WM impairments are not only evident in 
patients diagnosed with psychiatric conditions, but in disorders with a genetic basis, impairment has 
also been reported in healthy family members (García-Laredo, 2018; Park & Gooding, 2014). 
Subsequently, it has been suggested that cognitive deficits such as WM could be a potential 
endophenotypic marker of disorder susceptibility (García-Laredo, 2018; Park & Gooding, 2014). WM has 
been identified as a critical process, the dysfunction of which underlies multiple cognitive domains and 
may be at the core of other cognitive deficits associated with neuropsychiatric disease (Baddeley, 2012; 
Diamond, 2013; Hall et al., 2015; McCabe et al., 2010; Stiles et al., 2015).  
Inhibition of cognitive flexibility (CF) is also commonly reported in psychiatric conditions. The 
ability to adapt to a changing environment is key to selecting appropriate behavioural responses for 
success and survival (Carruthers et al., 2019; Dajani & Uddin, 2015; Diamond, 2013; Fernández-Serrano 
et al., 2011; Giraldo-Chica et al., 2018; Orellana & Slachevsky, 2013; Stalnaker et al., 2009; Svoboda et 
al., 2015). Current treatments target the psychotic symptoms, such as delusions, hallucinations or mood 
in psychiatric disorders (Buckley, 2001; Ceskova & Silhan, 2018; Patel et al., 2014; Taber et al., 2010). 
However, little progress has been made in treating the cognitive processes (Wallace et al., 2011). This 
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highlights a growing need for behavioural and pharmacological strategies targeting cognitive deficits 
associated with neuropsychiatric disorders. Thus, the aim throughout this thesis is to address this critical 
need to improve our understanding of the mechanisms that underlie cognitive processes, particularly 
those associated with neuropsychiatric disorders, that can be severe and potentially debilitating, with 
substantial impacts on quality of life. However, identification of such mechanisms in animal models 
alone is not enough. Greater still is the need to improve the translational relevance of such findings to 
aid in bridging the chasm between preclinical and clinical markers of disease. The lack of fluency 
between animal models of cognition and human cognition has severely hampered the therapeutic effort 
in targeting abnormal cognitive symptomology. This fact is addressed throughout this work.   
 
1.2 Working memory and cognitive flexibility. 
WM is the process of obtaining and holding small amounts of information in mind, readily available for 
manipulation and use in other executive functions, such as planning, decision-making and problem-
solving (Baddeley, 1992; Baddeley & Hitch, 1974). WM is an essential process to successfully carry out 
everyday tasks (Baddeley, 2010). For example, when asking directions to the nearest shop, if you are 
told take the second left, then the first right and the shop is halfway down the road on the left-hand side, 
in order to reach your desired destination, the unique information about the specific stimuli (e.g., the 
location of the shop) needs to be retained until an appropriate response has been formulated (e.g., 
planning a route to the shop). Information is held whilst temporal organization of behaviour is carried 
out to allow planning and execution of the responses necessary to reach the specified goal (e.g., arriving 
at the shop) (Baddeley, 2012). Properly functioning WM enables the maintenance of information for a 
period long enough to successfully complete the goal. Impaired WM may limit retainment of 
information, reducing the amount that can be held (e.g., take the second left is stored but the rest is lost 
before action can be taken). Severe WM deficits could result in the information being lost as soon as it 
has been relayed, preventing it from being combined into a coherent thought, ultimately leaving the 
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individual with no information available for processing (Cowan, 2014). This level of impairment can be 
extremely debilitating with huge consequences on quality of life. 
  Cognitive flexibility (CF) has been broadly defined as the ability to switch between behaviours, 
strategies, thoughts and perspectives (Dajani & Uddin, 2015; Diamond, 2013; Klanker et al., 2013; Waltz, 
2017). Commonly referred to set shifting or task switching, it represents the processes of adapting 
responses in accordance to changing environmental demands or multitasking (Birrell & Brown, 2000; 
Dajani & Uddin, 2015). Humans, and animals, will maintain a particular behavioural strategy as long it is 
deemed the optimal strategy for achieving the current goal. However, when the need for change is 
sufficiently salient and it becomes apparent that the current strategy is no longer working, or there is a 
more efficient way to achieve the same goal, these strategies can be flexibly updated (R. Cools, 2015). 
WM has been identified as a crucial process underlying CF, in which continuously maintaining task 
representations or rules is essential (Diamond, 2013). Impairments in CF are regularly reported in 
conjunction with impaired WM (Baldacchino et al., 2012; Orellana & Slachevsky, 2013; Rasmussen, 2005; 
Tanaka et al., 2019; Wobrock et al., 2009). Additionally, many studies have demonstrated that higher 
WM capacity is strongly correlated with improved CF (i.e. reduced error rates or decreased switching 
costs) (Blackwell et al., 2009; McCabe et al., 2010). 
 
1.3 The cortical-striatal-thalamo-cortical (CSTC) loop and cognition 
The prefrontal cortex (PFC), the striatum and the thalamus form a neural circuitry loop that has 
been demonstrated to subserve cognitive processes in humans and animals (Floresco et al., 1999;  
Huang et al., 2018; Peters et al., 2016;  Puig et al., 2015; Rǎdulescu et al., 2017). Executive functions, such 
as WM and CF, have been assumed to be maintained by persistent neuronal activity in these regions 
(Furlan et al., 2017). The strength of persistent activity is suggested to represent the degree of 
information manipulation, which is likely reflected by the complexity of the task (Masse et al., 2019). 
Lesion and imaging studies have revealed that the PFC is critical to both the holding of information 
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(short-term memory) and manipulation of information, involved in WM and CF processes. WM 
assessments, particularly the short-term memory aspect, have revealed a critical role for the reciprocal 
connectivity between the thalamus and the PFC (Bolkan et al., 2017; Wolff & Vann, 2019). Damage or 
dysfunction in this circuitry impacts working and short-term memory and associated behavioural 
performance (Voets et al., 2015). Although some studies have also implicated the thalamus in flexible 
goal-directed behaviours (Huang et al., 2018; Peters et al., 2016; Wolff & Vann, 2019), a larger body of 
evidence suggests a key role of the striatum and cortico-striatal loops in controlling CF, rule learning, 
planning and selecting between competing potential responses or actions (Grospe et al., 2018; Kehagia 
et al., 2010; Provost et al., 2015; Vaghi et al., 2017; van Schouwenburg et al., 2012). However, overlapping 
connections and functions mean that dysregulation in any of these regions or the crosstalk between 
them is likely to result in aberrant cognitive processing with potential behaviour altering effects (Peters 
et al., 2016).  
 
1.4 The role of dopamine (DA) in cognitive function 
Dopamine (DA) has been identified as a key neuromodulator in regulating neuronal activity in the 
cortical-striatal-thalamo-cortical (CSTC) loop (Carli & Invernizzi, 2014; Dandash et al., 2017; Haber, 2014; 
Ikemoto et al., 2015; Shipp, 2017). Dopaminergic neurons project from the ventral tegmental area (VTA) 
into the dorsal and ventral striatum. Input from this region is then received in the globus pallidus which 
projects into the thalamus. From the thalamus, projections are received in the cortex, mainly the frontal 
regions, which have output back into the dorsal and ventral striatum. This formulates the direct pathway 
of dopaminergic communication in the CSTC loop (Fig. 1) (Floresco et al., 1999; Haber, 2016; Peters et 
al., 2016;Puig et al., 2015; Rǎdulescu et al., 2017). The striatum largely consists of projection neurons, 
with terminals located in the PFC and the thalamus which are reported to be within ~1 µm of 
dopaminergic synapses permitting the modulation of information entering the cortex or exerting a 
significantly sized, general effect on the striatum (Moss & Bolam, 2008). Subsequently, few 














Historically, the role of persistent neural activity was implemented in maintenance of 
information used in WM processes (Gazzaley et al., 2004; Goldman-Rakic, 1995; Nyberg & Eriksson, 
2016; Srimal & Curtis, 2008). However, this view has since evolved and recent studies using brain 
imaging and computational models have now revealed a role of persistent neural activity in the 
processes used to manipulate held information to forge appropriate behavioural responses (Masse et 
al., 2019; Sreenivasan et al., 2014).  Activation patterns of dopaminergic neurons can modulate neural 
Figure 1. Circuit diagram demonstrating connectivity between dopaminergic projections and the 
direct pathway of the cortico-striatal-thalamo-cortical (CSTC) loop which subserves executive 
functions such as working memory (WM) and cognitive flexibility (CF) and plays a critical role in 
altered cognitive function in neuropsychiatric disorders. Arrows represent direction of information 
flow, a single headed arrow represents unidirectional information transfer. Dopaminergic 
projections (light blue), prefrontal cortex (PFC), dorsal and ventral striatum (DS/VS), ventral 
tegmental area (VTA), globus pallidus (GP), thalamus (Thal).   




activity in the CSTC pathway. Varied firing patterns induced by dopaminergic neuron activation, 
consisting of transient or phasic DA release, caused by DA neuron firing, and sustained tonic DA release, 
regulated by PFC afferents, are implicated in learning and motivation. A range of dopaminergic firing 
patterns, from regular pacemaker firing to burst firing, have been related to particular behavioural states 
(Dreyer et al., 2010; Grace, 1991). Alterations in firing patterns  are used to relay an infinite number of 
‘messages’ based on temporal organisation of activity sequences locally and globally, which has 
demonstrated a robust influence on coordinated ensemble activity (Lohani et al., 2019). In addition to 
differences in sustained and burst firing patterns, neuronal populations (specifically medium spiny 
neurons) are subcategorised into excitatory and inhibitory depending on whether neurons are DA D1 
receptor (DRD1) or DA D2 receptor (DRD2) expressing (Johnson, 2017; Ott & Nieder, 2019; Rǎdulescu 
et al., 2017). Combined, through dopaminergic induced activity patterns, a plethora of messages can be 
encoded and used to select cue-specific behavioural responses. It is easy then, to imagine how 
dysregulation in DA availability, resulting in altered firing patterns, could impact the encoded messages 
sent through to influence behavioural output. In neuropsychiatric disorders, such as schizophrenia and 
substance abuse, aberrant DA signalling disrupts aspects of CSTC connections, altering informational 
updates to the detriment of cognitive processing, ultimately influencing long and short-term 
behavioural responses (Grace, 1991; Rǎdulescu et al., 2017; Samanez-Larkin et al., 2013; Schultz, 2001; 
Surmeier et al., 2007; Takahashi et al., 2012).  
 
1.5 Animal models of neuropsychiatric disorders 
As outlined above neuropsychiatric disorders are extremely complex and multifaceted conditions that 
can be constructed of broadly defined symptoms of cognitive and social impairments that can be 
correlated with animal behaviours (e.g., WM, CF, social interactions), and uniquely human symptoms, 
such as alterations in thoughts and feelings (e.g., hallucinations, delusions, sadness), that cannot 
convincingly be replicated in animal models (Nestler & Hyman, 2010). Despite decades of using animals 
for modelling mental illness, identifying biomarkers, developing novel treatments and general progress 
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in understanding the underlying pathophysiology has been disappointingly slow, with treatment 
options representing more a one size fits all than a targeted therapeutic approach (Anderzhanova et al., 
2017; Bale et al., 2019; Burrows et al., 2011; Gass & Wotjak, 2013; Koob, 2012; Stanford, 2017). 
Consequently, the discussion has been continuously raised as to the appropriateness, value and 
reliability of animal models for neuropsychiatric disorders. Although it is clear that not all aspects of the 
human condition can simultaneously or individually be replicated in animals, there is still an opinion 
that animal models can be useful tools for basic and translational neuroscience (Anderzhanova et al., 
2017; Bale et al., 2019; Gass & Wotjak, 2013). Additionally, as cognitive deficits are such a prevalent and 
core feature of psychiatric conditions, and represent a subset of symptoms that can be related to a vast 
repertoire of animal behaviours, their continued use in combination with advancing imaging, molecular, 
cellular and gene altering techniques may yet prove fruitful in the advancement of treatment strategies 
and improving the lives of those suffering with what can often be life-long conditions (Baker et al., 2020; 
Koob, 2012).  
To date the vast majority of animal research on neuropsychiatric disorders has been carried out 
in mammals (Baker et al., 2020; Gururajan et al., 2019; Kokras & Dalla, 2014;McCormick & Green, 2013; 
Sagvolden et al., 2005; Verbitsky et al., 2020). In possession of homologous brain regions, neural 
circuitry, chemicals and genes that relate to psychiatric illness in humans, and with many studies 
showing high face, construct and/or predictive validity to the human condition, rodents have been 
imperative in elucidating mechanisms of action, development of drug targets and preclinical testing of 
novel therapeutics (Anderzhanova et al., 2017; Bale et al., 2019; Gass & Wotjak, 2013). Additionally, it is 
through rodent studies that many chicken and egg questions can be answered, for example in 
understanding the pathological and cognitive changes associated with substance abuse disorders, 
animal studies have been able to identify if cognitive deficits are a product of those with a pre-existing 
susceptibility to developing addiction, or as a direct consequence of chronic exposure to addictive drugs 
(Stalnaker et al., 2009). These are important questions that may otherwise be practically or ethically 
challenging to answer using patients alone. Considering the long history of using rodents, it is then 
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perhaps surprising that there has been an uprising in the use of what, on the surface, appears to be a 
less evolutionarily close animal model: the zebrafish.  
The zebrafish has been demonstrated as a powerful model organism for investigating 
psychiatric disorders (Fontana et al., 2018; Kalueff et al., 2014; Mathur & Guo, 2010;Stewart et al., 2015). 
High genetic homology to humans and ease of genetic manipulation have resulted in a number of 
zebrafish lines characteristic of many human neuropsychiatric conditions, including schizophrenia 
(Eachus et al., 2017; Thyme et al., 2019; Woods et al., 2014; Zimmermann et al., 2016), substance abuse 
(Bossé & Peterson, 2017; Collier et al., 2014; Gerlai, 2013; Kily et al., 2008; Parker & Brennan, 2012; Parker 
et al., 2016) and ADHD (Lange et al., 2018; Parker & Brennan, 2016; Parker, Brock, et al., 2014), all of 
which demonstrate abnormalities in cognitive processing. The well conserved syntenic groups between 
the human and zebrafish genome (Barbazuk et al., 2000) has resulted in the conservation of 
evolutionarily ancient pathways such as the reward pathway (Klee et al., 2012), which has orthologues 
in the zebrafish brain. The neurotransmitters DA (Holzschuh et al., 2001; Kalueff & Cachet, 2011; Lambert 
et al., 2012), noradrenaline (Stewart et al., 2015), serotonin (Maximino et al., 2013), glutamate (Stewart 
et al., 2015) and GABA along with their associated receptors (Kalueff, 2017), dopamine receptors 
(Boehmler et al., 2007; Wendy Boehmler et al., 2004; Lambert et al., 2012; Naderi et al., 2016), opioid 
receptors (Sanchez-Simon & Rodriguez, 2008), nicotinic acetylcholine receptors (nAChRs) (Klee et al., 
2011; Parker, Brock, Walton, et al., 2013) and alcohol dehydrogenases (Tran, Nowicki, Chatterjee, & 
Gerlai, 2015) all have orthologs in zebrafish.  
Despite topographical differences between the zebrafish and mammalian brain, regional 
homologues have been identified. Equivalent areas to the PFC, striatum, thalamus and VTA in humans 
and rodents, have been located in zebrafish as the dorsal pallium, ventral and dorsal telencephalic nuclei 
(part of the subpallium), thalamic nuclei and posterior tuberal nucleus respectively (Fig. 2) (Lambert et 
al., 2012; Mueller et al., 2012; Parker, Brock, Walton, et al., 2013). In addition to possessing the 
neurotransmitter DA, similar ascending midbrain dopaminergic pathways have been identified with 
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projections from the posterior tuberal nucleus (VTA) into the subpallium (striatum) that are evident from 
96 hours post fertilisation (hpf) (Du et al., 2016). However, as yet there has not been a direct homologue 
for the CSTC circuitry, despite neurons in the telencephalon being identified as mainly dopaminergic. 
Highlighting a need to identify the networks between related regions to establish if their relationship is 
equivocal to that seen in mammals (Du et al., 2016;Parker, Brock, Walton, et al., 2013). These key 
characteristics, and similarities between teleosts and mammals, suggest that the response of zebrafish 
to pharmacological treatments and genetic mutations will be similar molecularly and mechanistically to 
humans. Thus, information gained from studying zebrafish models of neuropsychiatric disorders will 
likely have bearings on human conditions (Kalueff, 2017; Lieschke & Currie, 2007; Norton, 2013; Parker 




1.5 Assessments of Working Memory and Cognitive Flexibility 
There is a vast array of tests available for assessing cognitive functions in humans. As WM has been 
identified as a central cognitive function, there has been extensive development and validation of WM 
Figure 2. Parasagittal schematic overviews of the dopaminergic projection from the midbrain to the 
forebrain (light blue) and homologous regions of the cortico-striatal-thalamic network in adult (A) 
humans, (B) rodents (mouse) and (C) teleosts (zebrafish).  
Adapted from (Mueller et al., 2012; Perrone-Capano et al., 2008) 
12 
 
tests. The n-back test is frequently used as a measure of continuous WM performance. The basic premise 
is to match the current stimulus to a stimulus n number of steps back. Thus, participants are required 
not only to keep in mind what has gone before but must also be aware of what is currently being 
presented so that the sequence can progress. The n-back test represents a task of both verbal and 
spatial WM. Despite this being a widely used test for assessing WM in the clinic, its use of both verbal 
and spatial WM makes this a challenging test to replicate in animal models. Therefore, a substantial 
number of animal models test WM using spatial WM tasks. Consequently, a plethora of tests have been 
developed for rodents that are primarily based on mazes. Spatial WM tests can be used to assess WM 
function by the need to maintain spatial locations, e.g., of a reward, and manipulate this information to 
ascertain the reward, optimise the strategy to gain maximal reward or to minimise effort in obtaining 
reward. To test different scenarios a series of maze tasks have been adapted to alter task mechanisms 
and complexity. Behavioural paradigms for the assessment of spatial WM in rodents include the T and 
Y-mazes, radial arm maze, Barnes maze, Morris water maze, and others (Sharma et al., 2010; Stewart et 
al., 2011). All these maze tasks have been assessed using combinations of pharmacological, toxicological 
and genetic models and have identified critical roles for specific brain regions, such as the PFC and 
neurotransmitter systems (Carr et al., 2017; Myhrer, 2003; Paul et al., 2009; Ragozzino et al., 1998, 1999; 
Rich & Shapiro, 2009; Sharma et al., 2010; Stewart et al., 2011; Vorhees & Williams, 2014). Through their 
use, many insights into the neurobiological mechanisms of psychiatric disorders, including SZ and 
substance abuse have been elucidated. The variety of labour intensiveness, stimulus use (rewarded 
versus non-rewarded) and complexity provide a substantial range of assessments that can be readily 
carried out on models of disease. However, the translation of some of these tasks into an aquatic version 
for fish has not been straight forward. Discrete-trial tasks, like the T-maze require a substantial amount 
of animal handling, and although aquatic versions have been developed, there is the risk of stress-
induced confounds construing data. One of the most used tasks for assessing WM in rodents, the Morris 
water maze, cannot be replicated in fish as the water provides a mildly aversive environment that is used 
to motivate the rodent to find an escape platform. This has obvious difficulties in replication. Several 
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zebrafish specific tests of WM have been developed to closely match rodent equivalents, however. The 
plus maze and Y-maze have both been used for assessing WM in zebrafish (Aoki et al., 2015; Cognato 
et al., 2012; Gaikwad et al., 2011). In addition, there have been some non-maze-based tests developed 
such as the delayed spatial alternation and the one-trial memory test (Levin & Chen, 2004; Lucon-
Xiccato & Dadda, 2014). However, as noted above, these tests have seldom been used to assess WM in 
zebrafish models of neuropsychiatric disorders. 
The above discussions highlight the importance of WM to maintaining good mental health and 
deviations from properly functioning WM is a major factor underlying numerous neuropsychiatric 
disorders, as well as neurodevelopmental disorders, such as autism spectrum disorders (ASD), 
neurodegenerative disorders, such as Alzheimer’s disease (AD) and general cognitive dysfunction 
associated with old age. Considering its critical role, it is interesting, if not a little disappointing, that 
one of the most frequently used tasks for assessing WM in humans cannot be replicated in animal 
models. Thus, a divide has clearly emerged between the precise measure of WM assessed in animal 
models of disease and the associated human condition. Critics of the validity of animal models for 
assessing human psychiatric disorders have often quoted poor translational relevance and “species 
specific” tests as a hinderance to the success of developing novel drug targets for treating such 
disorders. The disparity between the measures of WM may provide a possible route for improvement 
of the face, construct and predictive validity of cognitive assessments from animals to humans. Some 
have already attempted to bridge the gap by creating analogous tasks that are used in both rodents 
and humans, often using a virtual version of the rodent task to replicate the same measure in both 
species. This is quite possibly the way forward to improve test validity. However, as yet, this does not 
seem to have to reached mainstream use. Perhaps further development is required until a suitable task 
has been developed that not only minimises the differences between rodents and humans, but also to 
other animal models, expanding, instead of limiting, the models that can be used as each model 
organism surely has an alternative point of view that can be vital in elucidating the mechanisms and 




1.6 Conclusion  
Studies show that there are model appropriate tasks for assessing WM and CF in humans, rodents and 
zebrafish. Extensive work has been conducted to validate these cognitive tasks in mammals and to 
identify brain regions, circuitry and chemistry involved in optimal responses and aberrations caused by 
disease or disorders. However, thus far this information is limited in zebrafish. Having demonstrated a 
clear ability to complete complex behavioural tasks that can be used to assess cognitive function, it is 
apparent that further validation, and perhaps a greater number of tasks, are required to fully appreciate 
the potential of zebrafish for examining cognitive abilities in health and disease.  Additionally, it is 
evident that there is a great need for translationally relevant measures of cognition. The sustained use 
of animal models of human conditions for the identification and development of novel therapeutic 
strategies targeting the cognitive deficits that preside over many neuropsychiatric disorders, is reliant 
on high construct and predictive validity. Without it, as we have witnessed over the last 50 years, 
progress is slow. Thus, there is need to improve and validate the behavioural tests of cognition that are 
currently being used, and potentially the development of new cross species assessments, the topic of 












General Materials and Methods 
This chapter describes the general protocols used over the course of this thesis and is subdivided into two 
sections. The first section pertains to animal husbandry, behavioural procedures and apparatus. The second 
section describes laboratory practices and protocols following optimisation. Specific details of the 
procedures used for each experiment are outlined in the relevant chapters.  
 
2.1 Experimental Animals 
2.1.1 Zebrafish husbandry 
Zebrafish adults were housed in ~50:50 male:female groups of 8-10 per 2.8L tank or up to 20 per 6L 
tank on a re-circulating system (Aquaneering Inc., San Diego, CA, USA) fed from the local water supply 
(referred to as ‘aquarium water’ throughout the remainder of this thesis). Room and tank water 
temperatures were maintained at 25-27°C, pH 8.4 (±0.4), on a 14:10-hour light/dark cycle (lights on 
8.15-8.45 am). Fish were fed on ZM fry food from 5 dpf until adulthood when they were moved onto a 
diet of flake food and live brine shrimp (ZM Systems, UK) 3 times/day (once/day on weekends).  
 
2.1.2 Breeding and embryo collection 
Two methods of embryo collection were used, marbling and pair-breeding. Preparation for breeding 
was set up the evening before embryos were required. Spawning, release of eggs from females and 
sperm from males, is initiated with first light (when the room lights come on). Breeding is carried out in 
areas that allow the embryos to filter though (either marbles or a slotted base), to protect them from 
being eaten by adults.  
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Marbling: In 6L home tanks, marbling boxes (rectangular boxes filled with marbles) were placed on the 
bottom of the tank the evening before embryo collection. Eggs were laid over the marbles.  
 
Pair-breeding: The evening before breeding, two females and two males for each pair-breeding set were 
isolated (by sex) in a separate tank. 15 min before lights on fish were transferred to a breeding tank (a 
shallow, stand-alone tank with a slotted base), filled with 0.5-1.0L of aquarium water. Males and females 
were separated by a clear divider. Upon lights on, the divider was removed to allow the fish to mix. Fish 
were left in the tank for 30-45 min. Once eggs were laid, adult fish were returned to home tanks.  
 
Laid embryos were washed and placed in petri dishes in maximum groups of 50 embryos per dish in 
aquarium water. Dead embryos were removed regularly, and partial water exchanges were done daily 
to prevent water contamination from dead embryos, build-up of chorions (casing surrounding embryos) 
after hatching and to avoid bacterial infections. Fertilised embryos were maintained in a transparent 
incubator at 28°C on the same light dark cycle as adult fish. Fish were kept in petri dishes until 5 dpf, at 
which point they were transferred to larger dishes with maximal group sizes of ~30 embryos per dish. 
Fish were transferred to the recirculating system at 14 dpf.    
 
2.1.3 Zebrafish strains 
Wild-type, ageing and pharmacological studies were conducted using AB zebrafish (Danio rerio). Live, 
in vivo imaging studies were performed using Tg(elavl3:GCaMP6s) on a mixed casper/nacre/AB 
background which produce pigmentless larvae. The mutant line was provided by Dr Matthew Winter 
(College of Life and Environmental Sciences, University of Exeter). Slit3 mutant line was generated in-




2.1.4 Sample collection for genotyping 
Carriers of the Tg(elavl3:GCaMP6s) mutation have bright, fluorescent green brains, which were detected 
using fluorescence detection goggles at 3 dpf. Slit3 mutant adults were identified by fin clipping. From 
3 months of age, fish were anaesthetised using Aqua-Sed (100% 2-phenoxyethanol) anaesthetic 
treatment (Aqua-SedTM, Vetark, Winchester, UK) in accordance with manufacturer guidelines, in 500 mL 
of aquarium water. Once fish were fully anaesthetised, checked with a tail pinch, they were removed 
from the tank and fin clipping was performed using a scalpel and removing tail fin, without damaging 
the body of the tail. Clippings were either snap-frozen in liquid nitrogen or stored in RNA later solution 
(Thermofisher, UK) and stored at -20°C until ready for downstream applications. Following fin clipping, 
fish were placed in a recovery tank, filled with aquarium water until they had fully recovered from the 
anaesthetic and then returned to home tanks, split into four sections by dividing tanks with clear acrylic 
dividers, with small holes, to allow fish to remain separate whilst waiting for genotyping results, whilst 
maintaining visual and olfactory contact. Genotyping was carried out in house. For full details on 
genotyping protocol see Laboratory.  
 
2.1.5 Tissue collection 
All fish were culled by submersion in ice cold water followed by severing the spinal cord as a secondary 
confirmation of death. Required tissue was removed and placed into Eppendorf tubes. Samples were 
either snap frozen in liquid nitrogen, or placed in RNA later solution (Thermofisher, UK) and stored at -
20°C until further use.  
 
2.1.6 Rodent husbandry  
 Mice were bred in house and reared with littermates (mixed sexes). Mice were housed in Allentown IVC 
racks and kept at 21°C (±2°C), 55% humidity (±10%) on a 12:12-hour light/dark cycle. Mice were fed on 
a diet of irradiated SDS RM3 pellets, with food and water available ad libitum.  
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2.1.7 Rodent strains 
Wild-type strains were C57BL/6 mice (Mus musculus). The APP/PS1 (B6C3-Tg(APPswe,PSEN1sE9) mutant 
line express a chimeric mouse/human amyloid precursor protein (Mo/HuAPP695swe) and a mutant 
human presenilin 1 (PS1-dE9) gene which result in accelerated production of human Aβ peptide. 
Breeding pairs were obtained from the Jackson Laboratory (USA) and provided by Professor Jerome 
Swinny (School of Pharmacy and Biomedical Science, University of Portsmouth). The colony was 
established by crossing transgenic mice with C57BL/6J mice. Genotyping was carried out by the 
University of Portsmouth Animal Facility.  
 
2.2 Behavioural testing  
All behavioural testing was conducted between 9:00 am and 18:00 pm. All behavioural tests, for larvae 
and adult zebrafish and rodents were performed using the Zantiks behavioural units (Zantiks Ltd, 













2.3 Laboratory Procedures 
2.3.1 gDNA extraction from zebrafish tissues 
This method was used to obtain gDNA from fin clippings for genotyping slit3 mutant lines. Tissue was 
extracted following GeneJET Genomic DNA Purification Kit protocol from ThermoFisher Scientific.  
▪ Tail clippings were homogenized in 180 µL of Digestion Solution using a homogeniser. 
▪ 20 µL of Proteinase K Solution was added to the sample and mixed thoroughly by vortexing. 
▪ Samples were incubated at 56°C for ~1-2 hours, or until tissue was completely lysed and no 
particles were remaining. During incubation samples were regularly vortexed.  
▪ 20 µL of RNase A Solution was added to samples and mixed thoroughly by vortexing for 15 s.  
▪ 400 µL of 50% ethanol was added and mixed by vortexing or pipetting. 
▪ Samples were transferred to GeneJET Genomic DNA Purification Column inserted in a collection 
tube. Centrifuge for 1 min at 6000 x g. Discard the collection tube containing the flow-through 
solution. Place the column into a new 2 mL collection tube.  
▪ Add 500 mL of Wash Buffer I (with ethanol added) to the column. Centrifuge for 1 min at 8000 
x g. Discard the flow-through and place the column back in the collection tube.  
▪ Add 500 mL of Wash Buffer II (with ethanol added) to the column. Centrifuge for 3 min at 
maximum speed (~21000 x g). Discard the collection tube containing the flow-through solution 
and transfer the column to a sterile 1.5 mL Eppendorf tube. 
▪ Add 50 µL of Elution Buffer to the centre of the column membrane to elute genomic DNA. 
Incubate for 2 min at room temperature and centrifuge for 2 min at 8000 x g. Discard the 
column, keep flow-through for downstream applications.  
▪ gDNA concentration was determined using nanodrop ND 100 spectrophotometer.  





2.3.2 RNA extraction from zebrafish tissues 
This method was used to obtain total RNA from zebrafish tissue for generating cDNA stocks. Total RNA 
was extracted following the RNeasy Mini Kit protocol from Qiagen.  
▪ Up to 20 mg of tissue was homogenised in 350 µL of RTL lysis buffer using a homogeniser (for 
at least 30 s per sample, timings were consistent across samples). 
▪ Samples were centrifuged at maximum speed (~ 21000 x g) for 3 min to pellet debris.  
▪ Supernatant was transferred to sterile 1.5 mL Eppendorf tubes. 350 µL of 70% ethanol was 
added and mixed thoroughly by pipetting.  
▪ 700 µL of sample was added to the RNeasy mini column in a 2 mL collection tube and 
centrifuged for 45 s at 9500 x g.  
▪ The flow-through was discarded and the column placed back in the tube.  
▪ 700 µL of RW1 buffer was added to the column and centrifuged for 45 s at 9500 x g, the flow-
through was discarded. 
▪ 500 µL of RPE buffer was added to the column and centrifuged for 1 min at 9500 x g, the flow-
through was discarded and the column was placed into a new 2 mL collection tube.  
▪ 500 µL of RPE buffer was added to the column and centrifuged for 2 min at 9500 x g, the flow-
through was discarded and the column was placed back into the same collection tube.  
▪ The column was centrifuged empty to dry the column, for 2 min at maximum speed (~21000 x 
g). The column was placed into a sterile 1.5 mL Eppendorf tube.  
▪ 30-50 µL (typically 40 µL) of RNase free water was added directly to the column membrane and 
left for 1 min at room temperature.  
▪ The column was centrifuged for 2 min at 9500 x g. The column was discarded and the flow-
though was kept.  
▪ Total RNA concentration was determined using nanodrop ND 1000 spectrophotometer.  




2.3.3 Removal of gDNA from RNA samples 
This method was used for the removal of gDNA from RNA samples which can contaminate downstream 
samples and artificially inflate gene expression levels, particularly when using primers that do not span 
an exon-exon junction. Contaminating gDNA was removed from purified total RNA (from the step 
above) by RapidOut DNA Removal Kit protocol from Thermo Scientific.  
▪ Up to 8.5 µL (5 pg – 2 µg) of RNA sample was loaded into a 0.2 mL PCR tube.  
▪ 1 µL of 10X DNase buffer with MgCl2 and 0.5 µL of DNase I enzyme was added to RNA sample 
and mixed by vortexing. 
▪ Nuclease-free water was added to a total volume of 10 µL (this reaction could be scaled up 
accordingly). 
▪ Sample was incubated at 37°C for 30 min. 
▪ DNase Removal Reagent (DRR) was vortexed prior to use to completely resuspend mixture.  
▪ 2 µL of DRR was added to sample (this could be scaled up accordingly, however, minimum 
volume of DRR should be equal to or greater than 10% of reaction volume). 
▪ Sample was incubated at room temperature for ~2 min, vortexing 2-3 times to maintaining a 
homogenous solution.  
▪ Centrifuge sample at ~800 x g for 1 min to pellet the DRR. Remove supernatant (do not transfer 
any DRR reagent as this can interfere with downstream applications) and transfer to a new PCR 
tube. 
▪ To determine final RNA concentration following gDNA removal use nanodrop ND 1000 
spectrophotometer.  






2.3.4 cDNA synthesis from total RNA 
This method was used to convert the mRNA from total RNA into cDNA to be used in qPCR reactions to 
quantify mRNA expression. Reverse transcription was done using the High Capacity RNA-to-cDNA Kit 
protocol from Applied Biosystems. 
▪ To ensure the same amount of cDNA was synthesised for each sample a maximum of 1 µg of 
total RNA was used per reaction (loaded RNA concentration was determined based on the 
sample with the lowest concentration per experiment. The same total concentration of RNA was 
loaded into each reaction with variable volumes of water added to make up the total reaction 
volume). 
▪ 10 µL of RT Buffer Mix and 1 µL of RT Enzyme Mix were aliquoted per reaction.  
▪ Up to 9 µL of RNA, plus nuclease-free water was added to the reaction to a total volume of 20 
µL per reaction.  
▪ A thermocycler was used for the reaction, using the following conditions: 
37°C for 60 min 
95°C for 5 min 
4°C for ∞ 
▪ Samples that were not immediately used were stored at -20°C for short-term storage or -80°C 










2.3.5 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
All reagents and templates were stored at -20°C or -80°C. Primer stocks were made up to 100 µM 
concentration in nuclease-free water. Working aliquots were 10 µM of forward and reverse primers. Two 
SYBR green master mixes were used throughout depending on the protocol being run. For samples 
requiring high resolution melt curve analysis the Roche LightCycler 480 High Resolution Melting Master 
was used. For other applications, the Thermo Scientific PowerTrack SYBR Green PCR Master Mix was 
used. The basic reaction volumes and cycling conditions are provided for both master mixes, however, 
some conditions vary depending on samples and primers. The protocol below is the result of extensive 
optimisation, however, some samples/genes required slightly altered conditions and therefore detailed 
protocols are provided in the respective chapters.  
Roche LightCycler 480 High Resolution Melting Master 
▪ 10 µL of Master Mix (SYBR Green) 
▪ 1 µL of primer pairs (10 µM stock) 
▪ 2.4 µL of MgCl2 (25 mM stock) 
▪ 5 µL DNA template (5 ng/ µL stock-cDNA/gDNA) 
▪ 1.6 µL ddhH2O 
An initial reaction volume of 20 µL was made up. 10 µL was aliquoted per well to provide replicate 
samples. 
Running conditions: 
95°C for 600 s   -   x1 
95°C for 20 s 
58°C for 25 s      x40 




For HRM analysis, high resolution melt curve analysis was completed after the qPCR as follows: 
95°C for 60 s - Ramp rate 4.4°C/s  
40°C for 60 s - Ramp rate 2.2°C/s 
65°C for 1 s  - Ramp rate 2.2°C/s   
97°C for 1 s  - Ramp rate-0.04°C/s, continuous acquisition, 25 readings/°C 
Thermo Scientific PowerTrack SYBR Green PCR Master Mix 
▪ 10 µL of Master Mix (SYBR Green) 
▪ 1 µL of primer pairs (10 µM stock) 
▪ 0.5 µL of loading dye 
▪ 2-4 µL DNA template (5 ng/ µL stock-cDNA) 
▪ 6.5 µL ddhH2O 
An initial reaction volume of 20 µL was made up. 10 µL was aliquoted per well to provide replicate 
samples. 
Running conditions: 
95°C for 120 s   -   x1 
95°C for 15 s 
60°C for 25 s  
 
2.3.6 PCR 
This method was used for amplifying amplicons of >300 bp. The main application of PCR was to amplify 
samples for genotyping and sending for Sanger sequencing.  
▪ 12 µL of VWR Red Taq Master Mix 




▪ 0.5 µL of MgCl2 (25 mM stock) 
▪ 2 µL DNA template (10 ng/ µL stock-gDNA) 
▪ 9.5 µL ddhH2O 
Total volume loaded per reaction was 25 µL. 
Running conditions: 
95°C for 2 min   -   x1 
95°C for 20 s 
60°C for 20 s      x30 
72°C for 30 s 
72°C for 5 min  -   x1 
4°C for ∞ 
 
2.3.7 Gel electrophoresis 
RNA/DNA samples were typically run on a 1.5% (w/v) agarose gel, which was prepared by mixing 0.75g 
of agarose with 50 mL of 1X TBE buffer in a conical flask. The mixture was heated in the microwave until 
it was a completely homogenous solution. 5 µL of SYBR safe (Thermo Scientific) was added and gently 
swirled to mix. The liquid agarose was then poured into a casting tray containing a comb for loading 
wells and left to set. Once solidified, the ends of the cast were removed and the gel was placed into the 
gel doc. 1X TBE buffer was added until the entire gel was emersed, then the comb was removed. For 
loading a 50 bp ladder (1 µL (GeneRuler, Thermo Scientific) + 1 µL of 6X TriTrack DNA Loading Dye + 4 
µL nuclease-free water) and sample (5 µL of DNA (~0.5 µg DNA, equal concentration to ladder) + 1 µL 
of 6X TriTrack DNA Loading Dye) were prepared and a total of 6 µL was loaded onto the gel. The gel 
was run at 100 V and visualised using a gel imager. 
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2.3.8 Amplicon purification 
This method was used to purify post-PCR reactions for further downstream processing via enzymatic 
purification in accordance with ExoSAP-IT PCR Product Cleanup protocol from Applied Biosystems. This 
method was used to purify post-PCR reactions for further downstream processing via enzymatic 
purification in accordance with ExoSAP-IT PCR Product Cleanup protocol from Applied Biosystems.  
• 5 µL of the post-PCR reaction product was combined with 2 µL of ExoSAP-IT reagent (reaction 
volumes could be scaled up as required). 
• Incubate at 37°C for 15 min to degrade remaining primers and nucleotides.  
• Inactivate the enzyme by heating the reaction to 80°C for 15 min.  
 
2.3.9 T7 Endonuclease I assay (T7E1) 
This method was used to detect heterozygous mutations following CRISPR/Cas9 injections using T7 
Endonuclease I Kit protocol from New England Biolabs.  
▪ 200 ng DNA from post-PCR reaction product (amplicon ≥500 bp). 
▪ 2 µL of 10X NEBuffer 2 was added to reaction. 
▪ Nuclease-free water was added to a final volume of 19 µL. 
Hybridization was conducted using a thermocycler using the following conditions: 
▪ 95°C for 5 min  
▪ 95-85°C - Ramp rate -2°C/s 
▪ 85-25°C - Ramp rate -0.1°C/s   
▪ 4°C for ∞ 
▪ Once the reaction is completed at 1 µL of T7 Endonuclease I and incubate at 37°C for 15 min. 
▪ Stop the reaction by adding 1.5 µL of 0.25 M EDTA.  
▪ Samples are run on an agarose gel for identifying heterozygous mutations.  
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2.3.10 CRISPR/Cas9 genome editing 
This method was used for CRISPR gene editing of specific loci in the genome of zebrafish. Here it was 
used to create a point mutation in the slit3 gene.  
▪ 20 nucleotide target sequence was designed using ChopChop web tool for selecting target sites 
for CRISPR/Cas9 knock-out that result in frameshift mutations in the gene of interest, with no-
low predicted off-target binding sites.  
▪ Target sequences were designed using traditional Cas9 PAM sequence (NGG). 
▪ Several target sequences were selected based on off-target sites, mismatches and predicted 
efficiency.  
▪ Target sequences were validated using NCBI Blast, UCSC genome browser and Ensembl 
genome browser.   
▪ T7 promoter (NGG) sequence was added at the 5’ of the target sequence and an overlapping 
crRNA-TracrRNA sequence at the 3’ end of target sequence: 
      T7 promoter Target region             gRNA  
           Overlapping crRNA-TracrRNA  
 
 
Oligo assembly and preparation of sgRNA 
To complete oligo assembly of the sgRNA a T7 promoter (GG) sequence was added to the 5’ end of 
the slit-3 specific sequence and at the 3’ end an overlapping crRNA-TracrRNA sequence. 
Slit-3 targeting oligo: 
TAATACGACTCACTATA GGAGGACTCACATGGTGGAA GTTTTAGAGCTAGAAATAGC 
      PCR mix: 25 µL (GoTaq) PCR master mix 
1 µL Forward primer (slit-3 gRNA stock) 
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1 µL Reverse primer (crRNA-TracrRNA, universal T7 tail) 
1 µL MgCl2 
22 µL ddH2O 
Total volume = 50 µL 
  
• PCR run: Denature at 98℃ for 2 minutes 
Anneal at 50℃ for 10 minutes 
Extend at 72℃ for 10 minutes 
• NanoDrop 1000 for sample concentration. 
• Stored at -20℃ until use 
 
2.3.11 Embryo injections 
• Using newly synthesised (guide) gRNA, combine with phenol red, water and Cas9 RNA using 
the following concentrations: 300 pg of Cas9 RNA, 50 pg of sgRNA  
• Vortex injection mix 
• Set incubator to 24℃ to slow cell division 
• Backfill pulled needle using Hamilton syringe and mineral oil 
• Drop sizes are set to 1.4 nL 
• Injections are nuclear (or as close the nucleus as possible) 
• Upon injection completion embryos are returned to petri dishes filled with aquarium water, 
dead embryos are removed 








A commonly reoccurring theme in the discussion of understanding and treating neuropsychiatric and 
neurodegenerative disorders is the stall in the development of novel therapeutic strategies, as has been 
discussed above. A critical issue is that effective treatments in animal models are seldom effective in 
patients or have unexpected side effects. One regularly quoted problem is the lack of translationally 
relevant behavioural tasks for assessing analogous domains in animals and humans. The following chapter 
addresses this translational gap by discussing the development of a simplistic cognitive test aimed at 
assessing WM and cognitive flexibility. This task has been validated with zebrafish and evaluated for cross-
species efficacy, not only to humans, but to other animal models as well. The aim of this work is to develop 














The Free-Movement Pattern Y-Maze: A Cross-Species Measure 
of Working Memory and Executive Function 
This chapter has been published (submitted formatting has been retained):  
 
Cleal, M., Fontana, B.D., Ranson, D.C. et al. The Free-movement pattern Y-maze: A cross-species measure 




Numerous neurodegenerative and psychiatric disorders are associated with deficits in executive 
functions, such as WM and CF. Progress in developing effective treatments for disorders may benefit 
from targeting these cognitive impairments, the success of which is predicated on the development of 
animal models with validated behavioural assays. Zebrafish offer a promising model for studying 
complex brain disorders, but tasks assessing executive function are lacking. The Free movement pattern 
(FMP) Y-maze combines aspects of the common Y-maze assay, which exploits the inherent motivation 
of an organism to explore an unknown environment, with analysis based on a series of sequential two-
choice discriminations. We validated the task as a measure of WM and executive function by comparing 
task performance parameters in adult zebrafish treated with a range of glutamatergic, cholinergic and 
dopaminergic drugs known to impair WM and CF. We then demonstrated the cross-species validity of 
the task by assessing performance parameters in adapted versions of the task for mice and Drosophila, 
and finally a virtual version in humans, and identify remarkable commonalities between vertebrate 
species whilst navigating the maze. Together, our results demonstrate that the FMP Y-maze is a sensitive 
assay for assessing WM and CF across species from invertebrates to humans, providing a simple and 




Neurodegenerative and neuropsychiatric disorders are widespread causing premature morbidity and 
increasing social and personal burden (Feigin et al., 2019; Jongsma et al., 2019). These disorders are 
characterised by diverse cognitive impairments, which can vary significantly within diagnoses, but often 
have overlapping deficits between disorders (Cope et al., 2016). Impairments in WM and CF are 
commonly reported in many neurological and neuropsychiatric disorders, such as AD (Guarino et al., 
2019a), Parkinson’s disease (Handra et al., 2019; Koerts et al., 2011), SZ (Giraldo-Chica et al., 2018; 
Orellana & Slachevsky, 2013), depression (Darcet et al., 2016; Hammar & Årdal, 2009; Snyder, 2013), 
substance abuse (Cunha et al., 2010; Gould, 2010), and ASD (Craig et al., 2016; Demetriou et al., 2019). 
Impairments in WM and CF are well-defined behavioural endophenotypes (Harro, 2019; Parker & 
Brennan, 2012; Wong & Josselyn, 2016) and combined with animal models have become an integral 
part of translational research (Fontana et al., 2018). However, animal models and behavioural assays 
have become increasingly diverse, limiting the behavioural fidelity across model species and in clinical 
findings in human subjects (Day et al., 2008; Young et al., 2009). Therefore, to improve validity of cross-
species paradigms there is a need to design assays of executive function that target the same 
behavioural dimensions or neurobiological measures in a range of species, including humans, to 
increase validity and translational relevance (Homberg, 2013; Markou et al., 2009).  
There is a diverse array of experiments used for assessing animal cognition, with mazes among 
the most popular (Paul et al., 2009). Existing in numerous behavioural paradigms, the maze can be 
designed to vary in complexity and target phenotype depending on the task parameters (Sharma et al., 
2010). The Y-maze is one of the simplest methods and has been used extensively in learning and 
memory paradigms for both rodent (Arendash et al., 2001; Conrad et al., 1997; King & Arendash, 2002; 
Lainiola et al., 2014;  Ma et al., 2007) and zebrafish (Aoki et al., 2015; Cognato et al., 2012) models. There 
are two commonly used methods, the two-choice task in which there is a ‘starting’ arm, a ‘blocked’ arm 
and the ‘other’ arm. In the first trial, the animal is free to explore, and upon entry into the unblocked 
arm, is returned to the starting arm. On the second trial, the previously blocked arm is opened. 
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Measurements are recorded for time spent exploring the novel arm (Lalonde, 2002). The alternative 
method is the continuous Y-maze, in which animals are permitted free exploration throughout the trial, 
typically lasting 5-8 minutes. The sequence of arm entries is recorded and WM capability is determined 
by the percentage of spontaneous alternation (entry into three different arms in succession) (Hughes, 
2004). The Y-maze is proving a useful tool for providing test conditions that do not require rule learning, 
extensive handling or repeated manipulation (Heredia-López et al., 2016). Other maze tasks, such as the 
T-maze and radial arm maze require extensive training, high levels of animal handling and, in reward-
based trials, food or water deprivation for prolonged periods (Anderson et al., 2000; Bizon et al., 2007; 
Deacon, Nicholas, et al., 2006; Kotagale et al., 2020; Schmitt et al., 2003; Sharma et al., 2010). Each of 
these factors can result in potential confounders, leading to high levels of between-subject variability 
(Sharma et al., 2010)  
Although valuable, the Y-maze task has several limitations. Some studies have reported 
difficulties interpreting results, particularly if models tested had hypo or hyperlocomotion, stereotypic 
behaviours or anxiety-related novelty avoidance, as a consequence of the test condition or treatment, 
which could significantly interfere with the measurement of spontaneous alternation. (Herbert & 
Hughes, 2009; Hughes, 2004; King & Arendash, 2002; Kumar et al., 2015; Miedel et al., 2017; Stewart et 
al., 2011). A primary issue, as raised by (Stewart et al., 2011) is that a perfect score in the continuous Y-
maze, as is currently measured, is a reflection of highly stereotyped behaviour. Therefore interpretation 
of results can be confusing when test models present with repetitive or perseverative behaviours (Cash-
Padgett et al., 2016; Miedel et al., 2017).  
To address the limitations of current maze methods, we have designed the Free movement 
pattern (FMP) Y-maze, a physical maze for animal models and a virtual maze for humans that is 
analogous to animal versions. The FMP Y-maze is a continuous protocol, run using automated tracking 
software, with built in data logging of arm entries, aimed at minimising experimenter handling, 
interference and bias of data interpretation. Our method of data analysis has been developed to allow 
detail of complex patterns of exploration, using sequences of left and right turns apportioned into 16 
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overlapping tetragrams (four choices) of left/right combinations ranging from LLLL to RRRR, 
subsequently shifting the focus away from novelty response to navigational search patterns. Stereotypic 
responses have been classified as particular search strategies, the presence of which do not overlap with 
other patterns of normal exploration. Other confounds such as altered locomotor responses are 
accounted for in the analysis. Use of each sequence pattern is calculated as a proportion of total turns 
(percentage) and analysed using total turns as a covariate in a general linear mixed model, thus 
preventing potential inflation of results due to hyper-activity of treatment groups compared to control 
groups. Prevention of anxiety responses has been diminished by the extension of the run time to 1 h of 
free exploration. Not only does this permit a habituation period, it removes the need for any pre-trial 
training and additionally, the extended trial time also allows this method to assess WM and CF in a 
single paradigm without having to interfere with any of the task parameters during the trial.  
To validate the FMP Y-maze as a measure of WM and CF we systemically blocked glutamatergic, 
cholinergic and dopaminergic pathways, all known for roles in executive function (Blake & Boccia, 2018; 
Cools & D’Esposito, 2011; Ellis & Nathan, 2001; Ragozzino, 2002; Ragozzino et al., 2002) and 
dysregulation of these systems has been linked to neurodegenerative and neuropsychiatric disorders 
(Ballinger et al., 2016; Brisch et al., 2014; Herman & Roberto, 2015; Hindle, 2010; Murueta-Goyena et al., 
2017). Additionally, we used time series analysis and autocorrelation to model effects on WM. Zebrafish 
treated with antagonists compared to control groups, demonstrated decreased WM capacity and 
changes in search patterns, which were influenced by altered behavioural flexibility. We further validated 
this task with a range of organisms, including Drosophila, mice and humans. Mazes were adapted to 
suit each organism, but behavioural measures were consistent in all versions. Findings suggested that 
vertebrate species, zebrafish, rodents and humans, explored in similar patterns, however, invertebrates 
adopted an alternative search strategy. Combined, our findings validate the FMP Y-maze as a test of 
executive function in a range of model organisms, including humans, to create a multifunctional task 




3.3 Experiment 1 
Experiment 1 was designed to determine the exploration strategy of zebrafish in the FMP Y-maze (Fig. 
1). Without prior training or habituation, fish freely explored the novel arena for 1 hour (h) with 
continuous recording of arm entries and exits for the duration of the trial. The absence of reinforcement 
meant that fish did not require periods of pre-trial food deprivation, therefore fish were directly taken 
from home tank to test tank, back to home tank, minimising handling and stress in accordance with the 
3Rs (Sneddon et al., 2017). Our primary aim was to identify if the FMP Y-maze could be used as a test 
of memory. Data from the task was output as a discrete time series (Boyce et al., 2010; Mwaffo et al., 
2015), from which we mathematically modelled the randomness of serial observations (Robinson, 2003). 
Using the two-choice guessing task system, introduced by Frith and Done (1983), tetragram analysis 
was used to identify discernible patterns that departed from a random process (Frith & Done, 1983; 
Gross et al., 2011).  Sequential left and right turns were grouped into overlapping sequences of four 
turns (tetragrams), giving a total of 16 possible tetragram sequences. The sum of each of 16 overlapping 
tetragrams of left and/or right turns (e.g. left, left, left, left [L,L,L,L] or right, right, left, left [R,R,L,L]) were 






Materials and Methods 
Animals and housing  
A total of N=18 zebrafish (Danio rerio) of AB wild-type strain (4 months-old at time of testing) male and 
female (~50:50) were bred in house and raised in the University of Portsmouth Fish Facility. Extensive 
pilot and published work from our lab has revealed no differences in search strategy between male and 
female zebrafish (Fontana, Cleal, & Parker, 2019). Fish were housed in groups of 8-10 per 2.8L tank on 
a re-circulating system (Aquaneering Inc., San Diego, CA, USA). Sample sizes were calculated based on 
power analyses (α = 0.05; β = 0.8) from effect sizes observed in pilot studies, and previous published 
work from our group (Cleal & Parker, 2018). Room and tank temperatures were maintained at 25-27°C 
on a 14:10-hour light/dark cycle, water was aquarium treatment (dechlorinated) and pH was 8.4 (±0.4). 
Fish were fed on ZM fry food from 5 days post fertilisation (dpf) until adulthood when they were moved 
onto a diet of flake food and live brine shrimp (ZM Systems, UK) 3 times/day (once/day on weekends).  
 
Figure 1. FMP Y-maze diagram depicting maze dimensions and zones used for automated logging 
of arm entries and exits. 
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On completion of behavioural testing fish were culled using Aqua-Sed anaesthetic treatment (Aqua-
SedTM, Vetark, Winchester, UK) in accordance with manufacturer guidelines.  
 
Apparatus  
Behavioural testing was carried out in the Zantiks AD system for adult zebrafish (Zantiks Ltd., Cambridge, 
UK).  Zebrafish were tested in white acrylic Y-maze inserts of two identical mazes (provided with the AD 
Zantiks base package) fitted into a black water-tight tank with a transparent base 
(https://www.zantiks.com/products/zantiks-ad) (Fig 2.). Maze dimensions were as follows: L50, W20, 
H140 (mm). Tanks were filled with 3 L of aquarium water. Each system was fully controlled via a web 
enabled device (laptop, phone or tablet). Filming was carried out from above, which allowed live 
monitoring within the behaviour system (Supplemental video 1). The FMP Y-maze had three equally 
sized arms which had no intra-maze cues. However, extra-maze (distal) cues were visible from within 
the maze (e.g., walls and open side of the Zantiks equipment which allowed a small amount of light in). 
These egocentric cues allow fish to orientate within the maze, but previous studies have demonstrated 
that these cues do not influence exploratory behaviour (data not shown) (Cleal & Parker, 2018; Fontana, 
Cleal, & Parker, 2019; Fontana, Cleal, Clay, et al., 2019). For consistency between tests, light levels were 
maintained at a consistent level, at a maximum of 2 lux during exploration.  
 
Procedure  
The protocol was based on that described in our previous papers (Cleal & Parker, 2018; Fontana, Cleal, 
& Parker, 2019; Fontana, Cleal, Clay, et al., 2019). Animal handling and experimenter visibility were both 
kept to a minimum. Fish were netted directly from home tanks into FMP Y-mazes, inserted into test 
tanks, prefilled with 3L of aquarium water.  Test tanks were placed inside the Zantiks behaviour unit. 
Water was allowed to settle before starting the protocol to ensure accurate tracking of fish. This step is 
important as the initial detection of the animal is crucial to ensure that tracking is accurate throughout 
the trial. Once the system has successfully detected the animal a white cross will appear over the animal 
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which will continuously track its movements and log zone entries and exits. Two fish were tested in each 
behavioural apparatus. Data were initially output as a time series of arm entries and exits, normalised 
(proportions of total turns) and analysed according to 16 overlapping tetragrams (RLLR, LLRR, RRRL, 
etc.) (Table 1) of which particular note was taken with regard to search strategies termed alternations 
(RLRL, LRLR) and repetitions (LLLL, RRRR), having previously seen that these are most notably affected 
by different treatments. If the fish were adopting a random search strategy, it would be predicted that 
the distribution of tetragrams over a 1 h period would be approximately stochastic (i.e., the relative 
frequency of each tetragram ~6.25%), and the data would generate autocorrelation plots equivalent to 






Figure 2. Aquatic FMP Y-maze for zebrafish. (A) Zantiks AD behavioural unit for automated animal 
tracking. (B) Top-down view of two FMP Y-mazes for zebrafish inserted into a black water-tight tank, 
L50:W20:H140mm, filled with 3 L of aquarium water. A mesh lid was used to cover the top of the 
tank to prevent fish from jumping out during the trial, without interfering with the tracking 




All experiments conducted for this study were carried out following approval from the University of 
Portsmouth Animal Welfare and Ethical Review Board, and under license from the UK Home Office 
(Animals (Scientific Procedures) Act, 1986) [PPL: P9D87106F] 
 
Table 1.  
Tetragram analysis was based on a series of 16 unique, overlapping sequences of left and/or right turns. 
Below is a list of each tetragram used for analysis, with reference to key strategies and the associated term. 
Sequence Term Step length Sequence Term Step length 
LLLL Repetition -8 RLRL Alternation 1 
LLLR  -7 RLLR  2 
LLRL  -6 RRLL  3 
LRLL  -5 LRRR  4 
RLLL  -4 RLRR  5 
LLRR  -3 RRLR  6 
LRRL  -2 RRRL  7 
LRLR Alternation -1 RRRR Repetition 8 
 
Data preparation and analysis 
Tetragram Analysis. In a test paradigm consisting of two equally likely choice variants; left (L) or right 
(R) turn, we assume choice selection to be completely random. However, we know from human 
behaviour in guessing tasks (Paulus et al., 1999; Stroe-Kunold et al., 2009), or animals in choice behaviour 
tasks, such as rodents in a T-maze, there is a preference to alternate L and R turns. Even in paradigms 
of equal arm reinforcement choices are never completely random (Deacon, Nick, et al., 2006; Robert 
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Gerlai, 1998). In a Markov process, a process of completely random events, the probability of choosing 
L or R depends only on the most recent choice (Grecian et al., 2018). For example, the probability of 
turning L would be: 
P(L) = ⅟₂, 
regardless of whether the previous turn had been L or R. Despite the overall process being random, it 
is possible to detect patterns in large data series by dividing sequences into groups of like-terms and 
using information theory to detect any departures from randomness (Meehl & Guze, 1993). Let pi be 
the probability of event i in a time series, such as the probability of turning L or R. Using general 
information theory, the first order ‘uncertainty’ of turning L after previously turning R can be measured 
using:  
L = ∑ pilog2 pi, 
where base 2 for the logarithm stipulates that from two equally likely events (L or R), one choice (one 
unit of information) is transmitted to resolve the uncertainty of the occurrence of either choice. Relative 
uncertainty, Lmax, is the ratio of observed L turns to maximum L turns, for the given number of 
alternatives, the complement of this is: 
1-L/Lmax 
Different levels of complexity can be used to determine the probability of turning L based on two 
previous turns, LR (digram), three previous turns, LRL (trigram), four previous turns, LRLR (tetragram), 
etc. The larger the number of alternative choices the greater the computational power required. Previous 
work has demonstrated that in human guessing tasks, examination of past events exceeding four or five 
choices becomes irrelevant when calculating the probability of a current event (Hochberg & Attneave, 
1961; Meehl & Guze, 1993). Therefore, in line with previous two-choice guessing task protocols, we have 
selected to concentrate on the use of tetragram sequences, limiting the number of alternatives to 24 = 
40 
 
16 possible tetragram sequences. The information measure for a sequence of four turn choices for 
turning L is: 
L4 = L(tetragram) – L(trigram) 
Tetragram analysis was used to identify patterns over long and short periods of exploration. Tetragram 
sequences were examined for ‘immediate’ search strategies, those performed during 10 minutes of 
exploration and ‘global’ search strategies that were a consensus of the overall strategy used for the 
entire hour of exploration. Division of analysis into immediate and global strategies allowed data to be 
collected on the general exploration strategy and how this strategy was affected by time. This permits 
examination of multiple characteristics of executive function.   
 
Time series analysis. Time series, χn= χ1, χ2…………. χk were defined as step length, ω(k), at discrete 
time-point, k, where k was representative of equal length time points comprised of tetragram 
sequences. Therefore, each point in the time series was equal to one tetragram, described as one step. 
Each experiment was made up of n time points. The autocorrelation lag coefficients of steps were 
calculated for each individual, using step length, ω(k). ACF was computed in PYTHON using MATLAB 
(Pal & Prakash, 2017). The lag-1 autocorrelation for the corresponding time lag k is: 






where ?̅? is the mean step length for that individuals time series, ω(k). As the model demonstrated non-
stationary and non-random properties, the usual calculation of confidence interval, ?̅? ± 2𝜎 ∕ √𝑛 , where 
σ is the standard deviation, was not used. Instead, the 95% confidence interval was based on a moving 
average calculated using the Bartlett test: 
𝑇 =
(𝑛 − 𝑘) 𝑙𝑛 𝜎𝑝
2 −∑ (𝑛𝑖 − 1) 𝑙𝑛 𝜎𝑖
2𝑘
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2 is the variance of the ith group, n is the total number of steps, ni is the step length of the ith 
group, k is the number of groups and 𝜎𝑝
2 is the weighted mean of the group variances, defined as: 
𝜎𝑝
2 =∑ (𝑛𝑖 − 1)𝜎𝑖
2𝑘
𝑖=1
∕ (𝑛 − 𝑘)  
Tetragram sequences were used to define step length and fix time intervals of the discrete time series. 
Each sequence was arbitrarily assigned a value ranging from 1 to 8. Left-dominant sequences were 
arbitrarily denoted as negative, whilst right-dominant sequences were positive (Table 1), from this point 
on referred to as ‘steps’. Each step was assumed equal time, therefore each observation in the time 
series was one tetragram sequence or the equivalent of one step. The analysis for zebrafish were based 
on 1000 arm entries, sequentially divided into overlapping sequences of four arm entries, resulting in a 
total of 250 steps, n=250 time points. The limit was chosen arbitrarily for consistency only as total turns 
varied between individuals. Animals with more than ten steps of missing data were excluded from 
subsequent time series analysis. Animals with fewer than ten missing steps had zeros replacing missing 
values to make up the total number of steps required. The cumulative sum of steps was used to 
determine the relationship between successive observations and identify if steps were taken randomly 
and completely independent of one another. This was tested by computing the lag plot and 
autocorrelation function (ACF) using a custom designed script in MATLAB. 
 
Statistical Analysis 
All turn choices recorded in the FMP Y-maze were converted into tetragrams using customised Excel 
spreadsheets. Each tetragram sequence was reported as a percentage of total turns completed in the 
allotted trial time. Based on previous research, alternation (LRLR, RLRL) and repetition (RRRR, LLLL) 
sequences were analysed independently as dependent variables, as these were the most frequently 
observed amongst all species. Data were fitted to a linear mixed effect model (LMM), with “time” as a 
within-subjects factor, “total turns” as a covariate, to control for general activity levels in statistical 
models and “ID” as a random factor. Significant effects were followed by Tukey’s post hoc multiple 
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comparison test in which each organism was compared to all other organisms. Alpha values of p ≤ 0.05 
were considered statistically significant. Data were presented as means ± S.E.M.s. 
 
Results and Discussion 
Analysis of tetragram sequences used as a global strategy (over the course of the entire trial) revealed 
that adult zebrafish demonstrated use of a strategy that was significantly dependent on tetragram 
sequences containing alternating left and right turns (LRLR, RLRL), referred to as alternations (one-way 
ANOVA: F(15, 272) = 17.31, p<0.0001; n=21). Although similar to the alternating pattern from the T-maze, 
in the FMP Y-maze alternations were not used exclusively (which might be consistent with stereotypic 
behaviour), but instead were distributed regularly throughout the trial (Fig. 3). Alternations were used 
as a search strategy ~26% of the time, regularly dispersed with other combinations of the remaining 14 
tetragrams. The regular occurrence of a specific type of tetragram, the alternation, indicates a complex 
level of behaviour in which the preceding trigram sequences LRL or RLR, are predictors that the following 
turn choice will be a R or L turn respectively, demonstrating strong intra-sequence dependencies. Thus, 
despite the overall probability of turning L or R being equally likely, the use of tetragram analysis has 















Figure 3. Frequency distribution of global tetragram strategy over the course of 1 h of exploration in 
the FMP Y-maze (N=18). The dashed line represents random selection, at 6.25%. Dominant strategy 
preferentially uses alternation patterns (LRLR, RLRL) (Top). Percentage use of each tetragram 
sequence per 10 min of exploration, demonstrating a clear dominant use of alterations throughout 
the trial, fluctuating over time (Bottom). Bars represent mean, error bars are mean ± SEM. 
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Although tetragram analysis can be used to identify preferential turn choices and dependency 
of a choice based on the three preceding turns, it cannot be used to determine the persistence of that 
dependency. Put simply: for a turn choice at position i, to what extent are subsequent future turns 
influenced? Using the lag-1 autocorrelation function (ACF) it is possible to determine the relationship 
between successive tetragram sequences and identify if dependency lasts beyond the tetragram set ( 
Bailey & Thompson, 2006). ACFs that rapidly decay, fluctuating around zero, are indicative of a 
completely random, or memoryless process (Stadnytska & Werner, 2006), i.e. a Markovian process 
(Reynolds, 2010). However, as we have demonstrated strong intra-sequence dependency of specific 
tetragrams, we know that turn choice is not random. However, there is no indication of whether a 
tetragram can influence future tetragram sequences.  
Our evidence strongly suggests that movement patterns were the result of a global strategy, 
relying on memory of past turn choices. We therefore hypothesised that subsequent steps (each step 
representing a tetragram) would demonstrate significant autocorrelation, which would be suggestive of 
a time series with memory of previous events, which exert influence on choice-behaviour for a large 
number of steps. We found that time series plots for individual zebrafish showed either left or right bias, 
but the ACF of the cumulative sum of steps showed prolonged autocorrelation, which decayed slowly 
to zero (Fig. 4). These ‘long-range correlations’ between turn choices reflect a long-lasting effect of 
previous behaviour on subsequent choice-behaviour. In sum, our data suggest that the generation of 
the behavioural sequences of turns by wild type adult zebrafish in the FMP Y-maze are characterised by 











3.4 Experiment 2 
In Experiment 1, we characterised search strategies in the FMP Y-maze and demonstrated that zebrafish 
rely on WM to formulate search strategies. To further substantiate the use of memory to navigate the 
FMP Y-maze we pharmacologically targeted neurotransmitter systems involved in memory processing. 
The glutamatergic, cholinergic and dopaminergic systems are well documented for their roles in 
executive functions, particularly WM (Ellis & Nathan, 2001; Handra et al., 2019; Myhrer, 2003). Both 
human and animal studies have demonstrated that pharmacologically blocking these pathways can lead 
to impairments in WM tasks (Myhrer, 2003). We hypothesis that blocking N-Methyl-D-aspartic acid 
(NMDA), muscarinic and D1 receptors would lead to a reduction in alternations due to impaired WM. 
However, as D2 receptors are strongly associated with reward and motivation learning and memory 
processing (El-Ghundi et al., 2007; Kwak et al., 2014), we expect pharmacologically blocking D2 receptors 
Figure 4. Time series analysis of movement patterns of an individual zebrafish, zf11 (n = 1), 
showing time series plot of the cumulative sum of step length for n = 250 time points (A). Lag plot 
of data at lag-0 (ω(k)) and lag-1 (ω(k + 1)) demonstrating a positive linear correlation (B). 
Autocorrelation function plot showing the first 20 lags of 250 lag plot (C). The plot shows slow 
decay towards zero, with 18 lag points outside of the 95% CI, depicted by the blue cone. 
Autocorrelation between data points is indicative of dependency between successive turn 
choices, demonstrating memory of previous choice events 
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will not affect search strategy as exploration is conducted in the absence of reward. To this end, we pre-
treated zebrafish with a high, mid and low concentration of four antagonists, inhibiting key receptors in 
the memory process: MK 801, a non-competitive NMDA receptor (NMDA-r) antagonist known to impair 
WM by inhibiting long-term potentiation (LTP) (Adler et al., 1998; Lisman et al., 1998; Nam et al., 2004; 
Nicoll, 2017; Shapiro & Caramanos, 1990); scopolamine, a non-specific muscarinic receptor (M-r) 
antagonist, similarly to MK-801, reduces LTP in the hippocampus and impairs WM (Ellis et al., 2005; 
Granon et al., 1995; Hirotsu et al., 1989), SCH-23390, a D1 receptor antagonist and sulpiride, a dopamine 
D2 receptor antagonist  (El-Ghundi et al., 2007; Sylvie Granon et al., 2000; Klanker et al., 2013).    
 
Materials and Methods 
Animals  
Animals were housed under the same conditions as Experiment 1. A total of N=166 animals were used. 
Fish were assigned at random to each treatment group from 10 groups of n=15-20 fish per 6 L tank.  
 
Apparatus 




 To examine the effects of MK801 (Sigma-Aldrich), scopolamine (Sigma-Aldrich), SCH-23390 (Tocris) 
and sulpiride (Sigma-Aldrich) on performance in the FMP Y-maze, fish were randomly allocated (from 
>10 groups of age-matched stocks in our fish facility) to a drug treatment group with ~13 fish assigned 
per group (n=18 control per drug group; MK801: n=13 0.1 mg/L, n=13 0.75 mg/L, n=13 2.0 mg/L; 
Scopolamine: n=13. 0.25 mg/L, n=13 0.5 mg/L, n=13 1.0 mg/L; SCH-23390: n=12 0.5 mg/L, n=12 1.0 
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mg/L, n=12 1.5 mg/L; Sulpiride: n=12 5 mg/L, n=11 10 mg/L, n=11 20 mg/L). Concentrations used were 
based on previously published works as well as range-finding pilot experiments in our laboratory (Blank 
et al., 2009; Cognato et al., 2012;Ng et al., 2012; Scerbina et al., 2012; Sison & Gerlai, 2011b).  
 
Behavioural procedures.  
Fish were netted from home tanks and placed in 400 mL beakers containing 300 mL of either drug or 
aquarium water for 1 h. During pre-treatment, fish were visually isolated. This avoided impact of 
conspecifics or experimenters on treatment response. Following treatment fish were immediately placed 
into the FMP Y-maze. Behavioural procedures were conducted in accordance with Experiment 1.  
 
Statistical Analysis 
Tetragram analysis and time series analysis were carried out using the same methods outlined in 
Experiment 1. In addition, tetragram sequences were fitted to linear mixed effects models, with 
individual ID as the random effect. Initially, we examined differences in alternations and repetitions. For 
subsequent analyses, we were interested in putative changes in immediate and global strategies, 
therefore “time” was included as the within-subjects factor. To control for variations in general activity 
levels “total turns” were included as a covariate in all analyses. The primary endpoint for analysis was 
the number of choices for each of the 16 tetragrams as a proportion of total turns. Two-way ANOVA 
was applied separately to the behavioural data obtained from each drug treated group to examine 
effect of drug concentration on use of alternations and repetitions. ANOVA was followed by Sidak’s 
post-hoc tests (Graphpad 8.4.2). A p-value <0.05 was used as a criterion for significant difference. The 







Results and Discussion 
MK-801 caused a significant decrease in the use of alternations compared to control fish (LMM, F(3, 318) 
= 34.221, p < 0.0001, 0.1 mg/L n=13, 0.75 mg/L n=13 and 2.0 mg/L n=13, control n= 18) (Fig. 5A). 
Chance selection of each tetragram sequence would be ∼6.25%. All concentrations of MK801 reduced 
alternations to <6%, effectively blocking alternations as a strategy. In mid and high concentrations of 
MK 801 (0.75 and 2.0 mg/L) the search strategy was inverted, Sidak’s post-hoc test revealed repetitions 
were used significantly more than alternations (main effect of drug treatment on strategy, F(3, 110) = 12.01, 
p<0.001; Sidak’s post-hoc test, 0.1 mg/L alts v reps, p=0.9994, 0.75 mg/L alts v reps, p=0.0028, 2.0 mg/L 
alts v reps, p=0.0182) (Fig. 6A). Scopolamine similarly decreased alternations, but to a lesser extent than 
MK-801 (LMM, F(3, 316) = 8.025, p < 0.0001, 0.25mg/L, n=13; p<0.001, 0.5, n=13 and 1.0 mg/L, n=13) (Fig. 
5B). Post-hoc analysis revealed that alternations were only used significantly more than repetitions in 
fish treated with 0.5 mg/L (main effect of drug treatment on strategy, F(3, 110) = 5.01, p=0.0027; Sidak’s 
post-hoc test, 0.25 mg/L alts v reps, p=0.0728, 0.5 mg/L alts v reps, p=0.0408, 1.0 mg/L alts v reps, 
p=0.5443) (Fig. 6A). Treatment with SCH-23390, caused two major changes in search strategy. At all 
concentrations, there was a decrease in the use of alternations, similarly to that caused by MK-801. 
Additionally, the highest concentration caused an increase in the use of repetitions (LLLL, RRRR) (LMM 
test, F(3, 311) = 19.692, p< 0.0001, 0.5 mg/L, n=12; 1.0 mg/L, n=12; 1.5 mg/L, n=12. LMM test, F(3, 312) = 
8.954, p<0.001, 1.5 mg/L, n=12) (Fig. 5C). There was no significant difference between the use of 
alternations and repetitions at 0.5 and 1.0 mg/L, however treatment with 1.5 mg/L resulted in repetitions 
being used more than alternations (main effect of drug treatment on strategy, F(3, 110) = 6.591, p=0.0004; 
Sidak’s post-hoc test, 0.5 mg/L alts v reps, p=0.9060, 1.0 mg/L alts v reps, p=0.0993, 1.5 mg/L alts v reps, 
p=0.0002) (Fig. 6A). No such effect was evident in fish treated with D2 antagonist, sulpiride, which 







Figure 5. Effects of three concentrations of (A) MK-801 (n = 18 control, n = 13 0.1 mg/L, n = 13 0.75 
mg/L, n = 13 2.0 mg/L), (B) scopolamine (n = 18 control, n = 13 0.25 mg/L, n = 13 0.5 mg/L, n = 13 
1.0 mg/L), (C) SCH-23390 (n = 18 control, n = 12 0.5 mg/L, n = 12 1.0 mg/L, n = 12 1.5 mg/L) and (D) 
sulpiride (n = 18 control, n = 11 5 mg/L, n = 11 10 mg/L, n = 11 20 mg/L) on locomotor activity, in 
the form of total turns (left), percentage use of repetitions used in the global strategy (middle) and 
the percentage of alternations used as part of the global strategy (right). Bars show mean relative 






Figure 6. Comparison of total alternations compared to total repetitions for the control fish (0), low, 
mid and high concentration of antagonist (A). Change in total alternations (left) and repetitions 
(right) during 1 h of exploration divided into 6 equal time bins  of 10 min per bin. Graphs 
representative of control group versus the highest concentration for each antagonist treated group. 
Points are mean, error bars are mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, 




The control group showed a clear effect of time on exploration pattern, specifically effecting alternations 
over successive 10 min search periods (GLMM test, F(5, 186) = 5.140, p=0.0002). However, there appeared 
to be a slight decrease in alternations during the last 20 minutes of exploration. There is no obvious 
reason for this decrease, and further investigation will be required to examine this change in strategy. 
MK 801 completely blocked changes in alternation-based search strategy, locking animals in an 
‘immediate’ search strategy phase without progression to a global strategy, demonstrating a reduction 
in behavioural plasticity (GLMM test, F(5, 264.82) = 1.499, p=0.191). However, this effect was subject to 
concentration [F(3, 54.33) = 9.70, p<0.001], concentration by time [F(15, 264.81) = 2.063, p=0.012] and group 
interaction [F(1, 54.31) = 92.628, p<0.001]. Additionally, MK 801 revealed a significant effect on repetitions 
over time [F(5, 264.53) = 4.36, p=0.001]. Scopolamine reduced alternations in a manner resembling MK 801 
treatment. However, inhibiting muscarinic receptors did not have the same effect on impeding 
behavioural flexibility. Fish treated with scopolamine maintained a significant effect of time on 
alternations throughout the trial (GLMM test, F(5, 263.79) = 4.626, p<0.001), additionally there was an effect 
of concentration [F(3, 55.41) = 2.730, p=0.05], a concentration by time interaction [F(15, 263.62)=1.897, 
p=0.024] and group interaction [F(1, 55.53) = 141.43, p<0.001], but, unlike MK 801, there was no effect of 
time on repetitions [F(5, 263.62) = 1.936, p=0.089]. Dopamine antagonist SCH-23390 maintained an overall 
effect of time on strategy [F(5, 259.03) = 3.785, p=0.003], however, this effect was disrupted at the highest 
concentration. Similarly to MK 801, 1.5 mg/L of SCH-23390 blocked the effect of time on alternations 
[F(5, 60) = 0.514, p=0.765]. SCH-23390 also showed an effect of concentration [F(3, 51.98) = 5.485, p=0.002], 
concentration by time [F(15, 259.03) = 1.791, p=0.036] and interaction [F(1, 51.98) = 105.217, p<0.001]. Finally, 
the D2 receptor antagonist sulpiride resulted in exploration behaviour resembling that of the control 
group, with a significant effect of time on alternations [F(5, 250) = 5.831, p<0.001] and group interaction 
[F(1, 50) = 136.211, p<0.001], but showed no effect of concentration [F(3, 50) = 0.594, p=0.622] or 
concentration by time effect [F(15, 250) = 0.686, p=0.798] (Fig. 6B). ACF plots of each concentration of 
drug resulted in a decrease in the number of significantly correlated lags compared to control fish (One-
way ANOVA; F(11, 127) = 13.94, p<0.0001) (Fig. 8). Thus, memory impaired zebrafish resulted in shorter-
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range correlations, limiting the number of steps influenced by choice behaviours showing a reduction 




Figure 7. Change in frequency distribution of each of the 16 tetragram sequences as a factor of time, 
each bar representing a 10 min time bin (A). Heat map of changes in global use of all tetragram 








Figure 8. Autocorrelation function plot showing the first 20 lags of 250 lag plot. Each plot shows 
decays towards zero, with lag points outside of the 95% CI, depicted by the blue cone. ACF plots 
are of individual animal responses in the FMP Y-maze and are therefore representative of the 
control group, and drug treatment groups exposure to the highest dose of antagonist for each 
group for MK-801, scopolamine, SCH-23390 and sulpiride, respectively (A). Comparison of the 
mean significant lags of drug treated groups at low, mid and high concentrations compared to 
control group. equal time bins of 10 min per bin (B). Graphs representative of control group versus 






3.5 Experiment 3 
In Experiments 1 and 2, we demonstrated the suitability of the FMP Y-maze for assessing fish. In 
Experiment 3 we tested the system with other widely used laboratory species (mice and Drosophila). 
Applying an identical protocol to that used with zebrafish, we characterised the exploration strategies 
of rodents and flies in the FMP Y-maze. 
 
Materials and Methods 
Animals  
Mice. A total of N=16 C57BL/6 mice (Mus musculus) wild types (6-8 weeks old at the time of testing), 
male and female (50:50) were bred in house and raised in the University of Portsmouth Animal facility. 
Mice were housed in Allentown IVC racks and kept at 21°C (±2°C), 55% humidity (±10%) on a 12:12-
hour light/dark cycle. Mice were fed on a diet of irradiated SDS RM3 pellets, with food and water 
available ad libitum. Following use, mice were retained as breeders in the University facility. 
 
Drosophila. A total of N=30 Canton S wild-type (#64349) Drosophila melanogaster (6-7 days old at the 
time of testing), male and female (50:50), were obtained from Bloomington Drosophila Stock Centre, 
Indiana, USA. Flies were kept at 25°C with an average humidity of 60-80% on a 12:12-hour light/dark 
cycle. Flies were housed on ready mixed dried food (Phillip Harris, UK). Flies were collected via light CO2 
anaesthesia and were allowed 48 hours recovery before behavioural testing was conducted. Following 
completion of the task Drosophila were culled using absolute ethanol.  
 
Apparatus 
Mice were tested in a stand-alone white acrylic Y-maze insert with transparent base (provided with the 
LT Zantiks base package) (https://zantiks.com/products/zantiks-lt). Drosophila were tested in a clear 
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acrylic Y-maze insert of 6 identical mazes. Each maze had a sliding cover with a hole which could be 
moved over the maze as an entry point for introducing the fly (extra for the MWP Zantiks unit) fitted 
into white opaque holding base for consistent maze alignment (https://zantiks.com/products/zantiks-
mwp). Mazes had equal arm length and angle. Maze dimensions were as follows; L152, W50, H155 
(mm)-mice, L5, W3, H4 (mm)-Drosophila. Mazes were place into their respective Zantiks behaviour units, 
one maze for mice and 6 mazes for Drosophila (Fig. 9). Systems used worked on the same basis as the 







Mice were transported from home cage to maze using clear, plastic tubes that were kept in their home 
cages, preventing direct handling prior to the task. Drosophila were guided into a pipette tip and tapped 
gently into the maze through a hole in the lid which could be moved over the maze for entry and once 
Figure 9. Zantiks behaviour systems, from left to right, MWP system, LT system and AD system, used 
for Drosophila, mice and zebrafish, respectively. Units are completely automated with a computer 
built into the base, allowing for image/light projection into test arenas, and a camera positioned 
above, allowing live imaging of animals in the testing unit. This set up reduces experimenter 
disturbance during testing (A). Mouse Y-maze insert. One mouse per maze (B). Drosophila Y-maze 
insert, 6 identical mazes with sliding covers (C).  
 
A. B. C. 
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in the maze, moved away to prevent escape. All animals were recorded for 1 h. As with Experiment 1 
and 2, data were output as a time series normalised as a proportion of total turns and analysed using 
tetragram sequences. The same statistical analysis was applied from Experiment 1 and 2. 
 
Statistical analysis 
Two-way mixed design ANOCVA with one between subjects’ factor with three-levels (species-zebrafish, 
mice and flies), and one within-subjects factor with 16 levels (tetragrams), total turns as the covariate, 
and proportion of choices as the dependent variable, was used to compare global strategies. To examine 
alternations in more detail, one-way ANOVA determined the difference between tetragram frequencies 
and as a cross-species comparison of total alternation (LRLR+RLRL) use. 
 
Results and Discussion 
Mice navigated the FMP Y-maze using an almost identical strategy to zebrafish, showing dominant use 
of alternations throughout the task (Fig. 10B). There was no significant difference between tetragram 
frequency distributions for the global strategy (Two-way ANOVA, F(1, 496)=1.7-6, p=0.999) between 
mice and fish, however there was a significant difference in alternations, with mice using alternations 
~38% compared to ~26% for zebrafish [F(15, 496)=45.34, p<0.001]. Drosophila, however, differed from 
mice and zebrafish (Fig. 10A), characterized by flies employing an exploration strategy reliant on 
repetitions as opposed to alternations, which accounted for ~38% of their total search strategy (One-
way ANOVA, F(7, 472)=55.12, p<0.001) (Fig. 10C). This alternative navigational pattern could be 
influenced by Drosophila’s natural tendency to explore using wall-following behaviour (Soibam et al., 
2012). Like mice and zebrafish, Drosophila displayed the dominant ‘repetition’ strategy at evenly 
distributed times throughout the task, regularly interspersed with different sequences of the other 14 




Figure 10.  
 
Figure 10. Comparison of zebrafish, mouse and fly global tetragram usage over a 1 h search (A). 
Frequency distribution of global tetragram strategy over the course of 1 h of exploration in the FMP 
Y-maze for mice (n = 15) (B) and Drosophila (n = 30) (C). Dashed line represents random selection 
at 6.25%. Dominant strategy uses alternation patterns (LRLR, RLRL) for mice and zebrafish and 







Despite the strategic differences used to explore the maze, all organisms tested showed use of a single 
dominant strategy. Regardless of the search pattern, all species showed similar results in the ACF plots, 
with persistent, slowly decaying autocorrelation, indicative of long-lasting effect of choice on future 
choice selections (Fig. 11). These data collectively suggest that like zebrafish, mice and Drosophila did 
not search the test arena randomly, but in a systematic and deterministic way, demonstrating use of an 
underlying process of memory to recall previous turn choices, and guide subsequent turn patterns. This 
task provides further evidence of the suitability of the FMP Y-maze as a memory test for a range of 




Figure 11. Time series analysis of individual mouse (A) and Drosophila (B) showing time series plot 
of step length (n = 250 steps) (left). Lag plot showing positive correlation for both organisms 
(middle), ACF plot of the first 20 lags, with both organisms demonstrating over 15 lags of 





3.6 Experiment 4 
Experiment 1-3 demonstrated the cross-species validity of the FMP Y-maze in laboratory animals; mice, 
zebrafish and Drosophila. In order to test the translational utility of this model, we developed a virtual 
FMP Y-maze for humans. The maze was based on a honeycomb-layout, requiring participants to 
navigate a series of 'Y’ shaped choice points. In order to make the test clinically relevant and useful for 
a variety of human testing conditions, we ran the task for 5 minutes, at which point participants were 
automatically exited from the maze. Previous studies have investigated the relationship between 
participant response rate and response burden (the perceived effort required by participants to 
complete an online study, commonly in reference to questionnaires). Increased length of questionnaires 
has been associated with lower response rates and reduced completion (Presser et al., 2004; Rolstad et 
al., 2011). In order to increase the translational potential of the virtual FMP Y-maze and suitability to a 
clinical setting, our aim was to significantly minimise the required participation time to reduce boredom, 
encourage participants to continually traverse the maze for the allotted time and increase the response 
rate of participants requested to take part in future studies.  
 
Materials and Methods 
Participants  
Participants (n=12 male and n=12 female; age range 21-65) were recruited from staff and students at 
the University of Portsmouth. Following consent, after reading the information form, participants took 
part in a short task in which they had to ‘find the way out’ of an online maze. The human experiments 







Apparatus and Procedure 
Human Virtual FMP Y-maze. A honeycomb maze, representing multiple Y-shaped choice points 
formed the human virtual FMP Y-maze (Fig. 12). Participants could initiate the start of the trial when 
ready and, using the arrow keys on a standard laptop keyboard, navigate their way around the maze 
(Supplementary_Video.4). Participants were free to explore the maze for 5 minutes, after which they 
were automatically logged out. Turn directions were logged as x,y coordinates which were converted 





Statistical Analysis  
To examine tetragrams, we carried out a one-way within-subjects ANOVA with ‘tetragram’ as the 
independent variable and proportion as the DV. To example alternations in more detail, two-way 
ANOVA determined the difference between tetragram frequencies and as a cross-species comparison 
of total alternation (LRLR+RLRL) use (between-subjects factor – species; within subjects factor – time).    
 
Figure 12. Schematic of maze structure showing interconnected Y-shaped mazes, each of equal 
length and diameter (left). Screen shot taken from the perspective of the participant in the human 
FMP Y-maze (right).  
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Results and Discussion 
Tetragram analysis revealed that humans used an almost identical strategy to mice and zebrafish, 
predominately comprising of alternations, which occupied ~50% of the search strategy (One-way 
ANOVA; F(3, 164) = 60.88; p<0.0001) (Fig. 13A). Humans traversing the virtual FMP Y-maze demonstrated 
significantly greater use of alternations compared to mice, zebrafish and flies (Fig. 13C).  Despite, 
limiting the run time to 5 minutes, this prolific strategy was still detectable. On average, participants 
completed 39 steps (39 tetragrams) with a maximum of 68 and a minimum of 7 steps. The number of 
steps completed was substantially lower than any of the other animal models and was therefore based 
on 100 arm entries compared to 1000 arm entries for zebrafish, mice and Drosophila. Humans showed 
weak correlation in the lag plot and significant autocorrelation lasting only one or two lags, before 
rapidly decaying to fluctuate around zero (Fig. 13B). This indicates that the human FMP Y-maze 
exploration was characterised by choice selections that were only influenced by the immediate past. 
Based on the brevity of the trial and the limited number of turns this would be expected as the data set 
was not large enough to determine longer-term patterns. Additionally, there was a significant effect of 
time on alternations for all the vertebrate species tested (One-way ANOVA: Humans; F(5, 6) = 19.48; 
p=0.0012, mice; F(5, 174) = 7.635; p=0.0002, zebrafish; F(5, 186) = 2.369 p=0.0002), but no effect of time on 
the invertebrate species (Drosophila; F(5, 342) = 1.460; p=0.2994) (Fig. 13D). Our results have 
demonstrated the suitability of the FMP Y-maze as a test of memory, not just for animals, but also for 












Figure 13. Tetragram frequency distribution of human participants from a 5 min trial (n = 24) (A). 
Time series analysis of an individual participant showing time series plot, lag plot showing weak 
positive correlation and ACF plot of the first 20 lags, showing significant autocorrelation at lags 1 
and 2, which exponentially decay to zero (B). Relative means of alternation use in the FMP Y-maze 
of all organisms, showing an increase in percentage use of alternation with complexity of 
organism, with Drosophila have the lowest alternation use, increasing to humans with the highest 
(C). Alternation use for each time bin (trial time divided into 6 equal time segments) for humans, 
mice, zebrafish and flies. Points/bars are mean, error bars are mean ± SEM. *p < 0.05, **p < 0.01, 








3.7 General Discussion 
We demonstrate that the FMP Y-maze, when combined with tetragram analysis, is an effective tool for 
assessing executive function, particularly WM and CF. The ability to detect cognitive impairment in the 
absence of training, habituation, reward bias or aversive conditions, creates a reliable test that can be 
run singly or as part of a battery of behavioural tasks assessing cognition and memory. The non-invasive 
nature and low-impact on animals, provides a task with a strong ‘3Rs’ justification, with particular 
emphasis on refinement (Tannenbaum & Bennett, 2015). The conserved response strategies across 
vertebrates demonstrate exceptional high translational relevance of the task, offering clinical potential. 
The FMP Y-maze has implemented use of an extended protocol, which allows 1 h of free 
exploration, significantly longer than the 5-8 minutes used for the continuous Y-maze task. The 
increased runtime provides several advantages: firstly, as neither the T- or Y-maze tasks previously 
included habituation time at the beginning of the trial, it was possible that poor locomotor responses 
or reduced arm entries were a confound of anxiety in response to a novel environment. The duration of 
the FMP Y-maze trial permits enough time that persistent behavioural changes can be detected without 
interference from initial freezing bouts or hypo/hyperactivity. Secondly, exploration patterns more 
complex than the previously denoted ‘alternation’ strategy, in the continuous Y-maze, can be identified, 
without ceiling effects. A perfect score in spontaneous alternation tasks is represented by 100% 
alternations, therefore, it is only possible to detect improvements with this protocol if there is an initial 
deficit. In comparison, the detection of complex patterns in the FMP Y-maze allows examination of 
impairments and improvements with, so far, no detection of ceiling effects. Finally, the role of 
behavioural plasticity, can be included as a vital part of the analysis to examine how behaviour evolves 
over time in response to the environment.  
We investigated the role of WM in flies, fish, mice and humans, in formulating search patterns 
used to explore the FMP Y-maze. Tetragram analysis revealed two dominant strategies; a vertebrate 
strategy used by zebrafish, mice and humans, that largely consisted of alternations (LRLR, RLRL) and an 
invertebrate strategy used by Drosophila, that was reliant on repetitions (LLLL, RRRR). Search behaviour 
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was the result of complex moves that were highly dependent on past turn choices. Time series analysis 
and autocorrelation revealed that information of previous turn choices was held for long periods, 
demonstrated by significant autocorrelation for many steps, and used to influence future movement 
patterns. The length of time this information was held, was significantly impacted by pharmacological 
blockade of glutamatergic, cholinergic and dopaminergic, specifically D1, neurotransmitter systems, 
which showed a decrease in the number of steps with significant autocorrelation. Previous studies in 
rodents and humans have identified critical roles for each of these systems in maintaining WM (Ellis & 
Nathan, 2001; Handra et al., 2019; Myhrer, 2003). Zebrafish have homologues of each of these 
neurotransmitter systems (Horzmann & Freeman, 2016) and results from the present study support 
findings from human and rodent studies, of impaired WM as a result of pharmacologically blocking 
glutamatergic, cholinergic and dopaminergic receptors (Ellis & Nathan, 2001; Myhrer, 2003; Shapiro & 
Caramanos, 1990; Sokolenko et al., 2020; van der Staay et al., 2011). Thus, highlighting the suitability of 
zebrafish as a behavioural model for assessing WM.   
Many conditions that commonly report deficits in WM, such as neurodegenerative or 
psychiatric disorders, often also present with impaired CF (Pittenger, 2013). This represents a change in 
cognitive state to allow an organism to adapt their behaviour in response to perceived environmental 
contingencies (Brown & Tait, 2014). In the wild, animals have been found to alter search patterns in 
response to resources, using one strategy for food-rich areas, and another for unpredictable 
environments with patchy prey distributions (Humphries et al., 2010; Sims et al., 2008). The FMP Y-maze 
represents an unpredictable environment. Therefore, we would expect animals to alter strategy overtime 
as has been demonstrated by Namboodiri, et al (2016), in birds and humans. Cognitively complex 
organisms have the ability to learn from their environment and subsequently demonstrate modified 
search strategies when faced with time costs that can reduce the value of a reward or goal (Namboodiri 
et al., 2016). Here, we show that healthy fish, mice and humans all demonstrate some degree of 
behavioural flexibility whilst traversing the maze, by increasing the use of alternations over time. 
However, flies used a strategy that was static throughout the trial and did not differ significantly from 
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the first 10 minutes to the last 10 minutes of exploration. This method has demonstrated sensitivity to 
detect adaptive behaviours in response to time and the environment, in a range of cognitively complex 
organisms.  
Further testing with pharmacological agents, demonstrated the ability of this task to detect 
drug induced changes in adaptive behaviours. MK-801 has been used in previous studies to model SZ-
like behaviours, including deficits in WM and CF (Lobellova et al., 2013; Murueta-Goyena et al., 2017; 
Svoboda et al., 2015). Here we demonstrate that the FMP Y-maze protocol could detect impaired 
behavioural flexibility induced by systemic blockade of NMDA-r by acute MK-801 exposure. This task 
could also detect changes in behavioural adaptability after acute exposure to muscarinic and 
dopaminergic D1 receptor antagonists, but no effect of systemic D2 receptor blockade, in line with 
findings from previous rodent studies (Chen et al., 2004; Ragozzino et al., 2002; Winter et al., 2009). 
These results further support the use of the FMP Y-maze to detect changes in CF and the use of zebrafish 
to model cognitive impairment.  
Deficits in executive functions such as WM or CF are commonly reported in patients diagnosed 
with neurodegenerative diseases, such as AD (Guarino et al., 2019a)  and PD (Handra et al., 2019; Koerts 
et al., 2011), or as a feature in a variety of neuropsychiatric disorders, such as major depressive disorder 
(MDD) (Darcet et al., 2016; Hammar & Årdal, 2009; Snyder, 2013), substance abuse (Cunha et al., 2010; 
Gould, 2010) and SZ (Giraldo-Chica et al., 2018; Orellana & Slachevsky, 2013).  As WM and CF can be 
markers for many complex brain disorders, the FMP Y-maze could be used as a clinical behavioural task 
for assessing executive function and memory processing as part of a battery of diagnostic tools. The 
ease and brevity of the human FMP Y-maze task lends itself to testing all age groups, including 
adolescences that may have increased susceptibility to developing SZ (Bossong & Niesink, 2010; Hollis, 
1995). Additionally, the neurotransmitter groups tested here, have been implicated in a number of 
neurodegenerative and neuropsychiatric disorders and their treatments (Aarsland et al., 2017; Brisch et 
al., 2014; Francis, 2005; Li et al., 2019; Murueta-Goyena et al., 2017). 
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Despite the advantages of testing executive function in the FMP Y-maze, there are limitations 
to the protocol, primarily associated with run time. Animal versions of the FMP Y-maze are run over 1 
h. Although this provides some benefits, as outlined above, the time taken to run a full experiment is 
largely dependent on the resources available to the facility. We operated this task with one MWP unit, 
one LT unit and four AD units. Thus, we were able to run 8 zebrafish, 6 Drosophila and one mouse per 
hour. In total, it took three days of back-to-back trials to test 166 zebrafish, 5 hours to test 30 Drosophila 
and three days to run 16 mice. Therefore, the level of throughput is dependent on the organism being 
tested and the number of behavioural units available for simultaneous trials. Additionally, this run time 
could not be applied to the human maze as the extensive trial time would be expected to have a 
negative impact on participant recruitment. Therefore, the trial was reduced to 5 min of exploration. 
However, the time for the online trial may need amending depending on the target group. Preliminary 
studies showed that younger participants completed sufficient turns in the allotted time, however, older 
participants completed very few turns, and for some this resulted in exclusion due to insufficient data 
collection. Therefore, it is suggested that for studies targeting older groups, or treatment groups with 
cognitive impairments, that run time be increased.  
Here, we present a new behavioural task for testing deficits in executive function and WM. We 
demonstrate the reliability and sensitivity of the FMP Y-maze to alterations in cognition and memory 
processing in a range of model organisms. Additionally, an online virtual maze has been created as a 
translational cognitive paradigm for testing humans. This task has the potential to be used either as a 
diagnostic tool, or as a method for improving drug discovery using animal models of complex brain 
disorders that report memory and cognitive decline as hallmarks of disease. The FMP Y-maze lays the 
foundation of future translational research for a range of neurological disorders and could open new 
avenues of research into cognition and memory, allowing cross-species comparisons with exceptional 






The transition from infancy to adulthood is a period subject to extensive behavioural changes and 
coincides with development of the majority of psychiatric disorders (Gee et al., 2018; Spear, 2000a). During 
these stages is immense neuronal remodelling, developmental plasticity and biochemical fluctuations, 
particularly pertaining to hormones, which can alter sensitivity to environmental perturbations (Meyer & 
Lee, 2019). Disturbances during this critical period have been associated with long-term behavioural, 
cognitive and molecular changes that can maintain throughout adulthood, long after cessation of the 
disturbing stimuli (Lockhart et al., 2018). It has been reported that of all lifetime mental health conditions, 
including ADHD, anxiety disorders, SZ, substance abuse and mood disorders, approximately half have first 
onset during the mid-teens, highlighting the increasing motivation to understand susceptibility during 
these periods of development (Gomes et al., 2016; Kessler et al., 2007; Lockhart et al., 2018). The previous 
chapter demonstrated the suitability of the FMP Y-maze for assessing changes in cognitive function in 
adult zebrafish. Thus, the aim of the next chapter was three-fold: 1) to test the suitability of the FMP Y-
maze for assessing different age groups, 2) to identify the earliest stage that cognitive function could be 
assessed in zebrafish and 3) to further our understanding of the relationship between cognitive function 








The Ontogenetic Advancement of Working Memory, Behavioural 
Flexibility and The HPI Axis in Developing Zebrafish (Danio rerio) 
 
4.1 Abstract 
Critical periods during development promote the acquisition of necessary skills such as decision-
making, novelty seeking and adaptive responses to environmental demands. During these periods, 
immature organisms are vulnerable to disruptions, which can have life-long behavioural consequences. 
Zebrafish (Danio rerio) are being increasingly used to better understand the long-term behavioural 
effects of developmental disturbances, due to their high genetic homology to humans. This has 
highlighted a growing need to understand the life history and formation of executive functions and 
stress pathology during critical periods of development from larval to adult stages. Cognitive function 
of pre/postnatal stages in zebrafish (4, 7, 14, 30 and 90 dpf, larvae to young adulthood), were assessed 
to identify key periods of cognitive and Hypothalamic-Pituitary-Interrenal (HPI) axis development. We 
examined the co-occurrence of fluctuations in cognitive performance and HPI axis activity to identify 
potential vulnerability periods. Yolk-dependent and independent feeder were critical stages of cognitive 
development, demonstrating the transition between basic cue responding to complex behaviour, which 
steadily improved with age, plateauing from juveniles to young adulthood (30-90 dpf). The HPI axis, 
however, showed substantial age differences, with a 10-fold up-regulation of cortisol release, following 
acute stress, from larvae to juveniles (14-30 dpf) which, similar to cognitive performance, plateaued 
between juvenile and young adult stages (30-90 dpf). Glucocorticoid receptor (gr) expression equally had 
a 10-fold increase, but only in young adults (90 dpf). All other age groups had similar expression levels 
to 4 dpf larvae. Our findings indicate distinct stages of cognitive development and substantial age-
related physiological changes in HPI axis activity and regulation, which implicate juvenile stages as a 
critical period of development due to high stress responsivity whilst maintaining low levels of gr, critical 




In humans, the transition from infant to young adult is marked by significant maturation of the central 
nervous system  resulting in altered behaviour and cognitive function (Lupien et al., 2009; Roberts & 
Lopez-Duran, 2019). Drastic changes in cognitive development have taken place by the time a child 
reaches the age of 10 years, which likely reflects increases in brain size and weight to near adult 
proportions (Brenhouse & Andersen, 2011; Cromer et al., 2015; Gogtay et al., 2004). However, 
development continues into adulthood, and cognitive domain has a substantial impact on the rate of 
maturation and the age at which adult-levels of ability are achieved (Cromer et al., 2015; Gogtay et al., 
2004; Lewis et al., 2010; Luciana & Nelson, 2002). For example, frontal lobe functions, such as WM, have 
been suggested to reach adult-levels of performance during late-teens to early twenties (Luna et al., 
2004; Zald & Iacono, 1998). Cognitive development has largely been reported as a linear progression of 
increasing ability with increasing age from childhood to adulthood (Brenhouse & Andersen, 2011; 
Cromer et al., 2015).  
Simultaneous to cognitive development, is the maturation of the neuroendocrine system 
controlling stress responsivity. Unlike cognition, emotional and stress reactivity do not progress linearly, 
but have been shown to follow an inverted U-shaped response curve, suggested to peak during 
adolescence (Brenhouse & Andersen, 2011; Spear, 2000b). The impact of HPA axis activity on cognitive 
function has been well established, with long-term hypo and hyperfunctioning causing impairments in 
cognitive abilities, including WM, but the reverse may be true for acute increases, which have been 
reported to positively associate with enhanced WM performance (Romeo, 2013; Stauble et al., 2013). 
The development of the HPA axis is marked by a significant shift in reactivity during adolescence and is 
reported in conjunction with increased stress-sensitivity during this period (Romeo, 2013). In humans, 
studies have suggested that during adolescence there is a greater stress response compared to younger 
children and increased duration compared to adults (Lupien et al., 2009; Platje et al., 2013; Roberts & 
Lopez-Duran, 2019). This implicates certain developmental periods with increased psychopathology 
vulnerability (Cheryl M. McCormick & Mathews, 2010; Platje et al., 2013; Roberts & Lopez-Duran, 2019). 
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Thus, adolescence is as a critical stage of development and explains adolescents’ increased vulnerability 
to develop stress-induced pathologies, such as SZ and substance abuse.   
Activation of the HPA axis, through exposure to stressful stimuli, leads to the rapid release of 
cortisol, levels of which generally peak between 20-40 min after stressor detection (Dickerson & 
Kemeny, 2004). Cortisol levels are then decreased through binding to glucocorticoid receptors (GR), 
which play a critical role in the negative feedback mechanism used to down regulate the HPA axis 
response and maintain homeostasis (Ramamoorthy & Cidlowski, 2016). The activation of this system 
has been reported to influence cognition and behaviour (Lupien et al., 2009; Shields et al., 2016; Van 
Niekerk et al., 2001).   
One model organism that has been growing in use in the field of psychiatric research is the 
zebrafish (Danio rerio) (Gerlai, 2011). Providing an alternative vertebrate model to rodents and non-
human primates, zebrafish have proved a useful model for prenatal, postnatal and early life, pre-adult 
investigation into disrupted neural circuitry and resulting behavioural changes that can persist into 
adulthood (de Abreu et al., 2019; Kozol, 2018; Souza & Tropepe, 2011; Adam Michael Stewart, Nguyen, 
et al., 2014). Zebrafish possess several advantages for assessing the development of cognitive and 
biological functions. Firstly, the distinction of in utero development of mammals compared to in vitro 
development of zebrafish larvae permits examination of early developmental stages, while avoiding 
maternal interference (Ge et al., 2019). Therefore, behavioural examination can begin whilst larvae are 
still yolk-dependent, compared to free-feeding, allowing comparison of cognitive and behavioural 
abilities and associated biochemistry at distinct life stages.  
Much of the zebrafish genome has high genetic homology to human counterparts, including 
those responsible for regulating stress biology. For example, zebrafish have an analogous system to the 
human HPA axis, the hypothalamic-pituitary-interrenal (HPI) axis (Derek Alsop & Vijayan, 2009), which, 
similarly to humans, utilises a single glucocorticoid receptor (gr) gene, and several splice variants, to 
regulate cortisol levels following a stress response (Aponte & Petrunich-Rutherford, 2019; Schaaf et al., 
2009; Wilson et al., 2013). Additionally, zebrafish reach sexual maturity in just 12-weeks and can 
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therefore provide a model of early life, juvenile and young adult stages within just 3 months (Singleman 
& Holtzman, 2014). Taken together, zebrafish provide an excellent model for understanding cognitive 
and behavioural abilities and molecular underpinnings of the HPI axis from early development to 
adulthood in health and disease (Adam Michael Stewart, Braubach, et al., 2014). Although previous 
studies have investigated aspects of the HPI axis during development, they have been restricted to a 
specific stage (i.e., multiple stages of larval development) (Derek Alsop & Vijayan, 2009). To our 
knowledge, this is the first comprehensive examination of cognitive development in zebrafish and the 
first study to describe HPI axis development from young larvae to young adulthood.  
The FMP Y-maze has been used in several studies to investigate changes in WM and cognitive 
flexibility by analysing sequence strings of left and right turn choices made during one hour (1 h) of free 
exploration (Cleal, Fontana, et al., 2020; Cleal & Parker, 2018; Fontana, Cleal, & Parker, 2019; Fontana, 
Cleal, Clay, et al., 2019). The ‘chunking’ of turn choices into overlapping sequences of four turns, known 
as tetragrams, allows the identification of repeating patterns within the data. Previous studies have 
identified strong correlations between WM performance and changes in global and immediate search 
strategies, which can be influenced by early developmental drug exposure, neuropharmacological 
manipulation and ageing (Cleal, Fontana, et al., 2020; Cleal & Parker, 2018). To investigate the impact 
of developmental stage on cognitive abilities, we tested a cross section of five age groups in the FMP 
Y-maze, ranging from yolk-dependent larvae to young adult. We further examined whole-body cortisol 
following an acute stress and basal levels of glucocorticoid receptors (gr) to disseminate changes in the 
HPI axis. We aimed to identify critical stages of development which may highlight periods of increased 







4.3 Materials and Methods 
Animals and housing 
Zebrafish were bred in-house at the University of Portsmouth Fish Facility, with eggs collected via the 
addition of marble-trays to tanks of ~20 adult, AB zebrafish. Offspring were reared in petri-dishes of 
aquarium-treated water in groups of ~50 embryos from collection until 5 days post fertilisation (dpf) 
and maintained in a larval incubator at ~28.5°C on a 14/10-hour light/dark cycle. From 5 dpf larvae were 
transferred into larger dishes in the incubator. From ~20 dpf larvae were split into groups of 20 fish in 
6L tanks, until 60 dpf when fish were further split into groups of 8-12 fish in a 2.8L tanks on a re-
circulating system (Aquaneering Inc., San Diego, CA, USA). From 5 dpf fish were fed on ZM fry food until 
30 dpf and then put on a diet of dried fish flakes and live brine shrimp until 90 dpf, 3 times per day 
during the week and once a day at weekends (am).  Aquarium water was maintained at ~25-27°C, pH 
8.4 (±0.4), and fish remained on a 14/10-hour light/dark cycle. All fish used were experimentally naïve. 
Due to the non-invasive nature and low impact of the behavioural testing, on completion of the FMP Y-
maze fish were returned to housing tanks and incorporated into the breeding program. 
 
Ethical statement 
Experiments carried out as part of this study were under license from the UK Home Office (Animals 
(Scientific Procedures) Act, 1986) [PPL: P9D87106F] and with approval from and in accordance with the 
University of Portsmouth Animal Welfare and Ethical Review Board guidelines. 
 
FMP Y-maze apparatus 
For testing larvae, juvenile and young adult zebrafish three different sizes of Y-maze were used, made 
of multiple, identical Y-mazes (Figure 1) with clear acrylic bases and white acrylic walls consisting of 3 
arms of equal proportions, at 120° angle. Larval mazes (4-7 dpf): arms were length 1.2 x width 0.4 x 
depth 0.3 cm; each maze was filled with aquarium water that was changed between larvae. Six mazes 
were run per test in the Zantiks MWP behavioural unit (Zantiks ltd, Cambridge, UK). Juvenile (14-30 dpf): 
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a solid Y-maze surround consisting of 3 equal arms of length 2.5 x width 1.0 x depth 0.5 cm, mazes were 
filled with aquarium water and changed between fish. Two mazes were run per test in the Zantiks MWP 
behavioural unit. Young adult (90 dpf): arms were length 5 x width 2 x depth 14 cm; mazes were filled 
with 3 L of aquarium water to allow sufficient swimming depth. To prevent fish from jumping out of the 
test arena, a fine mesh cover was used during testing. Two mazes were fitted into a water-tight tank 
and run in the Zantiks AD behavioural unit. 
All units were web-enabled and capable of live streaming video feed of in test activity of 
zebrafish to a laptop or mobile device. Starting and finishing trials was done remotely and logging of 
arm entries was written into the program script, recorded automatically and output in an excel 
spreadsheet. Cameras were located above the maze and enable continuous tracking of individual 
animals throughout the trial. Experimenter visibility and handling were kept to a minimum to reduce 
stress and distraction whilst animals were exploring the maze. Ambient light was a maximum of 2 lux in 
each of the testing units.  
 
Figure 1.  
 
 
Figure 1. FMP Y-maze. Three different size mazes were used to assess working memory and 
cognitive flexibility. Each consisted of white acrylic walls and clear acrylic base, inserted into housing 
blocks and fitted into behavioural testing units to automatically track animal movements and record 
arm entries and exits. (A) Six mazes used for larvae, aged 4-14 dpf (arms; L1.2xW0.4xD0.3 cm). (B) 
Two juvenile mazes, for age 30 dpf (arms; L2.5xW1.0xD0.5 cm). (C) Two adult mazes, for age 90 dpf 




One-hundred and fifteen larval (4 and 7 dpf, n = 45), juvenile (14 and 30 dpf, n = 52) and young adult 
(90 dpf, n = 18) AB zebrafish were used for assessing differences in WM and cognitive flexibility in 
zebrafish developing from larvae to young adults. Sample sizes were calculated based on power 
analyses and previous studies, and based on α-levels of 0.05 and power (β) of 0.8 (Cleal & Parker, 2018; 
Fontana, Cleal, & Parker, 2019; Fontana, Cleal, Clay, et al., 2019). Fish were experimentally naïve, and 
each fish was only used in one trial. There was no training or habituation required prior to testing in the 
FMP Y-maze. Fish were individually netted or pipetted (dependent on size) directly from home tanks (or 
dishes) into their respective mazes and placed into behavioural units. Behavioural tests were conducted 
in the Zantiks, fully automated behavioural testing units for adults [AD unit] and larvae/juveniles [MWP 
unit] (Zantiks Ltd., Cambridge, UK). Each fish was free to explore the maze for 1 h, no changes in 
environment, novelty or food rewards were introduced during the trial. Logging data of arm entries 
were recorded automatically and analysed on completion of all testing groups as performed in previous 
studies (Cleal, Fontana, et al., 2020; Cleal & Parker, 2018; Fontana, Cleal, & Parker, 2019; Fontana, Cleal, 
Clay, et al., 2019).   
 
Whole-body cortisol 
For determination of cortisol levels following an acute stress zebrafish were grouped in 90 mm petri 
dishes or 2.8L housing tanks for larvae/young juveniles (4 dpf n=50, 7 dpf n=40, 14 dpf n=10) and 
juveniles/young adults (30 dpf n=10, 90 dpf n=5) respectively. Acute stress was delivered through 
mechanical stirring of the water using a Pasteur pipette for 4-14 dpf or using a net for 30-90 dpf. Acute 
stress was delivered for 5-min, after which all fish were left to recover for 10-min, as previous research 
has shown peak cortisol responses within 3-15 min of receiving a stressor in zebrafish (Ramsay et al., 
2009). Following the recovery period, zebrafish were immediately culled by immersion in ice-water and 
snap-frozen using liquid nitrogen. To ensure sufficient cortisol levels for detection, fish were pooled 
according to their age group into the following group sizes: 4 dpf n=50, 7 dpf n=50, 14 dpf n=10, 30 
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dpf n=3, 90 dpf n=1. Cortisol levels were detected using the Salimetrics Salivary Cortisol ELISA kit for 
human samples (Stratech, Cambridge, UK), which has been found to reliably detect cortisol in zebrafish 
using the method previously described by (Cachat et al., 2010;Parker et al., 2012). Briefly, samples were 
homogenised in 5 mL of chilled PBS. Following complete homogenisation, 5 mL of diethyl ether was 
mixed with the homogenised samples and centrifuged at 7000 x g for 15 min. The top, organic layer 
was removed, and the process was repeated until all the cortisol-containing layer was removed, and 
then subsequent evaporation of the diethyl ether was continued overnight at room temperature. The 
resulting cortisol was reconstituted using 1 mL of chilled PBS. The ELISA was carried out in a 96-well 
plate following the manufacturer’s instructions. Standards were used to determine the final cortisol 
concentration (ng/g-1) using OD readings. Five biological replicates were run for each age group, with 
each biological replicate being run in duplicate. Inter- and intra-assay coefficients of variation were 
determined.      
 
RNA extraction and gDNA removal  
Fish were culled using ice-water immersion, followed by severing of spinal cord. Whole larvae (4-14 dpf) 
or whole brains (from 30-90 dpf) were removed and snap frozen using liquid nitrogen. Samples were 
homogenised and total RNA was extracted using the RNeasy Mini Kit (Qiagen) following the 
manufacturer’s instruction. After extracting and purifying RNA, samples were treated using the 
RapidOut DNA Removal Kit (Thermo Scientific), following manufacturer’s instructions to remove 
contaminating gDNA from RNA samples prior to conversion into cDNA.  
 
cDNA synthesis 
Following removal of gDNA from RNA, sample concentrations were measured using the ND 1000 
spectrophotometer. To ensure the same amount of cDNA was synthesised for each sample a maximum 
of 1 µg of total RNA was used per reaction (the same total concentration of RNA was loaded into each 
reaction). Reverse transcription of mRNA to cDNA was done using the High Capacity RNA-to-cDNA Kit 
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(Applied Biosystems) following the manufacturer’s protocol. After conversion into cDNA, samples were 
diluted with ddH2O to a final concentration of 5 ng/µL. Samples were stored at -20°C until use.  
 
Quantitative Real-Time PCR (RT-qPCR) 
Quantitative real-time PCR (RT-qPCR) assays were used to validate relative gene expression based on 
SYBR green detection. Gr primers were predesigned by qPrimerDB (Lu et al., 2018), eef1a primers were 
based on previous studies (Parker et al., 2016; Tang et al., 2007). Primers were synthesised by Invitrogen 
and are listed in Table 1. The Roche LightCycler® 480 High Resolution Melting Master mix and the 
LightCycler® 96 (Roche Life Science) were used to amplify and detect the transcripts of interest. Thermal 
cycling conditions were as follows: 95°C for 600s (recommended by manufacturer), 40 cycles of 95°C for 
15s, 58°C for 20s and 72°C for 35s followed by melt curve analysis. Melt curve analysis, negative reverse 
transcription (RT) controls and negative template controls were used to determine specificity and to 
check for genomic contamination. Elongation factor 1 alpha (eelf1a) was used as a housekeeping gene 
(Tang et al., 2007). Gene-expression levels were calculated using delta-delta CT method and normalised 
to eelf1a. Changes in expression were relative to 4 dpf to demonstrate fold increases during 
development. Data are presented as means ± SD (n = 4 per group; assayed in duplicate).  
 
Table 1. Primer sets used for qPCR  



















Data processing and statistical analysis 
Data pertaining to Y-maze performance were collected as a series of binary left and right turns, 
which in the absence of bias, would be equally likely to be selected (Deacon, Nick, et al., 2006; Frith & 
Done, 1983; Robert Gerlai, 1998; Stroe-Kunold et al., 2009). In order to discover if turn choice in the FMP 
Y-maze was a Markov process (overall patterns of turns were chosen randomly) we used a two-choice 
guessing task analysis (Frith & Done, 1983) to exploit information theory to detect patterns in large data 
series by ‘chunking' turn choices into small groups of information (i.e. groups of four turns, left, left, 
right, right-LLRR) (Guze, 1993). Previous studies, using two-choice guessing tasks with human 
participants, have found that examining greater than four or five previous choices results in the 
calculation of the probability of a current event occurring redundant (Guze, 1993; Hochberg & Attneave, 
1961). Therefore, we used a third order uncertainty to chunk consecutive turn choices into overlapping 
groups of four turns, limiting the number of alternative sequences to 24= 16 possible turn 
configurations, known as tetragrams (Table 2). If tetragram selection was completely random, a Markov 
or ‘memoryless’ process, the relative frequency of all tetragram sequences would be equal at 
approximately 6.25% (100% of turns/16 tetragram possibilities = 6.25%). Higher rates would be evidence 
of strategic tetragram selection (Gross et al., 2011). Using a custom written program we transformed 
the raw data (arm entry) into tetragram sequences of overlapping choices of turn (i.e. [L,R,{L,R],R,R}L- 
the first 3 tetragram sequences would be; [LRLR], RLRR, {LRRR}). Previous studies highlighted a role for 
two particular tetragram configurations, which were alternations (LRLR, RLRL) and repetitions (LLLL, 
RRRR), therefore particular attention was paid to these patterns (Cleal & Parker, 2018; Fontana, Cleal, & 
Parker, 2019; Fontana, Cleal, Clay, et al., 2019; Gross et al., 2011).  
Data were split into two formats for analysis; total percentage use (calculated as a proportion 
of total turns) of each tetragram sequence for the 1 h of exploration, referred to as ‘global’ search 
strategy. This was used as a measure of WM as repetition of previous turn choices must be remembered 
for patterns of movement to be repeated over 1 h of exploration, requiring memory of arm entries and 
order of entry. The second type of strategy, known as an ‘immediate’ search strategy, analysed search 
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pattern configurations over 10 min time bins throughout the trial, equating to six equal, consecutive 
time bins. This analysis was used to assess cognitive flexibility. Animals that are not able to update 
information gained during exploration of the FMP Y-maze will likely perform similar strategies over each 
time bin. However, those that are able to change behaviour in response to new information would be 
expected to change movement patterns over time, therefore differences in tetragram usage would be 
expected with each 10 min time bin.   
Data were analysed in IBM SPSS 25.0 and GraphPad Prism 8.4.2. All data were log transformed 
and a linear mixed model (LMM) was employed to assess alternations and repetitions for all age groups 
with effect of age and time (as a between subject factors), animal ID (as a random effect) and total turns 
(as a covariate) to account for the individual variability of movement within and between age groups. 
One-way ANOVA was used to compare strategies within age groups. Shapiro-Wilk test of normality and 
boxplot with Tukey confidence interval was used to identify outliers. Tukey’s test and Sidak’s test for 
multiple comparisons was used as a post hoc analysis. Locomotion was analysed using total turns 
completed during 1 h of exploration in the FMP Y-maze.  Data from total turns, ELISA and qPCR were 
tested for normality using the Shapiro-Wilk test and analysed using one-way ANOVA followed by 
Tukey’s post hoc analysis. Results were considered significant when p ≤0.05. Two adult zebrafish (90 dpf, 
#5, #7) were excluded from analysis due to tracking errors. Three data points were excluded from 
locomotion analysis (30 dpf, #2, #18, #26) due to falling outside of the 95% confidence interval. 
However, as data are normalised as a proportion of total turns for assessing tetragram usage, these 
animals were not excluded from strategy analysis. No data points were excluded from ELISA or qPCR 































WM from larval development to young adulthood 
Search strategies were compared between developing larvae to young adult zebrafish. Our data showed 
that 4dpf larvae used all tetragram configurations at random. We, therefore, found no evidence of any 
strategic preference to specific tetragram sequences when exploring the maze. Use of a decipherable 
strategy is not evident until 7 dpf, at which stage larval zebrafish begin to show signs of a specific search 
strategy that consisted of non-random selection of alternating patterns of left and right turns (LRLR, 
RLRL). Alternations dominated exploration patterns and were intermittently used between random 
selection of each of the other 14 tetragram sequences (Fig 2A). This selective use of alternations was 
evident in 7, 14, 30 and 90 dpf zebrafish which all used alternations above chance (6.25%) and 
significantly greater than any other tetragram sequence [One-way ANOVA, F (7, 263) = 27.23, p <0.0001], 
only 4 dpf larvae did not have a significant difference between alternations and any other configuration 
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(Fig. 2B). The two main strategy configurations shown to be susceptible to cognitive perturbations are 
alternations (LRLR, RLRL) and repetitions (LLLL, RRRR). We therefore compared the effect of age, on use 
of each of these sequences, revealing a significant effect on of age on alternation use (LMM: F(4,116.31) = 
3.56, p = 0.009), but no effect on repetitions (LMM: F(4,105.26) = 1.22, p = 0.305) (Fig. 3).  
 
Increasing cognitive flexibility with age 
We have investigated how developmental stage affects the capability to update information presented 
in the FMP Y-maze and alter behaviour, as necessary. We examined tetragram use for successive 10-
min intervals during the 1 h of exploration for each age group (Fig. 4). Due to the greatly reduced 
locomotor activity of 4 dpf larvae compared to all other age groups, and no evidence of strategy during 
exploration, this age group was removed from time analyses. Our results show that only 90 dpf adults 
demonstrated cognitive flexibility by increasing use of alternations over time (7 dpf: F(5,50.69) = 0.97, p = 
0.446; 14 dpf: F(5,109.29) = 1.75, p = 0.129; 30 dpf: F(5,103.76) = 0.62, p = 0.682; 90 dpf: F(5,71.08) = 3.37, p = 















Figure 2. Global search strategy in the FMP Y-maze. (A) Frequency distribution of tetragram use 
after 1 h of free exploration for 4 dpf (n= 24), 7 dpf (n= 21), 14 dpf (n= 25), 30 dpf (n= 24) and 90 
dpf (n= 16) zebrafish. Patterns show inflated use of alternations. (B) Mean use of each tetragram 
pair (i.e., LLLR+RRRL, LLRR+RRLL) compared to alternations (RLRL+LRLR). Normality checked using 
the Shapiro-Wilk test. Normally distributed data were analysed using One-way ANOVA. The dashed 
line denotes to chance selection (~6.25%). Bars are mean, error bars are mean + SEM. * p < 0.05, 


































































Figure 3. Age comparison of global use of repetitions (LLLL+RRRR) and alternations (LRLR+ RLRL).  
Data were log transformed and analysed using a LMM. The dashed line equates to chance selection 

























































































































































































































































































































Figure 4. Frequency distribution of each tetragram sequence over successive 10 min intervals over 
1 h of exploration in the FMP Y-maze for 7 dpf (n= 21), 14 dpf (n= 25), 30 dpf (n= 24) and 90 dpf (n= 
16) zebrafish. The dashed line denotes to chance selection (~6.25%). Bars are mean, error bars are 






















































































































Figure 5. Effect of time on alternation use across six successive 10 min time bins, during 1 h of 
exploration. Data were log transformed and analysed using a LMM. The dashed line equates to 
chance selection of sequences (approximately 6.25%). Points are mean, error bars are mean ± SEM. 
***p ≤ 0.001.  
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Effect of age on locomotion 
Locomotion was measured by the number of arm entries (denoted by total turns) in the FMP Y-maze. 
We examined the effect of age on movement during the first 10 minutes and over the full hour of 
exploration. We found that there was a significant effect of age on total turns for both the first 10 mins 
[One-way ANOVA, F (4, 109) = 16.72, p <0.0001] and 1 h [One-way ANOVA, F (4, 107) = 47.04, p <0.0001] of 
search, demonstrating increased number of turns with increasing age (Figure 6). Tukey’s post hoc 
analysis revealed that all age groups travelled significantly less than 90 dpf young adults. 4 and 7 dpf 
larvae performed a similar number of turns, but both were significantly lower than all other age groups 










































































Figure 6. Locomotor activity measured by total turns for each age group for (A) the first 10 mins of 
exploration (4 v 7 dpf = c; 4 v 14, 30 and 90 dpf = d; 7 v 14 dpf = a; 7 v 30 dpf = b; 7 v 90 dpf = d; 14 
v 90 dpf = b; 30 v 90 dpf = a) and (B) the full hour of exploration in the FMP Y-maze (4 v 14 30 and 
90 dpf = d; 7 v 14 and 30 dpf = b; 7 v 90 dpf = d; 14 v 30 dpf = d; 30 v 90 dpf = d). Mean is depicted 
by the line across the box, whiskers represent 95% confidence interval. a= * p≤ 0.05, b= ** p≤ 0.01, 




Table 3.  
Age Group 
95% CI of diff. 
10 mins of 
exploration P-value 
 
Significance 95% CI of diff. 
1 h of exploration P-value Significance 
4 dpf vs. 7 dpf -29.49 to 12.88 0.8127 ns -645.4 to 36.79 0.1040 ns 
4 dpf vs. 14 dpf -49.74 to -9.214 0.0009 *** -1090 to -437.5 <0.0001 **** 
4 dpf vs. 30 dpf -54.71 to -14.58 <0.0001 **** -1071 to -412.0 <0.0001 **** 
4 dpf vs. 90 dpf -80.37 to -36.16 <0.0001 **** -2024 to -1313 <0.0001 **** 
7 dpf vs. 14 dpf -42.16 to -0.1854 0.0469 
* 
-797.3 to -121.5 0.0024 
** 
7 dpf vs. 30 dpf -47.14 to -5.540 0.0057 ** -778.3 to -96.09 0.0050 ** 
7 dpf vs. 90 dpf -72.73 to -27.19 <0.0001 **** -1731 to -997.5 <0.0001 **** 
14 dpf vs. 30 dpf -25.03 to 14.69 0.9510 ns -304.0 to 348.5 0.9997 ns 
14 dpf vs. 90 dpf -50.70 to -6.873 0.0037 ** -1258 to -551.9 <0.0001 **** 
30 dpf vs. 90 dpf -45.36 to -1.881 0.0261 * -1283 to -571.1 <0.0001 **** 
 
Effect of age on whole-body cortisol and gr mRNA expression 
To assess age related changes in HPI axis stress response, whole-body cortisol levels were measured 
after 5 min acute stress followed by a 10 min rest period. There was a significant effect of age on post 
stress cortisol levels (One-way ANOVA, F (4,18) = 5.96, p = 0.0031). Sidak’s multiple comparison post-hoc 
analysis revealed a significant difference between 30 dpf and 4 (p = 0.0131), 7 (p = 0.0144) and 14 (p = 
0.0178) dpf resulting in an almost 10-fold increase in cortisol levels in 30 dpf juvenile zebrafish 
compared to cortisol responses in larvae. There was no difference between cortisol levels in 30 dpf 
juveniles and 90 dpf (p = 0.7272) young adults. There were no significant differences between any other 
age group (Fig. 7A). 
We investigated the effect of age on whole brain gr mRNA expression analysing fold change from 4 dpf 
larvae to 90 dpf young adult zebrafish. (Fig. 7B) shows gene expression data of each age group relative 
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to 4 dpf larvae. We found a significant effect of age on gr expression [One-way ANOVA, F (4, 15) = 138.1, 
p <0.0001]. Post-hoc analysis revealed that there was no difference between 4, 7, 14 and 30 dpf mRNA 
expression levels, however, all ages were significantly different to 90 dpf (4 dpf vs. 90 dpf; 95% CI -11.88 
to -8.457; 7 dpf vs. 90 dpf; 95% CI -11.87 to -8.450; 14 dpf vs. 90 dpf; 95% CI -12.19 to -8.765; 30 dpf vs. 









































































































Figure 7. Whole-body cortisol levels for 4, 7, 14, 30 and 90 dpf zebrafish following exposure to an 
acute stressor (A). Relative, whole brain gr mRNA expression in 4, 7, 14, 30 and 90 dpf (n=4 per 
group). Data were normalised to housekeeping gene eelf1α and defined as fold change relative to 
4 dpf larvae (B). Groups were analysed using One-way ANOVA followed by Tukey’s post-hoc 





The aim of this study was to understand how executive functions and HPI axis activity in zebrafish are 
affected by developmental stage. Using the FMP Y-maze, we discovered specific movement patterns 
used for exploring a novel environment. We observed random search patterns used by larvae dependent 
on the yolk-sac, but a strategic pattern of exploration in free-feeding larvae, juveniles and young adults, 
showing preferential use of alternation sequences consisting of consecutive left and right turns (LRLR, 
RLRL), which has previously been reported to correlate with WM performance (Cleal, Fontana, et al., 
2020). Thus, indicating a role for enhancing WM processing in improved strategy development. Through 
fine-scale analysis we further revealed a changeable strategy that was adapted during trial progression, 
implicating a role for cognitive flexibility in updating behavioural responses within the maze. In addition 
to improved cognitive performance with increasing age, we found a significant effect of increased age 
on increased HPI activation that was evident from 30 dpf. Age was also found to influence gr mRNA 
expression with a sharp rise upon reaching young adulthood, 90 dpf. Combined our data suggest three 
independent stages for maturation of cognitive processing, stress reactivity and the mechanisms for 
homeostatic regulation of stress responses.   
The ability to learn from experience and to recall information about the surrounding 
environment is critical to an organism’s survival and ability to exploit their natural habitat (Roy & Bhat, 
2016). Numerous studies in teleosts and mammals have revealed sophisticated behaviour regarding the 
use of cognitive control to appropriate action selection in the most efficient manner (Howard et al., 
2017; Kottler et al., 2019; Monsell & Driver, 2000). However, in order to achieve adult optimised 
performance, there is continuous development and improvement throughout larval and juvenile stages 
(Anderson et al., 2004; Browman & O’Brien, 1992; Grecian et al., 2018; Osborne et al., 2013). In the FMP 
Y-maze young 4 dpf larvae were the only age group to search the maze completely at random, with all 
tetragram configurations used at a rate less than or equal to chance. Life history of zebrafish may play 
a critical role in the stage at which sophisticated search strategies are implicated. For example, zebrafish 
have very low motility rates during the early stages of development, whilst dependent on the yolk-sac 
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for survival (Colwill & Creton, 2011). However, free-swimming occurs once larvae are independent 
feeders and have begun foraging for live prey. This is reported at 5 dpf when resources from the yolk 
sac have been almost completely consumed and swimming activity and duration have increased in 
response to the need to search for food (Strähle et al., 2012). Yolk-feeding larvae were comparatively 
inactive compared to other age groups, raising the question whether hypolocomotion was responsible 
for the random movement patterns (Selderslaghs et al., 2010; Strähle et al., 2012). Alternatively, 
dependence on an available food source, and incomplete development of neural structures could result 
in under-developed cognitive capacity. The lack of systematic search strategy in 4 dpf larvae may be 
due to the continued development of anatomical structures and axonal pathways. Analysis of 
dopaminergic development, critical to motor activity and executive function, showed that despite most 
dopaminergic neurons being present by 4 dpf, many axonal projections, such as those into the 
telencephalon (equivalent to prefrontal cortex in mammals, and a crucial area for learning and memory) 
(Salas et al., 2006) are not completed until 5 dpf (Du et al., 2016). This may provide a potential 
explanation as to why 4 dpf larvae are unable to develop strategies above random choice selection to 
strategically navigate the maze (Hernandez et al., 2018; Roy & Bhat, 2016). Many studies have relied on 
external stimuli, such as light/dark changes, to provoke increased movement behaviour in larvae and 
enable detection of changes in behavioural responses to varying conditions (de Esch et al., 2012). To 
identify the underlying processes used for exploratory or information seeking behaviour of yolk-
dependent larvae, alternative paradigms, either not dependent on locomotion or increasing locomotor 
activity, would be required.     
Older age groups, unlike yolk-dependent larvae, were observed using a specific global search 
strategy for the full period of exploration in the FMP Y-maze. Although the majority of search 
configurations were selected randomly, there was evidence of dominant, intermitted use of alternation 
strategies that relied on equal left and right turns (LRLR, RLRL), performed at a higher frequency than 
chance. Previous work by our group has demonstrated a correlation between greater use of alternations 
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and WM performance, thus demonstrating that 4 dpf show no discernible WM use, whilst from 7 to 90 
dpf WM is being utilised to enhance exploration strategy.   
A key aspect of animals with higher cognitive functions, such as learning and memory, is the 
ability to update their knowledge of a search area based on recent experiences and adapt their 
behaviour accordingly (Bracis et al., 2015). The FMP Y-maze protocol provides a negative feed-back 
task, in which animals exploring the maze are continually presented with an absence of novel stimuli, 
e.g., food or reward. This would be expected to cause a strategy change, based on an animal’s ability to 
alter behaviour in response to environmental cues. Previous studies from our lab have shown that adult 
zebrafish at 6 months old are able to use information obtained exploring the FMP Y-maze to alter search 
strategy by increasing the use of alternations over time (Cleal, Fontana, et al., 2020). However, this ability 
is strongly affected by senescence or inhibiting memory forming or retrieval pathways (see Part 1: Chpt 
5) (Cleal et al., 2020 Aging) (Cleal, Fontana, et al., 2020). The only age group to demonstrate CF in the 
FMP Y-maze, by significantly up-regulating alternation use with increasing time, were the young adults 
(90 dpf). No other age showed significant differences between the use of alternations in the first 10 min 
of exploration compared to the last 10 min, whilst young adult zebrafish linearly shifted alternation-use 
from below chance, to greater than one fifth of movement patterns from the first to last 10 mins of 
exploration, demonstrating substantial overlap with the adult strategy. Changes in alternation use 
during extensive exploration supports a role for experience based, individual learning, influencing search 
strategy and is reflective of the ability to adapt to environmental cues. The absence of this behaviour in 
younger age groups is reflective of an immature cognitive performance that has not yet reached adult-
level abilities.    
Zebrafish whole-body cortisol levels, in response to a mild, acute stressor, remained consistently 
low in 4, 7 and 14 dpf zebrafish. However, juvenile zebrafish, 30 dpf, showed a significant increase in 
HPI axis activation resulting in an almost 10-fold greater cortisol level compared to larvae, but no 
difference between juveniles and young adults. Previous studies in zebrafish have assessed ontogeny 
of cortisol response to stressful stimuli during embryonic to early larval development and during 
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adulthood (from young adult, 3 months, to ageing adult, 19 months) (Ramsay et al., 2009; Wilson et al., 
2013). No differences during adult development were identified; however, there was a significant effect 
of age during embryonic/early stage larval development due to the maternal deposit of cortisol, which 
is depleted prior to hatching and then the larvae begins to synthesis its own cortisol causing an increase 
after hatching (D. Alsop & Aluru, 2011).   
Examination of whole brain gr mRNA expression revealed age-related changes in increasing 
expression levels that were significantly different in young adults (90 dpf) compared to larvae and 
juveniles. The postnatal ontogeny of GR gene expression has been examined in a number of species 
including humans, marmosets, rats and mice, similarly with the aim of identifying critical periods of 
development that represent increased psychopathological vulnerabilities (Perlman et al., 2007; Pryce, 
2008; Pryce et al., 2005; Yi et al., 1994). Our findings are slightly at odds with mammalian studies which 
either show no age-related differences (particularly in the hippocampus) or in regions that do show 
differences there is generally an increase from infant to adolescence, but no difference between 
adolescence to adult (Pryce, 2008). In humans there was no discernible difference between age groups 
(infant, adolescent, young adult, adult, aged) and GR expression in the hippocampus. However, distinct 
age-related differences were detected in the dorsal lateral prefrontal cortex (dlPFC), which showed an 
increase in expression in adolescence compared to infants and aged adults in the dlPFC II-VI layers and 
an increase in adults to infants in the dlPFC IV and VI layers, but no differences between adolescence 
and adults in any dlPFC layer (Perlman et al., 2007). Two possible reasons for increases being identified 
in young adult zebrafish, opposed to during the juvenile stage, could be due to the ages tested and 
examination of whole brain tissue. In zebrafish maturity is better determined by morphological and 
anatomical features opposed to ‘age’. In a study by (Singleman & Holtzman, 2014), they propose the 
use of factors such as length, pigment pattern and fin morphology to provide a normalised staging of 
development in maturing zebrafish. Based on rearing at ~28.5°C, the embryonic stage has been 
classified as ending at ~3 dpf. Following the embryonic stage is the larval stage, which they suggest 
lasts for ~6 weeks, ending around 45 dpf. This marks the beginning of the juvenile stage. Finally, 
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zebrafish reared at ~28.5°C reach sexual maturity by ~3 months (90 dpf) at which point they are 
considered adults (Singleman & Holtzman, 2014). It is therefore possible that at 30 dpf, our ‘juvenile’ 
group have not sufficiently matured and thus do not demonstrate the neuronal changes associated with 
this age group, i.e. increased expression of gr mRNA. It is possible that more detailed examination 
between 30 to 90 dpf may reveal an alternative period of adolescence that demonstrates up regulation 
of gr expression prior to young adulthood. In addition to age considerations, is the broad use of whole 
brain analysis used in zebrafish. Many mammalian studies have focused on expression changes in 
specific regions and can thus evaluate regional changes instead of global changes. This is a difficult feat 
in zebrafish using the method of qPCR, and therefore more in-depth study using alternative measures 
of gr expression, such as whole-mount in situ hybridisation, could provide more detailed information of 
localised, age-related changes.   
Regardless of the age of onset of expressional changes, there has been little consistency in 
understanding the relevance of increases in GR expression in disease pathology. Recently, however, 
Alder et al (2018) investigated, in humans, the outcome following HPA axis stimulation (following septic 
shock). They examined not just basal expression levels of GR and cortisol levels following stress, but 
they furthered their analysis by identifying groups as high or low GR expression and cortisol level. Their 
findings suggest no direct correlation between general GR expression, cortisol levels and patient 
outcome. However, when subcategorising patients into groups of high and low levels they identified a 
pattern of recovery outcome. They identified four groups: high/high, high/low, low/high and low/low 
(relative cortisol level/relative GR expression level). They found that patients in the group with high 
cortisol levels following stress and low GR expression at baseline, as those at the greatest risk of 
complications after septic shock, accounting for 75%. Those in the high/high or the low/low groups had 
the same outcome likelihood of a complicated course both at 33% and those that had low cortisol levels 
and high GR expression were the least susceptible, with only 13% having a complicated course (Alder 
et al., 2018). This study suggests a critical role for the ratio of cortisol to GR expression as an indicator 
of increased vulnerability to disease following stress-induced activation of the HPA axis. Applying this 
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theory to the work presented here, identifying fish as low or high expression of cortisol and gr expression 
by designating group means those that fall below the median values of cortisol and gr expression levels 
are “low expression” and those above the median are “high expression” (cortisol: median (IQR) = 0.03 
(0.01-0.19), gr: median (IQR) = 1.1 (0.61-1.4)). Therefore, 4 and 7 dpf larvae would be in the moderate 
effect category with low/low expression, as are 90 dpf young adults with high/high expression, but 14 
and 30 dpf larvae would be in the highest susceptibility group, both with  a high/low cortisol/gr 
expression level. Crucially, this implicates a mechanism of increased vulnerability (i.e., a ‘critical period’ 
of development) in late-stage larvae and juveniles. However, further work would be required to identify 
the relationship between the ratio of stress-induced cortisol levels compared to basal gr expression in 
decreasing the stress response (i.e. how rapidly are cortisol levels returned to baseline following stress 
in the different expression groups) and how this altered ratio of cortisol to gr impacts cognitive function.  
 
4.6 Conclusion 
Combined our data identify a single age group of particularly high vulnerability. 30 dpf juveniles 
demonstrate adult-level WM performance, however, they lack matured CF and show a lack of response 
to negative stimuli (i.e., the absence of reward or novelty presented in the FMP Y-maze). They are the 
first developmental stage to exhibit an exaggerated cortisol response following acute stress, causing a 
10-fold increase in cortisol compared to larvae. Despite this level of cortisol reactivity being similarly 
reported in young adults, there is the addition of low levels of gr expression that is not evident in young 
adults, as they show substantial up-regulation of gr by this age. Combined with the increased stress 
responsivity, juveniles demonstrate a significant imbalance in the ratio of post stress cortisol levels and 
basal gr. Human studies of adolescence and patients with neuropsychiatric disorders, such as SZ and 
substance abuse, have reported prolonged stress responses, i.e., less efficient down-regulation of the 
HPA axis following a stress, and slower return of cortisol to pre-stress levels (Lupien et al., 2009; Nugent 
et al., 2015; Platje et al., 2013; A. G. Roberts & Lopez-Duran, 2019). This has often been suggested to be 
the result of aberrant HPA axis activity in neuropsychiatric disorders. However, this aberrant HPI axis 
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regulation appears to also be common to healthy juveniles. Thus, a negative feedback loop of poor 
behavioural responses and increased stress-sensitivity in adolescence becomes apparent: gr are a critical 
mechanism in restoring homeostasis quickly after activation. Low levels of receptors and high levels of 
circulating cortisol following stress, results in a delay in restoring homeostasis. However, the additional 
absence of up-dating behaviour in response to negative stimuli (i.e., poor CF) may potentially result in 
behaviours that cannot appropriately adapt to their environment, which may perpetuate the stress 
response further. Under extreme circumstances, it could be hypothesised that prolonged elevation of 
circulating cortisol may ultimately lead to impairments in other cognitive functions, such as WM, which 
may influence behaviours that perpetuate the stress response further. This hypothesis represents an 
extreme and simplistic view, but, none-the-less a plausible mode of altered stress responsivity during 
adolescent stages of development and provide a potential mechanism of increased susceptibility to 














So far, we have demonstrated the FMP Y-maze as a cognitive task suitable for assessing zebrafish. It has 
shown sensitivity to alterations in cognitive performance through pharmacological intervention and 
maturation of cognitive function from larvae to young adulthood. We have shown that this task can be 
used with larvae as young as 7 dpf. Our aim now, it is to test the applicability of the FMP Y-maze at the 
opposite end of the age scale. Here, we test the sensitivity of the FMP Y-maze to subtle changes in cognitive 
function associated with healthy ageing. In humans, even in healthy senescence, there are still reports of 
cognitive decline compared to younger adults. We thus hypothesised that healthy, ageing zebrafish would 
similarly show signs of decline in cognitive performance. We therefore anticipate a decrease in the use of 
the alternation strategy in ageing compared to younger counterparts. To understand the mechanisms 
involved in altered cognitive performance in ageing fish, we assess the role of the dopaminergic system as 
both a possible cause and therapeutic strategy to restore cognitive deficits. Furthermore, to assess the 
translational relevance of these findings, we tested young and ageing humans in the virtual FMP Y-maze 
to examine 1) task sensitivity to age related cognitive decline in a healthy human cohort, 2) translational 
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5.1 Abstract  
Healthy aging is associated with a decline in memory and executive function, which have both been 
linked with aberrant dopaminergic signalling. We examined the relationship between cognitive 
performance and dopamine function of young, 6-month-old and aging, 24-month-old adult zebrafish 
(Danio rerio), revealing age-related decreases in WM and cognitive flexibility in the Free-Movement 
Pattern (FMP) Y-maze. Young and older adults received a D1-like agonist (SKF-38393, 35 µM) 30 minutes 
prior to behavioural assessment. We observed differences in WM performance, but not behavioural 
flexibility in aged zebrafish. Decline in dopamine transporter mRNA and oxygen metabolism were also 
evident in older zebrafish. These data suggest a potential role for dopamine via D1-like receptors for 
restoring deficits in WM during normal aging. The translational relevance of these findings was 
established by testing young-adult, 18-35-year-olds, and aged adults, 70+ year olds, in a virtual FMP Y-
maze, which revealed a similar age-related decline in WM. Thus, strongly supporting zebrafish as a 
translational model of aging and cognitive decline.   






During the process of ‘natural’ aging, the brain undergoes gradual structural and functional changes 
that cause deterioration in cognitive ability, even in the absence of neurodegenerative disease (Harada 
et al., 2013; Salthouse, 2009). The rate of decline is highly variable, with many able to maintain good 
health and mental ability into their late 80s, whilst others are greatly susceptible to debilitating cognitive 
impairment and disease (Deary et al., 2012). Individual differences in cognitive aging have driven the 
identification of underlying biological factors that can predict vulnerability to decline or development 
of age-related diseases (Berry et al., 2016). Many studies of healthy aging have implicated multiple 
components of the dopaminergic system in declining cognition, with individual differences in dopamine 
signalling playing a profound role in performance of cognitive tasks and response to dopamine-altering 
medications (Cools & D’Esposito, 2011; Kimberg et al., 1997; Volkow et al., 1998). As a result, dopamine 
has become a focus of research investigating age-associated changes in cognition.  
Dopamine plays an important role in many aspects of cerebral functions related to cognition 
such as attention, learning, WM and mental flexibility (Girault & Greengard, 2004; Naderi et al., 2016). 
Three key modulators of dopamine function are dopamine synthesis, reuptake and activation of 
dopaminergic receptors (Klanker et al., 2013). Through pharmacological manipulations, a complex 
network of interactions involving these modulatory systems are used to maintain dopamine 
homeostasis (Cools & D’Esposito, 2011), dysregulation of which has been shown to have severe, and 
sometimes opposing, effects on cognition, particularly WM and cognitive flexibility in health and disease 
(Brozoski et al., 1979; Cai & Arnsten, 1997; El-Ghundi et al., 2007; Rothmond et al., 2012; Zahrt et al., 
1997). In a previous study (see Part 1: Chpt 3), we sought to delineate the role dopaminergic receptor 
subtypes play in formulating search strategies in zebrafish exploring the FMP Y-maze. We used SCH-
23390, a selective D1 and D5 receptor antagonist (from here in referred to as D1-like receptors) and 
sulpiride, a selective D2, D3 and D4 receptor antagonist (from here in referred to as D2-like receptors) 
(Neve, 2013). We demonstrated a significant role for D1-like receptors in strategy formation in the FMP 
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Y-maze, with an associated impact on WM and cognitive flexibility. However, in the absence of reward 
or motivational learning, no such role was identified for D2-like receptors in exploring the maze (Cleal, 
Fontana, et al., 2020). Consequently, in models with deficits in WM or behavioural plasticity in the FMP 
Y-maze, we hypothesised that increasing D1-like receptor activation would enhance these cognitive 
domains. 
Zebrafish (Danio rerio) have recently emerged as a promising model of cognitive aging 
(Gerhard, 2007; Lili Yu et al., 2006). Zebrafish live on average for ~3 years, but can have a life span as 
long as 4-5 years under laboratory conditions (Kishi, 2011). Changes in cognition are evident from ~2 
years, increasing the accessibility of researching gradual senescence in a model of old age (Gerhard et 
al., 2002; Tsai et al., 2007). In humans, cellular senescence can be detected by a number of age-
associated phenotypes using biological and biochemical markers. One such marker is beta-
galactosidase, which in humans is only expressed in senescent cells (Dimri et al., 1995). Like humans, 
zebrafish also demonstrate senescence associated beta-galactosidase activity, with only faint signals 
detectable at 9-months old, increasing significantly once fish reach 17-months and older (Kishi, 2004). 
Additionally, like humans and rodents, zebrafish also show age-associated accumulation of oxidative 
proteins in skeletal muscles. (Kishi et al., 2003), showed higher levels of oxidised proteins in aged fish, 
at 24-months old compared to younger 3 and 6-month old fish (Kishi, 2004; Kishi et al., 2003; Tsai et al., 
2007). We therefore selected 6- and 24-month-old zebrafish as these developmental stages show clear 
differences in biological markers of aging, both in zebrafish and in humans. Also, like humans and 
rodents, zebrafish have homologues of neurotransmitters, associated systems and brain regions 
necessary to assess learning, memory and executive functions such as attention and cognitive flexibility 
(K. A. Horzmann & Freeman, 2016; Matthew O. Parker, Brock, Walton, et al., 2013; Tufi et al., 2016). Ease 
of pharmacological manipulation and high throughput behavioural testing, additionally add to the 
convenience and suitability of zebrafish to model the effects of aging and age-related diseases (Gerhard, 
2003; Gerhard & Cheng, 2002; Keller & Murtha, 2004; Kishi, 2004).   
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The FMP Y-maze has been developed to assess cognition, specifically, exploration, WM and 
behavioural flexibility, in a range of organisms, including zebrafish, flies, rodents and a virtual task for 
assessing humans (Cleal, Fontana, et al., 2020; Cleal & Parker, 2018; Fontana, Cleal, & Parker, 2019; 
Fontana, Cleal, Clay, et al., 2019). Analysis of exploration patterns has led to the observation that 
vertebrate species are biased towards strategies utilizing alternating left and right turns, known as an 
‘alternation’ (left, right, left, right-LRLR, right, left, right, left-RLRL). Pharmacological blockade of memory 
forming pathways in zebrafish, revealed a role for memory processing and behavioural flexibility in the 
formulation of search patterns and updating exploration strategies during task progression (Cleal, 
Fontana, et al., 2020). In the FMP Y-maze, WM is based on the ability to recall previous arm entries, 
similar to the alternation task of the T- or Y-maze (Stewart et al., 2011; van der Staay et al., 2011). 
Recording percentage-use of reoccurring patterns of four consecutive turn choices, known as 
tetragrams, over one hour of exploration gives rise to a ‘global’ search strategy. Similar exploration 
strategies, predominantly reliant on alternations, have been reported in rodents, both in the FMP Y-
maze and T-maze using the same analysis (Cleal, Fontana, et al., 2020; Gross et al., 2011). Behavioural 
assessment of 1 h of free exploration in the FMP Y-maze enables the identification of WM abilities and 
cognitive flexibility, presenting the FMP Y-maze as a useful tool for assessing memory processing in 
animal models and potentially patients with disorders characterised by cognitive decline.  
We used the FMP Y-maze and pharmacological agonism of D1-like receptors, to understand 
the role of dopamine in healthy aging in zebrafish. We compared behavioural phenotypes of 6-month-
old adults with aged, 24-month-old adults in the early stages of senescence. Our hypothesis was that 
24-month-old zebrafish may have begun experiencing mild cognitive decline with the increase of age-
associated biological markers. We examined changes in WM and cognitive flexibility in a recently 
developed behavioural paradigm that can be used to assess both cognitive functions simultaneously 
with minimal handling and experimenter interference. We furthered our investigation by comparing 
changes in WM of young and aging zebrafish to changes in WM between young and old, healthy 
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humans. Our aim was to assess the translational relevance of age-related changes in memory processing 
in zebrafish compared to humans.  
 
5.3 Materials and Methods 
Ethical statement 
The University of Portsmouth Animal Welfare and Ethical Review Board guidelines were followed for all 
experiments carried out as part of this study, and under license from the UK Home Office (Animals 
(Scientific Procedures) Act, 1986) [PPL: P9D87106F]. Human experiments were conducted following 
approval from the University of Portsmouth Science Faculty Ethics Committee (SFEC-2019-062).  
 
Animals and housing  
71 male and female wild type (AB) zebrafish (Danio rerio) aged 6-months old (young adult, n=33) and 
24-months old (aged, n=38) were used to assess cognitive aging as a commonly used strain of zebrafish 
for investigating aging (Kishi, 2004). Previous work in our lab has shown that there are no sex differences 
in the FMP Y-maze and therefore we did not examine the effect of sex as part of this study (Fontana, 
Cleal, & Parker, 2019). Zebrafish were bred in-house and raised in the University of Portsmouth Fish 
Facility. Fish were housed in groups of ~10-12 fish per 2.8L tank on a re-circulating system (Aquaneering 
Inc., San Diego, CA, USA), aquarium-water was maintained at pH 8.4 (±0.4). Previous work from our 
group and extensive pilot studies were used to calculate power analysis and inform sample sizes used 
in this study (Cleal et al., In press; Cleal & Parker, 2018; Fontana, Cleal, & Parker, 2019; Fontana, Cleal, 
Clay, et al., 2019). Room and tank temperatures were maintained at 25-27°C on a 14/10-hour light/dark 
cycle. From 5 days post fertilisation (dpf) fish were fed on ZM fry food until adulthood when they were 
fed on a daily diet of live brine shrimp (maintained at the fish facility) and dried flake food (ZM Systems, 
UK) 3 times/day (once/day at weekends). All fish used in this study were experimentally naïve. Once 
behavioural testing had been completed test fish were euthanized by rapid cooling (immersion in 2oC 




To study the effect on WM, cognitive flexibility and mRNA expression of dopamine receptors, adults 
were incubated for 30 min in 35 µM (10 mg/L) of the selective dopamine D1/D5 receptor partial agonist 
SKF-38393 hydrochloride (Medchemexpress). Due to the water solubility, drug stock solutions were 
made by dissolving SKF-38393 in aquarium water. Drug administration was adapted from (Naderi et al., 
2016), in which individual fish were entirely immersed in drug solution or aquarium water (control) by 
gently netting fish from home tank to a 400 mL beaker filled with 300 mL of drug or water and covered 
with a lid to prevent fish from escaping. Fish were netted into the beaker 30 mins prior to behavioural 
testing. Treatment time was based on previous studies with dopaminergic agonists, demonstrating that 
30 mins of free-swimming during drug immersion was sufficient for drug to influence zebrafish 
behaviour (Irons et al., 2013; Naderi et al., 2016). Immediately following treatment fish were transferred 
into the FMP Y-maze.  
 
FMP Y-maze  
The protocol was carried out as described in our previous papers (Cleal, et al., in press; (Cleal & Parker, 
2018; Fontana, Cleal, & Parker, 2019; Fontana, Cleal, Clay, et al., 2019).  Fish were recorded in a Y-maze 
for 1 hour. If the fish were adopting a random search strategy, it would be predicted that the distribution 
of tetragrams over a 1-hour period would be approximately stochastic (i.e., the relative frequency of 
each tetragram would be ~6.25%). Figure 1 shows an example of a series of movement sequences 
performed in the FMP Y-maze, a combination of which provide a picture of the global search strategy 
used. To minimise stress, fish handling and experimenter visibility were both kept to a minimum. 
Behavioural testing was conducted using a commercially available, fully integrated testing environment, 
the Zantiks AD system for adult zebrafish (Zantiks Ltd., Cambridge, UK). Tanks were black, opaque acrylic 
with a transparent base. A white acrylic Y-maze insert was fitted into each tank. Two Y-maze inserts 
could be fitted per tank.  The Y-maze dimensions were as follows: L500 mm x W200 mm x D1400 mm, 
with a 120° angle between arms. Tanks were filled with 3L of aquarium-water and placed into Zantiks 
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behaviour units, one tank per unit. Each system was fully controlled via a web enabled device. Filming 
was carried out from above, which allowed live monitoring of fish within the behaviour system. Data 




   
Virtual FMP Y-maze 
The human FMP Y-maze is based on a series of adjoining Y-shaped points, forming a honeycomb maze. 
At each choice point, participants must choose to turn either left or right (Figure 1A). In order to test for 
aging related cognitive decline, we recruited N = 80 participants, n = 40 ‘old’ (>70) and n = 40 ‘young’ 
(18-35). Based on power analyses from our previous studies (Cleal et al 2020), we required a minimum 
of n = 16 per group. An individual’s data were excluded if they completed fewer than 10 turns. Following 
exclusions, the final sample size for the ‘young’ group was n = 35 subjects (mean age = 24±4.79 years; 
B. 
Figure 1A. FMP Y-maze behaviour of free-swimming zebrafish. (A) FMP Y-maze arena divided into 
three arms (1,2,3) and a neutral zone (4). (B-D) Examples of movement sequences based on 16 
overlapping tetragrams of left and right turns. (B) Represents the dominant search strategy of 
alternations, made up of a series of left-right-left-right or right-left-right-left turn choices. (C) 
Demonstrates repetitions, where an animal turns in a clockwise or anticlockwise rotation for four 
continuous choices, represented by RRRR or LLLL. (D) An example of an alternate strategy possible 
using tetragram sequences. Here is shown LRRR In on anticlockwise direction, equivalent to RLLL in 
a clockwise direction. 
A. C. D. 
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23:12 male:female), and the ‘old’ group was n = 30 subjects (mean age = 73.83±3.93 years; 18:12 
male:female). The maze was uploaded onto the crowdsourcing website Prolific Academic Ltd 
(https://www.prolific.ac), an online platform which recruits subjects explicitly for participation in research 
(Palan & Schitter, 2018). Specifically, Prolific can be used to set eligibility criteria, and allows participation 
of eligible subjects on a first-come, first-served basis until the total number of required participants is 
fulfilled. We established two studies, with the eligibility criteria based on age only. Once in the maze, 
participants were free to explore for a total of 5 minutes, after which they were automatically logged 
out and, via a link, returned to the Prolific website. Turn directions of participants were reported as x, y 
coordinates which were converted into left and right turns and subsequently transformed into tetragram 
sequences. Each participant was only permitted to enter the maze once. All participants were 








A. B. C. 
Figure 1B. Virtual FMP Y-maze for human participants. A) In maze screenshot taken from the 
perspective of the participant exploring the maze. B) Schematic depicting the honeycomb pattern 
made up of adjoining Y-shaped mazes. C) Overlay of the left and right turns made by a participant 
in the maze during 5 minutes of free exploration. The left and right turns have been converted from 




RNA Extraction and cDNA Synthesis 
Immediately following behavioural testing, fish were euthanised in ice water, brains were removed, 
snap-frozen in liquid nitrogen and stored at -80°C until further use. RNA was isolated using the RNeasy 
Micro kit (Qiagen) as described in the manufacture’s protocol. Upon purification, the quality and 
concentration of all samples were assessed using the NanoDrop ND-1000 (Thermo Scientific). The 
purities of acceptable RNA samples (as measured by 260:280 and 230:260 absorbance ratios) were equal 
to or greater than 1.8. All samples were therefore of sufficient quality for expression-level analysis. Total 
cDNA was prepared using Applied Biosystems High Capacity RNA-to-cDNA Kit for RT-qPCR. Each 20 µL 
reaction was diluted 10-fold in nuclease-free water and used as the template for the real-time qPCR 
assays.  
 
Quantitative Real-Time PCR (RT-qPCR) 
Quantitative real-time PCR (RT-qPCR) assays were used to validate relative gene expression based on 
SYBR green detection. Primers used in this study were predesigned primers from qPrimerDB (Lu et al., 
2018) or based on previous studies (Parker et al., 2016; R. Tang et al., 2007). Primers were synthesised 
by Invitrogen and are listed in Table 1. The Roche LightCycler® 480 High Resolution Melting Master 
mix and the LightCycler® 96 (Roche Life Science) were used to amplify and detect the transcripts of 
interest. Thermal cycling conditions included an initial denaturation step at 95°C for 600s 
(recommended by manufacturer), 40 cycles of 95°C for 15s, 58°C for 20s and 72°C for 35s followed by 
melt curve analysis to confirm product specificity for all transcripts. Primers were tested with melt curve 
analysis and negative reverse transcription (RT) controls and negative template controls to optimise 
reaction conditions to generate a single melt peak in control samples, check for genomic contamination 
in negative RT controls and primer dimers in negative template controls. Elongation factor 1 alpha 
(eelf1a) was used as a housekeeping gene (Tang et al., 2007). Gene-expression levels were calculated 
using delta-delta CT method and normalised to eelf1a. Changes in expression were presented as means 





Table 1. Primer sets used for qPCR  





factor 1 alpha  
eef1a  CTGGAGGCCAGCTCAAACAT  ATCAAGAAGAGTAGTACCGCTAGC ATTAC   87  
Dopamine 
transporter 
dat  GTTGCTGACTTTAGGAATCGAC  GCGTAAACACATAGATTCCACC  179  
Dopamine 
receptor D1 
drd1  TGGTTCCTTTCTGCAACCCA  AGTGATGAGTTCGCCCAACC  100  
Dopamine 
receptor D2a 
drd2a  ATACTTCCGCTCTTTGGATGAA  CGTGATGCATTTTCAAAGAAGC  119  
Dopamine 
receptor D2b 


















Oxygen consumption measurements 
Standard oxygen consumption rates of individual fish were measured based on wet weight (g) and 
amount of oxygen consumed during 1 h of free exploration of the FMP Y-maze. Method for measuring 
oxygen consumption were adapted from (Voutilainen et al., 2011). Briefly, each behaviour tank was filled 
with exactly 3 L of aquarium-water and an initial reading of oxygen saturation were recorded using a 
HQ30D portable dissolved oxygen meter. Zebrafish were netted directly into the maze which was 
covered with parafilm to create a closed system. Tanks were immediately placed into the behaviour unit 
and the trial started. At the end of 1 h of exploration oxygen readings were recorded for each fish. 
Zebrafish were then briefly anaesthetised using Aqua-Sed anaesthetic treatment (Aqua-SedTM, Vetark, 
Winchester, UK) in accordance to manufacturer guidelines. A wet weight was recorded for each fish in 
grams. Oxygen consumption was expressed as mg/L O2 x g-1 x h-1, in which g-1 is per gram, based on 
the wet weight of each fish and h-1 is per hour, based on 1 hour of exploration. Temperature readings 
were recorded pre- and post-behaviour to ensure that temperature did not fluctuate significantly over 
the course of the behavioural task, as this could impact metabolic rate. However, temperature only 
fluctuated by ±1°C which has been shown to be too small a change to influence oxygen metabolism 
(Barrionuevo & Burggren, 1999; Okomoda et al., 2020). 
 
Statistical analysis   
The primary endpoint for analysis of exploration patterns in the FMP Y-maze was the number of choices 
for each of the 16 tetragrams as a proportion of total turns (percentage use). Based on previous research 
we were interested particularly in the proportion of choices that represented alternations (LRLR, RLRL) 
and repetitions (RRRR, LLLL) as these tetragrams were the most observed. All analyses were carried out 
using IBM SPSS statistics version 25 and GraphPad Prism version 8, with all graphical representations 
completed in GraphPad Prism. Analysis of paired tetragram sequences (e.g., LRLR+RLRL, LLLL+RRRR, 
etc) for a single age group was carried out using a One-way analysis of variance (ANOVA) followed by 
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Tukey’s post-hoc test. Comparison of tetragram frequency distributions for age x treatment were 
analysed using Two-way ANOVA. Data were represented as mean + standard error of the mean (SEM). 
For subsequent tetragram analyses, we were interested in putative changes in strategy during the search 
period, and we therefore included “time” as the within-subjects factor. We also included “total turns” as 
a covariate in all analyses, in order to control for general activity levels in statistical models. For age 
groups in which drug was added, we included drug (present vs absent) as a between-subjects’ factor. 
Data for time were represented as mean + SEM. For all data sets the Shapiro-Wilk test of normality was 
conducted. Parametric and non-parametric tests were performed as appropriate for each analysis as 
detailed below. Comparison of percentage use of alternations and repetitions for each age and 
treatment group were analysed using the Kolmogorov-Smirnov test for non-normally distributed data 
sets and the unpaired t-test for normally distributed data sets. Data were represented as the mean + 
SEM. Oxygen consumption was analysed using a One-way ANOVA for age and Two-way ANOVA 
followed by Sidak’s multiple comparison post-hoc test for age x treatment. Data were represented as 
mean + SEM. Body mass was analysed using unpaired t-test. Data were represented as mean ± SEM. 
Locomotor data were analysed for age x treatment using Two-way ANOVA followed by Tukey’s post-
hoc test. Data were represented as mean ± SEM. qPCR data were all tested for normality using the 
Shapiro-Wilk test, as above. Normally distributed data were analysed using unpaired t-test, non-
normally distributed data were analysed using Mann-Whitney test. Data were represented as mean ± 










Aging zebrafish show mild cognitive decline in the FMP Y-maze 
Tetragram analysis revealed that global strategy (percentage use of each tetragram over the entire trial) 
relied on a similar pattern of turn choice, however, key differences were observed in the use of 
alternations (LRLR, RLRL) and repetitions (LLLL, RRRR). (Fig. 2) shows tetragram frequency distribution 
for 1 h of free swimming in the FMP Y-maze for 6-month-old v 24-month-old zebrafish. Equal 
distribution of all possible tetragram configurations would be characteristic of a random search strategy 
(100% turns completed/16 tetragram configurations = 6.25%), whereas choices made above the 6.25% 
threshold are considered intentional and part of a global strategy. Most tetragrams were used randomly 
with bars falling below 6.25% (represented by the dashed line in (Fig. 2). 6-month-old fish used 
alternations significantly more than all other search strategies (One-way ANOVA, F (7, 280 = 36.85, p 
<0.0001). However, there was a significant interaction between age and turn choice (Interaction, F (1, 
68) = 11.94, p = 0.0009) with Tukey’s post hoc test showing 6-month-old zebrafish used alternations 
significantly more than 24-month old zebrafish (95% CI diff = 3.32-14.27, p = 0.0004***). This reduction 
in alternations in 24-month old zebrafish resulted in a change in the global strategy to split dominance 
between two tetragram sequences, alternations and repetitions, instead of just alternations as seen with 






























Figure 2. Global search strategy after 1 h of exploration in the FMP Y-maze. (A) Percentage use of 
each tetragram sequence by 6-month old zebrafish in the FMP Y-maze (n = 18), demonstrating clear 
dominant use of alternations. (B) Percentage use of tetragram sequence by 24-month old zebrafish 
in the FMP Y-maze (n = 20) with comparable use of alternations and repetitions. (C) Alternations 
versus repetitions for 6-month old and 24-month old zebrafish. Normality analysed using Shapiro-
Wilk test. Normally distributed data were analysed using One-way ANOVA. The dashed line denotes 
chance performance (approximately 6.25%). *** p ≤ 0.001, **** p ≤ 0.0001, ns – not significant. Error 





Treatment with D1/D5 agonist, SKF-38393, rescues working-memory deficit in aged zebrafish 
Having shown a deficit in WM of 24-month old zebrafish compared to 6-month old counterparts, shown 
by a change in global exploration strategy, we pre-treated zebrafish with D1/D5 agonist SKF-38393 for 
30 mins prior to testing in the FMP Y-maze. SKF-38393 treatment had no effect on global strategy in 6-
month old zebrafish, with both alternations and repetitions showing no effect between treated (n=15) 
and untreated (n=18) fish (Two-way ANOVA, F (1, 496) = 0.44, p = 0.5078). However, treatment of 24-
month old zebrafish caused a significant increase in the use of alterations (KS, D = 0.33, p = 0.0297), 
without affecting use of repetitions (KS, D = 0.14, p = 0.8582) (Fig. 3). WM, as measured by global 
strategy showed a significant effect of age (F (1,69) = 9.037, p = 0.037), but no significant interaction (F 
(1,69) = 2.546, p = 0.115) and no main effect of treatment (F (1,69) = 1.643, p = 0.204). However, Tukey’s 
post hoc tests revealed that treatment with SKF-38393 rescued the deficit in alternations between aged 
24-month old and young 6-month old zebrafish (95% CI = -3.74-10.52, p = 0.5969) compared to 






















Healthy aging impacts cognitive flexibility which cannot be recovered by treatment with SKF-38393 
The FMP Y-maze is a dual-action behavioural task which enables assessment of WM based on global 
strategy, but also cognitive flexibility by analysing ‘immediate’ strategies consisting of exploration 
patterns for the total trial divided into equal length time bins (six 10 min time bins). This enables the 
identification of changes in strategy over time. (Fig. 4) illustrates the percentage use of each tetragram 
sequence per 10 mins of exploration clearly denoting differences in the use of alternations over 
successive 10 min exploration intervals for 6-month old zebrafish, but a diminished effect of time on 
alternations in the 24-month old zebrafish. As alternations have been revealed as the dominant strategy 
and prone to change with age and treatment, we further explored the effect of time on alternation use. 
6-month old control zebrafish showed the greatest effect of time on alternations as demonstrated in 
(Fig 5). From the initial 10 mins of exploration, alternations were already used above random selection 
and continue to rise significantly with each successive time bin (One-way ANOVA, F (5, 210) = 4.33, p = 
0.009). The maximum mean difference between time bins was 9.7%, indicating that the alternation 
strategy was not static, but was altered in response to a constant environment. 24-month old aging 
zebrafish demonstrate a deficit in the ability to adapt their strategy over time, as shown by the stable 
use of alternations in consecutive time bins (One-way ANOVA, F (5, 234) = 1.35, p = 0.2449), with a 
maximum mean difference of 3.6% between time bins. Treatment of 6-month old zebrafish with SKF-
38393 did not affect global strategy as seen in Figure 3, however, it did appear to have a dampening 
Figure 3. Effective pre-treatment with D1/D5 agonist SKF-38393 on global search strategy of 
zebrafish in the FMP Y-maze. Effect of SKF-38393 on search strategy of (A) 6-month old treated 
compared to control zebrafish and (B) 24-month old treated compared to control zebrafish after 1 
h of exploration. (C) Comparison of alternations and repetitions in 6-month old and 24-month old 
control v treated zebrafish. C – control, T – treated with D1/D5 agonist SKF-38393. Normality 
analysed using Shapiro-Wilk test. Normally distributed data analysed using two-way ANOVA and t-
test. Non-normally distributed data analysed using Kolmogorov-Smirnov (KS) test. * p ≤ 0.05, ns – 




effect of changes in alternation use over time (Fig. 5). Though still significant, the effect was greatly 
reduced compared to controls (One-way ANOVA, F (5, 164) = 2.73, p = 0.0215). In 24-month old 
zebrafish treated with SKF-38393 the global use of alternations was increased to a performance level 
equivalent to 6-month old controls; however, the drug treatment was unable to restore adaptability of 
search over time, resulting in a stable strategy (One-way ANOVA, F (5, 208) = 0.185, p = 0.9681), which 
















































Figure 4. Shows the use of each tetragram per 10 min time bin for a 1 h trial of free FMP Y-maze 
exploration. (A) Depicts tetragram use for 6-month old adult controls compared to (B) SKF-38393 
treated. Both groups clearly illustrate an increasing use of alterations across successive time bins. 
(C) Shows the same frequency distribution for 24-month old aging adult controls versus (D) SKF-
38393 treated. Although the agonist treated group shows an increased percentage of alternations 
per time bin compared to controls, both groups have a heavily blunted effect of time, resulting in 




Figure 5.  
 
Figure 5. Percentage use of alternations in successive 10 min time bins of exploration (A) 6-month 
old controls (left) and treated with SKF-38393 (right) and (B) 24-month old controls (left) and 
treated (right). (C) Combined effect of time on percentage use of alternations for all ages and 
treatment groups. Analysed using one-way ANOVA. * p ≤ 0.05, ** p ≤ 0.01, ns – not significant. The 







Metabolic rate is not a factor in changing search strategy with age 
There appeared to be a substantial size difference between age groups, therefore, to identify if 
metabolism played any role in the change in search strategy, wet weight and oxygen consumption over 
the course of the trial were recorded as an indirect measure of metabolism (Nelson, 2016). We identified 
a significant difference in wet body mass (t = 7.195, df = 19, p <0.0001) with a mean wet weight of 0.39g 
for 6-month old and 0.83g for 24-month old zebrafish. We furthered this analysis by comparing oxygen 
consumption between age groups and found no significant difference (t = 1.660, df = 8, p =0.1356). 
However, there was an effect of treatment on oxygen consumption (Two-way ANOVA, F(1, 17) = 11.41, 
p = 0.0036), Sidak’s multiple comparison post-hoc test revealed that treatment with D1/D5 agonist SKF-
38393 caused a significant decrease in oxygen consumption in 6-month old (95% CI = 0.433-1.787, p = 


















Regulation of dopaminergic gene expression by aging 
We investigated the effect of age on the dopaminergic system by analysing expression changes 
between 6 and 24-month old zebrafish. Figure 7 shows the qPCR data of relative gene expression from 
whole brain tissue. We found no significant difference between 6 and 24-month old zebrafish for dat (U 
= 4, p =0.1667), drd1 (t = 1.25, df = 8 , p =0.2460), drd2a (t = 1.20, df = 7 , p =0.2699), drd2b (t = 0.21, 
Figure 6. (A) The mean difference in body mass between 6-month old (n=10) and 24-month old 
(n=12) zebrafish. (B) Locomotor activity measured by total turns completed in 1 h of exploration. 
(C) Oxygen consumption of 6-month old controls (n=4) compared to 24-month old controls (n=6). 
(D) Effect of SKF-38393 on oxygen consumption over 1 h of exploration in 6-month old and 24-
month old control v treated. Normality analysed using Shapiro-Wilk test, normally distributed data 
analysed by Two-way ANOVA (B,D) or unpaired t-test (A,C). Data for a and b are mean ± SEM, data 






df = 7 , p =0.8434) or th (t = 0.55, df = 7 , p =0.5985) mRNA expression levels. However, there was a 







Figure 7. Quantitative real-time PCR analysis showing variations in the relative amounts of dat, drd1, 
drd2a, drd2b, drd5 and th mRNA in whole brain tissue extracted from 6-month old controls (n=4) 
and 24-month old controls (n=6). Data were normalised to housekeeping gene eelf1α and defined 
as fold change relative to 6-month old controls. Normality was analysed using Shapiro-Wilk test. 
Normally distributed data were analysed using unpaired t-test, non-normally distributed data were 




Effect of SKF-38393 on dopaminergic gene expression 
The qPCR data in Figure 8 shows that 35µM SKF-38393 was able to decrease the expression of dat in 6-
month old zebrafish (U = 0, p = 0.0048) but not 24-month olds (U = 9, p = 0.1645). However, 30 min 
treatment with SKF-38393 did not elicit expression changes in drd1 (6-months old; t = 1.36, df = 7 , p 
=0.2170, 24-months old; t = 0.83, df = 10 , p =0.4266), drd2a (6-month old; t = 1.33, df = 7 , p =0.2259, 
24-month old; t = 1.31, df = 8 , p =0.2265), drd2b (6-months old; t = 1.17, df = 8 , p =0.2753, 24-months 
old; t = 0.18, df = 8 , p =0.8651), drd5 (6-months old; t = 1.38, df = 8, p = 0.2064, 24-months old; t = 
1.62, df = 9, p = 0.1405) or th (6-months old; t = 0.72, df = 8 , p =0.4950, 24-months old; t = 0.14, df = 

























Figure 8. Quantitative real-time PCR analysis showing variations in the relative amounts of dat, drd1, 
drd2a, drd2b, drd5 and th mRNA in whole brain tissue of controls and treated groups exposed to 
35 µM SKF-38393 in 6-month old controls (n=4) and treated (n=5) and 24-month old controls (n=6) 
and treated (n=6) zebrafish. Data were normalised to housekeeping gene eelf1α and defined as fold 
change relative to controls. Normality was analysed using Shapiro-Wilk test. Normally distributed 
data were analysed using unpaired t-test, non-normally distributed data were analysed using the 




Healthy aging humans show mild cognitive decline  
Having shown a deficit in WM of old versus young zebrafish, to understand the translational relevance 
of these findings, we assessed WM in healthy populations of young and old humans in a previously 
developed virtual FMP Y-maze, which is analogous to the animal version (Cleal, et al., 2020). To establish 
clinically relevant findings, we ran participants in the FMP Y-maze for 5 minutes of free exploration. Like 
zebrafish, humans showed dominant use of the alternation strategy and similarly there appeared to be 
a significant reduction in the use of alternations in older (70+ year-olds) compared to younger (18-35 
year-old) adults (F (1, 65) = 7.175, p = 0.009) (Figure 9). Thus, we demonstrated a deficit in WM in healthy 
aged adults compared to their younger counterparts.  
 




Figure 9. Global search strategy after 5 minutes of exploration in the human virtual FMP Y-maze. A) 
Percentage use of each tetragram sequence by young adults aged 18-35 years old (n=35) compared 
to older adults aged 70+ years old (n=32). Both demonstrating dominant use of the alternation 
strategy. B) Comparison of young and old aged groups and the use of total alternations (LRLR+RLRL) 
and total repetitions (LLLL+RRRR). Analysed using LMM. The dashed line denotes random choice 






Using a zebrafish model of aging we have investigated changes in WM and cognitive flexibility between 
young adulthood and aging, suggesting mild cognitive decline. The present findings indicate that WM 
and strategy changes are both impaired in aged zebrafish; however, acute exposure to SKF-38393, a 
selective dopamine D1/D5 receptor partial agonist, enhanced WM in aging, but had no detectable effect 
on behavioural flexibility. Real-time qPCR analysis identified an up-regulation of drd5 in 24-month old 
zebrafish compared to 6-month old counterparts. Treatment with SKF-38393 caused a down regulation 
of dat mRNA expression in 6-month old adults, but no effect on aged adults, supporting the role of dat 
in regulating dopamine availability and cognitive flexibility. These findings provide characterisation of 
cognitive changes in healthy aging which can be partially rescued by activating D1-like receptors, 
promoting the role of maintaining WM, but not behavioural flexibility. This study, to our knowledge, 
provides the first examination of changes in dopaminergic gene expression in the aging brain of 
zebrafish. To address the translational relevance of the zebrafish model of aging, we examined WM of 
healthy adults using an analogous version of the FMP Y-maze adapted for humans. We identified a 
similar reduction in alternations in old versus young adults, comparable with the changes seen in 
zebrafish. Thus, our findings demonstrate for the first time that zebrafish faithfully replicate aspects of 
healthy aging seen in humans, that results in a decline in WM with old age.  
 
Changes in WM in healthy aging zebrafish 
Younger adult zebrafish have demonstrated a very specific global strategy used to explore the FMP Y-
maze. Using tetragram sequence analysis, we identified patterns of choice selection of left and right 
turns in 6-month old adults that use alternation sequences (LRLR, RLRL) for more than 25% of the global 
search strategy, four times the use if selected randomly. All other sequences were used at a level 
equivalent to chance selection.  Prior work has demonstrated that changes in global spatial activity 
patterns, particularly those relating to alternations and repetitions, are representative of changes in WM 
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processing (see Part 1:  Chpt 3) (Cleal, et al., 2020). Previous work has also demonstrated similar patterns 
of alternations in young adult zebrafish ranging from 3-6-month old (see Part 1: Chpt 4) (Cleal & Parker, 
2018; Fontana, Cleal, & Parker, 2019; Fontana, Cleal, Clay, et al., 2019). Aging zebrafish at 24-month old 
have, however, demonstrated a marked change in global spatial activity patterns reducing the use of 
alternations by ~8%, bringing the use of alternations and repetitions almost in line at 18% and 16% 
respectively. This deficit in alternations may represent an inability to recall which arms of the maze have 
previously been entered and/or the order of entry, a process which has been shown to be dependent 
on WM (Lalonde et al., 1986; Moran et al., 1995; Myhrer, 2003). These findings further support that 
zebrafish, like humans, have a natural decline in cognitive abilities as part of healthy aging, resulting in 
deficits in WM (Berry et al., 2016; Dreher et al., 2008; Goldberg, 2017; Salthouse, 2009).  
The role of aging in cognitive decline has been well documented in humans, with many animal 
models replicating similar deficits in cognitive performance (Gerhard, 2007; McQuail & Nicolle, 2012). 
Human and animal studies, have implicated disruption of the dopaminergic system in age-related 
decline in executive functions such as WM (Castner & Goldman-Rakic, 2004; Costa, 2014; Decker & 
McGaugh, 1991; Dreher et al., 2008; Godefroy et al., 1989).  To this end we pre-treated adult and aging 
zebrafish with the partial dopamine D1/D5 receptor agonist to identify what role D1-like receptors play 
in the cognitive decline in healthy aging zebrafish. Similar to animal and human studies (Castner & 
Goldman-Rakic, 2004; Hemby et al., 2003; Molloy & Waddington, 1988; M. Wang et al., 2019), we found 
that treatment with a partial D1/D5 agonist enhanced WM in aging zebrafish, resulting in a rise in the 
use of alternations as part of the global strategy. 24-month old treated zebrafish increased alternations 
by nearly 7%, bringing alternation use to a level comparable with 6-month old zebrafish. The effect of 
SKF-38393 was age specific, as no such changes in WM were observed in treated 6-month old zebrafish. 
Our findings support work from (Part 1: Chpt 3), indicating that boosting D1-like receptor activation is 
only beneficial if there is pre-existing dysregulation within the dopaminergic system (Cools & 




The role of metabolism and the effect of SKF-38393 on cognitive flexibility 
Fine-scale analysis revealed that not only do fish use an overall, global strategy of alternations and 
repetitions to explore the FMP Y-maze, but this strategy is subject to change over time. We observed a 
pattern of increasing use of alternations throughout the trial in young, 6-month old adults. However, 
this natural tendency to modify search strategy with time ceases in aged adults. Throughout the life-
span of an organism there is a continuous, dynamic equilibrium between goal stabilised and destabilised 
behaviours, in which an individual is required to balance focus on the current task against new 
information altering current goal perceptions (Cools, 2016). This cognitive flexibility has been strongly 
associated with the dopaminergic system and WM (Cañas et al., 2003). In the FMP Y-maze the current 
goal could be perceived as foraging for potential food sources, or information seeking. This behavioural 
paradigm works on the basis of negative feedback (a continuous lack of food or reward) to update 
knowledge of the environment and inform decisions to select appropriate behaviours, in this task 
reflected as search strategy. In young, healthy adult zebrafish the negative feedback loop dictates an 
increasing use of alternations over time. However, in line with previous studies in humans (Harada et al., 
2013), aged zebrafish could not utilise negative feedback to update behaviour in response to the lack 
of environmental change and thus relied on the ‘immediate’ strategy, that was employed within the first 
10 mins of novel exploration, as the only strategy used to explore the maze. This strategy was used 
regardless of how familiar the environment had become or in light of continuous lack of reward or 
novelty whilst exploring the FMP Y-maze. Changes in cognition is a normal aspect of healthy aging and 
similarly to humans, zebrafish exhibit age-related deficits in cognitive abilities (Adams & Kafaligonul, 
2018). It is therefore unsurprising that in aging adults there is no longer an effect of time on alternations. 
The ability to adapt behaviour based on new information is fundamental to healthy cognitive 
processing, the disruption of which is common to psychiatric illness and neurodegenerative diseases 
(Pittenger, 2013; Waltz, 2017). The inability to adapt behaviour in response to the environment is of 
critical importance in aging conditions, and thus highlights the suitability of zebrafish to aid in informing 
human conditions of cognitive decline in aging.  
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An interesting finding from this study was that treatment with SKF38393 caused a reduction in 
the effect of time on search strategy in younger adults. However, aged adults showed no effect of time 
on search strategy, regardless of whether they were treated with SKF-38393. Dopamine acts as a 
neuromodulator, which is essential for achieving and maintaining cognitive control functions such as 
flexibly adjusting goal-directed behaviours (Ott & Nieder, 2019). Via D1-like receptor activation, 
dopamine can modulate WM performance and sustain goal-focused behaviour by stabilising neuronal 
activity and generating a high signal to noise ratio, reducing the influence of interfering (off target or 
distracting) stimuli (Durstewitz et al., 2000).  However, in order to achieve goal-orientated behaviour 
with flexible adaptations a balance is required between a D1 (including both D1 and D5 receptors)- and 
D2- (including D2, D3 and D4 receptors) dominant state, known as Dual state theory (Cools, 2016). Dual 
state theory implicates intermediate neural levels of dopamine, primarily acting via D1-like receptors, 
resulting in low firing rate (lower energy use) and increased goal-directed behaviour as the D1-dominant 
state. The D2-dominant state, activation via D2-like receptors, is characterised by fast firing rates (high 
energy use) and behavioural flexibility, e.g. set shifting or behavioural adaptations (Cools, 2016). A shift 
to the D1-dominant state by pharmacological intervention, for example following pre-treatment with a 
selective D1/D5 receptor agonist, would result in system bias in favour of goal stabilisation, which is 
good for achieving the current goal (e.g. searching for food), but bad for adapting behaviour in response 
to new information (e.g. no food and a constant, unchanging environment, as presented in the FMP Y-
maze) (Cools, 2016; Lianchun Yu & Yu, 2017).  
We measured oxygen consumption in control and treated groups to identify if changes in 
metabolic activity played a role in the change in behaviour. Supporting the theory of dual state action 
between D1-like - goal-directed behaviour and D2-like - flexible behaviour. We found that 6-month old 
controls showed the greatest behavioural flexibility, but also had the highest mean oxygen consumption 
of 1.54 mg/L O2 over 1 h of exploration. Treatment with SKF-38393 caused a significant decrease in 
oxygen consumption and a reduction in adaptive search behaviour over time. However, no such effect 
was evident in aged adults which had similar search strategies over time and similar oxygen 
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consumption in control and treated groups. Our findings support over activation of the D1-like receptor 
pathways, in 6-month old adults’ treated with SKF-38393, potentially biasing the dopaminergic system 
in favour of a goal stabilised state, which decreased the amount of flexibility and reduced energy 
consumption by switching to a state with a lower firing rate in dopaminergic neurons.  
The lack of change in search patterns over time in aged adults and the accompanying lack of 
change in oxygen consumption between treated and control groups, further supports this hypothesis. 
Examples of the Dual state theory have been evidenced in human, primate and computational studies 
(Durstewitz et al., 2000; Durstewitz & Seamans, 2008; Fallon & Cools, 2014; Ott & Nieder, 2019). Here 
we see that increasing D1-like receptor signalling interferes with cognitive flexibility in younger adults 
and is unable to restore it in aged adults. Thus, biasing away from flexible behaviour appears to be a 
robust mechanism; however, as we have outlined above, in order to positively influence goal-directed 
behaviour a specific level of receptor activation is required. It is also noteworthy that these changes do 
not appear to be related to locomotion as there are no changes in total turns between controls and 
treated fish of either age group, despite changes in metabolism in 6-month old adults and changes in 
global strategy in 24-month old fish in response to SKF-38393 treatment. This further supports the 
hypothesis that changes are mechanistic and dependent on age, opposed to physical, i.e. increased 
number of turns resulting in an increased number of alternations, or decreased activity decreasing 
oxygen consumption. Here we provide the first evidence that the Dual state theory may also apply to 
zebrafish. However, the modulatory effect of dopamine is complex, influenced by dopamine receptor 
activation and age. These findings provide further understanding of the role of the dopaminergic system 
in age-related changes in cognition, but more work is necessary to fully elucidate the mechanisms and 






Molecular changes in dopaminergic gene expression  
To further understand the role of dopamine in healthy aging we investigated the expression of genes 
critical to the dopaminergic system including tyrosine hydroxylase (th), dopamine transporter (dat) and 
the dopamine receptors (drd1, drd2a, drd2b and drd5). Contrary to previous studies, we did not observe 
any age-dependent alterations in expression levels of th, dat, drd1 or drd2 receptor subtypes, however, 
there was a significant increase in drd5 gene expression in aged compared to young adult zebrafish. 
Few studies have investigated gene expression of D5 receptors in aging in the healthy brain of 
mammals, and to our knowledge this has not previously been investigated in zebrafish. Our finding of 
increased drd5 expression is somewhat at odds with the few mammalian studies of D5 receptors in 
aging (Hemby et al., 2003; Rothmond et al., 2012). Rothmond, et al, found that D5 receptor mRNA 
expression was negatively correlated with age from neonate (6 weeks old) to adult (up to 49 years old), 
however they noted that there was no significant difference between the age groups examined, 
including young adults (20-25 years old) and adults (35-50 years old). Hemby, et al, examined age-
related changes in mRNA expression of dopamine receptor subtypes. They found a significant age-
related decline in relative abundance of D5 receptors in CA1 pyramidal neurons, but no change in the 
entorhinal cortex layer II stellate neurons. Despite a negative correlation of D5 receptor expression in 
the CA1 pyramidal neurons with increasing age, from 19-92 years, there was greater variability in 
expression of D5 receptor expression (R = 0.533) compared to the other four dopamine receptor 
subtypes (D1 R = 0.764; D2 R= 0.775; D3 R = 0.895; D4 R = 0.789) (Hemby et al., 2003). Additionally, the 
author’s noted that age-related changes in D5 receptor expression were only possible due to the ability 
to examine specific neuronal populations. Both studies found overall negative correlations with D5 
receptor mRNA expression and increasing age, however, this was over multiple age groups differing by 
~49 years and ~70 years respectively (Hemby et al., 2003; Rothmond et al., 2012). The difference in drd5 
receptor mRNA expression between 6 and 24-month old zebrafish may be a consequence of analysing 
whole brain expression instead of specific regions or neuronal populations. The high variability of 
samples may also be reflective of sex differences or different rates of aging between individuals, 
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potentially demonstrating high sensitivity of drd5 receptors to these changes. Kishi, et al, noted that in 
aging zebrafish there was significant variation in the levels of biochemical and biological markers used 
as an indicator for the onset of senescence (Kishi et al., 2003) and this may be the case for drd5 
expression.  
Similarly, the absence of differences in the other dopaminergic mRNA expression levels may be 
due to the use of region-specific tissue for analysis in mammalian studies, e.g. the hippocampus, 
prefrontal cortex, ventral or dorsal regions of the striatum (Araki et al., 2007; Godefroy et al., 1989; 
Hemby et al., 2003). The asymmetric distribution of dopamine receptors throughout the brain strongly 
correlates localization with functional specificity (El-Ghundi et al., 2007). It is therefore, a possibility, that 
regional differences in expression may counteract one another when the system is subject to subtle 
changes in expression. It is also possible that differences in expression are not typical between 6 and 
24-month old zebrafish as, to our knowledge, this is the first work to examine age-associated differences 
in dopaminergic gene expression in aging zebrafish. Therefore, our initial findings should be interpreted 
with care and further clarity is needed to understand the species-specific changes in the dopaminergic 
system during healthy aging in zebrafish and what potential role sex differences may play.  
Large or regionally uniform changes may be detectable with whole brain gene expression 
analysis. To this end we examined if there were any detectable changes in expression related to fish 
treated with SKF-38393. We found a significant reduction in expression of dat in 6-month old treated 
adults compared to controls, an effect that was not replicated in 24-month old treated fish, suggesting 
an age specific effect. Dat, a plasma membrane protein exclusively expressed in dopamine synthesising 
neurons, plays a crucial role in regulating the amplitude and duration of dopamine-mediated 
neurotransmission by clearing dopamine from the synaptic cleft (Bannon, 2005; Bannon et al., 2001; 
Mortensen & Amara, 2003). The constitutive process of transporter trafficking of dopamine allows for 
rapid up- and down- regulation of cell surface transporter expression and, thus, transport activity (Gulley 
& Zahniser, 2003). Down-regulation of dat, thus resulting in an increase of synaptic dopamine 
availability by reducing reuptake, is a likely explanation for the reduction in cognitive flexibility over time 
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in the treated 6-month old zebrafish. Studies investigating dopamine system function modulating 
behaviour, have identified a role for presynaptic dopamine transporters (dat). Studies examining 
cognitive flexibility in patients with PD have found that patients taking dopamine-enhancing medication 
(e.g. dopamine receptor agonists or L-DOPA) perform poorly on reversal or reinforcement learning tasks 
compared to patients that are not receiving medication (Cools et al., 2001; Rutledge et al., 2009; Waltz, 
2017). Additionally it was noted that learning rates that were enhanced by dopaminergic medications 
only impacted positive reward learning and had no effect on negative outcome learning (Rutledge et 
al., 2009). These findings are consistent with other studies using methylphenidate or cocaine- both 
substances blocking dopamine reuptake by inhibiting dat (Gatley et al., 1999). (Clatworthy et al., 2009) 
found that young healthy subject’s orally administered methylphenidate had the least cognitive 
flexibility in reversal learning when associated with the greatest amount of striatal dopamine release; 
however, spatial WM performance was improved with increasing amounts of striatal dopamine. Similarly 
studies of cocaine-use found that cognitive flexibility was selectively impaired, with some studies 
showing that WM remained unaffected (Colzato et al., 2009; Stalnaker et al., 2009). Combined, these 
experiments support the findings from this study that increased synaptic dopamine, either by reducing 
dopamine transporters or treatment with dopamine-enhancing drugs, can impair behavioural flexibility 
in healthy subjects, or patients treated with enhancing drugs, by causing an ‘over-dose’ of dopamine in 
regions with optimal dopamine levels, in relation to other dopamine depleted regions resulting in 
distinct functional changes, i.e. no effect on WM, but a decrease in behavioural flexibility as seen here 
in 6-month old treated zebrafish compared to controls. This hypothesis would also explain the lack of 
effect of SKF-38393 on dat expression in 24-month old adults, which had already shown a deficit in 
cognitive flexibility in the control group, therefore pre-existing dysregulation of the dopamine system 





Changes in WM in healthy aging humans 
Deficits in WM found in aging zebrafish compared to younger counterparts, support findings from 
human studies (Berry et al., 2016; Dreher et al., 2008; Goldberg, 2017; Salthouse, 2009). However, to fully 
appreciate the translational relevance of zebrafish as a model of aging and the FMP Y-maze as a 
sensitive measure of cognition, we used a previously developed virtual version of the FMP Y-maze with 
healthy human subjects to assess WM in aging. Previous tests in the FMP Y-maze found that humans, 
like zebrafish, relied on alternations as the dominant strategy for exploration in the maze (Cleal, et al., 
2020). However, the sensitivity of this task to subtle changes in cognitive decline have yet to be 
examined. We used a virtual version of the FMP Y-maze, run using a clinically relevant protocol requiring 
only 5 minutes of subject participation, to assess exploration strategies. We found that young adults, 
aged 18-35, used alternations more than adults aged 70 and above. Demonstrating an age-related 
deficit in WM, in line with previous studies (Glisky, 2019; Goldberg, 2017; Pliatsikas et al., 2019). Our 
findings in humans, replicate those seen in zebrafish, supporting their use as a model of aging and 
additionally demonstrating the suitability of the FMP Y-maze as a measure of cognition that can be 
used to assess the same neurobiological measures in humans and fish.  
 
5.6 Conclusion 
Our study shows that mild cognitive decline is a common component of healthy aging in both humans 
and zebrafish. Using the FMP Y-maze, subtle changes in WM can be detect in aged compared to young 
adults. Our results are consistent with previous findings that the dopamine system plays a vital role in 
maintaining normal cognition and consequently appropriate behaviour selection in natural, healthy 
aging. We found that aged adult zebrafish have impaired WM and cognitive flexibility compared to their 
younger counterparts, however, treatment with a D1/D5 agonist could improve WM performance in the 
FMP Y-maze. We also identified a role for ‘over-dosing’ of dopamine and regulation of dat expression 
in subjects without dopamine depletion, which consequently resulted in reduced cognitive flexibility in 
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healthy treated adults compared to controls. Further study is required to fully elucidate the mechanisms 
underlying responses to dopamine-enhancing drugs, with particular focus on regional brain changes 
and specific behavioural impairment and enhancement. Our work further supports the use of zebrafish 
as a model organism for studying behavioural changes and cognitive decline in aging, with significant 




















    Chapter 6 
 
The FMP Y-maze has now been used to assess cognitive function in zebrafish from 4 dpf larvae to 2 year 
old adults. We have identified critical periods during development and ageing that impact on cognitive 
performance. The flexible use of the same task for assessing cognition across all ages makes it possible to 
map cognitive development. The lack of recurrent cognitive tests for children and adults has been raised 
as a potential caveat in investigations of cognitive maturation and identification of abnormal cognitive 
trajectories, such as those observed in neuropsychiatric disorders and neurodegenerative disease (Cromer 
et al., 2015). This highlights another positive application of the FMP Y-maze as a cognitive task that has 
the capability to assess cognitive performance at a broad range of ages.  
 
When considering diseases which are characterised by impaired memory performance AD is one of the 
most well-known. During development of new behavioural tasks it is important to ensure that they have 
of a combination of face, construct and predictive validity, particularly when using them as measures for 
translational research. The previous three chapters have detailed use of the FMP Y-maze with a range of 
organisms, including humans, a broad spectrum of ages and sensitivity to pharmacologically induced 
cognitive alterations, designed to test the uses and limitations of the FMP Y-maze. However,  investigations 
completed so far have all utilised healthy animals and humans. An important test of validation is with the 
use of a genetic model of known cognitive impairment. To this end, we have utilised one of the best 
characterised models of one of the most well-known diseases to cause memory impairment: AD. We are 
using the rodent APP/PS1 double transgenic model of AD. Deficits in WM in this model have been well 
characterised and extensively reported in the literature. The next chapter describes cognitive performance 




Validation of The FMP Y-maze as a Simple, non-invasive Test to 




To date, cognitive tests in mouse models of Alzheimer’s disease (AD) have provided challenges in 
translating findings to the clinic, due to the animal specific nature of many behavioural tasks. Improving 
face, construct and predictive validity of animal models is greatly needed to better recapitulate 
symptoms associated with the human condition. The Free Movement Pattern (FMP) Y-maze has been 
demonstrated as a reliable measure of cognitive function that can not only be translated to humans, 
but also to multiple animal models. Thus, a larger breadth of model can be utilised for the assessment 
of human conditions, such as AD, and can be retrospectively combined to provide a broader, more 
informed view of the mechanisms and treatments that contribute to disease onset, progression and 
improvement. Here we further validate the FMP Y-maze as a measure of cognitive function using the 
rodent APP/PS1 model of AD to verify the detection of cognitive deficits, specifically WM, demonstrating 
sensitivity to changes in cognitive function and suitability to testing rodent models of AD.     
 
6.2 Introduction 
Cognitive impairments are a core feature of neurodegenerative disorders, such as AD, which is most 
notably characterised by a loss of memory function (Hugo & Ganguli, 2014). Several types of memory 
loss are well established in patients with AD, including episodic memory, semantic memory, recognition 
memory and working memory (WM) (Baddeley et al., 1991; Jahn, 2013). Previous work has highlighted 
WM capabilities as a central cognitive function which underlies the processing of other complex 
executive functions, such as planning, decision-making and cognitive flexibility (Baddeley, 1992, 2012). 
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Therefore, impairment of WM performance has the capacity to impact a subset of executive functions, 
deficits of which are regularly reported in AD patients (Guarino et al., 2019b; Kirova et al., 2015).   
WM assessments in rodents are commonly carried out using maze-based tasks, such as the T 
and Y-mazes, radial arm maze, Morris water maze (MWM) and Barnes circular maze (Dudchenko, 2004; 
Shepherd et al., 2016; Stewart et al., 2011). WM impairments have been identified using a variety of 
maze tests, for assessing rodent models of AD, including the APP/PS1 mouse line (Bayer & Wirths, 2008; 
Ferguson et al., 2013; Wirths et al., 2008). However, discrepancies in findings are not uncommon with 
some investigators reporting deficits whilst others testing the same strain-matched model find no 
differences between transgenic mice and controls (Puzzo et al., 2015). A critical factor in determining 
WM deficits is the method of assessment used, with significant variation in impairment detection 
between tasks (Stewart et al., 2011). These discrepancies may arise as a consequence of confounding 
factors that often involve non-cognitive processes, such as locomotor and visual impairments, anxiety, 
fear and environmental disturbances, which can mask or exaggerate inferred cognitive dysfunction 
(Kapadia et al., 2016; Shepherd et al., 2016).  
To successfully translate findings from animal models to humans, methodologies used for 
testing rodents need to minimise the effects of confounding variables and generate tasks that, as closely 
as possible, resemble clinical assessments (Bussey et al., 2008). To this end the FMP Y-maze has been 
designed as a task with improved translational relevance, that targets analogous cognitive domains 
across a range of species. The FMP Y-maze has been shown to be a reliable test of exploration strategy 
and WM performance in humans, rodents and zebrafish, demonstrating sensitivity to drug-induced 
cognitive changes (Cleal & Parker, 2018), ageing humans and zebrafish (Cleal, et al., under review) and 
is sensitive to perturbation in glutamatergic, cholinergic and dopaminergic systems (see Part 1: Chpt 3 
& 5) (Cleal, Fontana, et al., 2020). Although the effectiveness of the FMP Y-maze has been tested 
pharmacologically and in healthy humans and animals, it has not yet been assessed using a transgenic 
model of cognitive impairment. To this end we tested the transgenic APP/PS1 rodent model of AD which 
has been used in a number of maze paradigms to assess WM deficits (Arendash et al., 2001; Bayer & 
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Wirths, 2008; Ferguson et al., 2013; Huang et al., 2011; Zhang et al., 2019; Zhu et al., 2017). We compared 
search strategies employed by carriers versus noncarrier littermate controls. Using tetragram sequence 
analyse we identified differences in exploratory behaviour between the two groups and demonstrate 
sensitivity of the FMP Y-maze to cognitive differences in rodents during the early stages of amyloid 
plaque formation (Zhu et al., 2017). Here, we further validate the FMP Y-maze as a method for assessing 
cognitive deficits, particularly WM, using a rodent model of AD. 
 
6.3 Materials and Methods 
Animals 
Five double-transgenic and five noncarrier male mice (B6C3-Tg(APPswe,PSEN1sE9) at 7 months of age 
were assessed for cognitive deficits in WM in the FMP Y-maze. APP/PS1 mice express a chimeric 
mouse/human amyloid precursor protein (Mo/HuAPP695swe) and a mutant human presenilin 1 (PS1-
dE9) gene which result in accelerated production of human Aβ peptide. Breeding pairs were obtained 
from the Jackson Laboratory (USA). In the University of Portsmouth Animal Facility, a colony was 
established by crossing transgenic mice with C57BL/6J mice. Controls used were noncarrier littermates 
for the APP/PS1 subjects. Mice were group housed and provided food and water ad libitum and 
maintained on a 12h:12h light/dark cycle (7 a.m.-7 p.m.) at 21 ± 2°C and 45-55% humidity. Procedures 
were carried out in accordance with the Animals (Scientific Procedures) Act, 1986 (UK) and the University 









Behavioural testing was carried out in the Zantiks LT unit and rodent Y-maze (Zantiks Ltd., Cambridge, 
UK). A single, white acrylic Y-maze, L152, W50, H155 (mm) was used per mouse, with a clear plastic base 
and top to prevent mice from escaping the maze during testing. Live tracking, incorporated into the 
Zantiks unit, was used to record movement patterns by automatically logging arm entries and exits. 
Light levels in the apparatus were constantly maintained at a maximum of 2 lux during testing.  
 
Protocol 
The protocol used was based on previous work (Cleal, Fontana, et al., 2020). Briefly, mice were 
habituated to the behaviour room the day before testing. Animal handling was kept to a minimum by 
using a clear plastic tube, that was kept in the home cage, to transfer mice into the FMP Y-maze. One 
mouse was assessed per test. Once in the maze, mice were permitted free exploration for 1 hour (1 h). 
Arm entries and exits were automatically logged and exported as an excel. Arm entries are converted 
into a time sequence of left and right turns, which are subsequently ‘chunked’ into overlapping 
tetragram sequences (four consecutive turn choices, e.g. right, left, left, left (RLLL)). There are 16 possible 
tetragram sequences. Exploration strategies are analysed for patterns in sequence selection. The 
number of arm entries were additionally recorded to monitor locomotor response in the maze.  
 
Statistics 
 Analysis were carried out using IBM SPSS (v25) and GraphPad Prism (v8). Previous studies have 
identified alternations (LRLR+RLRL) as the dominant strategy used by rodents, zebrafish and humans 
(Cleal, Fontana, et al., 2020). Variations in the use of alternations have been associated with changes in 
WM processing (Cleal, Fontana, et al., 2020; Cleal & Parker, 2018; Fontana, Cleal, Clay, et al., 2019). 
Residuals were taken of total percentage use of alternations for the duration of the trial. Residuals were 
plotted to assess normality, using Shapiro-Wilk test, and to screen for outliers. Extreme values (>3*IQR) 
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were removed from further analysis. Linear mixed model (LMM) analysis was carried out using “total 
turns” as the dependent variable, “condition” (control, APP/PS1), “time” and “condition*time” as the 
within-subjects factor and “ID” as a random effect. Analysis was followed by Bonferroni-corrected post-
hoc test. Comparison between total strategy use for each pair of tetragram sequences (e.g. RRRR+LLLL, 
LLRR+RRLL) was analysed using One-way ANOVA followed by Dunnett’s multiple comparison test 
comparing each tetragram pair to alternations. Locomotion was analysed using unpaired t-test. Data 
are represented as mean + standard error of the mean (SEM). Alpha values of p ≤0.05 were considered 
statistically significant.  
 
6.4 Results 
WM performance was analysed using relative percentage use of alternations during 1 h of free 
exploration in the FMP Y-maze. There was a significant effect of condition (control v APP/PS1) (F1,45 = 
4.60, p = 0.037) and time (F5,45 = 4.96, p = 0.001) on alternations, but no effect of condition*time (F5,45 = 
0.71, p = 0.621) (Figure 1A). Relative to noncarrier control mice, the transgenic mice exhibited a decrease 
in global alternation use showing a decrease in WM performance. Analysis of strategy use revealed a 
significant difference between tetragram sequences in control mice, showing a clear preference for 
alternations compared to all other strategies (One-way ANOVA, F7,469 = 4.69, p < 0.0001) (Figure 1B); 
however, preferential strategy use is lost in transgenic mice that show equal use of all tetragram 
strategies with approximately chance selection of each tetragram sequence (One-way ANOVA, F7,472 = 
0.96, p = 0.459) (Figure 1C). Transgenic mice have shown a complete loss of strategy formation and 















Figure 1. Free exploration in the FMP Y-maze for noncarrier control mice and transgenic APP/PS1 
mice (n = 5/group). Comparison of search strategy based on 16 overlapping tetragram sequences 
used by control compared to littermate transgenic mice. A) shows the relative percentage use of 
each tetragram sequence. Comparison of paired tetragram sequences for B) control and C) APP/PS1 
mice to identify preferential search strategy. Data represent mean + SEM, ns = not significant, * p 





The FMP Y-maze has been shown as an effective method for analysing WM performance through 
examination of search strategy use during 1 h of free exploration. Assessment of the APP/PS1, double 
transgenic mouse model of AD showed deficits in WM performance compared to littermate controls. 
Deficits resulted in the loss of strategic planning to the extent that exploration by transgenic mice was 
performed completely at random. Wild type mice, however, maintained a specific strategy, consisting 
of preferential use of alternations, throughout exploration of the maze.  
Several studies have previously assessed WM performance of the APP/PS1 model and have 
demonstrated deficits starting from 5-months-old when Aβ plaques have started to develop and the 
number and area of plaques progresses in a near linear fashion up 22-months-old (Zhu et al., 2017). 
However, there are inconsistencies in detecting WM deficits at 5-months-old (Kelly et al., 2017). Mice 
from 6-months-old have been repeatedly shown to have deficits in WM when assessed in the T-maze, 
Y-maze and MWM, therefore, to ensure that amyloid plaque pathology and cognitive deficits had 
suitably progressed we used mice at 7-months-old. As with previous studies investigating WM in 
APP/PS1 transgenic mice we found a significant decrease in WM performance in the FMP Y-maze which 
resulted in the random, non-strategized exploration of the maze, compared to the alternation driven 
search strategy employed by littermate controls. 
Previous studies using AD mouse models have found differences in the deficits reported for  
WM performance between studies, even when using age-matched and strain-matched comparisons 
(Puzzo et al., 2015). As noted above, previous studies investigating APP/PS1 do not confer on age of 
onset of cognitive impairment, with some studies reporting deficits from 5-months-old and others 
finding no differences at this stage compared to controls (Kelly et al., 2017; Zhu et al., 2017). A critical 
factor in determining WM deficits is the method of assessment used, with significant variation in 
impairment detection between tasks (Stewart et al., 2011). These discrepancies may arise as a 
consequence of confounding factors that often involve non-cognitive processes, such as locomotor 
impairments, or those arising from other cognitive domains, such as fear and anxiety. Impairments in 
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locomotion are commonly reported in rodent models of AD, which may result in ceiling effects in some 
WM tasks such as the MWM where swimming velocity may impact the route or latency to platform and 
could impact progression in subsequent trials (Kapadia et al., 2016). Hypo and hyperlocomotion caused 
by environmental factors such as novelty-induced anxiety, fear or fatigue, can also influence the 
outcome of maze-based tasks. Short, one-trial tests, such as the T and Y-mazes have been identified as 
particularly susceptible to altered locomotion as the brevity of these tasks does not permit a habituation 
time to allow for the subsidence of anxiety (due to entering a novel environment) or stress (due to 
experimenter handling) which may impact results (Hughes, 2004; Shepherd et al., 2016; Stewart et al., 
2011). Many of these tasks additionally have long training periods required to learn task rules and are 
often motivated by rewards, as in some versions of the T- or radial arm maze, or aversive environments, 
such as the water in the MWM (Sharma et al., 2010; Stewart et al., 2011). Rewarding and aversive stimuli 
can both influence how attention is allocated, resulting in the diversion of resources either away from 
or in favour of the current task, thus influencing behavioural performance (Steel et al., 2016; Yokoyama 
et al., 2015). Another drawback to maze tasks is that once probe tests have been completed, the same 
animals cannot repeat the task. This significantly limits re-run facilities (Shepherd et al., 2016) which 
substantially impacts following disease progression or treatments that aim at slowing cognitive decline.   
The FMP Y-maze task addresses several issues associated with traditional rodent tests of WM. 
Firstly, to avoid locomotor induced biases in task completion, the number of turns completed by each 
individual is used as a covariate in the analysis so that differences in alternations are not the result of 
hypo or hyperlocomotion of the model or environmental factors. Secondly, allowing animals to freely 
explore the arena for 1 h both minimises experimenter interference and incorporates sufficient time for 
a habituation period without affecting the overall results of the trial, i.e. if rodents were to freeze on first 
entry into the maze, but after a short period, 5-10 min, begin exploring, the prolonged trial time will still 
enable exploration pattern analysis based on the movements completed over the rest of the trial. 
Thirdly, there is no instruction, learning or correct way to explore the maze. Although previous studies 
have demonstrated a common search strategy employed by healthy rodents, humans and zebrafish, 
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there were no cues or prior training to achieve this method of exploration, it is a natural, instinctive 
mechanism (Cleal, Fontana, et al., 2020). Therefore, there is no need for extensive pre-trial training 
regimes, or the need for prolonged periods of food or water withdrawal as if often required to motivate 
rodents to respond to reward based learning trials. Although not demonstrated here, previous zebrafish 
trials have shown that the FMP Y-maze can be used as a repeated measures test, maintaining its 
sensitivity to detect differences in WM performance (see Part 2: Chpt 3) (Cleal, et al., under review). 
Finally, and most importantly, the FMP Y-maze has direct translational relevance to humans. Previous 
studies in healthy adults have identified analogous search strategies to rodents and reported decline in 
WM performance in aged (70+ year-old) compared to young (18-35-year-old) adults (see Part 1: Chpt 
5) (Cleal, et al., under review). The similar search strategies and findings in ageing compared to animal 
models suggests that the FMP Y-maze animal task is measuring similar cognitive domains to the human 
virtual task. High sensitivity to age-related cognitive decline and reliable and robust cross-species 
protocol, suggests the FMP Y-maze is a task with potential to identify preclinical, therapeutic strategies 
and translate them to humans.   
 
6.7 Conclusion 
Assessment of the APP/PS1 transgenic mouse model in the FMP Y-maze reliably recapitulates cognitive 
deficits found in previous studies using rodent tests of memory. Exploration in the FMP Y-maze was 
characterised by an overall reduction in the use of alternations, the dominant strategy in healthy rodents 
and humans, and a loss of strategic exploration, which was instead replaced by random investigation of 
the maze. Prior studies have examined the exploration patterns of zebrafish, rodents and humans in the 
FMP Y-maze and have identified a specific strategy of increased alternation use that was evident in all 
three species. Thus, highlighting the relevance and potential that the FMP Y-maze has to reliably 
translate findings from animal models to humans. The use of a transgenic mouse model of AD, which 
has been extensively assessed in other, rodent specific, memory tasks and has reliably reported deficits 





7.1 General discussion 
The studies covered in this portion of the thesis describe the development of a new assessment of 
cognitive function, with a particular focus on WM and cognitive flexibility. Initial studies successfully 
demonstrated that with the application of species-specific modifications, the FMP Y-maze could be used 
to assess cognition in Drosophila, zebrafish and rodents using a physical maze, in which animals freely 
explore for 1 h, and a virtual maze for humans, in which participants explore for 5 min, making the FMP 
Y-maze a short and simple task that could be applied in the clinic. Pharmacological manipulation of 
adult zebrafish suggested roles for the glutamatergic, cholinergic and dopaminergic systems in the 
maintenance of normal, healthy explorative behaviour and the associated executive functions. Studies 
of zebrafish from early larval stages through to senescence have not only demonstrated the sensitivity 
of the FMP Y-maze to subtle age-related changes in cognitive processing, but also provides a more 
comprehensive understanding of the ontogeny of advancingly complex behaviours and the gradual 
decline in these abilities during ageing in zebrafish. With the growing use of zebrafish to model complex 
neuropsychiatric disorders, understanding of species-specific learning and memory processes can aid 
in identifying commonalities with humans that may possibly mark evolutionarily conserved mechanisms. 
Thus, highlighting specific areas that have high translational relevance and may prove useful in future 
investigations of human disorders associated with these analogous areas. Commonalities such as 
altered vulnerabilities due to learning, memory and stress processing in juveniles/adolescence and the 
effects of senescence on decreasing cognitive capacity, which have been demonstrated here. These 
processes are similar in humans and zebrafish, and the preliminary findings discussed in the first part of 
this thesis highlight research areas that could greatly benefit from further work utilising zebrafish as a 
model organism.  
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The utility of the FMP Y-maze has been extended by examination of a rodent model of AD 
which had identifiable cognitive deficits compared to littermate, non-carrier controls. Thus, showcasing 
the FMP Y-maze as a possible assessment for cognitive impairments associated with AD. Combined this 
subset of studies provide strong evidence as to the suitability of the FMP Y-maze as a preclinical and 
clinical method for assessing subtle changes in cognitive processing in health and disease. However, 
further studies fully characterising the underlying pathways and processes used for developing 
particular strategies in the FMP Y-maze would greatly benefit both animal and human studies, providing 
a more comprehensive knowledge of the mechanisms detected in the maze and how these relate to 
behavioural changes associated with neuropsychiatric disorders and other conditions that affect 
cognitive processing.   
Having extensively assessed cognitive function in health, the next two parts of this thesis will 
focus on aberrations in cognitive performance associated with disease. Part II will investigate the role of 
drugs of abuse on cognitive control using a prenatal and sensitization paradigm. The final section will 
build on the impacts of drugs of abuse and investigate their effects and relationship in SZ-like models. 
Combined, these two sections will provide a comprehensive view of zebrafish as a model of 
neuropsychiatric disorders and provide further evidence for the utility of the FMP Y-maze as a measure 







































1.1 Addiction – How do drugs of abuse alter cognitive state in health? 
“Addiction represents a pathological usurpation of the neural mechanisms of learning and memory that 
under normal circumstances serve to shape survival behaviours related to the pursuit of rewards and the 
cues that predict them.” (Hyman, 2005) 
Addiction has only relatively recently been recognised as a disease of the brain and is now one of the 
most pressing health concerns we encounter today. Drug use disorders are reported to affect 35 million 
people using opioids, psychostimulants (such as cocaine, amphetamine, methamphetamine and 
opiates) and cannabis (United Nations Office on Drugs and Crime, 2019), a further 107 million people 
are estimated to have an alcohol dependence disorder  (Ritchie & Roser, 2019) and a staggering 1.3 
billion people use tobacco products worldwide (World Health Organization, 2015, 2020). Addiction to 
drugs of abuse is characterised by a compulsive-seeking and taking of a drug through a cycle of 
occasional intoxication which becomes increasingly chronic and uncontrolled, developing into 
withdrawal and anticipation/preoccupation in the absence of drug taking, culminating in physical and 
psychological dependency: addiction (Herman & Roberto, 2015). The neurological source of these 
symptoms is dysregulation of the brain’s reward system, which encompasses the VTA, striatum 
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(particularly the ventral striatum which includes the nucleus accumbens) and the PFC (both the ventral 
and dorsal aspects) (Arias-Carrián et al., 2010), altering cognitive processing through DA availability, to 
favour drug-seeking and taking behaviour over normal and essential life-sustaining activities such as 
eating and procreating (Gould, 2010; Hyman, 2005). Early stages of drug taking alters synaptic plasticity 
to foster maladaptive drug-associated cues, often taking previously irrelevant features (such as being 
outdoors) and forging strong connections with the thoughts and feelings associated with a drug (e.g. 
nicotine-smoking) (Gould, 2010). Combined, this connection results in the user craving or taking a drug 
when in the presence of the drug-associated cue (e.g. on entering an outdoor space immediately craving 
a cigarette) (Baker et al., 2004; Hyman, 2005). As anything can become a drug-associated cue, avoiding 
environments or circumstances that elicit drug cravings can be difficult, with sufficient drug taking 
episodes having the potential to ultimately result in physical dependence which can disrupt cognitive 
processes essential to maintain abstinence.  
 WM deficits are a less pronounced deficit in substance abuse than other executive functions 
such as CF, planning, decision-making and risk taking (Baldacchino et al., 2012; Cousijn et al., 2014; 
Kelley et al., 2004; Stavro et al., 2013; Sen Yan et al., 2014). Although there is extensive literature 
examining the cognitive effects of substance abuse disorder on WM performance (Baldacchino et al., 
2012; Butler & Le Foll, 2019; Edwards & Koob, 2012; Krueger et al., 2009; Patterson et al., 2010; Ramey 
& Regier, 2019). Several studies have reported WM deficits associated with chronic alcohol, cocaine, 
methamphetamine, opioid and nicotine abuse (Bechara & Martin, 2004; Goldstein et al., 2004; Hester et 
al., 2010; Liang et al., 2016). Additionally, WM performance has been suggested to be linked with 
smoking relapse, with poorer WM during abstinence predicting more rapid smoking resumption 
(Patterson et al., 2010). In alcoholics deficits in WM were not just evident during periods of alcohol 
abuse, but have been shown to last, on average, for a year of sobriety before deficits start to abate 
(Stavro et al., 2013). However, there has been a strong link between baseline WM performance (e.g. WM 
capacity) and abuse potential (Ramey & Regier, 2019). A recent study by (Soutschek et al., 2020) has 
demonstrated a critical role for baseline WM functioning in the effect of increased DRD1 activation 
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(using a D1 agonist) on reactivity to reward-associated cues and flexibility of cue reward-associations 
(i.e. the ability to flexibly update stimulus-reward associations). Further demonstrating the relationship 
between WM and CF processing for normal behavioural responding. Additionally, WM performance has 
been implicated as a potential therapeutic target (Bickel et al., 2011). WM training has been suggested 
as a possible therapeutic mechanism for improving impulse control and self-regulation in substance 
abuse disorders. This method is based on the premise of encouraging alternative neural plasticity 
networks to formulate within targeted neural systems by repetitive and increasingly difficult cognitive 
training to improve cognitive processing. As WM is a central cognitive function that underlies multiple 
other executive functions is it hoped that by targeting such as crucial system that other cognitive 
processes, such as aberrant decision-making, may also improve (Bickel et al., 2011, 2014; Brooks et al., 
2016; Herold et al., 2012; Stavroulaki et al., 2017).  
Aberrant CF has been well established as a core feature of substance abuse disorders (Butler & 
Le Foll, 2019). Addiction itself can be considered as an inability to alter responses when presented with 
a cue that has previously been associated with a drug reward. Such changes in CF can often be long-
lasting and may play a critical role in enhanced vulnerability to relapse and compulsive drug-seeking 
and taking (Stalnaker et al., 2009). Thus, poor adaptability and response rigidity to specific drug-related 
cues, could contribute an important underlying behavioural pattern that perpetuates addiction ( Day et 
al., 2015). Humans addicted to cocaine, alcohol, methamphetamine, 𝛥 9-tetrahydrocannabinol 
hydrochloride (THC) and opioids present with impaired CF, which is particularly evident on reversal 
learning and WCST tasks (Baldacchino et al., 2012; Butler & Le Foll, 2019; Colzato et al., 2009; Fillmore 
& Rush, 2006; Kroener et al., 2012a; Rogers & Robbins, 2001; Thomson et al., 2020). There is significant 
overlap in the brain regions associated with the reward system and those involved in control of executive 
functions. The PFC and striatum, as outlined above are central to the mesolimbic reward system and the 
CSTC network, critical for cognitive processing, including CF. Imaging studies have identified the PFC as 
a critical region associated with tracking and anticipating outcome reward values, represented by 
changes in neuronal firing (Blair et al., 2006; Dolan, 2007; Gottfried et al., 2003). The lack of this altered 
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neuronal activity demonstrates an absence of information updating, without which it becomes difficult 
to recognise changes in condition contingencies and thus, causes deficits in identifying the correct 
behavioural response under the new conditions (Schoenbaum et al., 2009; Stalnaker et al., 2009). This 
deficit has been shown following chronic cocaine exposure using predicted versus unpredicted outcome 
variables. Controls demonstrated the ability to recognise differences (in neural activity patterns) 
associated with the predicted outcome compared to the unpredicted outcome. However, the cocaine 
exposed group failed to achieve this (Stalnaker et al., 2009). Additionally, cocaine addicts show 
diminished feedback mechanisms that are equally important for information updating, but with regard 
to negative outcomes, i.e. when outcomes do not match expectations. Therefore, this potentially inhibits 
the mechanism used to inform us of behaviours that have negative implications, such as the impact of 
chronically seeking and taking drugs of abuse (Stalnaker et al., 2009). Changes are not only seen in the 
PFC of addicts, but additionally the striatum and the thalamus have also been reported to have structural 
and functional changes in response to chronic drug taking. Imaging studies in humans have shown 
reduced functional connectivity between the thalamus, the striatum and frontal cortices (PFC) as well a 
reduction in white matter tracts, as is similarly found in SZ patients. Additionally, correlations have been 
found between heaviness of smoking, alcohol, cocaine and heroin addiction and  reduced connectivity 
between regions of the CSTC network (Huang et al., 2018).  
DA is known for its role in the reward pathway, which is essential for rewarding us for carrying 
out crucial activities for survival, such as eating, drinking and reproducing. When these tasks are carried 
out our brain sends messages of pleasure to reinforce these actions and encourage us to seek out the 
stimulus again and again (Di Chiara & Bassareo, 2007). When we engage a naturally rewarding stimuli, 
dopaminergic neurons in the VTA are stimulated to release DA. This reward signal is emitted to the PFC, 
the nucleus accumbens (NAcc), amygdala and the hippocampus: the mesolimibic pathway (Di Chiara & 
Bassareo, 2007; Parker, Brock, Walton, & Brennan, 2013). Drugs of abuse act by hijacking this system 
and causing large and rapid surges in DA availability, that greatly exceed, in duration and intensity, 
those usually caused by natural rewards. Different drugs increase DA via different routes, for example 
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alcohol, heroin and nicotine act by increasing the amount of DA released into the synaptic cleft by 
exciting DA neurons in the VTA to produce more action potentials, thus increasing the amount of DA 
released. Whilst amphetamine and cocaine inhibit mechanisms of removing DA from the synaptic cleft 
by blocking DAT, causing a rapid and persistent rise in synaptic DA levels. Opioid-dependent individuals 
have demonstrated impaired WM and CF, with increased errors and perseverative responses compared 
to controls. Repeated opioid exposure was also found to reduce striatal DAT density which negatively 
correlated with WM performance (Liang et al., 2016). Methamphetamine and cocaine similarly have 
demonstrated reduced DAT levels in the striatum, an effect which has been shown to reverse after 
prolonged periods of abstinence (Berke & Hyman, 2000). Regardless of the mechanism to achieve 
increased levels of DA availability, continued upsurges in DA has the ultimate consequence of blunting 
the DA system to everyday stimuli. This is often associated with increased anhedonia, which is a frequent 
feature in addiction and has significant correlation with drug craving, withdrawal and relapse 
(Hatzigiakoumis et al., 2011).  
One of the major difficulties in creating animal models of addiction, as with many 
neuropsychiatric disorders, is being able to extract a relevant sample of conditions that relate to a 
disorder that is extremely complex and multifaceted both in its pathology and the circumstances 
required to develop the condition (Edwards & Koob, 2012). Similarly to SZ, there is no single gene 
responsible for the development of addiction. Instead, there are a series of interactions between genetic 
traits, behaviours, environmental exposures and experiences that culminate in the physical and 
psychological dependence on a drug. There are two main types of animal model of substance abuse, 
non-contingent models in which animals are passively exposed to drugs. This can be via intravenous 
injection, provided in food or water for rodents or put into the tank water of zebrafish. The other model 
is the contingent model which commonly involves animals self-administering rewarding stimuli, relying 
on the self-motivation of the animal to seek out the drug (Kuroda et al., 2017; Markou et al., 1999). The 
most commonly used method in zebrafish models is the non-contingent model as drugs can be 
administered to zebrafish easily, with minimal handling and stress by simple addition to tank water. 
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Therefore, the focus here will be on non-contingent models of drug abuse that used measures of 
executive function, particularly WM and CF. Many substance abuse models have used chronic drug 
exposure to model long-term effects of drugs of abuse. Rodent studies have shown WM and CF deficits 
following chronic alcohol, cocaine, morphine, methadone and methamphetamine exposure in line with 
human studies (Barron et al., 2005; Brockett et al., 2018; DePoy et al., 2013; Dougherty et al., 1996; 
Kroener et al., 2012b; Miladi-Gorji et al., 2011; Spain & Newsom, 1991; Stalnaker et al., 2009; Tramullas 
et al., 2007; W. Sen Yan et al., 2014). Structural and functional changes in the PFC and striatum, caused 
by chronic drug taking, have been implicated for their role in priming the brain, causing alterations in 
connectivity that potentially underlie the development of persistent drug taking and addiction 
witnessed in humans (Herman & Roberto, 2015; Hyman, 2005; Koob & Volkow, 2010; Ramey & Regier, 
2019).  The use of zebrafish as a model of addiction has grown dramatically over the last two decades 
(Maximino et al., 2013). Extensive studies on nicotine (Gómez, Carrasco, & Redolat, 2008; Levin, Bencan, 
& Cerutti, 2007; Levin, Limpuangthip, Rachakonda, & Peterson, 2006), ethanol (Miller & al., 2013; Parker, 
Annan, et al., 2014; Parker, Evans, et al., 2014), cocaine (Darland & Dowling, 2001; López-Patiño, Yu, 
Cabral, & Zhdanova, 2008; Mersereau, Poitra, Espinoza, Crossley, & Darland, 2015) and morphine 
(Bretaud et al., 2007; Khor, Jamil, Adenan, & Shu-Chien, 2011; Fatima Macho Sanchez-Simon, Zhang, 
Loh, Law, & Rodriguez, 2010), have been carried out using zebrafish. Similar to humans, chronic drug 
exposure in zebrafish has demonstrated altered dopaminergic parameters. However, by far the most 
commonly used measure for assessing addiction phenotypes in zebrafish is the use of the conditioned 
place preference (CPP) task, in which animals are non-contingently administered a drug that is 
associated with a specific cue, such as striped background. Fish are trained to expect drug reward in the 
presence of the reward-associated cue, and therefore in the absence of drug still show a preference of 
the drug paired side. This demonstrates the drug-induced reinforcement pathway that is strongly 
implicated in addiction. This method is commonly used in rodents and has been demonstrated with a 
vast array of drugs in zebrafish, including cocaine, amphetamine, nicotine and opiates (Bretaud et al., 
2007; Alistair James Brock et al., 2017; Darland & Dowling, 2001; Ninkovic & Bally-Cuif, 2006). However, 
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there are comparatively few studies in zebrafish that specifically target cognitive processes such as WM 
and CF and the few that have generally assess cognition only after acute exposures (Edward D. Levin & 
Chen, 2004; Luchiari et al., 2015). This further highlights a great need to improve and increase testing of 























The first chapter of this section on drugs of abuse is focused on a technicality of drug administration in 
zebrafish. Although not striking in its contribution to addiction pathology, it is a much overlooked 
consideration in zebrafish studies of drugs of abuse (or any drug for that matter). It is important to 
understand the chemistry of drugs, their biological targets and the interface between them. Environmental 
influences can be a substantive factor in drug affect. This is particularly important in non-contingent drug 
exposure models, in which drugs are passively, opposed to actively, administered. One positive often cited 
by researchers using zebrafish is the ease of drug administration - simply add to tank water. However, 
several factors are generally overlooked by researchers when conducting such studies. Here we discuss the 
importance of one of them: pH. Preliminary and pilot work in our group had shown unexpected differences 
in responses to drugs, and drug toxicity, and we decided to test the hypothesis that pH might impact on 
the effects of the drugs on the fish.  To date, few studies report the pH of drugs and, as described in this 










The Importance of pH: How Aquarium Water is Affecting 
Behavioural Responses to Drug Exposure in Larval Zebrafish. 
 
This chapter has been published (formatting has been retained):  
 




There has been rapid growth in the use of larval zebrafish as a complementary vertebrate model for 
drug discovery, abuse liability and pharmacological toxicology, resulting in a huge increase in zebrafish 
facilities worldwide. However, many research groups working with zebrafish do not typically report the 
pH of husbandry conditions in methodologies, nor are the pH of drug treatments reported in many 
research articles. This unknown factor can be a major contributor in the differential effects of drug 
treatments. Therefore, as a case study, we tested the impact of altering pH of several drugs of abuse 
and assessed locomotor changes associated with a single drug concentration delivered at different pHs. 
We found that a change of a single pH unit, within the pH ranges commonly used in zebrafish 
husbandry, was enough to alter locomotor activity at a fixed drug concentration. Many pharmacological 
agents are dependent on environmental factors, such as pH, to determine bioavailability. Efficaciousness 
for many classes of drug is dependent on their ionization state in which shifts towards uncharged 
species can influence the easy of a drug crossing biological membranes. Thus, we urge users to report 






Zebrafish have been rapidly growing in popularity as a model organism (Kalueff et al., 2014; Parker, 
Brock, Walton, et al., 2013; Stewart et al., 2015), lending themselves exceptionally well to studies of 
environmental toxicity, teratogenesis, neurotoxicity, and preclinical drug discovery (Chapela et al., 2019; 
Gehrig et al., 2018; Kalueff et al., 2014; Charles Ben Lovely et al., 2016). The high numbers of offspring, 
external fertilisation, transparent eggs, cost-effective maintenance and ease of genetic and 
pharmacological manipulation have resulted in what can now be considered as one of the most versatile 
and well characterised vertebrate models (Kalueff, 2017). Currently used in over 1,200 labs worldwide 
(zfin.org), there is growing use of zebrafish as an alternative model for both environmental and 
translational models. Aided by advancements in technology, zebrafish embryos and larvae have been 
gaining ground as a model for drug discovery due to the ease of drug administration and high-
throughput whole-animal assays (; Gehrig et al., 2018; Lieschke & Currie, 2007; Strähle et al., 2012). 
Despite the success of mammalian pharmacokinetic and efficacy models, they are often expensive, time 
consuming, require large quantities of compounds and can be extremely invasive, particularly for dosing 
(Zon & Peterson, 2005). Zebrafish, on the other hand, offer a cost-effective alternative which has low 
compound requirement and an easy method for drug delivery which is facilitated through the aqueous 
environment (Vaz et al., 2018a; Zon & Peterson, 2005). Thus, zebrafish are an invaluable species for 
screening the pre-regulatory and preclinical phases of drug discovery and pharmacological toxicology 
(Basnet et al., 2019; Chapela et al., 2019; Gehrig et al., 2018; Norton, 2013; Stewart, Braubach, et al., 
2014). 
 Understanding the pharmacology of compounds is crucial to interpreting the interaction 
between chemicals and organisms. This is of particular importance when screening novel drugs for 
therapeutic treatments or for abuse liability, as biochemical function can be altered by temperature and 
pH, critically influencing pharmacokinetics (Dowd, 2017; Mitra & Kesisoglou, 2013; Stevens & Balahura, 
2007). Currently, ‘Materials and Methods’ sections in publications report general husbandry parameters, 
including a description of water temperature, light-dark cycles and feeding routines; however, it is not 
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mandatory to report pH. Subsequently, many studies do not report either environmental aquarium 
water (the main system water used for the majority of fish husbandry) or pH values of drug containing 
solutions. An article by Aleström, et al, outlines updated recommendations for the husbandry and care 
of zebrafish in line with the EU Commission Recommendation 2007/526/EC and the EU Directive 
2010/63 concerning care and well-being of experimental animals (Aleström et al., 2019). This article 
recommends pH levels between 6.5-8.0. This range is inclusive of weakly acid to weakly basic conditions. 
Of the 154 articles examined here, only 34.4% of them reported pH, with a range of 5.8-9.0, representing 
a maximal change of 2.2 units. These changes in pH may be accounted for by the water source for 
recirculating systems. This can either be from local water supplies (e.g. tap water), which is subject to 
effects of the local environment, such as hard versus soft water, or RO systems which rely on pre-
filtration. The initial water source may influence overall pH levels. For example, hard water areas have 
increased concentrations of multivalent cations, most commonly calcium or magnesium ions, which 
consequently increase water pH. Thus, with the global distribution of zebrafish facilities, fed off a vast 
range of water sources, it is reasonable to expect that baseline pH levels of aquarium water will vary 
from lab to lab. Although many facilities that have reported pH fall within the recommended pH levels, 
we demonstrate that some facilities operate outside of these parameters, thus, extending the pH range 
at which drug studies are conducted.  
 Here, we varied the pH of the test environment by a single unit, within the pH range 
recommended by Aleström, et al. We selected pH 7.0 and 8.0 to identify if this small change can 
influence survival or locomotor responses of larvae exposed to fixed concentrations of drug treatments. 
The drugs tested have been regularly used to investigate mechanisms underlying neuropsychiatric 
disorders, such as substance abuse, and have been selected from the same family of organic bases, to 
identify if pH is a significant factor which can alter behavioural responses to compounds that share 
similar chemical structures. Our findings suggest that at the concentrations selected, there were no 
detrimental effects on survival. However, slight structural differences between compounds, resulting in 
variable pKa values, are significant predictors of altered organism-drug interactions that potentially 
157 
 
result in modified locomotor responses to the same dose of drug when exposed at different pH 
conditions. Our study suggests that, when using locomotor activity as a measure of behavioural 
response to a drug, pH is a critical factor. The growing use of zebrafish as a model for screening 
compounds or testing novel therapeutics and many studies using locomotor activity as a behavioural 
end point, further supports the need to accurately report environmental conditions in which test 
compounds are introduced.  
 
2.3 Materials and Methods 
Systematic Review 
We carried out a systematic analysis of the reporting of pH in zebrafish behavioural experiments over 
the past 20 years. Using PubMed, we inserted the search terms “zebrafish” AND “behavio*” AND 
“locomoto*” AND “drug”. This returned 465 results, of which 154 had full free text available. Table 1 
displays a summary of the data from these studies relating to reporting of pH. 
 
Breeding and husbandry  
Adult, AB wild-type zebrafish (Danio rerio) were retained as breeders in the University of Portsmouth 
Fish Facility. Housing conditions were maintained on a re-circulating system (Aquaneering Inc., San 
Diego, CA, USA), with aquarium water at pH 8.4 (±0.4), temperature 25-27 °C, on a 14H: 10H light/dark 
cycle. The day prior to embryo collection male and female breeders were housed in separate tanks 
overnight. On the day of embryo collection, 15 mins prior to light onset, all adults were placed in a 
breeding tank, with males and females separated by a transparent divider. Upon light onset, the divider 
was removed. One hour after light onset, the adults were returned to the colony, and embryos were 
collected from the breeder tank. The embryos were pooled, and placed in petri dishes of aquarium 
water, in groups of ~50 embryos per petri dish and reared at 28 °C in aquarium water at pH 8.4, to 
mimic adult conditions, in a clear incubator for three days (toxicity assessment) or seven days 
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(behavioural assessment) on a 14H:10H light/dark cycle. All studies were conducted following the 
guidelines of the University of Portsmouth Animal Welfare and Ethical Review Board and under licence 
from the UK Home Office. 
 
Pharmacological agents  
To study the effect of pH on different drug conditions, four commonly used drugs of abuse were 
selected for this study. Nicotine (Sigma-Aldrich) was administered at a concentration of 5 µM (García-
González et al., 2020; Petzold et al., 2009; Yoo et al., 2018), morphine sulphate (Sigma-Aldrich) was 
administered at 2.6 µM (Lopez-Luna et al., 2017), d-amphetamine (Sigma-Aldrich) was administered at 
22 µM (Irons et al., 2010), and caffeine (Tocris) was administered at 200 µM (Gutiérrez et al., 2020). 
Concentrations were based on a combination of larval and adult zebrafish studies investigating effects 
on locomotor activity.   
 
Toxicity assessment 
For control groups, aquarium water was buffered with citric acid to either pH 7.0 or 8.0. For treatment 
groups, respective concentrations of drug were added to aquarium water and then buffered using either 
NaHCO3 or citric acid to bring the final pH to either pH 7.0 or 8.0. The final solution pH values were 
reported at 26°C. From the final buffered solution, 0.9 mL was added to each well of a 48-well plate. 
Individual, 3 dpf larvae were transferred into each well for 24H. Tail-touch-evoked motor (TEM) 
responses were used to assess survival at 0.5H, 1H, 1.5H, 2H, 3H, 4H, 5H and 24H intervals. Plates were 
maintained at room temperature, 26°C. Each drug challenge/control was conducted in separate plates 
with n = 8 larvae/dose/pH. 48-well plates were used due to the well sizes minimising volume of drug 
required per test and providing enough space for larvae to swim and for TEM to be conducted with 
ease. Pilot work was conducted demonstrating that TEM was a suitable and effective method for 
assessing survival with the drugs tested as part of this study. However, it is worth noting here that when 
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testing drugs with analgesic properties or causing extreme hypolocomotion, TEM may be an unsuitable 
method for assessing survival. Under these circumstances it would be recommended that heartbeat is 
used as an alternative method for assessing survival. During the transfer of larvae to individual wells and 
the use of TEM have the potential to inflict a low level of mortality due to regular handling of larvae. To 
account for this, a significant effect of drug on survival was determined by treatments that caused more 
than 50% mortality.     
 
Larval locomotor response 
Following toxicity assessments, drugs that did not cause a significant impact on survival were used for 
subsequent detailed behavioural analysis. The same method of buffering drug treated, and control 
groups were applied as above. 7 dpf larvae show spontaneous movement and were used to assess 
locomotor changes in response to drug and pH challenges. 7dpf larvae were placed in individual wells 
of a 48-well plate. Movement was tracked by placing plates immediately into the Zantiks MWP larval 
behavioural unit. Each larva was tracked individually using automated tracking software (Zantiks MWP, 
Cambridge, UK). Locomotor assays were run in the dark as previous studies have demonstrated that 
larvae move more in dark than light environments (Burgess & Granato, 2007). Movement data were 
logged after 0.5H (acute) and 4H (prolonged) exposure, larvae were recorded for 30 mins. Any larvae 
that displayed severe immobility behaviour, defined as less than 10 mm travelled during each 
assessment, were not included in any data analyses or figures. Variance in immobility was due to 
individual larval differences (i.e. not overrepresented in any drug or pH condition), and from the total 
animals tested represented less than 2% of the total population.  
Statistical analyses 
All data were analysed using GraphPad Prism (version 8.4.2). Toxicity was assessed using Kaplan-Mayer 
survival curves, proportion of survival was compared to pre-drug exposure viability. Outliers from 
behavioural groups were identified using boxplot with Tukey analysis and excluded from subsequent 
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analysis. Comparison of each pH condition was tested for normality using the Shapiro-Wilk test. Groups 
that were normally distributed were analysed using the unpaired t-test on data after outliers were 
excluded. Groups with non-normally distributed data were analysed using the Mann Whitney test, after 
the exclusion of outliers. Within each treatment group, an interaction was considered significant when 
p ≤ 0.05. All data are presented as mean ± standard error of the mean (SEM).    
 
2.4 Results  
Systematic Review 
To identify the extent to which pH of either husbandry or drug treatment conditions were reported in 
research articles relating to zebrafish behaviour, we conducted a systematic analysis of a population of 
published research articles in the fields of toxicology, neuroscience, drug discovery, drug testing, 
genetics or other. Table 1 provides a summary of our findings. We found that for each research field, 
50% or less studies reported pH, and for toxicology, neuroscience, drug discovery and drug testing, the 
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The survival curve for larvae exposed to aquarium water, buffered with citric acid to either pH 7.0 or 8.0, 
is shown below in (Fig. 1A). 3 dpf larvae showed no adverse effects on survival when exposed to altered 
pH conditions for 24H. (Fig. 1B) shows the effect of pH on the total activity levels of 7 dpf larvae during 
the first 0.5H and after a further 4H of exposure to their respective pH conditions. In the absence of 
drug, changes of ± 1.0 pH was not sufficient to evoke changes in locomotor activity (0.5H: t = 1.719, df 


























Figure 1. The effect of pH controlled aquarium water on (A) survival of 3 dpf larvae over 24 hours, 
assessed using tail-touch-evoked (TEM) motor response at 0.5H, 1H, 1.5H, 2H, 3H, 4H, 5H and 24H 
intervals. Analysis was carried out using the Kaplan-Mayer survival curve, with proportion of survival 
compared to pre-drug exposure viability. Curves show 100% survival for both pH conditions. pH7, 
n=8; pH8, n=8 (B) The effect of pH controlled aquarium water on locomotor behaviour in 7 dpf larvae 
during the first 0.5H of exposure, and at 4H of exposure was analysed for outliers using boxplot with 
Tukey analysis. Following removal of outliers, Shapiro-Wilk normality test was conducted. Samples 
that were not normally distributed were analysed using Mann Whitney test. pH7 n=46; pH8 n=46. 
There was no significant difference in distance travelled between the two groups. Bars represent 




Larvae at 3 dpf were treated with four commonly used drugs of abuse; nicotine, morphine sulphate, d-
amphetamine and caffeine. Treatment water was buffered to either pH 7.0 or 8.0 and the effect on 
survival was monitored over 24H of exposure (Fig. 2). Like control animals, nearly all treatment groups 
at both pH 7.0 and 8.0 had 100% survival after 1 day of continuous treatment. The only exception was 
in the nicotine treated group at pH 7.0, in which a single larva was reported to have died at the 24H 
time point, which, as an isolated death, it is unlikely to be the result of the treatment on survival. The 
survival curve analyses, demonstrated that at each of the tested concentrations, the drugs and pH 
conditions used were safe to conduct behavioural analysis on older larvae.  
Following survival curve analysis, acute (0.5H) and prolonged (4H) exposures to a single 
concentration of drug under two pH conditions were conducted using 7 dpf larvae. (Fig. 3A) shows the 
response of larvae exposed to 5 µM of nicotine, which caused an increase in locomotor activity in larvae 
treated at pH 8.0 compared to those treated at pH 7.0. This increased activity level was evident after 
acute and prolonged exposure (0.5H: t = 2.175, df = 13, p = 0.0487; 4H: t = 2.446, df = 13, p = 0.0294). 
Treatment with 2.6 µM of morphine sulphate, showed no locomotor difference after an acute exposure 
(0.5H: t = 0.314, df = 14, p = 0.758). However, differences in activity levels were evident after prolonged 
treatment, resulting in a significant increase in the distance travelled by larvae in the group buffered to 
pH 8.0 (4H: t = 2.990, df = 14, p = 0.0098) (Fig. 3B). Larvae treated with 22 µM of d-amphetamine 
showed no differences between pH groups after acute exposure (0.5H: t = 1.984, df = 13, p = 0.0688). 
However, after prolonged exposure there was a significant effect of pH 8.0 causing a decrease in 
locomotor activity compared to larvae treated at pH 7.0 (4H: t = 2.883, df = 13, p = 0.0128) (Fig. 3C). 
Caffeine caused no detectable differences between pH groups either at the acute or prolonged 







Figure 2. The effect of pH-controlled drug treatment on the survival of 3 dpf larvae over 24 hours, 
assessed using tail flick at 0.5H, 1H, 1.5H, 2H, 3H, 4H, 5H and 24H intervals for A) 5 µM nicotine, B) 
2.6 µM morphine sulphate, C) 22 µM of d-amphetamine and D) 200 µM caffeine. Analysis was 
carried out using the Kaplan-Mayer survival curve, with proportion of survival compared to pre-drug 
exposure viability. Survival curves show 100% survival for both pH conditions for all drug exposures, 










The aim of this study was to assess if a change of environmental pH was substantive enough to cause 
a change in behavioural activity when larvae were exposed to the same concentration of drug at 
different pH’s. We found that a change in pH of ± 1.0 unit significantly impacted locomotor activity of 
larvae for three of the four test drugs. Nicotine was found to have a pH-dependent effect that 
immediately impacted locomotor activity. This effect was sustained over both acute and prolonged 
exposure. Morphine and d-amphetamine both showed altered locomotor responses based on pH, but 
only after prolonged exposure. Caffeine was the only drug tested that did not cause different activity 
levels between pH groups. Our findings suggest that the chemical composition of a drug can be a strong 
determinant in the effect of pH on behavioural response, potentially due to altered bioavailability. Our 
results thus highlight the differential effects that small changes in pH can have on behavioural output 
in response to drug exposure.  
 Zebrafish have been found to live in bodies of water with pH varying from 6 to 10, 
demonstrating suitability to a wide range of environments (Aleström et al., 2019; Arunachalam et al., 
2013). However, in laboratory settings, the aim has been to provide stable husbandry conditions, and 
Figure 3. The effect of pH controlled drug treatments on locomotor activity of 7 dpf larvae assessed 
using automated tracking software for the first 0.5H of exposure (acute) and after 4H of exposure 
(prolonged). Treatments were buffered to either pH 7.0 or pH 8.0 (±0.1) using citric acid. A) 5 µM 
nicotine, B) 2.6 µM morphine sulphate, C) 22 µM of d-amphetamine and D) 200 µM caffeine. 
Analysis for outliers was carried out using boxplot with Tukey analysis. Following removal of outliers, 
Shapiro-Wilk normality test was conducted. Samples that were normally distributed were analysed by 
unpaired t-test, not normally distributed samples were analysed using Mann-Whitney test. Nicotine, 
0.5H: pH7 n=7, pH8 n=8, 4H: pH7 n=7, pH8 n=8. Morphine, 0.5H: pH7 n=8, pH8 n=8, 4H: pH7 n=8, 
pH8 n=8. Amphetamine, 0.5H: pH7 n=8, pH8 n=7, 4H: pH7 n=8, pH8 n=7. Caffeine, 0.5H: pH7 n=8, 
pH8 n=8, 4H: pH7 n=8, pH8 n=8. Bars represent mean, error bars are SEM; ns – not significant, * p < 
0.05, ** p < 0.01. 
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thus zebrafish housing systems have been recommended at pH 6.5-8.0 (Aleström et al., 2019). Analysis 
of 154 studies assessing effects of drugs on zebrafish behaviour showed the most widely used pH levels 
fell between pH 7.0-8.0, found in 77% of studies reporting pH. We assessed if aquarium water buffered 
to either pH 7.0 or 8.0, reducing our normal aquarium water levels by 1.4 or 0.4 respectively, caused 
differences in toxicity to 3 dpf larvae or baseline locomotor activity of 7 dpf larvae. We found that there 
was no difference in the survival rate over 24H, in which both pH conditions had 100% survival. There 
was also no evidence of pH related changes in locomotion, as both groups showed similar distances 
moved after acute and prolonged exposure to pH altered aquarium water. Similar to control groups, 
toxicity studies of test drugs at pH 7.0 and 8.0, revealed that over 24H of exposure, the selected 
concentrations did not cause any toxic effects, thus resulting in 100% survival in all conditions. However, 
behavioural assessment of locomotion at 7 dpf revealed significant pH-dependent differences in 
response to a fixed dose of drug with variable pH conditions.  
Here, we demonstrated that within the first 0.5H of exposure of 7 dpf larvae to 5 µM nicotine, 
there was an immediate difference in the locomotor activity of larvae at pH 7.0 compared to those 
treated at pH 8.0. Nicotine is a weakly basic drug and can exist in three forms in aqueous solution: the 
univalent (pyrrolidinium) cation, divalent cation and the unionized ‘free base’ (Barlow & Hamilton, 1962). 
At physiological pH (ca. 7.4), 69% of nicotine is present in the ionized form (predominantly the univalent 
cation) (Pogocki et al., 2007). The rest remains unionized (uncharged) and it is in this form that molecules 
are easily absorbed, as the free base can readily pass across biological membranes (Benowitz et al., 
2009; Pogocki et al., 2007). Absorption in this state is rapid, and in conjunction with moderate 
hydrophobicity and low polarity (due to the presence of the pyridine and pyrrolidine rings) nicotine can 
easily cross the blood-brain barrier to access the brain (Oldendorf, 1974;Oldendorf et al., 1993; Spector 
& Goldberg, 1982; Tega et al., 2018). When nicotine is present in aqueous solution at 25 °C, it has two 
pKa values; 8.02 and 3.12. If the environmental pH, that the drug is dissolved in, is equal to the pKa value, 
then there are equal quantities of drug in the ionized and nonionized forms (50:50) (Dowd, 2017). 
Therefore, when nicotine is solubilized in pH 8.0, equal to the pka value, ~50% of the nicotine must be 
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in the unionized state. Many studies have reported that at physiological pH, 31% of nicotine is the free 
base species. Therefore, at pH 7.0, it would be expected that an even higher degree of ionization would 
occur, thus reducing the total amount of free base available to less than 30% (Pogocki et al., 2007). This 
represents a difference of greater than 20% nonionized, biologically available nicotine between pH 7.0 
and 8.0. Zebrafish larvae treated at pH 8.0 had a mean of 572.4 mm travelled during acute exposure to 
nicotine, while larvae treated at pH 7.0 on average only travelled 294.2 mm, almost half the distance 
travelled by the pH 8.0 treated group. These findings of increasing locomotor activity with increasing 
nicotine concentration is supported by a previous study from Petzold, et al, investigating the effect of 
nicotine concentration on zebrafish larvae locomotion. They demonstrated that increasing 
concentrations of nicotine from 2.5 µM to 50 µM resulted in increases in movement (Petzold et al., 
2009). Therefore, it is likely that hyperlocomotion of larvae treated at pH 8.0 are the result of increased 
nicotine availability (effectively increasing brain concentration of nicotine) by altering the amount of 
unionized nicotine in solution.   
 Morphine and d-amphetamine have similar chemical properties to nicotine. In aqueous 
solution, morphine can be found in three forms: two ionized forms (one with a charge on the nitrogen 
atom and the other lacking a proton on the phenolic hydroxyl group at carbon 3) and an uncharged, 
free base (Stevens & Balahura, 2007). D-amphetamine is only found in two forms: an ionized cation and 
the free base (Pubchem). Morphine, like nicotine, has two equilibrium constants (pKa) of 8.00 and 9.75, 
whilst d-amphetamine has one of 9.9 at 25 °C (Heal et al., 2013). Due to the weakly basic properties of 
both drugs, like nicotine, there is consequently more of the drug present in the lipid soluble, free base 
form when in more alkali pH conditions, thus increasing absorption and brain concentration of drug 
(Dowd, 2017). Acute exposure to both morphine and d-amphetamine, had no pH-induced differences 
in motor activity. However, the effect of altered pH condition became evident after prolonged exposure 
(4H of treatment), which caused significant differences in the distances travelled in the drug treated 
groups at pH 7.0 compared to pH 8.0. Morphine treated larvae behaved similarly to nicotine treated 
larvae, both groups demonstrating hyperlocomotion in pH 8.0 compared to pH 7.0. Almost identical 
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pKa values of nicotine (8.02) and morphine (8.00) may be a principle factor in the similar behavioural 
responses of increased locomotion with increasing brain concentrations of available drug (Barlow & 
Hamilton, 1962; Stevens & Balahura, 2007; Tomar, Scott & Henningfield, Jack, 1997).  
The percentage of the ionized versus nonionized form depends on the number of pH units 
above or below the pKa (Bhagavan, 2002). As morphine and nicotine have pKa values of ~8.0 (±0.2), the 
degree of ionization at pH 7.0 would be expected to be similar, ~20% lower than at pH 8.0. Therefore, 
the increase in bioavailability of morphine would be expected to cause a similar response to nicotine 
based on the same degree of ionization at their respective pHs. D-amphetamine, however, caused the 
opposite effect in the prolonged treated group, resulting in hypolocomotion of larvae treated at pH 8.0 
compared to pH 7.0. Previous studies of zebrafish larvae exposed to d-amphetamine reported an 
“inverted U” dose-response in locomotor activity dependent on drug concentration (Irons et al., 2010). 
Irons, et al, reported that low doses, up to 2.2 µM caused hyperlocomotion, whilst doses from 6.6 µM 
began to cause increased hypolocomotion, with the maximal dose tested (20 µM) having the greatest 
effect on hypoactivity, similarly found here with a dose of 22 µM (Irons et al., 2010). Thus, in line with 
this study, we found that the pH with the highest level of d-amphetamine in the free base form, pH 8.0, 
caused the greatest reduction in distance moved in 7 dpf larvae.  
Differences in the onset of pH-dependent locomotor changes found between amphetamine 
and morphine compared to nicotine, could be the result of relative absorption times. Oral administration 
of nicotine has been reported to have an almost immediate effect, whilst previous studies using 
amphetamine have reported that peak responses from oral administration was 1-3H post exposure 
(Schepers et al., 2003). It is therefore possible, that the lack of effect seen in the acute dose of morphine 
and d-amphetamine was a result of incomplete or limited absorption at that stage, thus only after 
sufficient exposure time is there an effect of the drug on behavioural output. These three drugs each 
have similar chemical compositions which include an alkaloid amine group which is deprotonated 
forming the free base (nonionized) species (Völgyi et al., 2010). The weak alkalinity and the similar pKa 
values result in drugs that are readily absorbed under more basic conditions (Bhagavan, 2002).  
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The only drug tested that did not follow this trend of pH-dependent locomotor activity was 
caffeine. Although, like the other test drugs, caffeine also has an alkaloid amine group and is weakly 
basic, it has two pKa values of 0.7 and 14.0. Subsequently, caffeine is found in a neutral state at pH 5-9 
(National Center for Biotechnology Information, 2020; Švorc, 2013). Consequently, as the test 
environments both fall within this range, there is no difference in the percentage of ionized/nonionized 
caffeine in solution, thus behavioural changes as a result of exposure to 200 µM caffeine, would be 
expected to affect larvae in both pH groups equally. Therefore, as expected, there were no detectable 
changes in locomotor activity between pH groups treated with caffeine after acute or prolonged 
exposure. Previous studies investigating the effect of different concentrations of caffeine on locomotion 
have also reported no difference between doses (Gutiérrez et al., 2020).  
To our knowledge this is the first systematic investigation of the effects of varying pH conditions 
on the biological activity of drugs, using locomotion as a behavioural endpoint. The aim of this study 
was to highlight the importance of reporting this environmental condition, demonstrating that changes 
of a single pH unit can be sufficient to influence locomotor responses to a fixed concentration of drug. 
We appreciate that the controlling factor of pH conditions in aquatic facilities is the water source used 
to feed the system. Changing this system is impractical and, in many cases, can be cost prohibitive. We 
are therefore not suggesting that facilities attempted to alter husbandry conditions to fit within the 
range recommended by (Aleström et al., 2019). Zebrafish can be found living under a broad range of 
conditions in the wild, and as part of the literature review, we found no study that conducted work 
outside of the natural range that zebrafish have been found to live in. Although it has not been 
systematically assessed how long-term exposure to varying pH conditions affects behaviour in a 
laboratory setting, it is our belief that as long as fish are kept within the natural environmental range 
this should be acceptable. However, future investigations would be of great use as a resource to the 
zebrafish community. Based on our findings here, we suggest carrying out drug treatments at a similar 
pH to the housing conditions to prevent any shock responses from rapidly changing environmental 
conditions, which could require additional habituation periods or cause behavioural artefacts. Instead, 
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we propose that when carrying out drug treatments the pH value is taken into consideration as part of 
the experimental design. To prevent the addition of drug induced fluctuations to test conditions, we 
recommend either neutralising or matching drug solutions to aquarium water pH. Reporting of pH 
conditions and awareness of pKa values of test drugs when designing experiments and drawing 
conclusions will greatly aid in improving replicability between laboratories and provide a potential 
mechanism for interlab differences when testing the same drug at what appears to be the same 
concentration. Our understanding of how environmental conditions can influence experimental design, 
particularly in light of toxicology studies, drug discovery and drug testing using aquatic organisms is in 
its infancy. Future work investigating the effects of altered environmental conditions in the presence of 
a drug on behaviour and bioavailability and how drug x pH interactions apply to adult zebrafish 
behaviour would provide invaluable information for those testing zebrafish with drugs or toxins. 
Understanding how environmental conditions can influence experiments may prove a valuable tool in 
optimising zebrafish as a model organism.   
 
2.6 Conclusion 
With the increasing use of high-throughput behavioural screening of zebrafish larvae for assessing 
pharmacological agents, the need to improve inter-lab reproducibility is of critical importance. This 
study demonstrates that four drugs from the same family of organic bases can all exert different effects 
on locomotor responses by altering environmental conditions by a single pH unit. We have reported 
that even small changes can cause significant effects and could result in substantial differences in the 
way larvae, and potentially adult zebrafish respond to drug exposure. It is currently not mandatory to 
report the pH of aquarium water or of drug treated water in which fish are immersed. We demonstrated 
that from a sample of studies less than 35% reported pH. We therefore propose that the zebrafish 
community start to report pH values of drug conditions and general husbandry so that results can be 





This chapter represents the first use of the Y-maze as a test of cognitive performance, utilising the more 
complex tetragram configuration of pattern examination. Here we describe the first evidence that the Y-
maze could detect subtle differences in cognitive performance, demonstrating a reduction in the use of the 
alternation strategy. The findings from this chapter were the instigation of further investigation of the 
function of the Y-maze as a test of WM and lead to characterisation of the FMP Y-maze described in Part 
1, Chapter 3. Additionally, this chapter demonstrates the far-reaching effects that even low concentrations 
of alcohol can have on long term cognitive function. Exposure during the early stages of development to 
low concentrations of alcohol have been demonstrated to persist into adulthood and have been shown 














Moderate developmental alcohol exposure reduces repetitive 
alternation in a zebrafish model of fetal alcohol spectrum disorders 
This chapter has been published (formatting has been retained):  




The damaging effects of alcohol on a developing fetus are well known and cause a range of conditions 
known as fetal alcohol spectrum disorder (FASD). High levels of alcohol exposure lead to physical 
deformity and severe cognitive deficits, but more moderate exposure leads to a range of subtle 
cognitive effects such as reduced social behaviour, higher propensity to develop addictions, and 
reduced spatial WM. Previous studies have demonstrated that following exposure to relatively low levels 
of ethanol during early brain development (equivalent in humans to moderate exposure) zebrafish 
display a range of social and behavioural differences. Here, our aim was to test the hypothesis that 
moderate developmental ethanol exposure would affect aspects of learning and memory in zebrafish. 
In order to do this, we exposed zebrafish embryos to 20 mM [0.12% v/v] ethanol from 2 to 9 dpf to 
model the effects of moderate prenatal ethanol (MPE) exposure. At 3 months old, adult fish were tested 
for appetitive and aversive learning, and for spatial alternation in a novel unconditioned y-maze 
protocol. We found that MPE did not affect appetitive or aversive learning, but exposed-fish showed a 
robust reduction in alternations in the y-maze when compared to age matched controls. This study 
confirms that moderate levels of ethanol exposure to developing embryos have subtle effects on spatial 
WM in adulthood. Our data thus suggest that zebrafish may be a promising model system for studying 
the effects of alcohol on learning and decision-making, but also for developing treatments and 




Consumption of alcohol by women during pregnancy can result in a range of physical and behavioural 
abnormalities in the fetus, symptoms which are collectively known as fetal alcohol spectrum disorders 
(FASDs) (Dörrie et al., 2014; van Wieringen et al., 2010). The most severe and easily diagnosed disorder 
is fetal alcohol syndrome (FAS), which is characterised by craniofacial malformations, central nervous 
system dysfunction, growth retardation and reduced intellectual abilities (Archibaldma et al., 2001; 
Mattson, 1998). Although FAS is an extreme case caused by high levels of chronic alcohol abuse, lower 
levels of alcohol intake have also been shown to cause a range of milder, less obvious symptoms 
including deficits in social behaviour (Fernandes & Gerlai, 2009), decision-making and planning (Berman 
& Hannigan, 2000; Sood et al., 2001) and an increased susceptibility to substance abuse in later life, 
even following adoption (i.e., controlling for environmental effects (Cadoret et al., 1995)).  
Though heavy chronic abuse of alcohol by a pregnant woman leads to obvious symptoms in 
the child, behavioural symptoms of milder cases of FASD are rarely accompanied by physical deformities 
and are thus problematic to diagnose (Astley & Clarren, 2000). As a result, the number of children 
affected by milder forms of FASDs is likely to be much higher than those reported (May et al., 2014; 
Stoler & Holmes, 1999). In the absence of physical symptoms, details of any alcohol consumption must 
derive from self-report and is open to response biases (Jacobson et al., 1994). Thus, to better understand 
the effects of amount, frequency and timing of exposure of the embryo to alcohol, animal models have 
been used to bridge the gap (Patten et al., 2014). Traditionally most animal models of FASDs have been 
carried out in rodents. However, recently zebrafish have come to light as an alternative model for 
neurobehavioral research, striking a balance between similarities with human and rodent models, 
complex behavioural interactions, ease of genetic manipulation, low cost of maintenance and high 
throughput (Kalueff, 2017; Kalueff et al., 2014; Kalueff & Cachat, 2011).  
In rodents, the effects of moderate prenatal ethanol exposure on learning have been mixed and 
unclear, with some conflicting reports of effects on some aspects of learning (Abel, 1979; Carvan et al., 
2004; Patten et al., 2014). This lack of consistency may be due to the complexities associated with rodent 
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models of prenatal exposure, such as dosing regimen (injection vs gavage vs voluntary drinking), 
maternal effects (i.e. during gestation) and effects of rearing (e.g., cross-fostering vs maternal rearing 
(Marquardt & Brigman, 2016; Valenzuela et al., 2012). It is critical, therefore, to get a more developed 
understanding on the effects of moderate exposure to ethanol during early brain development, and 
zebrafish may offer a useful complementary model organism in which to achieve this.  
Since the pioneering work from the Gerlai (Fernandes & Gerlai, 2009) and Carvan III (Carvan et 
al., 2004) groups, zebrafish have been proving to be excellent models for examining the effects of low-
to-moderate concentrations of ethanol exposure on the developing embryo on behavioural endpoints. 
For example, previous work has shown that zebrafish exposed to moderate developmental alcohol 
exposure display alterations in adulthood of social and anxiety behaviour, an increased propensity to 
develop habits, and this corresponded to changes in mRNA expression of genes typically associated 
with the reward pathway, including dopamine, serotonin, µ-opioid and nicotinic acetylcholine receptors 
(Parker et al., 2016; Parker, Annan, et al., 2014). Despite some evidence that exposed embryos show 
reductions in ability to learn a spatial two-choice guessing task (Carvan et al., 2004) no studies have 
carried out a full assessment of the effects of moderate exposure to ethanol during early brain 
development on different aspects of learning and memory. The aim of this paper was therefore to 
characterize aspects of learning and memory in adult zebrafish that have been exposed to moderate 
levels of ethanol during early brain development. We approached our aim by examining appetitive and 
aversive learning, and repetitive alternation in a novel unconditioned search protocol using a Y-maze. 
Y-maze tests are widely used to measure exploratory behavior in rodents (Dember & Fowler, 1959; 







3.3 Materials and Methods 
Subjects and ethanol treatment  
Embryos (AB wild-type strain) were collected from multiple individual pairings, sorted and cleaned, and 
placed at random (fish from each individual pairing mixed into final groups) in groups of ~40/petri dish 
in a translucent incubator (28oC) on a 14/10-hour light/dark cycle. The concentration of ethanol used 
was based on our previous research, and the ethanol treatment protocol was as previously described 
(Parker et al., 2016;Parker et al., 2014). Briefly, at 48 hours post-fertilization, embryos were visually 
inspected and sorted to ensure all were at the same developmental stage (long-pec phase), then 
transferred into multiple replicates (5/concentration) of either 20 mM (0.12 percent [v/v] ethanol in 
aquarium water (ethanol-treatment), or to fresh aquarium water with no alcohol (control). Our previous 
work, and that of others, has shown that 20 mM ethanol gives a final alcohol concentration of ∼0.04 
g/dl blood alcohol [BAC]) (Fernandes et al., 2014; Parker et al., 2014; Parker & Brennan, 2012). The reason 
for choosing 48 h to start treatment, is that by this stage all embryos have emerged from the chorion, 
so we can be sure the concentration of ethanol getting into the embryos is uniform. In addition, 48 hpf 
represents the long-pec phase of development, when the main catecholaminergic neural development 
takes place (Guo et al., 1999). At 5 dpf, embryos were transferred, still in their treatment medium, into 
larger containers (10 × 10 × 20 cm [depth × width × length]) containing 500 ml solution (ethanol or 
aquarium water) and remained in the incubator. During treatment, water/ethanol media were changed 
daily. Fish remained in the treatment solution for 7 days, until 9 dpf, after which all fish were transferred 
within their initial treatment groups into fresh aquarium water and placed on our re-circulating system, 
initially in groups of 40 in 1.4 L tanks (Aquaneering Inc., San Diego, CA, USA). Juvenile zebrafish (30 dpf) 
moved to groups of ~20 in 2.8 L tanks on the re-circulating system, on a 14/10-hour light/dark cycle, at 
∼28.5°C, pH 8.4 ± 0.5. Fish were tested on behavioral procedures at 3 months of age. Fish were fed a 
mixture of live brine shrimp and flake food 3 times/day (once/day at weekend). No fish was used for 
multiple protocols, and following the experiment, all ethanol-exposed fish were euthanized (Aqua-
Sed™, Vetark, Winchester, UK). We used a mixture of male and female fish for all behavioral testing. 
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Previous research with zebrafish has not revealed sex effects for developmental alcohol exposure, and 
sex was not evaluated as a variable in this study. Finally, there were no differences in mortality or in 
gross morphology in any of the groups, although specific data are not reported here. 
 
Ethical Statement 
All experiments were carried out following scrutiny by the University of Portsmouth Animal Welfare and 
Ethical Review Board, and under license from the UK Home Office (Animals (Scientific Procedures) Act, 
1986) [PPL: P9D87106F]. 
 
Randomization and blinding 
All experiments were carried out under the ARRIVE guidelines (Kilkenny C, Browne WJ, Cuthill IC, 
Emerson M, 2010). First, all embryos were randomly allocated to treatment from multiple pair-
breeding’s. During treatment, experimental staff carried out ethanol treatment (see above) but technical 
staff were not aware of treatment allocation (blinded). This was achieved by putting the name of the 
experiment on treatment dishes and an individual dish identifier, but not indicating which level of 
treatment on the dish. This protocol was continued throughout development (i.e., when fish were on 
the housing rack). When testing was carried out, when fish were individually housed (for the appetitive 
learning protocol), they were numbered, but the treatment group was not known by either the 
experimenter or the technical staff. This was achieved by creating an excel sheet with identities in a 
hidden column. Identity was not revealed until data had been examined for outliers and analyses were 
carried out. For protocols where the fish came from a group (aversive learning and y-maze), fish were 
taken from housing tanks, but the treatment level was not revealed until after data had been examined 
for outliers and was ready for final analysis. Finally, sample sizes for all experiments were determined by 







Behavioral testing of adults was carried out using the Zantiks (Zantiks Ltd., Cambridge, UK) AD system 
(https://www.zantiks.com/products/zantiks-ad), a commercially available, fully integrated behavioral 
testing environment for adult zebrafish (Brock et al., 2017a) (Fig 1). All tank inserts were acrylic, with 
opaque sides and a transparent base. The test tanks were placed into the Zantiks AD system (Fig. 1A, 
B) one tank/time. Each Zantiks AD system was fully controlled via any mobile/web enabled device. (Fig. 
1B, C) display the tanks used to measure appetitive learning. This Zantiks AD unit is designed to carry 
Figure 1. (A) Zantiks AD testing system used for behavioural testing of adult zebrafish. This a 
completely automated system with built in computer for image projection, camera for live imaging 
and feeder mechanism. This allows for minimum experimenter disturbance during trials. (B) 
Behavioural tanks for measuring appetitive learning. (C) (top) 5-choice inserts, these can be fitted 
into each tank and were used in the appetitive learning task. (bottom) shows the trigger areas for 
fish during the 5-choice task. The initiator light (red*) comes on first, fish have to swim into the light 
to initiate the trial. Following initiation, a food reinforcer (ZM300 zebrafish food) was delivered into 
the feeding zone (orange*). When the fish passes through the feeding zone the light is turned off 
and the initiator light turns back on, ready for the next trial. Tanks are filled with 3 L of aquarium 
water during testing.  
*In trial lights are all white, colours have been added for the benefit of the diagram. 
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out multiple learning protocols in zebrafish but in the present experiment, fish were trained to swim 
into an initiator zone (Fig. 1C, red area) in order to receive a food reinforcer (ZM300 zebrafish food) in 
the food delivery zone (Fig. 1C, orange area). Tanks were filled with 1 L water during testing. The testing 





(Fig. 2) displays the tank equipment used for Pavlovian fear conditioning. The stimuli used were based 
on previous work (Brock et al., 2017; Valente et al., 2012), and comprised either a checker-board design 
(‘check’) (black/white alternating squares) or a dark grey (‘grey’) background. Each tank comprised four 
Figure 2. (A-B) Tank and shocking plates used for Pavlovian fear conditioning (aversive learning). (C) 
Stimuli used were based on previous work and comprised either a checker-board design (‘check’, 
black and white alternating squares) or a dark grey (‘grey’) background. Each tank comprised of four 
lanes, separated by opaque acrylic dividers. At each end of the tank was located a steel plate capable 
of passing a mild electric current through the tanks (9V). Tanks were filled with 1 L of water.  
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lanes (L16xW32 cm), separated by opaque acrylic dividers. At each end of the tank was located a steel 
plate, capable of passing a mild electric current through the tank (9V). Tanks were filled with 1 L of water, 
with ~4 cm water at the base. Pilot studies found this amount of water to be optimal for both tracking 
and conditioning.  
 
Figure 3.  
 
 
(Fig. 3) displays the tank set up for the y-maze alternation test. Fish were placed into one of two 
removable acrylic y-mazes (L7x W1.5 cm) in 3 L aquarium water (~40mm depth of water). Fish were 
filmed from above for a period of 1 h.  
 
Figure 3. (A-B) FMP Y-maze insert used to assess alternation use. (C) Tank set up for FMP Y-maze. 





Initially 20 fish were selected (n = 10 from each treatment) to allow for attrition. Any fish that did not 
respond (i.e., did not swim into stimulus areas or ‘froze’ and did not carry out the task) was excluded. 
Following attrition, a final sample of N = 16 adult (n = 8 control, n = 8 20 mM ethanol) zebrafish were 
tested on the appetitive conditioning protocol at 3-months of age. Final sample size was determined 
based on previous research examining appetitive learning in developmentally exposed fish (Fernandes 
et al., 2014). During appetitive conditioning training, fish were housed in pairs in 2.8 L tanks (divided 
breadthwise with transparent mesh dividers). The training was divided into two phases, and learning 
was assessed following the second phase. Initially, fish were shaped for one week to associate the noise 
of the feed dispenser with delivery of a small amount of ZM300 (~2 mg). In the second phase, fish were 
trained that swimming into an initiator area (Fig. 1, red zone) resulted in food delivery. They were trained 
on this protocol for 3 days (~30-trials/day). Following completion of training, we tested learning with a 
series of probe trials, during which fish were exposed to 5 trials of initiator light “on” (30-sec), or “off” 
(30-sec) and measured total number of entries to the initiator during light on/light off.  
 
Pavlovian fear conditioning 
N = 44 adult (n = 22 control, n = 22 20 mM ethanol) zebrafish were tested on the Pavlovian fear 
conditioning protocol at 3-months of age. Fear conditioning was based on a protocol developed based 
on published data (Valente et al., 2012); sample size was based on a power calculation of previous 
research (Valente et al., 2012) and following a pilot assessment of change in preference following mild 
shock (effect size [d] = 0.9, power = 0.8, alpha = 0.05, required sample = 22/treatment). First, fish were 
placed, individually, into one of four lanes in each Zantiks tank. Into each tank was placed n = 2 ethanol 
and n = 2 control fish (the experimenter was blinded at this stage to the treatment of the individual fish, 
and the position of fish from either treatment [a or b] counterbalanced between trials). Initially, fish were 
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habituated to the test environment for 30 mins, during which the base of the test tank was divided in 
half, lengthways, with the ‘check’ and ‘grey’ stimuli occupying half of the base each (Fig 2c), switching 
position every 5 min. Baseline preference was ascertained over 10 min. Following baseline preference 
assessment, conditioning was carried out, during which the conditioned stimulus (CS+; full screen of 
‘check’ or ‘grey’, randomized between subjects) was presented for 1.5 sec, at the end of which was 
delivered the unconditioned stimulus (US) a brief, mild shock (9V DC, 80ms), followed by an 8.5 sec 
inter-trial interval (ITI), during which the non-CS (CS-) exemplar was presented at the bottom of the 
tank. The CS+/US was presented nine times. Following conditioning, avoidance of CS+ was ascertained 
by repeating the baseline, presenting both CS+ and CS- simultaneously for 1 min, and switching 
positions after 30 sec. 
 
Y-maze test 
N = 28 adult (n = 14 control, n = 14 20 mM ethanol) zebrafish were used for the Y-maze test, at 3 
months of age. This was a novel protocol, and sample size was based on pilot data (effect size [d] = 1.2, 
power = 0.8, alpha = 0.05, required sample = 14/treatment). In order to characterize perseveration and 
alternation in zebrafish, we designed a simple Y-maze, with three identical arms. Although memory in 
zebrafish using a Y-maze has been previously evaluated (i.e., by blocking one arm, and exploring use of 
the novel arm once it is opened during training), simple unconditioned Y-maze search patterns and 
performance has yet to be evaluated in zebrafish, and this study represents the first reports of this 
protocol. There were no intra-maze cues, but extra-maze (distal) cues were visible from each maze (e.g., 
the walls and open side of the Zantiks equipment), providing egocentric cues and allowing the fish to 
orient within the apparatus. The experimenter was not visible to the fish at any point during the protocol. 
Fish were recorded in the Y-maze apparatus for up to 1 h, or until they performed 100 arm-entries, 
whichever the sooner (here, all fish performed 100 entries in the allowed h). This allowed for 97 
overlapping series of four choices (tetragrams), of which there were a total of 16 manifestations possible. 
Two tetragrams (RRRR and LLLL) represented pure repetitions, and two (RLRL, LRLR) pure alternations. 
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A completely random search strategy would be to choose every potential tetragram equally (97/16 = 
6-times). However, perseverant response sequences may encompass above-average use of alternations 
or of repetitions. Previous research using a T-maze in which each arm was baited with an equal 
probability reinforcement, has demonstrated that mice tend to show generally higher levels of 
alternations between arms (LRLR, RLRL) than other alternatives (Gross et al., 2011).    
 
Data analysis 
Data were analyzed in IBM SPSS® Statistics for Macintosh (Version 24). Appetitive conditioning was 
measured by examining both acquisition data, and a series of probe trials to test learning. Acquisition 
data was compared between control and 20 mM ethanol treated fish using a general linear mixed model, 
with fixed factors as treatment (2-levels: control, 20 mM ethanol) and day (3-levels), and their interaction, 
and fish ID nested in tank as the random effect (to account for non—independence of replicates). 
Denominator degrees of freedom were estimated using the Satterthwaite approximation. Probe trials 
comprised count data and were fitted to a generalized linear mixed effects model (Poisson distribution, 
log link function), with fixed effects as treatment (control, 20 mM ethanol) and light status (light on, 
light off) and the random effect as fish ID nested in tank (to account for non-independence of replicates). 
Denominator degrees of freedom were estimated using the Satterthwaite approximation. Fear 
conditioning was assessed by comparing change in preference for a stimulus following conditioning 
with 9 x 9V shocks. A two-way, mixed design analysis of variance (ANOVA) was applied, with proportion 
of CS+/CS- preference as the dependent variable, ethanol treatment as the between-subjects factor (2-
levels; control, 20 mM ethanol) and conditioning stage as the within-subjects factor (2-levels; pre- and 
post-conditioning). ‘Tank’ was added as a covariate into the initial model, but removed from the final 
model owing to lack of effect (F < 1). Finally, in order to examine perseveration in the Y-maze, we carried 
out two analyses. In the first, we considered whether there were differences in the frequency of each of 
the 16 tetragrams as a function of treatment. We fitted frequency data to a generalized linear mixed 
effects model (Poisson distribution, log link), with treatment (control, 20 mM ethanol) and tetragram 
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(16-levels) as fixed factors, and ID as the random effect (to account for non-independence of replicates). 
Denominator degrees of freedom were estimated using the Satterthwaite approximation. Next, to 
assess whether there were any effects of developmental ethanol on frequency of pure alternations (LRLR 
+ RLRL) or pure repetitions (RRRR + LLLL). This was assessed by fitting generalized linear models 
(Poisson distribution, log link function) to alternation and repetition frequency data. In both models, 
fixed factor for each was ethanol treatment (2-levels: control, 20 mM ethanol). Again, ‘Tank’ was added 
as a covariate into the initial model, but removed from the final model owing to lack of effect (F < 1). 
 
3.4 Results 
Moderate developmental ethanol exposure does not affect appetitive learning in zebrafish 
Acquisition of learning data for the 20 mM ethanol treated and control fish (Fig 4A). A GLMM revealed 
a significant main effect of day, F (2,28) = 9.15, P < .01 (Day 1 vs Day 2, P = .9; Day 1 < Day 3, P =.001; 
Day 2 < Day 3, P =.001), but no significant effect of treatment, F (1,14) = 1.17, P = .3, or day  treatment 
interaction, F < 1. Figure 4b displays the probe trial following appetitive conditioning, in which fish were 
presented with the stimulus light 5-times (10 sec), interspersed with non-light presentations (10 sec). A 
GLMM (Poisson distribution, log link function) was fitted to the data, with number of entries to the 
stimulus zone as the response variable, treatment and lights-on/off as the fixed factors, and fish ID 
nested in tank as the random effect. There was a main effect of lights on/off, F (1,18) = 9.41, P < 0.01 
(Lights ON > Lights OFF), but not effect of ethanol treatment or lights on/off  treatment interaction, Fs 










Moderate developmental ethanol exposure does not affect fear conditioning in zebrafish 
Mean preference for the conditioned stimulus following Pavlovian fear conditioning, during which fish 
were given 9 CS + US (shock) pairings with either a checker-board or grey image (Fig. 5). A Two-way 
ANOVA revealed a significant main effect of conditioning, F (1,42) = 62.79, P < .001, with fish showing 
a robust reduction in preference for the conditioned stimulus. There was no main effect of ethanol 
treatment (F < 1) nor conditioning*ethanol treatment interaction (F < 1). 
 
Figure 4. (A) Training data (appetitive condition) for 20 mM treated fish compared to control fish. 





Moderate development ethanol exposure reduces alternations in a Y-maze 
Total choices for each tetragram during a 100-trial search period for zebrafish in the FMP Y-maze (Fig. 
6A). A GLMM, with Poisson distribution specified and a log link function, revealed a significant main 
effect for ‘tetragram’, F (15, 416) = 8.74, P < .001, characterized as significant increases in frequency of 
alternations (LRLR, RLRL; P < .001). There were no main effects of ethanol treatment (F < 1), nor 
tetragram*ethanol treatment interaction (F < 1). (Fig. 6B) displays the frequency of pure alternations, 
and (Fig 6C) pure repetitions. GLMM (Poisson regression) revealed a significant effect of ethanol 
treatment on alternations (Figure 6b; 2 [df = 1] = 3.98, P =.046), but not on repetitions (Figure 4c; 2 




Figure 5. Preference for conditioned stimulus (CS+) prior to conditioning (baseline) and following 







In this study we combined operant and Pavlovian learning tasks with a spatial memory task to test 
whether moderate levels of ethanol exposure during early brain development in zebrafish affected 
aspects of learning and WM. We found that adults developmentally treated with 20 mM ethanol (the 
equivalent of 2-3 drinks in a single sitting) performed equally well as control groups in Pavlovian and 
operant learning tasks, but in a spatial memory task had a decreased frequency of pure alternations 
(LRLR, RLRL) in a Y-maze. These observations indicate that MPE can cause disruption in specific aspects 
of learning that persist into adulthood even when executive function is not obviously affected. This 
highlights the difficulty in diagnosing milder forms of FASD, but further supports the growing body of 
Figure 5. (A) Frequency distribution of tetragrams during unconditioned search in the Y-maze 
(Ethanol treated, n=14; control, n=14) comprising of mean (±SEM) choices during 100 trials. (B) 
Mean (±SEM) total pure alternations for control compared to 20 mM ethanol treatment. (C) Mean 
(±SEM) total pure repetitions for control and 20 mM ethanol treated fish. * p < 0.05. 
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evidence implementing low to moderate levels of alcohol exposure in cognitive and behavioral 
abnormalities.  
 
Appetitive and aversive learning tasks 
Operant learning tasks are used to measure executive functions involved in learning, planning, 
motivation and memory (Valente et al., 2012), higher functions that are often impaired in children with 
FASD (Green et al., 2009; Rasmussen, 2005). Here we found that exposure of larvae to 20 mM ethanol 
[0.12% v/v] from 2-9 dpf had no detectable differences in executive function in adulthood when tested 
in appetitive or aversive learning tasks. This was irrespective of whether the task was under a positive 
(food reward) or negative (shock) stimulus control. These findings are in contrast to models of high 
ethanol exposure which have reported marked deficits in behavioral tasks of exposed groups (Abel, 
1979; Brown et al., 2008; Fernandes et al., 2014). Although these findings may seem at odds with our 
own results, this disparity was not unexpected. Obvious deficits in executive function are found in 
humans with severe forms of FASD which are associated with periods of binge drinking during 
pregnancy (Bailey et al., 2004). The effects of high concentrations of ethanol exposure have been 
replicated in a number of primate (The effects of prenatal alcohol exposure on behavior: Rodent and 
primate studies, 2011), rodent (Riley et al., 1979; Wagner et al., 2014) and zebrafish models (Carvan et 
al., 2004; Fernandes & Gerlai, 2009), many showing a concentration-dependent effect on learning 
(Carvan et al., 2004). Children also show a concentration-dependent effect of alcohol exposure resulting 
in extreme variability between mild and severe cases (Sood et al., 2001). Those exposed to moderate 
intrauterine alcohol levels may not display obvious deficits in executive function, but have subtler effects 
that may not be evident until later in life. A study by Carvan III, et al (2004) looked at learning and 
memory in low to high concentrations of ethanol exposure in zebrafish and found a concentration-
dependent effect on learning and memory when embryos were exposed to low concentrations ranging 
from 10 mM-30 mM ethanol (Carvan et al., 2004). The disparity between our study showing no learning 
deficits at 20 mM could be explained by differences in the timing of concentrations. In their study dosing 
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began at 4 hpf compared to 48 hpf in this study. Studies in other species have also found discrepancies 
in concentration amount and effects on learning and memory tasks, a key difference between them 
being the timing and duration of concentration (Lovely et al., 2014;Lovely et al., 2016).  At 48 hpf 
zebrafish larvae are almost completely developed, the brain has developed into 5 distinct lobes, the 
circulatory system has developed and the heart is beating, fins develop and there is sensitivity to the 
environment and uncoordinated movements (Kimmel et al., 1995). This is the equivalent to late stages 
of development in the human fetus. We suspect that full brain development at the time of dosing may 
be a reason for executive functions still being intact and showing no obvious signs of dysfunction.  
Our findings highlight two major influences on severity and variability in FASD. Firstly, from 
findings of higher-concentration animal models (Abel, 1979; Carvan et al., 2004; Fernandes et al., 2014), 
we can draw the conclusion that concentrations higher than 0.12% v/v of ethanol exposure [up to 3% 
v/v] are required to cause functional deficits in executive function, specifically in goal-orientated reward 
tasks. Secondly, dosage is not the only key factor causing developmental defects, timing and duration 
of exposure are also crucial and can cause marked differences in cognitive and behavioral abilities even 
at lower concentrations of ethanol exposure (Carvan et al., 2004; Lovely et al., 2014). This ability to mirror 
the variability seen in human forms of FASD further strengthens the use of zebrafish as a model of 
complex neurological disorders.   
 
Y-maze Spontaneous Alternation Task 
The Y-maze has been established as a reliable protocol for testing spatial WM in zebrafish (Cognato et 
al., 2012). For the first time, here we use unconditioned free-search of the Y-maze as a behavioral test 
for fish prenatally exposed to moderate levels of ethanol. We observed that all fish had a tendency for 
highly alternating sequences (pure alternations, LRLR or RLRL). However, 20 mM ethanol treated fish 
used pure alternation as a search strategy significantly less than their untreated counterparts. Using 
tetragram configurations, similar to those used by (Gross et al., 2011), allowed us to compare random 
191 
 
or specific search strategies employed by fish when swimming freely in a Y-maze. We would expect that 
in a reward-absent maze, with no highly salient intra or extra-maze cues, that fish would choose each 
search configuration equally (i.e. in 100 trials each tetragram should be chosen n=6 times). However, 
for both treated and nontreated groups this was not the case. Our findings that all subjects have an 
increased preference for pure alternations was previously seen by (Gross et al., 2011) with rats and 
(Neuringer, 1992) with pigeons. Both studies similarly reinforced each option equally (here this was done 
by an absence of reward, opposed to associating each arm with a reward an equal number of times). 
This observation could be explained by the ‘law of least mental work’, an adaptation from Hull’s ‘law of 
less work’ (Hull, 1943), which suggests that in a non-reinforced task subjects will opt for the behavior 
that is least cognitively demanding. Simplified strategies, like repeating the last action, may be favored 
in non-discrete behavioral tasks, possibly identifying repetition of pure alternations as the least 
cognitively demanding strategy. The random incorporation of the other 14 possible search strategies 
could be influenced by information seeking or a desire for change or novelty (Kool et al., 2010), but in 
the absence of any new information being presented, the organism goes back to the least mentally 
demanding search pattern.  
 The reduction of pure alternations in ethanol treated fish is contradictory to what we would 
expect. Several animal models have used a form of spontaneous alternation to measure WM, whether 
it is in a T-maze (Deacon, Nicholas, et al., 2006; Gross et al., 2011), Y-maze (Dobson et al., 2012)  or plus 
maze (Sison & Gerlai, 2010), or the use of two-choice guessing tasks in humans (Frith & Done, 1983). 
Over a range of conditions frequency of pure alternations has normally been reported as higher in the 
treated group than in the control groups (Frith & Done, 1983; Gross et al., 2011). However, the 
mechanisms affected by moderate ethanol exposure that result in the deficit that we see here, are not 
completely clear. It is possible that these differences are due to damage to the hippocampus, effecting 
WM. Rats exposed to ethanol within the first 2 weeks of neonatal life, the rodent equivalent of the third 
trimester in humans, have been reported to have functional impairments of hippocampal neurons, 
specifically in the CA3 region (Baculis et al., 2015; Caldwell et al., 2015; West et al., 1984).  This could 
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potentially explain deficits seen here, as rodents with hippocampal lesions also perform poorly in spatial 
memory tasks, specifically with familiarization ( Roberts et al., 1962). However, if there were hippocampal 
impairments, we would expect to see some evidence of this during either of the other two operant 
learning tasks used. Even though these trials require extensive training and rely on associative memory 
to be successfully performed, they also require the hippocampus, and during the early process of 
learning, spatial WM, short-term memory and the ability to convert experiences into long-term 
memories. The combination of learning and memory tasks used and the paralleled ability of treated and 
control groups in the operant learning tasks thus suggest that memory may not be a fault for the 
changed behavioral pattern seen in the Y-maze by treated fish. 
 An alternative explanation is the theory of “choice hysteresis”. Choice hysteresis is the tendency 
of animals and humans to repeat recent choices. (Bonaiuto et al., 2016) describe a virtual model in which 
activity decay leftover from recently activated neural circuits increased repetition biases. They also 
describe how depolarizing or hyperpolarizing the dorsolateral prefrontal cortex (dlPFC) could increase 
or suppress choice hysteresis, respectively. Children born with FASD are often reported to have deficits 
in the dlPFC as is established by the Wisconsin Card Sorting task (neuropsychological test for executive 
function which is used to determine damage to the dlPFC) (VAURIO et al., 2008). Again, this is another 
area in which severity and variability are in strong correlation with concentration of alcohol exposure, 
with high, chronic concentrations of alcohol exposure, (i.e., those born to alcoholic mothers) performed 
the poorest on this task compared to those exposed to lower concentrations of alcohol and control 
groups.  
 This is the first time that the Y-maze has been used in the context of FASD and there are evident 
differences in the search strategies employed by treated and nontreated groups. However, the lack of 
comparative studies carried out at other concentrations limits what can be inferred from this data and 
therefore mechanisms and meanings are limited to theoretical ideas. Although many other studies have 
investigated the effects of PNEE on spatial WM (Berman & Hannigan, 2000; Hamilton et al., 2014; Vicari 
et al., 2004; Zimmerberg et al., 1991), the lack of standardized measures of spontaneous alternation 
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makes it difficult to compare findings from one study to another unless they have used similar data 
analysis. Also, significant differences can be seen between rewarded and reward-absent tasks. From this 
study we can concluded that moderate PNEE does alter behavior in a spontaneous alternation task. 
However, at this stage we can only hypothesize about possible mechanisms responsible for this change. 
It is also difficult to judge how this may relate to human behavior, thus, further work would be required 
to draw out anything conclusive.    
 
Limitations and future directions 
There are limitations to this study. First, only one concentration and one exposure time were used. In 
light of differences on learning and memory seen in other behavioral studies (see review: (Patten et al., 
2014)) future studies could use variations of these two factors to test if there are any behavioral changes 
in the tasks performed here. Most interestingly would be the effect on spontaneous alternations in the 
Y-maze. We predict that exposure to high concentrations of ethanol, to the extent that it causes 
cognitive impairment, would cause an increase in pure repetitions (LLLL ,RRRR) and pure alternations 
would occur at a rate equal to that of controls. Secondly, we used a mixture of male and female fish for 
our experiments. Many studies have found effects of sex in some species following developmental 
ethanol exposure (Zimmerberg et al., 1989, 1991). This may represent a limitation of the fish model in 
terms of translational relevance, as it appears at odds with other vertebrates in this regard. A further 
limitation could be that we did not measure locomotion in the study. Some have found that locomotor 
differences can lead to false results if not carefully controlled. However, because all fish were tested for 
the same period of time, and because the tests rely on movement (i.e., swimming in and out of the arms 
of the maze) we are not concerned that locomotion differences would lead to confounding results. 
Finally, our limited repertoire of behavioral tasks may result in other behavioral abnormalities being 
missed. Future studies should incorporate more tasks involving complex cognitive functions to fully 




In regard to the primary aim of this study we found that MPE caused marked behavioral changes in the 
search strategy employed by treated fish in a Y-maze. However, the concentration and timing of 
exposure did not impact on executive functions required for Pavlovian operant learning tasks. Thus, we 
can conclude that even in the absence of physical malformations, developmental exposure to moderate 
levels of ethanol can cause subtle behavioral and cognitive changes that persist into adulthood.  
Despite decades of investigation and a mountain of data examining the toxic and deleterious 
effects of alcohol on the developing fetus, the number of children born with FASD is on the rise (Mattson 
& Riley, 1998). Being the leading form of preventable mental retardation and having lifelong effects that 
can severely reduce the quality of life of those affected (Sokol et al., 2003), it is critical that we fully 
understand the impact that all levels of ethanol exposure can have. The effect of moderate levels of 
alcohol exposure are becoming even more crucial with the number of women having unplanned births 
and pregnancies being as high as 23% and 40% respectively (Bearak et al., 2018; Sedgh et al., 2014), 
worldwide. Therefore, the chance of drinking before becoming aware of being pregnant is a huge risk 
factor. Concentrations as low as 10 mM have been reported to affect cognitive abilities, this is the 
equivalent of 1-2 drinks in one sitting (Carvan et al., 2004). This is also the current UK recommend ‘safe 
level’ of consumption during pregnancy ((UK), 2008). With guidelines like these in place and a growing 
body of evidence suggesting detrimental effects of low and moderate levels of alcohol exposure, 
research in these areas is becoming even more important to help change health advice and the way 






     Chapter 4 
 
The literature is clear that the developing brain is particularly vulnerable to exposure to drugs of abuse. 
Modulation of developing neural networks and neurotransmitter systems can be severely impacted by 
prenatal exposure to legal drugs such as alcohol and nicotine. Such exposures can have long lasting 
implications for brain structure and function. In the previous chapter, we describe such altered functioning, 
even after a relatively low concentration of drug exposure, resulting in poorer cognitive performance, 
particularly pertaining to WM. These effects on the developing nervous system, may be heightened in 
sensitivity due to the lack of a fully matured homeostatic regulatory system, that is better placed to 
counteract such toxicological perturbations in adults. In this next chapter we investigate how legal drugs 
of abuse, nicotine and amphetamine, alter cognitive control. We use a sensitization model to assess the 
impact of chronic exposure, withdrawal and repeat exposure on cognitive performance and describe the 
first model of cognitive sensitization in zebrafish. We further implicate differences in stimulation of the 
dopaminergic and cholinergic systems in cognitive domain dependent shifts in cognitive function and 
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4.1 Abstract 
Background: Zebrafish are growing in use as a model for understanding drug dependence and 
addiction. Sensitization paradigms have been a useful tool in identifying mechanisms involved in drug-
induced behavioral and neurological changes, but in zebrafish have tended to focus on locomotor, 
rather than cognitive, endpoints.  
Methods: Here, we used a novel method, the FMP Y-Maze, which measures continuous performance 
through a series of repeated binary choices (L vs R), to establish a model for assessing parameters 
associated with psychostimulant-induced behavioral and cognitive sensitization in adult zebrafish. 
Results: Repeat, intermittent exposure to d-Amphetamine (AMPH) for 14 days increased alternations 
(LRLR) in the maze, suggesting improved working memory, which was enhanced further following drug 
challenge after a short withdrawal period, suggesting behavioral sensitization. However, this cognitive 
enhancement coincided with a reduction in the use of other exploration strategies, hypolocomotion 
and inhibition of cognitive flexibility. Like AMPH, exposure to nicotine (NIC) increased alternations 
following drug challenge after chronic treatment. Repeat NIC exposure appeared to induce both 
cognitive and psychomotor sensitization, as evidenced by increased working memory performance 
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(alternations) and locomotor activity, without negatively impacting other search strategies or cognitive 
flexibility.  
Conclusion: Chronic treatment with AMPH or NIC boosts cognitive performance in adult zebrafish. 
Cognitive sensitization occurred with both drugs, resulting in enhanced working memory, however, 
repeat AMPH exposure, following a withdrawal period, resulted in inhibited cognitive flexibility, an effect 
not evident with repeat NIC exposure. Cognitive and behavioral sensitization paradigms in zebrafish 
could serve as a useful tool for assessing cognitive states which result in cognitive enhancing or 
impairing effects of drugs.  
 
4.2 Introduction 
Psychostimulants, such as amphetamine (AMPH), nicotine (NIC), and cocaine, are known to increase 
extracellular synaptic dopamine (DA) concentrations and activate DA neurotransmission, resulting in 
altered behavioral and locomotor responses (Brown & Kolb, 2001; Cunningham et al., 1997; Dela Peña 
et al., 2015; Di Chiara & Bassareo, 2007; Niculescu et al., 2005; Volkow et al., 1999). Repeated 
administration of a psychostimulant drug enhances psychomotor responsiveness to the drug. This is 
mediated by enhancement of dopaminergic activation and modification of dendritic morphology, which 
can last for extended periods (Robinson & Berridge, 1993). This long-term ability of previously 
encountered drugs to activate DA neurotransmission and modify behavioral outputs is known as drug-
induced sensitization. Sensitization to repeated, intermittent drug exposure in humans is theorised to 
be a critical driver in maintaining drug use and escalation from casual experimentation to craving and 
abuse. Further, those attempting to withdraw from their habit can relapse following long periods of 
abstinence (Robinson & Berridge, 2008; Vezina, 2007). The psychostimulants AMPH and NIC have been 
well document for modulating locomotor responses (Buenrostro-Jáuregui et al., 2016; Cunningham et 
al., 1997; Pisera-Fuster et al., 2019; Valjent et al., 2010), as well as cognitive altering effects in both 
animals and humans (Kuhn et al., 2019; Steketee & Kalivas, 2011; Vezina, 2007; Vezina & Leyton, 2009). 
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Expanding our understanding of the mechanisms underlying drug-induced sensitization may boost the 
efficiency of therapies used to treat substance abuse and reduce the probability of relapse.   
 
Conservation of the ascending midbrain dopaminergic pathways between mammals and teleost fish, 
such as zebrafish, has resulted in the increasing use of zebrafish as a neurobehavioral model for 
assessing the effects of pharmaceutical and illicit drugs (Antunes & Biala, 2012; Barros et al., 2008; 
Goldsmith, 2004; Kalueff et al., 2014). Behavioral responses of zebrafish to psychostimulant drug 
exposure (e.g. amphetamine (Parker et al., 2012), cocaine (Lopez Patino et al., 2008) or nicotine (Suen 
et al., 2013)) have corroborated findings in rodents and humans , thus supporting the suitability of 
zebrafish as a translational model of psychostimulant abuse (Parker & Brennan, 2012; Stewart et al., 
2015). There have been several studies that have demonstrated drug-induced sensitization in zebrafish 
(Blaser et al., 2010; Pisera-Fuster et al., 2019). Although these studies have been a useful starting point, 
they have yet to further our understanding of the mechanisms underpinning sensitization, and the 
relationship between sensitization, addiction and relapse.  In addition, despite extensive investigation 
into psychomotor sensitization, few studies have investigated the role of cognitive sensitization (Castner 
& Goldman-Rakic, 2004; Muhammad & Kolb, 2011; Peleg-Raibstein et al., 2009) and none, to our 
knowledge, have done so in zebrafish.  
 
Here, we aimed to establish whether young-adult zebrafish develop cognitive or psychomotor 
sensitization to repeated administrations of AMPH and NIC, as assessed through the impact on working 
memory, locomotor activity and cognitive flexibility. To do this, we used an established behavioral assay 
for zebrafish that has high translational relevance to humans, the FMP Y-maze (Cleal et al 2020). We 
assessed locomotor activity, working memory and behavioral flexibility at four time points: baseline 
(prior to any drug exposure), chronic exposure (14 days of drug exposure), withdrawal (2 days without 
drug) and finally following drug challenge (single, repeat drug exposure). Changes in cognitive 
performance and motor activity were determined relative to baseline, pre-drug exposure levels. To our 
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knowledge this is the first study to examine the cognitive effects of psychostimulant sensitization in 
zebrafish.    
 
4.3 Materials and methods 
Subjects and drugs 
Thirty-six adult, AB wild-type, mixed sex (50:50 M:F) zebrafish (Danio rerio), aged 3 months old at the 
start of treatment, were used for this study. Sample size (N = 36 (n=12/treatment group) [50:50 M:F]) 
was determined by power analyses based on large effect sizes (f2 > .3) observed in extensive previous 
experiments in our group using the FMP Y-maze. Housing conditions were maintained on a re-
circulating system (Aquaneering Inc., San Diego, CA, USA), tank water was maintained at pH 8.4 (±0.4), 
temperature 25-27 °C, on a 14h:10h light/dark cycle. From free-feeding (5 days post fertilisation (dpf)) 
fish were fed on ZM fry food until adulthood when they were fed on a daily diet of live brine shrimp 
(maintained at the fish facility) and dried flake food (ZM Systems, UK) 3 times/day during the week and 
once/day at weekends. All fish used in this study were experimentally naïve. Ethical approval was granted 
by the University of Portsmouth Animal Welfare and Ethical Review Board and conducted in accordance 
to the Animals (Scientific Procedures) Act 1986. Drugs were obtained from Sigma-Aldrich (Dorset, UK). 
Drug solutions were made up in aquarium water at pH 8-9. Moderate doses of AMPH and NIC were 
based on previous studies which found these concentrations to have reinforcing effects on zebrafish, 
assessed in the conditioned placed preference (CPP) task (Brock et al., 2017; Kalueff, 2017; Kily et al., 
2008; Ninkovic & Bally-Cuif, 2006; Parker et al., 2013). All experiments were carried out in line with 
ARRIVE guidelines (NC3Rs, UK). 
 
FMP Y-maze 
The FMP Y-maze has been previously shown to be a useful method for assessing working memory, 
behavioral flexibility and locomotion, and has been described in detail elsewhere (Cleal, et al., 2020; 
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Cleal & Parker, 2018; Fontana et al., 2019). Briefly, fish were placed individually in white acrylic maze 
inserts (arms: L50 x W20 x D140 mm). Each arm of the maze was set at 120° angles. There were two 
inserts per tank, allowing two individuals to be tested simultaneously. The inserts were fitted into a tank 
containing 3L of aquarium water (Figure 1). The FMP Y-Maze comes as a standard protocol within the 
commercially available automated behavioral tracking unit (Zantiks AD system for adult zebrafish, 
Zantiks Ltd, Cambridge, UK). Fish were free to explore all arms of the maze for 1 hour (h). Entries and 
exits from each arm were automatically recorded and logged in an excel file for the duration of the task. 
Arm entry data was extrapolated to obtain a time series of left and right turns, which were subsequently 
divided into 16 overlapping sequences of tetragrams (four consecutive turn choices, e.g. left, left, right, 
right [LLRR] or right, left, right, left [RLRL]; for details of analysis of tetragrams, see Data analysis section 
below). Analyses of temporal dynamics of search patterns have demonstrated that zebrafish show 
flexibility in their behavior during the search parameters. Pharmacological analyses have demonstrated 
that alternations (LRLR, RLRL) are reduced by memory-blocking drugs in zebrafish (Cleal et al 2020), 
suggesting that alternations are linked to working memory. Locomotion was measured by the total 




Figure 1. Schematic showing dimensions of individual Y-mazes (left), two Y-maze inserts (middle) 




Experimental design  
First, all fish were screened for baseline performance in the FMP Y-maze for 1-h of free exploration. 
Zebrafish were then allocated randomly into treatment groups (n = 12 AMPH [25µM]; n = 12 NIC [5µM]; 
n = 12 control) and pair-housed in treatment groups for identification purposes. Experimenters were 
blinded to treatment-group allocation. We pair-housed the fish four days prior to the start of repeated 
intermittent exposure to drugs in order to ensure they had habituated to the new housing system, and 
during this time, technical staff were blinded to treatment allocation. Acquisition of AMPH or NIC 
sensitization was established over three treatment phases (Figure 2). Phase I: each fish was given 14 
consecutive 30-min daily sensitizing exposures to their respective treatment. On day 14, following their 
final 30-min exposure, fish were immediately placed into the FMP Y-maze for 1-h of free exploration. 
Phase II: zebrafish had two days without treatment wherein they remained in their home tanks, in pair-
housed conditions. After 48-h of withdrawal zebrafish were recorded in the FMP Y-maze for 1-h. Phase 
III: each group received a challenge-dose of their respective treatment for 30-min. Immediately 
following drug challenge, zebrafish were recorded in the FMP Y-maze for 1-h.  
 
 
Figure 2. Schematic representation of working memory, cognitive flexibility and locomotor 
assessments during pre-treatment phase to establish baseline performance, following 14 days of 
daily drug treatment (intermittent exposure), after two days of rest (withdrawal) and following repeat 





All analyses were carried out using IBM SPSS Statistics (v26) and graphical representations were 
completed using GraphPad Prism (v8). Studentized residuals were generated from statistical models 
and screened for outliers. Any data point identified as an extreme value (>3*IQR) was removed from 
further analysis. Previous work from our lab has identified two regular tetragram patterns (alternations 
[LRLR+RLRL] and repetitions [RRRR+LLLL]) that appear disproportionately regularly (compared to other 
sequences) throughout the duration of the trial. In order to study locomotor responses, we analysed 
each treatment stage based on the total number of turns completed during 1-h of exploration in the 
maze. LMM analysis was carried with “total turns” as the dependent variable, “treatment (AMPH, NIC, 
control)” and “treatment stage” (baseline, sensitizing, withdrawal, challenge) as the within-subjects 
factor and “ID” as a random effect. Analysis was followed by Bonferroni-corrected post-hoc test 
comparing each stage to baseline.  
Cognitive flexibility was based on changes in alternation strategy during trial progression. The 
percentage of alternations used during each 10 min time bin for six successive time bins was analysed 
using LMM with “alternations” as the dependent variable, “time” (6 levels, 10-min time bins), “treatment” 
and “treatment stage” as the within-subjects factors, “total turns” as a covariate and “ID” as a random 
effect. Analysis was followed by Bonferroni-corrected post-hoc analysis comparing each time bin to 
every other time bin for each treatment group. Data are represented as mean + standard error of the 










Development of sensitizing effects of AMPH and NIC on working memory and stereotypic behavior in adult 
zebrafish. 
Use of alternation strategy in the FMP Y-maze has been linked with changes in working memory. Adult 
zebrafish were assessed at pre-treatment stage, prior to drug exposure and then subsequently after 14-
day intermittent exposure, withdrawal and finally, following drug challenge, to assess sensitization 
effects in water (n=12), AMPH (n=12) and NIC treated (n=12) adult zebrafish. LMM showed a significant 
effect of treatment stage (F3, 683 = 10.23, p < 0.001), and a significant treatment x treatment stage 
interaction (F3, 684 = 6.84, p < 0.01). There was no effect of treatment alone (F2, 30 = 1.16, p = 0.33). Control 
fish treated with water showed no difference in alternation use between any treatment stage (p = 0.12). 
AMPH-treated fish demonstrated a significant effect of treatment stage with increased alternations after 
sensitization (95% CI, 12.24-30.60, p < 0.001), returning to near baseline levels after withdrawal 
(although this effect fell short of significance: 95% CI,-.141-16.75 p = 0.06). Drug challenge with AMPH 
caused alternation levels to increase significantly above baseline level (95% CI, 18.87-37.48, p < 0.001), 
demonstrating an increase in alternation use by ~11% after sensitization and ~19% following acute 
drug exposure. NIC has a significant effect on treatment stage (p = 0.03). Similarly to AMPH, NIC-treated 
fish showed no difference between sensitization and baseline (95% CI, -.814-16.45,  p = 0.09) or 
withdrawal and baseline (95% CI, -1.98-14.46,  p = 0.21) alternation levels, but demonstrated a 
significant increase in alternations from ~25% at baseline to ~36% following sensitization (95% CI, 
1.889-20.376, p = 0.01) compared to pre-treatment levels (Figure 3A). Neither controls (p = 0.92) nor 
NIC treated fish (p = 0.29) showed changes in repetition use at any treatment stage; however, AMPH 
treated fish showed a significant effect of repetitions on treatment stage following drug challenge 





Locomotor sensitization induced by AMPH and NIC.  
Locomotor activity was assessed by number of turns completed during 1 h of exploration. LMM revealed 
a significant effect on locomotor activity of treatment (F 2, 122 = 4.47, p = 0.01) and treatment * treatment 
stage interaction (F 3, 122 = 4.0, p < 0.01), but no main effect of treatment stage (F 3, 122 = 1.15 p = 0.33). 
NIC demonstrated psychomotor sensitization following acute NIC challenge, resulting in 
hyperlocomotion compared to baseline (95% CI, -4.41—16.13, p = 0.03) (Figure 3C), while AMPH 











AMPH treatment inhibits cognitive flexibility 
To assess cognitive flexibility the percentage use of alternations was analysed as a factor of time. For 
each treatment group LMM was used to examine the effect of treatment stage on alternations per time 
bin for six successive 10 min time bins. For controls, there was a significant effect on alternations of time 
(F5, 208 = 4.06, p < 0.01), but no main effect of treatment stage (F3, 210 = 2.12, p = 0.10), or treatment stage 
x time interaction (F5, 208 = 0.55, p = 0.91) (Figure 3E). NIC caused a significant effect on alternations of 
time (F5, 222 = 7.01, p < 0.01) of treatment stage (F3, 223.7 = 2.70, p = 0.05), but no effect of treatment stage 
x time interaction (F5, 222 = 0.70, p = 0.79) (Figure 3G). AMPH treated fish showed a significant effect on 
alternations of treatment stage (F3, 191 = 20.91, p < 0.001), but no effects of time (F5, 190 = 1.42, p = 0.22) 
or a treatment stage x time interaction (F5, 190 = 1.35, p = 0.18). Collectively, this demonstrated a 
significant impairment to alter use of alternations over time in fish treated with AMPH (Figure 3F).  
Fig 3. Behavioral response to repeat drug exposure in adult zebrafish treated with NIC or 
AMPH. Analysis of drug-induced sensitization of AMPH- and NIC-induced cognitive enhancement. 
Working memory and stereotypic behavior were determined during several stages of drug exposure 
using a repeated measure analysis of pre-treatment (baseline) abilities compared to cognition 
following 14 days of sensitization to either water (control/control), AMPH (AMPH/AMPH) or NIC 
(NIC/NIC), 2 days of withdrawal and after challenge with either water, AMPH or NIC (n=11 control, 
n=11 AMPH, n=12 NIC treated). All animals were given an acute dose of the same treatment that 
they were sensitized to. Data are expressed as mean + SEM of total percentage use of (A) 
alternations for assessment of working memory, (B) repetitions for the assessment of stereotypic 
behavior and mean ± SEM of (C) locomotor activity based on total turns completed during 1 h of 
exploration. Data were analysed using a LMM analysis followed by Bonferroni post-hoc analysis 
comparing each stage to baseline. (D) Analysis of total locomotor activity after repeated 
administration of water, AMPH or NIC. Analysis of percentage use of alternations over time for each 
treatment stage per treatment group was analysed using LMM followed by Bonferroni post-hoc 
analysing using pairwise comparison of each 10 minute time bin for a total of 6 time bins for (E) 
controls treated with water, (F) conditioned to AMPH followed by acute AMPH challenge and (G) 
conditioned to NIC followed by acute NIC challenge. Data are expressed as mean ± SEM. *p<0.05, 




Here, we investigated the sensitizing effects of the psychostimulants AMPH and NIC on both cognitive 
abilities and locomotor responses in zebrafish. Psychostimulants have performance-enhancing effects, 
best characterised in subjects with low baseline levels of cognitive abilities or pre-existing disorders that 
cause cognitive deficits, such as schizophrenia or attention deficit hyperactivity disorder (ADHD) (for 
reviews see: Valentine & Sofuoglu, 2017; Wood et al., 2014). AMPH is therefore the front-line 
pharmaceutical treatment for ADHD, with many studies reporting improvements in attention and 
concentration (Faraone & Biederman, 2002; James et al., 2001; Spencer et al., 2006). Nicotine has 
similarly been found to ameliorate cognitive impairment in ADHD (Levin et al., 1996; Levin et al., 2006; 
Liebrenz et al., 2014; Rezvani & Levin, 2001; Wilens, 2003). Although less conclusive, improvement in 
certain cognitive domains has also been reported in healthy subjects treated with nicotine or ‘clinically 
relevant’ doses of AMPH (Bagot & Kaminer, 2014; Barch & Carter, 2005; Heishman et al., 2010; Jasinska 
et al., 2014; Mattay et al., 2000; Turner et al., 2003; Valentine & Sofuoglu, 2017; Wood & Anagnostaras, 
2009). Here, we demonstrate that administering a moderate dose of AMPH, but not NIC, directly into 
the water of healthy adult zebrafish, for 14 days of intermittent, daily exposure, improved working 
memory compared to baseline levels. In addition, unlike AMPH, NIC did not cause degradation of 
cognitive flexibility, suggesting that it might have fewer unwanted negative effects compared to AMPH.  
 
Repeat administration of psychostimulants induces behavioral sensitization when exposed to a 
subsequent drug challenge, and this often manifests as an enhancement of cognitive function (Berridge 
et al., 2012). Following repeated intermittent exposure, both AMPH and NIC-treated adults showed 
cognitive sensitization, as evidenced by enhancement of performance, with alternation use increasing 
by ~11% for AMPH and ~8% for NIC (compared to baseline) immediately following chronic dosing. A 
further increase of ~8% and ~3%, respectively, was reported following the challenge dose. Decreased 
alternations in the FMP Y-maze have been pharmacologically characterised as a reduction of working 
memory, suggesting that increased alternations may be indicative of improved working memory (Cleal 
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et al., 2020). The sensitization of certain cognitive domains, such as working memory, are likely due to 
altered neurotransmission in ascending DA pathways from the striatum (Berke & Hyman, 2000). Previous 
studies have shown that after chronic administration of a psychostimulant, subsequent doses cause 
increased DA release (Herman & Roberto, 2015). The duration of this increased DA response can be 
several weeks, or as demonstrated here, can be evoked after 48 hours of withdrawal from sensitization 
treatment.  
 
AMPH and NIC increase striatal DA release (Krause et al., 2002), which can enhance striatum-dependent 
tasks, such as those requiring working memory and memory consolidation (Brown et al., 2000; Landau 
et al., 2009), and subsequently potentiate performance of a previously established pattern of behaviors; 
in this case, the increased use of alternations. Elevated striatal DA increases the use of ‘habits’, blocking 
the extinction of established behaviors following devaluation of the goal (Berke & Hyman, 2000). This 
may provide a possible mechanism for the persistent use of alternations, at the expense of other 
strategies, after AMPH-induced sensitization. This response strategy may also represent persistent 
behavioral changes that are associated with drug addiction, in which the persistent seeking and taking 
of drugs of abuse come at the expense of other normal and necessary behaviors. The fact that this 
habitual use of alternations, in favour of other search strategies, is only evident in AMPH-treated fish, 
could be suggestive of the different mechanisms of increasing extracellular DA through dopaminergic 
or cholinergic pathways. Alternatively, the differences we observed between AMPH and NIC could be a 
result of the concentration used, and thus future studies should examine the sensitizing effects of a 
range of drug concentrations.  
 
Psychomotor stimulants are known for their motor activity altering effects (Cunningham et al., 1997). 
Repeated, intermittent exposure to psychostimulants causes progressive enhancement of locomotor 
activity with subsequent challenge exposures (Adriani et al., 2006; Kuczenski & Segal, 2002; Peleg-
Raibstein et al., 2009; Pisera-Fuster et al., 2019). Here, NIC-treatment caused sensitized 
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hyperlocomotion, whereas AMPH-treated fish demonstrated hypolocomotion. Treatment with AMPH 
has been reported to have a paradoxical effect of cognitive enhancing attentional increases and 
behavioral-calming reductions of hyperactivity. Many studies have shown that these effects are not only 
evident in patients diagnosed with ADHD, but also in healthy subjects (Bagot & Kaminer, 2014; Holze 
et al., 2020; Roberts et al., 2020). Human studies with healthy participants have shown that dosing with 
AMPH can cause an overall decrease in activity levels in healthy boys and adults and similar decreases 
in hyperactive boys. At low-moderate concentrations of AMPH (as used here), increased hypoactivity is 
correlated with improved memory performance in cognitive tasks (Rapoport et al., 1980; Spencer et al., 
2015). Here, we demonstrate improved cognitive performance corresponding to hypolocomotion in 
zebrafish.  
 
NIC has regularly been reported as causing hyperlocomotion. Progressive long-lasting increases in 
locomotor and DA activating effects are generally associated with moderate exposure regimens, 
whereas high doses of NIC for prolonged periods are more closely associated with signs of withdrawal 
and typically do not demonstrate locomotor sensitization (Pisera-Fuster et al., 2019). Several studies 
have shown that a single low dose of NIC is ineffective at inducing locomotor or dopaminergic 
activation; however, daily low doses can induce locomotor sensitization after days of withdrawal from 
drug treatment (Fennell et al., 2020; Pisera-Fuster et al., 2019). These conclusions are in line with our 
findings here, demonstrating no differences in locomotor effects following intermittent dosing; 
however, after just two days of withdrawal, drug challenge resulted in psychomotor sensitization, 
demonstrated by a significant rise in motor activity from baseline to repeat drug challenge.  
The goal of exploring the FMP Y-maze could be perceived as information seeking or foraging behavior. 
As fish become familiar with and continue to explore the test arena, they are continuously updating 
their knowledge of the environment and this can subsequently be used to alter search strategies. In the 
FMP Y-maze the absence of reward during the 1 h of exploration has been shown to instigate a change 
in alternation use in healthy adult zebrafish. Many studies have investigated the relationship between 
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DA agonists, such as AMPH and methylphenidate (MPH), and the relationship between different 
cognitive domains such as working memory, attention and cognitive flexibility (Bagot & Kaminer, 2014). 
The inverted-U shaped response to psychostimulants has often been reported to result in the 
simultaneous enhancement and impairment of multiple cognitive functions (Wood et al., 2014). Studies 
investigating effects of psychostimulants on cognitive function have reported that high levels of 
sustained attention correlate with lowered levels of cognitive flexibility, assessed using set shifting tasks 
(Berridge et al., 2012).  
The PFC has been found to be a key region for the regulation of cognitive flexibility (Rougier et al., 
2005). Both high and low prefrontal D1 receptor stimulation has been linked with impaired flexibility 
responding in humans, using the Wisconsin Card Sorting Task (WCST) (Klanker et al., 2013; Takahashi 
et al., 2008, 2012). In a previous study conducted by our lab, we administered a serial dilution of acute 
doses of the D1-like antagonist SCH-23390 prior to testing in the FMP Y-maze. We found that SCH-
23390 severely impaired cognitive flexibility in the FMP Y-maze at the highest dose (1.5 mg/L), but not 
at the lower doses (0.5-1.0 mg/L) which still maintained an effect of time on alternations. Additionally, 
all doses of SCH-23390 caused a significant reduction in overall use of alternations, hypolocomotion 
and, at the highest dose, an increase in stereotypic behavior, shown by a significant increase in 
repetitions (Cleal et al., 2020). These findings, in conjunction with the present work, demonstrate a 
complex role for D1 in modulating cognitive flexibility. Further work is required to disentangle the 
relationship between DA receptor activation and extracellular levels of DA to fully understanding the 




We investigated the sensitizing effects of AMPH and NIC on working memory, locomotion and cognitive 
flexibility. We demonstrated that non-contingent exposure to the psychostimulants AMPH, but not NIC, 
improved working memory performance in the FMP Y-maze after 14 days of intermittent dosing, 
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returning to basal levels after two days of abstinence. Subsequent challenge resulted in sensitization of 
both drugs, resulting in greater use of alternations, demonstrating an increase in the preference for this 
exploration strategy. In AMPH this increase in alternation use was accompanied by a decrease in the 
use of other strategies, demonstrating a focused increase, bordering on stereotypic behavior. Only NIC 
demonstrated increased locomotor sensitization compared to pre-drug exposure levels. AMPH caused 
significant hypolocomotion during challenge. Additionally, our findings suggest a role for dopaminergic, 
but not cholinergic, overactivation in the inhibition of cognitive flexibility. Although the protocol for 
psychostimulant-induced motor sensitization is substantially less cumbersome to establish than other 
models of addiction, it is not a precise homologue for  psychostimulant addiction in humans (Berke & 
Hyman, 2000). Understanding drug-induced changes in neurotransmitter systems and neural plasticity 
by studying cognitive sensitization may provide a useful model with high face validity. These results 
demonstrate that previous exposure of fish to AMPH or NIC can enhance cognitive performance, but 
extreme levels of improved performance in one cognitive domain can result in disruption in another 
domain. This may demonstrate the first signs of drug-induced maladaptive activities. The distinction 
between cognitive enhancement and inhibition of normal behaviors, may be dependent on cognitive 
flexibility, the loss of which has been strongly linked with substance abuse disorders which are often 
characterised by deficits in cognitive flexibility and may underlie the persistence of harmful, drug 
seeking and taking behaviors.   
 
Finally, this paper is the first to demonstrate robust test-retest reliability for the FMP Y-Maze. In previous 
studies we have only looked at single exposures of animals to the maze. With the demonstration from 
our control animals here that there are no significant changes in total turns, alternations, repetitions or 
general search patterns in the maze during the hour test between the four test periods, suggesting that 







5.1 General discussion 
This section has focused on the effects of legally obtainable drugs of abuse on cognitive performances 
at two distinct developmental stages: prenatal and adult. Our initial study investigating the effects of 
low concentrations of prenatal alcohol exposure reported causal alterations in cognitive trajectory, 
resulting in poorer cognitive performance than their non-drug exposed counterparts in the FMP Y-
maze. Early developmental exposures have been well documented as being highly susceptible to 
environmental perturbations, even in the absence of any known genetic susceptibilities. However, this 
study highlights just how sensitive the developing brain is, as even low alcohol exposures, the equivalent 
of moderate drinking in humans, is sufficient to cause life-long disparities in cognitive function 
compared to unexposed controls. Although effects of low/moderate alcohol exposure during early brain 
development has been shown previously in humans and in other species, we demonstrated that the 
FMP Y-maze is sufficiently sensitive to detect even very small differences in cognition that are often 
observed.  
 The next section focused on the effect of drugs of abuse on cognitive performance following 
adult drug exposure regimes. Quite the reverse story was true for adult drug exposure compared to 
prenatal drug exposure. Both NIC and AMPH resulted in cognitive enhancing effects after 2 weeks of 
daily treatment. Not only did low doses improve WM after the initial exposure regime, but repeat 
exposure, after a short withdrawal period, demonstrated cognitive sensitization for both drugs. 
However, these pro-cognitive outcomes were not completely without negative ‘side effects’. AMPH 
exposure was also associated with significant deficits in CF. Findings that may have identified the first 
signs of drug induced maladaptive behavioural responses. These negative ‘side effects’ were not, 
however, evident in NIC treatment, as fish repeatedly exposed to NIC maintained behavioural flexibility 
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throughout. This study raises an interesting question as to the inequality in the modulation of cognitive 
functions through the activation of the dopaminergic system directly, through DA receptors, and 
indirectly through activation of the cholinergic system.  
In addition, although not in the same light of cognitive effects of drugs of abuse, we put a call 
out to zebrafish researchers to be mindful of potentially confounding variables when considering 
studies on non-contingent drug exposure in zebrafish. Our brief study effectively demonstrated the 
impact that even small changes in environmental conditions, such as water pH, could have on 
experimental design and output. In an attempt to improve inter-lab consistency and replicability of 
findings we suggest the regular reporting of pH conditions of zebrafish husbandry and, more 
importantly, pH of drug exposure conditions. This is especially important when immersing zebrafish in 
drug solutions as this can significantly impact up-take and ultimately influence final drug concentrations 
in the brain. This could potentially result in misleading data due to disparities in perceived dose and 
actual dose administered. Since identifying the susceptibility of up-take mechanisms to fluctuations in 
environmental pH conditions, we have endeavoured to consistently report pH levels of drug treatments 
in all of our studies.  
Finally, this section provides further validation of the FMP Y-maze as test of cognitive abilities, 
demonstrating the use not only with pharmacological models investigating the impact of drugs of abuse 
on cognition, but additionally highlights a role for repeat testing. This is a particularly interesting 
application of the FMP Y-maze as to date there are few quick, simple and reliable tests of cognitive 
function in zebrafish that have suitable retest potential. This potentially offers a strategy for longitudinal 


























Cognition in Schizophrenia-like models: Effects of 






Schizophrenia is a chronic mental health disorder affecting 20 million people worldwide (James et al., 
2018). It is characterised by positive symptoms (hallucinations, delusions, confused and disorganised 
thoughts), negative symptoms (anhedonia, reduction in emotional expression, motivation and social 
interactions) and cognitive symptoms (deficits in executive functions such as WM, CF, processing speed, 
inhibition and general intelligence) (Blanchard & Cohen, 2006; Dickinson et al., 2008; Heinrichs & 
Zakzanis, 1998; Peralta & Cuesta, 2001; Rector et al., 2005). Cognitive deficits are regarded as a core 
feature of SZ (Lett et al., 2014). Clinical studies have repeatedly found evidence of impaired executive 
function, particularly in WM and CF in patients diagnosed with SZ (Dickinson et al., 2008; Eryilmaz et al., 
2016; Frydecka et al., 2014; Giraldo-Chica et al., 2018; Grover et al., 2019; Heaton et al., 2001). Studies 
have identified the PFC, specifically the dorsal lateral aspect, as a region associated with dysfunction in 
SZ patients (Bolkan et al., 2017; Giraldo-Chica et al., 2018; Orellana & Slachevsky, 2013). Functional 
imaging studies and post-mortem examinations have reported volume deficits in the PFC, the MD 
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(medial dorsal thalamus) and the anterior limb of the internal capsule (ALIC) (the white matter tract that 
provides reciprocal connections between the cortex, striatum and thalamus) (Beasley et al., 2009). 
Additionally, the length and density of the ALIC were also reduced in SZ patients compared to controls 
(Beasley et al., 2009; Lang et al., 2006; Zhou et al., 2003), as well as a reduction in the total connectivity 
between the MD linking to the lateral PFC, which has been correlated with impaired WM (Giraldo-Chica 
et al., 2018). 
The dopaminergic system has been significantly implicated in the pathology of SZ (Brisch et al., 
2014; Kokkinou et al., 2020; Peleg-Raibstein et al., 2009; Rao et al., 2019). Abnormalities in DA synthesis, 
availability and receptor activation have all been linked to aberrant functioning and connectivity in the 
CSTC circuitry. All aspects of SZ have been associated with dysregulation of the dopaminergic system 
(Brisch et al., 2014). Hyperactivity of DRD2 neurotransmission in subcortical regions, including the 
thalamus and striatum, are associated with the positive, psychotic symptoms of SZ (Alfimova et al., 2013; 
Noble, 2003; Ripke et al., 2014). Whilst hypoactivation of DRD1 in the PFC have been implicated in 
negative symptoms and cognitive deficits (Rao et al., 2019). Patient studies have further implicated 
dopamine-related genes, such as dopamine transporter (DAT) (Rybakowski et al., 2006; Szekeres et al., 
2004; Xu et al., 2010), DRD3 (Szekeres et al., 2004), DRD4 (Alfimova et al., 2006; Hwang et al., 2012) and 
DRD5 (Golimbet et al., 2008) in neurocognitive deficits in SZ.  
 Substantial progress has been made in validating the aetiology, brain pathology and 
behavioural abnormalities in animal models of SZ. Drug-induced and genetic models of SZ have been 
extensively studied in rodents (for reviews see: Jones et al., 2011; Lee & Zhou, 2019; Neill et al., 2010) 
and are growing in use in zebrafish (Demin et al., 2019; Gawel et al., 2019). The most commonly used 
pharmacological model of SZ, pre-treatment with MK-801, captures aspects of positive (psychosis), 
negative (social interaction deficits) and cognitive symptoms (memory impairment) that present in the 
human disorder (Andiné et al., 1999; David et al., 2008; Lim et al., 2012; Maaswinkel et al., 2013; Rung et 
al., 2005; Sison & Gerlai, 2011a; Zimmermann et al., 2016). The effect of MK-801 on cognitive impairment 
has been assessed in zebrafish (Cleal, Fontana, et al., 2020; Cognato et al., 2012; M.-C. Ng et al., 2012; 
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Seibt et al., 2011; Sison & Gerlai, 2011b; Swain et al., 2004) and it is for this reason that we included it a 
pharmacological model for validating the FMP Y-maze as a test of WM (see Part 1: Chpt 3). It has also 
been tested in rodents (Abraham & Mason, 1988; Manahan-Vaughan et al., 2008; Neill et al., 2010; van 
der Staay et al., 2011) and humans (Thomases et al., 2013). It is an NMDA receptor (NMDA-r) antagonist 
that causes cognitive deficits by impairing long term potentiation (LTP) (Kovacic & Somanathan, 2010; 
Song et al., 2018; Wiescholleck & Manahan-Vaughan, 2012; Yoshiyama et al., 1991). LTP is the 
mechanism used to store information by activity-based modification of synapses, which has been 
associate with learning and memory formation (Aigner, 1995; Bliss & Lomo, 1973). NMDA-r are highly 
concentrated in the telencephalon in both mammals and zebrafish, and have been strongly implicated 
in memory formation (Fig. 1) (Aigner, 1995; Nam et al., 2004). NMDA-r antagonists act by modulation 
of voltage-gated currents, thus decreasing neuronal excitability by hyperpolarizing the affected cells, 
consequently decreasing the role of the neuron within a neural circuit, e.g. by impairing memory 
formation (Brosnan, 2011). Glutamatergic and dopaminergic pathways interdependently modulate one 
another. NMDA-r activation alters firing patterns of DA neurons, whilst dopamine receptors directly 
(DRD1) or indirectly (DRD2) regulate NMDA-r function (Chergui et al., 1993, 1994; Mereu et al., 1997; 
Overton & Clark, 1992; M. Wang et al., 2012). Taken together, the literature supports the use of MK-801 
as a model with high face and construct validity for mimicking the cognitive symptoms of SZ by evoking 
dopaminergic dysregulation resulting in altered DA neuron activity and behavioural endophenotypes 












Numerous candidate genes have been identified as markers for increased susceptibility for 
developing SZ (Ripke et al., 2014). Many of these genes have provided targets for generating animal 
models with SZ-like phenotypes including cognitive deficits (Papaleo et al., 2012; Winship et al., 2019). 
The leading risk-associated gene, and most extensively studied, is Disrupted in Schizophrenia-1 (Disc1). 
Several rodent models have been developed, targeting different mutation variations in Disc1 (Papaleo 
et al., 2012). Through this mutant line, a direct link was identified between Disc1 and NMDA-r functions, 
providing further support of the validity of the MK-801 pharmacological model of SZ (Ramsey et al., 
2011; Z. Yan et al., 2014). Models of Disc1 were found to have reduced cortex volume, as reported in 
humans, and a range of cognitive deficits, including WM and CF. One study by (Gamo et al., 2013) 
demonstrated exacerbated cognitive impairments with stress, specifically affecting WM performance. 
Recently, a role for an excitatory-inhibitory imbalance in the PFC in Disc1 locus impaired mice, revealed 
a reduction in inhibition, causing altered synaptic communication between the MD and the PFC circuitry 
(Delevich et al., 2020). This demonstrates a possible mechanism for the cognitive deficits identified in 
SZ patients. Rodent models additionally found deficits in WM and CF and implicated a role for the PFC 
Figure 3. Brain divisions of the telencephalic and diencephalic regions in adult (A) humans, (B) 
rodents (mouse) and (C) teleosts (zebrafish).  




in models of Dysbindin-1 (Dtnbp1) , Neuregulin 1 (Nrg1), Reelin and Proline dehydrogenase (Prodh), all 
genes that have been associated with increased risk of developing SZ (Papaleo et al., 2012).  
There are several genetic models of SZ-related phenotypes in zebrafish. Susceptibility genes 
associated with SZ, such as disrupted in schizophrenia-1 (disc1) (Eachus et al., 2017; Singh et al., 2011; 
Wood et al., 2009), neuregulin 1 (nrg1) (Wood et al., 2009) and regulator of G-protein signalling 4 (rgs4) 
(Cheng et al., 2013) have all been knockdown in zebrafish, and although some SZ-like phenotypes, 
mostly associated with positive or negative symptoms, have been assessed, none of these models to 
date have conducted comprehensive cognitive assessments, despite cognitive deficits being a core 
feature of SZ. A recent study by (Thyme et al., 2019) has completed a comprehensive genomic study of 
132 zebrafish orthologs of human SZ-associated genes, demonstrating the potential of zebrafish for 
conducting large-scale genetic mutation and screening of phenotypes associated with a specific 
disorder, a feat unimaginable in rodents. However, the lack of cognitive testing in assessment of SZ 
models highlights a huge gap in the use of zebrafish as a model of SZ and potentially raises the need 
to develop more reliable, robust and high-throughput cognitive tests available for assessing zebrafish 












As has been described above, there are only a few zebrafish models of SZ, compared to an extensive range 
of rodent lines. In addition, the few that have been developed in zebrafish have yet to investigate cognitive 
performance of these models, thus lacking description of one of the most prevalent features of SZ in 
humans. As we have suggested, this may be due to a lack of high throughput, robust methods for assessing 
cognition in zebrafish. The early sections of this thesis have described the use of the FMP Y-maze as 
behavioural task that can be used to fulfil these criteria. In addition, as discussed above, one of the most 
efficient pharmacological models for inducing SZ-like phenotypes is MK-801, which has been tested in 
humans, rodents and zebrafish. In conjunction with previous zebrafish models, we treated zebrafish with 
MK-801 to validate the FMP Y-maze as a test of memory, as MK-801 is well known for disrupting WM and 
cognitive flexibility. In Part 1, Chpt 3 we describe the cognitive impairing effects of MK-801 on zebrafish 
exploration patterns in the FMP Y-maze. This study has provided preliminary data on exploration patterns 
of zebrafish exhibiting SZ-like phenotypes in the FMP Y-maze.  
 The following chapter is concerned with the development of a new zebrafish line targeting another 
susceptibility gene for SZ: SLIT-3. Several genome association studies have now implicated dysfunction of 
this gene not only in SZ, but in several other neuropsychiatric disorders. The next chapter describes the 
characterisation and validation of this new zebrafish line exhibiting a broad spectrum of behavioural and 





CRISPR/Cas9-Induced Slit-3 Mutant Zebrafish (Danio rerio) 
Display Schizophrenia-Like Behaviours 
 
2.1 Abstract 
Human genetic studies have suggested a causal role of SLIT-3 deficiency in schizophrenia (SZ) and 
altered smoking behaviour potentially indicating a link between the high smoking-SZ comorbidity. 
However, the molecular mechanisms underlying SLIT-3 deficiency resulting in SZ and modified smoking 
behaviour are not fully understood. Recently, ENU-mutagenized zebrafish carrying a loss of function 
mutation in slit-3 have replicated modified smoking behaviour in humans, by demonstrating an 
increased preference for nicotine in the conditioned place preference (CPP) task. However, as of yet, no 
evidence of slit-3-induced SZ-like behaviour has been modelled using zebrafish. Here, we report the 
generation and characterisation of a slit-3 mutant zebrafish at adult stages using the CRISPR/Cas9 
genome editing technique. Slit-3 zebrafish exhibited abnormal anxiety responses, cognitive function, 
drug preference and hypothalamic-pituitary-interrenal (HPI) axis activation, which are partially rescued 
by treatment with nicotine but not ethanol. We generated the first slit-3 zebrafish model to exhibit 
robust SZ-like behaviours and demonstrate a therapeutic role for nicotine. Zebrafish models of complex 
neuropsychiatric disorders will likely have a significant contribution to future studies of human SLIT-3 
function and SZ and may play a critical role in identifying potential therapeutic strategies.  
 
2.2 Introduction 
Schizophrenia (SZ) is a severe mental health disorder that globally affects over 20 million people ( James 
et al., 2018). It is an extremely debilitating condition that is characterised by an extensive, heterogeneous 
combination of features that have been subcategorised into positive (hallucinations, thought disorders 
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and delusions), negative (anhedonia, emotional blunting and social withdrawal) and cognitive 
symptoms (impaired WM, attention and executive function) (Andreasen, 1995; Blanchard & Cohen, 
2006; Dickinson et al., 2008; Peralta & Cuesta, 2001). Cognitive deficits have been well documented as 
a core characteristic of SZ, with both patients (Dickinson et al., 2008; Eryilmaz et al., 2016; Frydecka et 
al., 2014; Giraldo-Chica et al., 2018) and animal models (Castner & Williams, 2007; Neill et al., 2010; 
Papaleo et al., 2012; Young et al., 2009) exhibiting deficits in memory processing, particularly WM. In 
addition to altered behavioural outcomes, there is substantial evidence for molecular changes 
particularly affecting the hypothalamic-pituitary-adrenocortical (HPA) axis activity in many psychiatric 
disorders, including SZ (Bradley & Dinan, 2010; Jacobson, 2014). Both hyper- and hypo-functioning of 
the HPA axis have been linked to altered stress response and have been suggested to contribute to 
poor physical health and premature mortality associated with SZ (Pruessner et al., 2013; Van Venrooij 
et al., 2012). There are a number of additional comorbidities, such as anxiety and substance abuse 
(Goodwin et al., 2003), that are frequently reported in SZ patients, in conjunction to the above 
behavioural and biological mechanisms. 
The most well documented comorbidity with SZ, is the extremely high prevalence of tobacco 
smoking (D’Souza & Markou, 2012). Altered smoking behaviour in patients diagnosed with SZ is widely 
reported, with higher frequency and intensity of smoking and difficulties in smoking cessation when 
compared to the general population and to other serious mental illnesses (De Leon & Diaz, 2012; Hartz 
et al., 2018; Lyon, 1999). There are several theories posited to explain the increased incidence of nicotine 
addiction in SZ patients which include genetic susceptibility to addiction, increased craving, self-
medication, modulation of negative symptoms and cognitive enhancing effects of nicotine (De Leon & 
Diaz, 2012; Lucatch et al., 2018; Wing et al., 2012). However, to date, the precise role of nicotine in SZ is 
still unclear.  
Extensive genome-wide association studies (GWAS) and genetic modelling studies have 
investigated increased incidence of specific SZ-risk genes that occur in the population. A genetic 
association study of the Han Chinese population, conducted by (Shi et al., 2004), identified SLIT-3 as a 
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susceptibility gene associated with SZ. The Slit family consists of large secreted proteins that act as 
guidance cues to regulate neuronal orientation, axon pathfinding, cell migration and differentiation 
during embryonic development (Brose et al., 1999; Little et al., 2002; Long et al., 2004). There are three 
Slit proteins that have been identified in vertebrates so far, Slit-1, 2 and 3 (Brose & Tessier-Lavigne, 
2000). Previously, dysregulation of SLIT-3 has been extensively associated with cancer development and 
progression (Dickinson et al., 2004; Jiang et al., 2019; Ng et al., 2018; Tong et al., 2019; Zhang et al., 
2015). However, more recently genetic association studies have supported the original findings of (Shi 
et al., 2004), identifying SLIT-3 as a SZ-susceptibility gene (Ma et al., 2019; Vieland et al., 2014; Wang et 
al., 2018), but it has also been identified as a risk gene for autism spectrum disorder (ASD) (Park et al., 
2018; Perez et al., 2016), major-depressive disorder (MDD) (Glessner et al., 2010), substance abuse 
(García-González et al., 2020) and Alzheimer’s disease (AD) (Antonell et al., 2013) and has been linked 
with intelligence pathways in humans (Najafi et al., 2018).  
A recent study by (García-González et al., 2020) identified single-nucleotide polymorphisms 
(SNPs) in the SLIT-3 gene in two human cohorts that associated with modified smoking behaviour, 
including nicotine dependence symptoms, age at onset of weekly smoking, number of cigarettes 
smoked per day and time to first cigarette after waking in the morning. The latter two have been 
suggested to be the most predictive measures used in the Fagerström Test for Nicotine Dependence 
(FTND) (De Leon & Diaz, 2012). They also reported increased sensitivity to the rewarding effects of 
nicotine, identified by increased preference for a nicotine-paired environmental cue in the conditioned 
place preference (CPP) task, using an N-ethyl-N-nitrosourea (ENU) mutagenized zebrafish model 
exhibiting a slit-3 loss of function mutation (García-González et al., 2020). This study not only supported 
the role for forward genetic screening and modelling of complex neuropsychiatric disorders in zebrafish, 
but additionally highlighted altered response to nicotine in SLIT-3 mutants, potentially identifying a 
genetic link between modified smoking behaviour and SZ that could aid in elucidating the comorbidity 
so frequently encountered between the two.  
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Zebrafish are growing in use as a model of neuropsychiatric disorders and thus far, several 
genetic models have been generated examining SZ-risk genes, the most notable of which is disrupted-
in-schizophrenia-1 (disc1) (see Part 3: Chpt 1) (De Rienzo et al., 2011; Eachus et al., 2017; Singh et al., 
2011) Although these models have faithfully replicated aspects of SZ-like phenotypes found in humans 
and rodents, they are mostly associated with either the positive or negative symptoms of SZ and as yet 
there are no models that have validated cognitive symptoms, despite these being a core feature of SZ 
(Cheng et al., 2013; Eachus et al., 2017; Singh et al., 2011; Wood et al., 2009). With the identification of 
SLIT-3 as a SZ-susceptibility gene and the discovery of altered nicotine preference in carries of SLIT-3 
SNPs, in both humans and zebrafish, we aimed to use CRISPR/Cas9 genome editing to generate a new 
zebrafish slit-3 mutant line to assess SZ-like phenotypes, including cognition and anxiety, and assess 
the impact of anxiolytic drugs of abuse to identify a causal link between SZ and substance abuse, 
particularly nicotine.  
Our findings support the role for slit-3 mutations in the development of SZ-like 
endophenotypes, including increased anxiety, attenuated cortisol levels following acute stress and 
impaired cognitive function, particularly relating to WM, increased stereotypic behaviour and altered 
drug preferences, which has been replicated together in a single model for the first time in a zebrafish 
model of SZ. Treatment with anxiolytic concentrations of two drugs of abuse, nicotine and ethanol, 
demonstrate increased preference for drug-paired cue compared to controls in the CPP task, but only 
nicotine exerted an anxiolytic effect on slit-3 mutants. Additionally, nicotine also rescued previously 
observed slit-3 mutant cognitive deficits. We have demonstrated the first slit-3-induced SZ animal 







2.3 Materials and Methods 
Generation of slit-3 mutant zebrafish 
The detailed procedure for CRISPR/Cas9 editing in zebrafish was described previously (Irion et al., 2014; 
Mali et al., 2013). The slit-3 target in this study was 5’ – CAGGCGCACAGAGCTCAAGCCGG - 3’. Injection 
mixtures included 300 pg of Cas9 mRNA and 50 pg of gRNA. Embryos were injected with 20 ng of Cas9-
gRNA mixture at the single-cell stage. Fish were grown until adulthood and fin clipped for genotyping 
using T7 endonuclease assay, high resolution melt (HRM) curve analysis and confirmed with sanger 
sequencing. Mutant sites were verified by comparison to the WT unaffected sequences.  
 
Animals and housing  
Zebrafish were bred in-house at the University of Portsmouth Fish Facility, with eggs collected from 
pair-breedings of adult Tg(elavl3:GCaMP6s) on a mixed casper/nacre/AB background. Females and male 
fish (two females and one male for each pair-breeding) were isolated (by sex) in a separate tank the 
evening before breeding. 15-min before lights on fish were transferred to a breeding tank (a shallow, 
stand-alone tank with a slotted base), filled with 0.5-1.0L of aquarium water. Males and females were 
separated by a clear divider. When lights were turned on, the divider was removed to allow the fish to 
mix. Fish were left in the tank for 30-45 min. Once eggs were laid, adult fish were returned to home 
tanks. Laid embryos were washed and placed in petri dishes in maximum groups of 50 embryos per dish 
in aquarium water and immediately used for CRISPR/Cas9 injections at single-cell stage then returned 
to the fish facility. Larvae were reared in the fish facility until adulthood. Fish were maintained on a re-
circulating system (Aquaneering Inc., San Diego, CA, USA). From 5 dpf fish were fed on ZM fry food until 
30 dpf and then put on a diet of dried fish flakes and live brine shrimp, 3 times per day during the week 
and once a day at weekends (am).  Aquarium water was maintained at ~25-27°C, pH 8.4 (±0.4), on a 





Ethical statement  
Experiments carried out as part of this study were under license from the UK Home Office (Animals 
(Scientific Procedures) Act, 1986) [PPL: P9D87106F] and with approval from and in accordance with the 
University of Portsmouth Animal Welfare and Ethical Review Board guidelines.  
  
Behavioural analysis  
Adult zebrafish, at ~3-5 months old, were used throughout this study. Fish were transferred into the 
behavioural room for 30 min prior to analysis to allow for acclimatization. A total of N=120 fish (~12 
per group) were used for all behavioural procedures. Novel tank diving tests were always run prior to 
cognition tests. All behaviour was carried out in the Zantiks adult behavioural unit (AD unit) (Zantiks Ltd, 
Cambridge, UK), which tracked fish continuously whilst in the test arena. Units were web-
enabled allowing live streaming video feed of zebrafish during testing, to a laptop or mobile device. 
Starting and finishing trials was done remotely. Pre-determined protocols were used that depicted 
specific zones and data was automatically logged and output into an excel file. Experimenter visibility 
and handling were kept to a minimum to reduce stress and distraction whilst animals were performing 
behavioural tasks. Ambient light was a maximum of 2 lux in testing units.  
  
Novel tank diving apparatus  
All fish were run individually in a clear rectangular tank, 20 cm length x 5 cm width x 17.5 cm depth and 
filled with 1 L of aquarium water. Fish were permitted free swimming for 6 min, starting from first entry 
into the tank. The test arena was divided into three equal, horizontal zones (bottom, middle, top) to 
allow evaluation of vertical activity. Anxiety behaviour was analysed using time spent in each zone and 
number of entries into the top zone as behavioural endpoints and distance travelled was used to assess 





Free-Movement Pattern (FMP) Y-maze apparatus  
All fish were run individually in a white acrylic Y-maze with clear base and mesh top (to prevent escape), 
maze dimensions are: 5 cm length x 2 cm width x 14 cm depth and filled with 3 L of aquarium water to 
allow sufficient swimming depth. Two mazes were fitted into a water-tight tank and run in the Zantiks 
AD unit. Logging of arm entries was written into the program script, recorded automatically and output 
in an excel spreadsheet. Arm entries and exits were continuously logged throughout the trial and 
converted into a series of left and right turns. Search strategy was based on overlapping sequences of 
four turn choices, giving rise to 16 possible tetragram configurations. Protocols for the FMP Y-
maze have been described in detail elsewhere (Cleal et al., 2020).  
  
Conditioned place preference (CPP) 
CPP was conducted as previously described (Brock et al., 2017; Parker, Brock, Millington, et al., 2013). 
Adult zebrafish were singly isolated in groups of four (fish maintained visual and olfactory contact with 
conspecifics but were kept separate for identification) for 4 days prior to habituation. Fish were 
habituated to the test arena, four fish per arena, for 20 min per day for two consecutive days prior to 
baseline testing. All four stages of the CPP (habituation, baseline, drug treatment and probe trial) were 
conducted in a black acrylic tank (14 cm width x 20 cm length x 15 cm height), longitudinally separated 
with black acrylic dividers, into four equally sized lanes, filled with 2 L of aquarium water. A clear acrylic 
base permitted the projection of visual cues (grey/black and white check squares). Following habituation 
was five days of drug testing consisting of: day 1 – baseline. Tanks were split vertically, half with grey 
and the other half with black and white checks. Fish were in the test arena for 10 min, the first 5 min 
were habituation with no light cues, the second 5 min had light cues and fish were tracked for the 
duration of test, basal preference was determined by the percentage of time spent in each half of the 
tank (% time spent grey v % time spent check). Day 2-4 - fish were conditioned to the least preferred 
side (i.e., fish that spent <50% on the grey side would receive drug treatments in the presence of the 
grey background). Fish were placed into the test arena with the favoured light cue for the first 20 min. 
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Then the least preferred light cue would be used for the second 20 min in conjunction with the addition 
of the drug at the beginning of the second 20 min. Following conditioning fish were returned to home 
tanks. Day 5 – fish tested in the probe test, using the same procedure as the baseline test. Testing was 
conducted in the absence of drug.  Change in preference was assessed by deducting the time spent on 
the drug-paired cue minus baseline preference to the same cue prior to drug exposure (i.e., for a fish 
with grey as the least preferred cue change in preference was calculated as: % time grey probe test - % 
time grey baseline).  
 
Drugs and concentrations  
Two commonly used drugs of abuse with anxiolytic properties, nicotine and ethanol, were selected for 
this study (Gebauer et al., 2011; Levin et al., 2007; Parker et al., 2012a). Nicotine (Sigma-Aldrich) was 
administered at a concentration of 5 µM (Cleal, Gibbon, et al., 2020; García-González et al., 2020; Petzold 
et al., 2009) and absolute ethanol (Thermo Scientific) was administered at a concentration of 171 mM 
(Brock et al., 2017). Both drugs were delivered as a stock to make up the final concentration in 2 L of 
aquarium water. Stock concentrations were ~pH 8.0 ± 0.5. Stock concentrations were divided into four 
equal parts and administered to each lane to ensure drug was evenly distributed throughout the test 
chamber. Concentrations were based on previous work by (Brock et al., 2017) assessing different 
concentrations of drug in the CPP using adult zebrafish. The concentrations selected here reflected 
concentrations that exhibited a positive, drug-induced change in the CPP. 
 
Acute stress 
To study the effect of acute stress on cognitive performance in WT and slit-3+/- mutants, fish were 
removed from home tanks and placed into 2.8 L tanks (5 fish per tank). Acute stress was delivered by 
net chasing for 5 min, then all fish were left to recover for 10 min, as previous research has shown peak 
cortisol responses within 3-15 min of receiving a stressor in zebrafish (Ramsay et al., 2009). Following 
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the rest period, zebrafish were immediately placed into the FMP Y-maze for behavioural testing or 
culled by immersion in ice-water and snap-frozen using liquid nitrogen for whole-body cortisol analysis. 
 
Whole-body cortisol  
Following acute stress, cortisol levels were detected using the Salimetrics Salivary Cortisol ELISA kit for 
human samples (Stratech, Cambridge, UK), which has been found to reliably detect cortisol in zebrafish 
using the method previously described by (Cachat et al., 2010; Parker et al., 2012). Briefly, samples 
were weighed and then homogenised in 1 mL of chilled PBS. 5 mL of diethyl ether was mixed with the 
homogenised samples and centrifuged at 7000 x g for 15 min. The top, organic layer was removed, and 
the process was repeated until all the cortisol-containing layer was removed, and then subsequent 
evaporation of the diethyl ether was continued overnight at room temperature. The resulting cortisol 
was reconstituted using 1 mL of chilled PBS. The ELISA was carried out in a 96-well plate following 
the manufacturer’s instructions. Standards were used to determine the final cortisol concentration using 
OD readings. Weights were used to calculate cortisol concentration per gram (ng/g-1). Inter- and intra-
assay coefficients of variation were determined. Data are represented as mean ± SD (n = 4 per group; 
assayed in duplicate).   
  
gDNA extraction 
Adult fish were anaesthetised using Aqua-Sed (100% 2-phenoxyethanol) anaesthetic treatment (Aqua-
SedTM, Vetark, Winchester, UK) in accordance to manufacturer guidelines, in 500 mL of aquarium water. 
Fin clippings were taken and stored in absolute ethanol at -20 °C until use. Following recovery from 
anaesthetic, fish were returned to home tanks. Genotyping was either performed significantly in advance 
of behavioural testing (i.e., with sufficient time for the tail to grow back or following behavioural testing 
to prevent confounding effects). Samples were homogenised and gDNA was extracted using the 
GeneJET Genomic DNA Purification Kit (Thermo Scientific) following the manufacturer’s instruction. 
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Sample concentrations were analysed using the ND 1000 and diluted to 10 ng/µL in DNase and RNase 
free water and stored at -20°C until use.  
 
High resolution melt curve (HRM) analysis 
Quantitative real-time PCR (RT-qPCR) followed by HRM analysis was used to genotype samples 
(Norambuena et al., 2009; Słomka et al., 2017; Wojdacz & Dobrovic, 2007). Primers were designed using 
NCBI blast and Primer3 and synthesised by Invitrogen (Table 1). The Roche LightCycler® 480 High 
Resolution Melting Master mix and the LightCycler® 96 (Roche Life Science) were used to amplify and 
detect the transcripts of interest. Thermal cycling conditions included an initial denaturation step at 
95°C for 600s (recommended by manufacturer), 40 cycles of 95°C for 25s, 58°C for 25s and 72°C for 35s 
followed by 25 readings of -0.1°C/s melt curve analysis for genotyping gDNA samples. Negative 
template controls were used for checking primer specificity. Differences in high resolution melt peaks 
were manually identified. 
 
Table 1. Primer sets used for HRM analysis   
Gene name  Gene  Primer sequence (Forward)  Primer sequence (Reverse)  Amplicon 
size  
Slit homolog 3 
protein 




Genotyping was confirmed using PCR to amplify a ~600 bp amplicon. Primers were designed using 
NCBI blast and Primer3 and synthesised by Invitrogen (Table 2). The VWR Red Taq Master Mix and 
BioRad T100 Thermal Cycler were used to amplify transcripts. Thermal cycling conditions included an 
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initial denaturation step at 95°C for 2 min (recommended by manufacturer), 30 cycles of 95°C for 20s, 
60°C for 20s and 72°C for 30s and one cycle of 72°C for 5 min and held at 4°C.  
 
Table 2. Primer sets used for PCR   
Gene name  Gene  Primer sequence (Forward)  Primer sequence (Reverse)  Amplicon 
size  
Slit homolog 3 
protein 
Slit-3   TGTTGAGCACTGTATATCCCTCA   AATAGGCGCTTGATTGGTGG  595 
 
 
T7 endonuclease assay/gel electrophoresis/purification 
Following PCR, amplicons were treated with the T7 Endonuclease I Kit (New England Biolabs) following 
the manufacturer’s instructions, to identify heterozygous mutations following CRISPR/Cas9 injections. 
Following the enzyme digest samples were immediately run on a 1.5% (w/v) agarose gel with 5 µL of 
SYBR safe and visualised using a gel imager. Samples were purified using the ExoSAP-IT Product Cleanup 
Kit (Applied Biosystems) in accordance to manufacturer’s instructions and outsourced for Sanger 
sequencing.  
 
RNA extraction and gDNA removal   
Fish were culled using ice-water immersion, followed by severing of spinal cord. Whole brains were 
removed and snap frozen using liquid nitrogen. Samples were homogenised and total RNA was 
extracted using the RNeasy Mini Kit (Qiagen) following the manufacturer’s instruction. After extracting 
and purifying RNA, samples were treated using the RapidOut DNA Removal Kit (Thermo Scientific), 
following manufacturer’s instructions to remove contaminating gDNA from RNA samples prior to 




cDNA synthesis  
Following removal of gDNA from RNA, sample concentrations were measured using the ND 1000 
spectrophotometer. To ensure the same amount of cDNA was synthesised for each sample a maximum 
of 1 µg of total RNA was used per reaction (the same total concentration of RNA was loaded into each 
reaction). Reverse transcription of mRNA to cDNA was done using the High Capacity RNA-to-cDNA 
Kit (Applied Biosystems) following the manufacturer’s protocol. After conversion into cDNA, samples 
were diluted with ddH2O to a final concentration of 5 ng/µL. Samples were stored at -20°C until use.   
  
Quantitative Real-Time PCR (RT-qPCR)/ 
Quantitative real-time PCR (RT-qPCR) assays were used to validate relative gene expression based on 
SYBR green detection. Slit1-3 and gr primers were predesigned by qPrimerDB (Lu et al., 2018), eef1a 
and bdnf primers were based on previous studies (Parker et al., 2016; Tang et al., 2007). Primers were 
synthesised by Invitrogen and are listed in Table 3. The Roche LightCycler® 480 High Resolution 
Melting Master mix and the LightCycler® 96 (Roche Life Science) were used to amplify and detect the 
transcripts of interest. Thermal cycling conditions included an initial denaturation step at 95°C for 600s 
(recommended by manufacturer), 40 cycles of 95°C for 15s, 58°C for 20s and 72°C for 35s. Negative 
reverse transcription (RT) controls and negative template controls were used to determine specificity 
and to check for genomic DNA contamination. Elongation factor 1 alpha (eelf1a) was used as a 
housekeeping gene (Tang et al., 2007). Gene-expression levels were calculated using delta-delta CT 
method and normalised to eelf1a. Changes in expression were relative to controls to demonstrate 
fold changes in slit-3 mutants. Data are presented as means ± SD (n = 6 per group; assayed in 







 Table 3. Primer sets used for qPCR gene-expression analysis   




elongation factor 1 
alpha  
eef1a  CTGGAGGCCAGCTCAAACAT  ATCAAGAAGAGTAGTACCGCTAGCATTAC   87  
Slit homolog 1 
protein 
slit-1 TAAATGCCGCTGTGAGTCTAAT TAAGAGTCTTGAAAGCACCCAT 149 
Slit homolog 2 
protein 
slit-2 GGACTTACTGAAATACCCACCA TATTCTTCGGAGTCGCTTGTAA 120 
















bdnf AACTCCAAAGGATCCGCTCA GCAGCTCTCATGCAACTGAA 262 
 
 
Statistical analysis  
Data were analysed in IBM SPSS 25.0 and GraphPad Prism 8.4.2.  Data from the FMP Y-maze were 
analysed in IBM SPSS, studentized residuals were generated from statistical models and screened for 
outliers. Any data point identified as an extreme value (>3*IQR) was removed from further 
analysis. Residuals were analysed for normality using histograms and Shapiro-Wilk normality test. All 
data were log transformed and a linear mixed model (LMM) was employed to assess alternations and 
repetitions, which, from previous work from our lab, have been identified as strategies susceptible to 
change with changing cognitive performance (Cleal et al., 2020; Cleal & Parker, 2018; Fontana, Cleal, 
Clay, et al., 2019). LMM analysis was carried out with “total turns” as the dependent variable, “condition” 
and “time” as the within-subjects factor and “ID” as a random effect. Analysis was followed by 
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Bonferroni-corrected post-hoc test. Locomotion was analysed using total turns completed during 1 h of 
exploration in the FMP Y-maze.  
All other data were analysed using Graphpad prism, normality analysis used the Shapiro-Wilk test and 
screened for outliers using the ROUT outlier analysis (Q = 1%) and boxplot with Tukey whiskers. Outliers 
were removed from further analysis. Zone data from the novel tank diving test were analysed using two-
way ANOVA followed by Sidaks multiple comparison test, distance travelled in the novel tank, total turns 
in the FMP Y-maze, ELISA and qPCR data were analysed using t-test for normally distributed data and 
Mann-Whitney U test for non-normally distributed data. Results were considered significant 
when p ≤0.05.   
Due to a tracking issues with the software, several fish were missing data from the behavioural tests. No 
data points were removed from ELISA or qPCR analysis due to small sample size.    
 
2.4 Results 
Genotyping slit-3 mutation 
The single guide RNA (sgRNA) targets exon 18 and overlaps the exon-intron boundary (Fig. 1A). 
Engineered nuclease-induced mutations are detected by various methods, including mismatch-sensitive 
T7 endonuclease I (T7E1) assay, DNA high resolution melt curve (HRM) analysis and Sanger sequencing. 
The T7E1 assay is used to detect heteroduplexes (formed by the hybridization of either two different 
mutant sequences or a wild type and mutant sequence) (Fig. 1B). Testing of slit-3 samples with the T7E1 
assay shows four samples with heterozygous mutations, as shown by a single band at ~600 bp and two 
other bands just below and just above 300 bp, all of reduced intensity compared to WT. All other slit-3 
samples and WT samples show a single band, of increased intensity, at ~600 bp. However, this method 
has the limitation that only heterozygous mutations can be detected, thus homozygous biallelic 
mutations cannot be distinguished from WT samples. Therefore, to distinguish between samples that 
did not carry a heterozygous mutation, as noncarriers or carriers of homozygous mutations, HRM 
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analysis was performed. This post-PCR analysis is used to identify variations in nucleic acid sequences, 
by detecting small differences in the melt curves of PCR amplicons. Slit-3 and WT samples analysed 
using HRM showed three distinguishable melt curves representing homozygous WT, homozygous 
mutant and heterozygous mutant (Fig. 1C). As expected, samples with the heterozygous melt curve 
(red) corresponded with samples showing heteroduplexes in the T7E1 assay, further confirming correct 
identification of heterozygous slit-3 mutations. Interestingly, the HRM method is a more efficient 
method for detecting homozygous mutations and differences between homozygous mutants and 
homozygous WT. To check for transcriptional differences and compensatory mechanisms, we assessed 
mRNA expression of slit-1, 2 and 3, but found no differences in slit-3 mutants compared to WT controls 













































Slit-3 mutation impairs WM, enhances stereotypic behaviour and increases anxiety responses 
To understand the impact of this mutation on adult behaviour, we first analysed baseline cognitive 
function. WM performance was analysed using relative percentage use of alternations (RLRL+LRLR) 
during 1 h of free exploration in the FMP Y-maze. There was a significant effect of condition (control v 
slit-3+/-) (F1,134.36 = 5.278, p = 0.023) on alternations (Fig. 2A). Relative to noncarrier control fish, the 
transgenic fish exhibited a decrease in global alternation use showing a decrease in WM performance. 
Stereotypic behaviour was analysed using relative percentage use of repetitions [RRRR+LLLL], which 
revealed a significant increase in repetitions in slit-3 compared to WT controls (F1,129.10 = 10.046, p = 
0.002), demonstrating an increase in stereotypic behaviour. Having demonstrated altered WM 
processing and increased stereotypic behaviour in slit-3  mutants, we analysed anxiety responses using 
the novel tank diving test. Slit-3 mutants showed a significantly increased anxiety response, with more 
time spent bottom dwelling compared to WT (Mann-Whitney U = 62, n1 = 18 n2 = 19, p = 0.0039, two-
tailed) (Fig. 2E). However, unlike in the FMP Y-maze the slit-3+/- mutants showed significant 
hyperlocomotion in the novel tank compared to WT controls. Suggesting that hyperlocomotion may be 
Figure 1. (A)(upper) Schematic of slit-3 exons and introns in zebrafish with identification of exon 18 
sgRNA target and target sequence (lower). Capital letters represent exon sequence, lower case letters 
represent intron sequence, highlighted area represents sgRNA sequence. (B) agarose gel with T7E1 
assay of slit-3 injected and WT samples. * = heterozygous mutation, # = homozygous mutation, WT = 
wild type control. Red arrows indicate heteroduplexes (left). Schematic of T7E1 results with WT, 
heterozygous and homozygous mutations (right). (C) HRM analysis of heterozygous (red), 
homozygous mutant (orange) and homozygous wild type (purple) represented in normalised melt 
curves (left) and normalised melt peaks (right). (D-F) whole-brain mRNA expression of slit-1 (D), slit-2 
(E) and slit-3 (F) (n = 6 per group). All data were analysed for normality using Shapiro-Wilk test. 
Normally distributed data were analysed using t-test, non-normally distributed data were analysed 
using Mann-Whitney U test. Bars are mean and error bars are mean ± SD, *p<0.05, **p<0.01.  
  Juvenile zebrafish in the novel tank diving test, showing time spent in the bottom, middle and top 
zones during 6 min of free exploration of controls and disc1Y472 mutants (Two-way ANOVA). There 
were no differences in time spent in the bottom of the tank C) or distance travelled D). However, there 
was a significant decrease in number of entries to the top zone made by disc1Y472 mutants compared 







part of the increased anxiety response that is not evident after substantial habituation to a test arena. 













Figure 2. Effect of slit-3 mutation on global search strategy of adult zebrafish in the FMP Y-maze 
compared to WT controls after 1 h of free exploration A). Comparison of relative percentage use of 
alternations (mean RLRL+ mean LRLR) B) and repetitions (mean RRRR+ mean LLLL) C) and total turns 
of slit-3 mutants compared to controls. Data were log transformed and analysed using LMM (n = 18 
controls, n = 11 slit-3). Analysis of anxiety response measured as time spent in the bottom in the 
novel tank diving test E) and locomotor response F) of slit-3 versus controls. Data were checked for 
normality using the Shapiro-Wilk test. Normally distributed data were analysed using the paired t-
test, non-normally distributed data were analysed using the Mann-Whitney U test (n = 18 controls, 
n = 19 slit-3).  * p ≤ 0.05, ** p ≤ 0.01. The dashed line denotes chance performance (6.25%). Bars are 






We assessed the effect of acute stress on cognitive performance of control and slit-3 fish on global 
search strategy (Fig. 3A). We found a trend towards significance of treatment group on percentage use 
of alternations (F3,143.84 = 2.57, p = 0.056), with slit-3 and slit-3+stress showing a slight decrease in the 
use of alternations compared to controls (Fig. 3B). Analysis of stereotypic behaviour showed a 
significant effect of treatment on relative repetitions (F3,168.16 = 3.892, p = 0.010), Bonferroni post-hoc 
analysis revealed a significant difference between controls compared to slit-3 (CI, -0.417 - -0.038, p = 
0.009), however, there was no difference between WT controls and control +stress (CI, -0.366 - -0.273, 
p = 1.000) or slit-3+stress (CI, -0.456 - -0.057, p = 0.235) (Fig. 3C). Our data demonstrate that acute 























Figure 3. Effect of acute stress on control and slit-3 transgenic fish on global search strategy in the 
FMP Y-maze after 1 h of free exploration A). Comparison of relative percentage use of alternations 
B) and repetitions C) of controls compared to control +stress, slit-3 and slit-3 +stress. Data were log 
transformed and analysed using LMM (n = 18 controls, n = 4 control +stress, n = 11 slit-3, n = 9 slit-
3 +stress). ** p ≤ 0.01. The dashed line denotes chance performance (6.25%). Bars are mean, error 





Slit-3 mutant exhibit aberrant HPI axis activation 
The HPA axis in humans and the HPI axis in zebrafish has been found to be dysregulated in patients 
with schizophrenia and in some zebrafish schizophrenia-like models. Having identified that slit-3+/- 
mutants exhibit an increased anxiety response in the novel tank and having shown that acute stress 
decreases the alternations in the FMP Y-maze, we analysed whole-body cortisol following acute stress. 
We found that in comparison to WT there was a significant decrease in cortisol levels in slit-3+/- mutants 
(t-test; t = 3.49, df = 5, p = 0.018) (Fig. 4A). In addition, qPCR analysis revealed a significant upregulation 
of basal levels of bdnf (t-test; t = 2.79, df = 6, p = 0.032) in slit-3+/- mutants compared to WT (Fig. 4B), 





Figure 4. A) Whole body cortisol following acute stress showed significant down regulation of 
cortisol levels in slit-3+/- mutants compared to WT (n = 4 per group). Quantitative RT-PCR for slit-3+/- 
mutants shows an increase in bdnf expression (n = 4 per group) B) but no difference between 
mutants and WT in gr whole brain mRNA expression (n = 2 per group) C). All data were analysed for 
normality using Shapiro-Wilk test. Normally distributed data were analysed using t-test, non-
normally distributed data were analysed using Mann-Whitney U test. Bars are mean and error bars 




Nicotine alleviates cognitive deficits and anxiety responses in slit-3+/- mutants 
The comorbidity between high smoking and schizophrenia is well documented and is hypothesised to 
ameliorate the underlying neurochemical deficits associated with schizophrenia (D’Souza & Markou, 
2012; De Leon & Diaz, 2012; Hartz et al., 2018; Lucatch et al., 2018). We investigated if slit-3+/- mutants 
exhibited changes in cognitive or anxiety responses. Our findings suggest that a single 20 min pre-
treatment with nicotine was sufficient to enhance cognitive performance to control levels, resulting in 
no significant difference between slit-3 and control groups on the percentage use of alternations (F1,112 
= 3.26, p = 0.074) (Fig. 5A). Nicotine pre-treatment also alleviated stereotypic behaviour, by decreasing 
repetitions in slit-3, whilst maintaining control repetitions to near random selection (F1,111 = 1.878, p = 
0.173) (Fig. 5A). Additionally, nicotine also exhibited an anxiolytic effect on slit-3 fish, decreasing anxiety 
responses in the novel tank (t-test; t = 1.036, df = 18, p = 0.314) (Fig. 5B), resulting in no difference 
between slit-3+/-mutants and WT fish.  
 
Figure 5.  
 
Figure 5. Effect of 5 µM nicotine on global search strategy of control and slit-3 mutant fish in the 
FMP Y-maze A). Data were log transformed and analysed using LMM (n = 13 controls, n = 10 slit-3). 
Analysis of anxiety response measured as time spent in the bottom in the novel tank diving test B) 
of nicotine treated slit-3 mutants compared to nicotine treated controls. Data were checked for 
normality using the Shapiro-Wilk test. Normally distributed data were analysed using the paired t-
test, (n = 13 controls, n = 10 slit-3).  The dashed line denotes chance performance (6.25%). Bars are 





Ethanol induces an increased CPP response, but has no effect on anxiety 
Like nicotine, ethanol is known to have anxiolytic properties. We therefore hypothesised that ethanol 
would have a similar effect on anxiety responses to nicotine in slit-3+/- mutants. To make the study 
comparable we tested a concentration of nicotine and ethanol that both were reported to induce an 
increased preference for the drug-paired side in the CPP. As previous studies have investigated the 
effects of 5 µM nicotine on inducing increased CPP response in different slit-3 variants, we tested 
ethanol with our slit-3+/-mutant line. Our findings showed that even with low doses of ethanol, slit-3 
fish showed a greater than 10% increased preference for the drug-paired side compared to controls (t-
test; t = 2.80, df = 16, p = 0.013) (Fig. 6A). Having identified that 171 mM of ethanol was sufficient to 
increase slit-3 ethanol preference in the CPP, we tested the effect of this concentration of ethanol on 
anxiety responses on slit-3 mutants in the novel tank diving test. We found that an effective dose of 
ethanol in the CPP was not sufficient to alleviate anxiety responses of slit-3 mutants in the novel tank 
(t-test; t = 4.28, df = 22, p = 0.0003) (Fig. 6B). To assess treatment effects on anxiety (slit-3 mutation, 
slit-3+nicotine, slit-3+ethanol) we pooled control data and compared tank diving responses of treated 
and untreated slit-3 mutants compared to WT controls. There was an overall effect of condition (Kruskal-
Wallis test; Kruskal-Wallis statistic = 17.67, p = 0.0005) on tank diving response, with post-hoc analysis 
revealing a significant effect of slit-3 with and without ethanol on increased anxiety responses compared 
to controls (control vs. slit-3; p = 0.0013: control vs. slit-3+ethanol; p = 0.026), but no difference between 
each other (slit-3 vs. slit-3+ethanol; p > 0.999). There was no difference between slit-3+nicotine and WT 
controls (control vs. slit-3+nicotine; p = 0.850) and no difference between slit-3+nicotine and slit-3 or 
slit-3+ethanol (slit-3 vs. slit-3+nicotine; p = 0.921: slit-3+ethanol vs. slit-3+nicotine; p > 0.999) (Fig. 6C). 
Thus, our data suggests that reinforcing concentrations of nicotine and ethanol do not have equivalent 













Figure 6. Effect of 171 mM ethanol on CPP of control and slit-3 mutant A). Analysis of anxiety 
response measured as time spent in the bottom in the novel tank diving test of ethanol treated slit-
3 mutants compared to ethanol treated controls B). Comparison of novel tank response, based on 
time spent in the bottom zone, of WT, slit-3, slit-3 + nicotine and slit-3 + ethanol C). Data were 
checked for normality using the Shapiro-Wilk test. Normally distributed data were analysed using 
the paired t-test, (n = 13 controls, n = 10 slit-3) or One-way ANOVA,  non-normally distributed data 






There is evidence that SLIT-3 is related to SZ in humans (Shi et al., 2004), but as yet there are no animal 
models to investigate these findings. Here we generate a slit-3 mutant line in zebrafish to examine SZ 
phenotypes. This study provides evidence of a role of mutations in the gene slit-3 in aberrant SZ-like 
behaviours which recapitulates multiple characteristics of human SZ patients, including cognitive 
deficits, increased stereotypic behaviours, increased anxiety responses, attenuation of cortisol levels 
following acute stress and increased sensitivity to drugs of abuse. Additionally, we demonstrate a 
therapeutic role for nicotine in reducing anxiety behaviours and enhancing cognitive performance, 
providing a possible explanation for high prevalence of tobacco smoking in SZ patients.  
  Characterisation of CRISPR/Cas9 genome editing of the slit-3 gene in zebrafish detected two 
mutant populations, a heterozygous and homozygous mutation, identified using multiple methods for 
genotyping. Due to time restrictions, all experiments were conducted on mixed populations of 
heterozygous and homozygous mutations as test populations were generated directly from 
CRISPR/Cas9 injected embryos (f0) to provide pilot data on the behavioural and biochemical 
phenotypes associated with the mutation. We analysed mRNA expression of slit genes and revealed no 
differences in whole-brain mRNA expression of slit-1, 2 or 3, between WT and slit-3 injected groups. 
Although some mutations can cause changes in mRNA expression levels of the target gene (Eachus et 
al., 2017), many functional mutations do not affect mRNA expression and rather, result in altered protein 
expression. Here, however, lack of mRNA expression changes may be due to the analysis of whole-brain 
tissue, opposed to regional amplification, as previous studies have identified localised regions of slit-3 
expression in the brain, particularly in the frontal cortex, dentate gyrus and hippocampus (Piper et al., 
2000; Sasaki et al., 2020). Additionally, slit-3 has been shown to be differentially regulated during 
embryonic compared to adult stages, implicating a role for spatiotemporal pattens affecting gene 
expression (Marillat et al., 2002). Therefore, further characterisation of the slit-3 mutation in zebrafish to 
assess regional expression changes in the brain, mRNA and protein expression during multiple stages 
of development, as well as differences between homozygous and heterozygous mutations is required.  
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Despite the need of further characterisation of functional changes of slit-3 following point 
mutations, clear and obvious behavioural differences were evident between slit-3 mutants and WT 
controls. Primarily, there were distinct exploratory differences pertaining to WM performance and 
stereotypic behaviours that were evident when tested in the FMP Y-maze. Slit-3 mutants demonstrated 
impaired WM performance and increased stereotypic behaviour compared to controls. WM deficits are 
regularly reported in patients and animal models of SZ-like behaviour (Carless et al., 2011; Castner & 
Williams, 2007; Eryilmaz et al., 2016; Frydecka et al., 2014). However, despite cognitive deficits being 
described as a core characteristic, no zebrafish model of SZ has to date reported cognitive function. 
Here, we describe the first SZ-like model to demonstrate cognitive deficits in zebrafish, in line with 
human performance. Like cognitive impairment, stereotypy is also a distinct feature of SZ and has been 
defined as a repetitive motor action (Bush et al., 1996; Morrens et al., 2006). In the FMP Y-maze, 
stereotypic behaviour has been attributed to increased use of the strategy termed ‘repetitions’, which 
is circling behaviour consisting of the repetitive use of left or right turns (LLLL, RRRR) to an extent greater 
than chance selection. In SZ patients, studies examining stereotypies have reported a correlation 
between stage of illness and stereotypic behaviour, suggesting that stereotypic behaviour progresses 
with illness stage, and is not present during early/prodromal stages (Morrens et al., 2006). It would, 
therefore, be interesting to investigate if stereotypic responses seen here are also evident during 
adolescence, as behavioural markers of disorder progression in an animal model of SZ would prove 
invaluable in understanding illness trajectory.   
Abnormal stress sensitivity is thought to be a major contributing factor to illness onset, 
exacerbation and relapse in SZ (Brunelin et al., 2008). Aberrant activation of the HPA axis has not only 
been associated with psychosis risk, but it has also been found to play a role in cognitive function 
(Baumeister et al., 2014; Cherian et al., 2019; McCormick & Mathews, 2010; van Looveren et al., 2019). 
We examined the effects of acute stress on cognition in slit-3 mutants and found a trend towards 
significance of lowered WM performance of stressed and non-stressed slit-3 mutants and stressed 
controls compared to non-stressed controls. Post-hoc analysis revealed a greater reduction in 
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alternations in stressed and non-stressed slit-3 mutants compared to non-stressed controls than 
stressed versus non-stressed control fish. Unexpectedly, the stressed slit-3 mutants showed a reduced 
effect of stereotypies, whilst non-stressed slit-3 fish maintained a much higher rate of repetitions 
compared to non-stressed controls. The trend in reduced alternations of slit-3 fish, but lack of 
significance, suggests that stressed groups may be underpowered and therefore, both WM performance 
and repetitive behaviours should be interpreted with care.  
It has been progressively recognised that there is an inter-play between genetic vulnerabilities 
and acute and chronic stress exposures which interact to cause emergence and maintenance of 
neuropsychiatric disorders (Gomes & Grace, 2017; Howes et al., 2017; Howes & Murray, 2014). With the 
suggestion of maintained WM deficits in both stressed and non-stressed slit-3 mutants, we investigated 
the underlying activity of the HPI axis based on cortisol levels and mRNA expression of glucocorticoid 
receptors (gr) and brain-derived neurotrophic factor (bdnf), all critical elements of the HPI axis. Acute 
environmental stress not only failed to up-regulate cortisol levels in slit-3 mutants, but actually showed 
a significant down-regulation of whole-body cortisol levels following acute stress, compared to control 
levels. Dysregulation of HPA axis function is one of the most consistent biological findings in SZ patients, 
and has been linked with altered stress-vulnerability and behavioural phenotypes in SZ and other 
serious mental illnesses (Baumeister et al., 2014). Evidence suggests that abnormalities in HPA axis 
activation may manifest as either hyper- or hypo-functioning, both conditions occurring in SZ and 
correlating with cognitive impairment (Baumeister et al., 2014; Shah & Malla, 2015). Studies have shown 
that SZ patients and patients that are clinically high risk for the development of psychosis or those 
having experienced their first episode of psychosis have all demonstrated a blunting effect of acute 
cortisol response following an acute stressor (Shah & Malla, 2015). Cortisol has shown an inverted U-
shaped dose-response curve with respect to cortisol levels and cognitive function, with both high and 
low concentrations resulting in deficits in cognitive performance (Cherian et al., 2019; Holtzman et al., 
2013; Lupien & McEwen, 1997). Here, we demonstrate that the slit-3 mutation causes hypoactivation of 
the HPI axis, which coincides with cognitive impairment.    
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BDNF and GR both play critical roles in the activation and modulation of the stress response via 
control of HPA axis reactivity. Aberrant genetic and functional activity of both regulators have been 
implicated in SZ (Garabedian et al., 2017; Jeanneteau et al., 2012). BDNF has been identified as a crucial 
neurotrophin in the regulation of synaptic plasticity, learning and memory, the dysregulation of which 
can have detrimental effects on cognition. Rodent models of BDNF overexpressing mice and genetic 
variations that increase BDNF levels, result in cognitive impairment and increased anxiety-related 
phenotypes (Jeanneteau et al., 2012; Lu & Martinowich, 2008; Papaleo et al., 2011), as seen in slit-3 
mutant fish. Additionally, up-regulation of BDNF has been implicated in SZ patients and, in combination 
with attenuated cortisol levels, implicate dysfunctional HPI axis reactivity in the SZ-like phenotypes 
identified in slit-3 mutant zebrafish. However, we did not detect any differences in gr expression in slit-
3 compared to WT fish. Although gr have also been implicated as an important regulator of HPI axis 
functioning (Derek Alsop & Vijayan, 2009; Liu et al., 2020; van Looveren et al., 2019). Previous studies of 
SZ models have identified sex differences in gr expression levels following acute stress (Desbonnet et 
al., 2019), therefore, differences could potentially be masked by combined sex groups or by the small 
sample sized used for assessing gr expression compared to bdnf and should therefore be repeated with 
increased power and potentially investigating sex differences. However, identification of sex differences 
would also be of interest in stimulated cortisol responses and bdnf expression levels and should be 
investigated further.  
Having identified impaired cognition, increased stereotypies and increased anxiety responses, 
potentially resulting from aberrant HPI axis activity, we investigated the effect of nicotine on these 
behaviours, to identify a relationship between the effect of nicotine exposure on SZ-like behaviours and 
the extremely high prevalence of tobacco smoking the SZ population. Theories of nicotine abuse in SZ 
have been attributed to several factors including self-medication, alleviation of negative symptoms and 
cognitive enhancing effects of nicotine. Although the ‘self-medication’ hypothesis has been met with 
much scepticism (De Leon & Diaz, 2012; Prochaska et al., 2008; Ziedonis et al., 2008), there have been 
several studies in animals and humans, and in both SZ and non-SZ patients/models that have reported 
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anxiolytic and pro-cognitive effects of nicotine (Bencan & Levin, 2008; Brielmaier et al., 2008; D’Souza 
& Markou, 2012; Ghatan et al., 1998; Gómez et al., 2008; Heishman et al., 2010; Jasinska et al., 2014; 
Levin et al., 2007; Patterson et al., 2010; Rezvani & Levin, 2001; Valentine & Sofuoglu, 2017). Previous 
work has demonstrated that in WT adult zebrafish, nicotine sensitization can have pro-cognitive effects 
on increased WM performance in the FMP Y-maze, depicted by increased alternations, that was evident 
even in the absence of baseline impairment (see Part 2; Chpt 4). Therefore, we hypothesised that in a 
SZ-like model, that demonstrates baseline cognitive impairment, acute pre-treatment with nicotine may 
improve cognitive performance in the FMP Y-maze.  
We found that even a low concentration of nicotine had cognitive enhancing effects and was 
sufficient to increase WM performance of slit-3 mutants to control levels. Not only did nicotine improve 
WM, but it also attenuated stereotypic behaviours, reducing the use of the repetition strategy to random 
selection and reduced anxiety responses to WT levels. Since the identification of increased smoking in 
SZ patients, there have been many studies conducted to identify the therapeutic potential of nicotine 
and nicotinic agonists in attenuating aberrant behaviours and dysregulation of underlying biochemical 
processes associated with SZ (Dondé et al., 2020; Evins et al., 2019; Jacobson, 2014; Parmar et al., 2020; 
Potasiewicz et al., 2019; Tregellas & Wylie, 2019). However, to our knowledge this is the first experiment 
examining nicotinic effects in a zebrafish SZ-like model of hypo-functioning HPI axis activity. The large 
number of human studies reporting pro-cognitive effects of nicotine-based treatments in SZ and the 
replication of these findings in slit-3 mutant zebrafish provides evidence of a promising model for 
examining comorbidities between SZ and substance abuse. Recent human studies have shown that 
nicotine improves WM performance by enhancing activation and functional connectivity between brain 
regions that mediate performance, such as the prefrontal cortex and the thalamus (Dondé et al., 2020; 
Evins et al., 2019; L. Jacobson, 2014; Parmar et al., 2020; Potasiewicz et al., 2019; Tregellas & Wylie, 2019). 
As previously discussed altered functional connectivity in the cortical-striatal-thalamo-cortical (CSTC) 
network can significantly impair cognition and has been particularly noted for WM deficits (Floresco et 
al., 1999) (see Part 1: Chpt 1).  
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Additionally, many SZ studies, in rodents and humans, have identified altered connectivity in 
the CSTC loop and it is, therefore, interesting to note that aberrations in slit-3 functioning may disrupt 
CSTC networks, particularly as spatiotemporal studies of slit-3 expression have identified frontal cortices 
as a significant region of slit-3 expression (Berni, 2015; Chisholm et al., 2016; Sasaki et al., 2020). It is 
also interesting to note that decreased gray matter has been associated with loss of structural and 
functional integrity of aspects of the CSTC loop resulting in impairment of cognitive control and has 
been implicated in a number of psychiatric disorders, including SZ (Peters et al., 2016). A recent study 
by (Ma et al., 2019) has identified SLIT-3 as a risk gene for altered gray matter volumes in the frontal 
cortex. Thus, potentially identifying a mechanism through which slit-3 affects cognition and nicotine 
restores it. This avenue of enquiry requires further investigation and may provide novel insights into the 
mechanisms underlying SZ-induced cognitive impairment and a potential therapeutic target.  
Substance abuse has high comorbidity with SZ (Goodwin et al., 2003), particularly, as noted 
above, with nicotine. Increased prevalence and sustainment of smoking behaviour has been suggested 
to be resultant of difficulties in cessation of smoking (D’Souza & Markou, 2012; Evins et al., 2019). Having 
identified that this may in part be due to attenuation of negative symptoms and cognitive enhancing 
effects, it is possible that other drugs of abuse with anxiolytic properties may exert similar beneficial 
effects on SZ behaviours and thus perpetuate continued use. We therefore assessed effects of ethanol 
on alterations in drug preference and anxiety response in fish carrying the slit-3 mutation. We did not 
investigate cognition as ethanol, unlike nicotine, is not a cognitive enhancer, therefore any benefits 
would likely be derived from its anxiolytic or rewarding effects. We firstly identify if slit-3 mutants have 
increased sensitivity to the reinforcing properties of ethanol, as has previously been described by 
(García-González et al., 2020) with nicotine, in the CPP task. As with nicotine, slit-3 mutants showed, on 
average, a 10% increase to the drug-paired side in the CPP compared to non-mutant controls. Having 
identified the reinforcing effects of ethanol on slit-3 fish, we tested the effect of pre-treatment on 
anxiety responses and, surprisingly, found that despite many reports of the anxiolytic properties of 
ethanol, pre-treatment did not alter anxiety response compared to untreated slit-3 mutants, and 
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demonstrated significantly greater anxiety in the novel tank test than WT controls. Alleviation of anxiety 
responses and pro-cognitive effects of nicotine may be a reason why there is a greater association 
between SZ and tobacco smoking than SZ and alcoholism and additionally why therapeutic strategies 
for improving cognitive symptoms in SZ target nicotinic pathways. As slit-3 mutants have demonstrated, 
increased sensitivity to the reinforcing properties of nicotine and ethanol in the CPP, and both drugs 
have reported anxiolytic properties, it is possible that their differential effect on behaviour is a 
consequence of differences in their interaction with the HPI axis.  
Nicotine is well known for increasing cortisol levels after smoking, which, in the presence of a pre-
existing down-regulation of cortisol, may be an additional mechanism through which nicotine improves 
cognitive function. However, studies of alcohol ingestion in humans have identified a potential role for 
high versus low doses of alcohol influencing either elevated or lowered plasma cortisol levels, 
respectively. However, the low levels of alcohol are more notably associated with anxiolytic responses, 
whilst high doses have been reported to cause anxiety-like behaviours (Blaine et al., 2016; Dai et al., 
2002, 2007). The absence of anxiolytic effect seen in slit-3 mutants, pre-treated with ethanol, may be a 
consequence of their basal alterations in HPI axis activity prior to ethanol exposure. Further examination 
of the altered concentration of ethanol pre-treatment may indicate dose-related shift in anxiolytic 
properties of ethanol in neuropsychiatric conditions with hypo- or hyper functionality of the HPI axis. 
Future studies with slit-3 mutant fish should investigate how drug pre-treatment alters cortisol levels 
after acute stress, as it would be hypothesised that nicotine would diminish cortisol level differences 
between slit-3 and controls, whilst at the dose given here, it would be expected that slit-3 fish would 








This study provides the first evidence of a reliable animal model of slit-3 induced SZ-associated 
molecular, cognitive and behavioural alterations. Slit-3 mutant zebrafish recapitulate a broad spectrum 
of SZ-like phenotypes that are typically reported in patients diagnosed with SZ. Here we describe, 
cognitive impairments relating to reduced WM performance, increased stereotypies, heightened anxiety 
responses, attenuated HPI axis reactivity and alterations to the rewarding effects of drugs of abuse. In 
addition, we identify behavioural alterations in response to nicotine exposure, that may implicate several 
pathways in the increased comorbidity of tobacco smoking in SZ patients and possible therapeutic 
mechanisms for treating negative and cognitive symptoms associated with SZ. We also note that not all 
drugs with anxiolytic properties may have therapeutic effects, highlighting a need to better understand 
how basal biochemical mechanisms can influence anxiolytic properties of drugs. This work further 
supports the use of zebrafish as a model for investigating a broad spectrum of symptomologies 
associated with complex neuropsychiatric disorders, including abnormalities in cognitive processing. 
We also highlight a complicated and multifaceted role for slit-3 in the development of psychiatric 












The previous chapter describes a new zebrafish slit-3 model of SZ-like phenotypes, that demonstrated 
dysfunction of cognitive processes, increased stereotypic and anxiety-like behaviours and abnormalities in 
HPI axis activity and regulation. To further validate this model as exhibiting SZ-like behaviours we assessed 
transgenic zebrafish carrying a mutation in one of the most well studied SZ-risk genes, disc1. The following 
chapter describes the cognitive performance, anxiety responses and HPI axis activity in disc1 mutant 
zebrafish. The penultimate chapter of this section discusses the similarities and differences between the 




















Disrupted-in-Schizophrenia-1 (disc1) Alters Anxiety Behaviour, 
Cognition, Glucocorticoid and Dopamine Receptor Expression 
 
3.1 Abstract 
Disrupted-in-schizophrenia 1 (DISC1) has been identified as a high susceptibility gene for developing 
neuropsychiatric disorders, such as schizophrenia. Human and rodent studies have implicated DISC1 in 
stress response and cognitive abnormalities. However, the underlying mechanisms are poorly 
understood. Additionally, only recently have zebrafish been utilised for understanding psychiatric 
disorders, such as schizophrenia and information regarding conservation of disc1 associated changes, 
particularly cognitive impairment, have not been fully investigated. Here, we demonstrate that juvenile 
zebrafish carrying the disc1Y472 nonsense, point mutation exhibit prolonged anxiety responses, and show 
severe cognitive deficits, including WM impairment and the loss of strategized exploration. Quantitative 
RT-PCR revealed up-regulation of gr mRNA expression and down-regulation of drd5 mRNA expression 
in the brain. Our study highlights severe cognitive deficits in disc1 mutants that can be reliably modelled 
in zebrafish during juvenile stages of development. Additionally, we have identified a novel role for 
altered gr and drd5 expression underlying abnormal stress response and cognitive function. Here, we 




The DISC1 variant in humans has been identified as one of the most important susceptibility genes for 
schizophrenia (SZ), but also affects a broad spectrum of other associated psychiatric illnesses (Ayhan et 
al., 2016; Twyman & Amin, 2009). DISC1 variants have been repeatedly shown to cause alterations in 
behavioural responses and cognitive function in humans (Callicott et al., 2005; Carless et al., 2011), non-
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human primates (Simen et al., 2009) and rodents (Ayhan et al., 2016; Johnstone et al., 2011; Lipina & 
Roder, 2014; Papaleo et al., 2012), with altered anxiety responses and deficits in WM regularly being 
reported in subjects carrying DISC1 variants (Carless et al., 2011; Gamo et al., 2013; Johnstone et al., 
2011; Wang et al., 2019).  
Early-onset SZ manifests in childhood or adolescence and, although similar to the adult-onset 
form of the disorder, it represents a more severe variant (Frangou, 2009; Röpcke & Eggers, 2005; Vyas 
et al., 2010). Adolescence is a sensitive neurodevelopmental period with increased susceptibility to stress 
and the onset of stress-related psychiatric disorders, such as SZ (Blakemore, 2008; Rapoport & Gogtay, 
2011; Van Os et al., 2010). Models of schizophrenia posit that this disorder is the result of environmental 
and genetic factors that converge with aberrant neurodevelopment that begins long before the onset 
of clinical symptoms (Rapoport et al., 2005; Rapoport & Gogtay, 2011) and greatly influences adult 
behaviour (Niwa et al., 2013). Thus, unique insights could be gained from studying early-onset forms of 
the disorder that could provide developmental trajectories and treatment opportunities for both early-
onset and adult-onset forms of SZ (Rapoport & Gogtay, 2011). 
The dopaminergic system has been significantly implicated in the pathology of SZ (Brisch et al., 
2014; Kokkinou et al., 2020; Peleg-Raibstein et al., 2009; Rao et al., 2019). Abnormalities in DA synthesis, 
availability or receptor activation have been linked to all aspects of SZ (Brisch et al., 2014). Abnormalities 
in DRD2 neurotransmission are associated with the positive, psychotic symptoms (Alfimova et al., 2013; 
Noble, 2003; Ripke et al., 2014), whilst DRD1 is implicated in negative symptoms and cognitive deficits 
(Rao et al., 2019). In addition to DRD1, aberrant functioning of the HPA axis has also been correlated 
with cognitive impairment (Jameison & Dinan, 2001) and in turn the HPA axis is regulated by DA 
(Sullivan & Dufresne, 2006). Thus activation and negative feedback are under the control of DA and GR 
for the maintenance of homeostasis in the neuroendocrine system and normal behaviour and cognition 
(van Looveren et al., 2019). Cognitive impairment and aberrant stress responses are hallmarks of SZ 
(Howes et al., 2017) and therefore, requires further investigation to unravel the complex interactions of 
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psychiatric susceptibility genes and dysregulation of the HPA axis and dopaminergic system, to better 
understand the underlying biology and potentially improve therapeutic strategies. 
Animals have been crucial in providing preclinical models of neuropsychiatric disorders to fully 
characterise genetic and neural mechanisms underlying psychiatric pathology (Baker et al., 2020). 
Although rodents have been particularly useful in elucidating gene x environment interactions involved 
in illness onset, other animal models are moving to the forefront and providing an alternative system 
for investigating these complex mechanisms (Fontana et al., 2018; Maximino et al., 2015). The zebrafish 
is being increasingly utilized for the study of complex brain disorders, including SZ (Gawel et al., 2019; 
Stewart et al., 2015). Thus far, studies with zebrafish have identified similar mechanisms to those found 
in SZ patients and rodent models of SZ (De Rienzo et al., 2011; Demin et al., 2019; Eachus et al., 2017; 
Gawel et al., 2019; Thyme et al., 2019). Using several targeted disc1 mutations, zebrafish models have 
found a conserved role for disc1 in aberrant behaviour, particularly anxiety responses (Eachus et al., 
2017; Tang et al., 2020), but as yet have not tested differences in cognitive abilities. Here we investigate 
functioning of the hypothalamus-pituitary-interrenal (HPI) axis, the zebrafish equivalent of the human 
HPA axis, by analysing anxiety responses, post-stress cortisol levels and gr mRNA expression in the brain 
of disc1 mutants. Additionally, we have conducted the first analysis of cognitive function in a zebrafish 
model of SZ and associated dopamine receptor expression in juvenile zebrafish, revealing altered 
behavioural, cognitive and molecular mechanisms and a novel role for altered drd5 expression. 
 
3.3 Materials and methods 
Animals and housing 
Homozygous disc1Y472 embryos and control embryos were kindly donated by Dr Caroline Brennan 
(Queen Mary University, London). All animals were maintained on a 14/10-hour light/dark cycle at ~25-
27°C, pH 8.4 (±0.4) on a re-circulating system (Aquaneering Inc., San Diego, CA, USA), at the University 
of Portsmouth in accordance to standard husbandry protocols (Nusslein-Volhard & Dahm, 2002). The 
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disc1 mutant line was identified from an ENU mutagenesis-based screening programme, this variant is 
also referred to as disc1fh292and has been described elsewhere (De Rienzo et al., 2011). Throughout 
chapter this line is referred to as disc1Y472. 
 
Ethical statement 
Experiments carried out as part of this study were under license from the UK Home Office (Animals 
(Scientific Procedures) Act, 1986) [PPL: P9D87106F] and with approval from and in accordance with the 
University of Portsmouth Animal Welfare and Ethical Review Board guidelines. 
 
Behavioural analysis 
Juvenile zebrafish, at ~2 months old, were used throughout this study. Fish were transferred into the 
behavioural room for 30 min prior to analysis to allow for acclimatization. A total of N=24 fish (12 per 
group) were used for all behavioural procedures. On the first day fish were analysed in the novel tank 
diving test, on the second day fish were run in the FMP Y-maze. All behaviour was carried out in the 
Zantiks adult behavioural unit (AD unit) (Zantiks Ltd, Cambridge, UK), which tracked fish continuously 
whilst in the test arena. Units were web-enabled allowing live streaming video feed of zebrafish during 
testing, to a laptop or mobile device. Starting and finishing trials was done remotely. Pre-determined 
protocols were used that depicted specific zones and data was automatically logged and output into 
an excel file. Experimenter visibility and handling were kept to a minimum to reduce stress and 
distraction whilst animals were performing behavioural tasks. Ambient light was a maximum of 2 lux in 
testing units. 
 
Novel tank diving apparatus 
All fish were run individually in a clear rectangular tank, 20 cm length x 5 cm width x 17.5 cm depth and 
filled with 1 L of aquarium water. Fish were permitted free swimming for 6 min, starting from first entry 
into the tank. The test arena was divided into three equal horizontal zones (bottom, middle, top) to 
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allow evaluation of vertical activity. Anxiety behaviour was analysed using time spent in each zone and 
number of entries into the top zone as behavioural endpoints and distance travelled was used to assess 
locomotor activity. 
 
FMP Y-maze apparatus 
All fish were run individually in a white acrylic Y-maze with clear base and mesh top (to prevent escape), 
maze dimensions are: 5 cm length x 2 cm width x 14 cm depth, and filled with 3 L of aquarium water to 
allow sufficient swimming depth. Two mazes were fitted into a water-tight tank and run in the Zantiks 
and logging of arm entries was written into the program script, recorded automatically and output in 
an excel spreadsheet. Arm entries and exits were continuously logged throughout the trial and 
converted into a series of left and right turns. Search strategy was based on overlapping sequences of 
four turn choices, giving rise to 16 possible tetragram configurations. Protocols for the FMP Y-maze 
have been described in detail elsewhere (Cleal, Fontana, et al., 2020). 
 
Whole-body cortisol 
For determination of cortisol levels following an acute stress zebrafish were grouped 2.8L housing tanks 
(n=4 fish per tank). Acute stress was delivered net chasing for 5 min, then all fish were left to recover 
for 10 min, as previous research has shown peak cortisol responses within 3-15 min of receiving a 
stressor in zebrafish (Ramsay et al., 2009). Following the rest period, zebrafish were immediately culled 
by immersion in ice-water and snap-frozen using liquid nitrogen. Whole-body cortisol levels were 
detected using the Salimetrics Salivary Cortisol ELISA kit for human samples (Stratech, Cambridge, UK), 
which has been found to reliably detect cortisol in zebrafish using the method previously described by 
(Cachat et al., 2010; Parker et al., 2012a). Briefly, samples were weighed and then homogenised in 1mL 
of chilled PBS. 5 mL of diethyl ether was mixed with the homogenised samples and centrifuged at 7000 
x g for 15 min. The top, organic layer was removed, and the process was repeated until all the cortisol-
containing layer was removed, and then subsequent evaporation of the diethyl ether was continued 
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overnight at room temperature. The resulting cortisol was reconstituted using 1 mL of chilled PBS. The 
ELISA was carried out in a 96-well plate following the manufacturer’s instructions. Standards were used 
to determine the final cortisol concentration using OD readings. Weights were used to calculate cortisol 
concentration per gram (ng/g-1). Inter- and intra-assay coefficients of variation were determined. Data 
are represented as mean ± SD (n = 4 per group; assayed in duplicate).  
 
RNA extraction and gDNA removal  
Fish were culled using ice-water immersion, followed by severing of spinal cord. Whole brains were 
removed and snap frozen using liquid nitrogen. Samples were homogenised and total RNA was 
extracted using the RNeasy Mini Kit (Qiagen) following the manufacturer’s instruction. After extracting 
and purifying RNA, samples were treated using the RapidOut DNA Removal Kit (Thermo Scientific), 
following manufacturer’s instructions to remove contaminating gDNA from RNA samples prior to 
conversion into cDNA.  
 
cDNA synthesis 
Following removal of gDNA from RNA, sample concentrations were measured using the ND 1000 
spectrophotometer. To ensure the same amount of cDNA was synthesised for each sample a maximum 
of 1 µg of total RNA was used per reaction (the same total concentration of RNA was loaded into each 
reaction). Reverse transcription of mRNA to cDNA was done using the High Capacity RNA-to-cDNA Kit 
(Applied Biosystems) following the manufacturer’s protocol. After conversion into cDNA, samples were 




Quantitative Real-Time PCR (RT-qPCR) 
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Quantitative real-time PCR (RT-qPCR) assays were used to validate relative gene expression based on 
SYBR green detection. Gr and drd5 primers were predesigned by qPrimerDB (Lu et al., 2018), eef1a 
primers were based on previous studies (Parker et al., 2016; Tang et al., 2007). Primers were synthesised 
by Invitrogen and are listed in Table 1. The Thermo Scientific PowerTrack SYBR Green PCR Master Mix 
and the LightCycler® 96 (Roche Life Science) were used to amplify and detect the transcripts of interest. 
Thermal cycling conditions were as follows: 95°C for 120s (recommended by manufacturer), 35 cycles 
of 95°C for 15s and 60°C for 25s, in a two-step protocol. Negative reverse transcription (RT) controls 
and negative template controls were used to determine specificity and to check for genomic DNA 
contamination. Elongation factor 1 alpha (eelf1a) was used as a housekeeping gene (Tang et al., 2007). 
Gene-expression levels were calculated using delta-delta CT method and normalised to eelf1a. Changes 
in expression were relative to controls to demonstrate fold changes in disc1 mutants. Data are presented 
as means ± SD (n = 6 per group; assayed in duplicate).  
 
 
Table 1. Primer sets used for qPCR  
Gene name Gene Primer sequence (Forward) Primer sequence (Reverse) Amplicon 
size 
Eukaryotic translation 
elongation factor 1 
alpha 
eef1a CTGGAGGCCAGCTCAAACAT ATCAAGAAGAGTAGTACCGCTAGCATTAC  87 
Glucocorticoid 
receptor 


















Data were analysed in IBM SPSS 25.0 and GraphPad Prism 8.4.2.  For data from the FMP Y-maze 
studentized residuals were generated from statistical models and screened for outliers. Any data point 
identified as an extreme value (>3*IQR) was removed from further analysis. Residuals were analysed for 
normality using histograms and Shapiro-Wilk normality test. Residuals for both conditions were 
significantly skewed, therefor all data were log transformed and a linear mixed model (LMM) was 
employed to assess alternations and repetitions, which, from previous work from our lab, have been 
identified as strategies susceptible to change with changing cognitive performance (Cleal, Fontana, et 
al., 2020; Cleal & Parker, 2018; Fontana, Cleal, Clay, et al., 2019). LMM analysis was carried with “total 
turns” as the dependent variable, “condition (wild type v disc1Y472)” and “time” as the within-subjects 
factor and “ID” as a random effect. Analysis was followed by Bonferroni-corrected post-hoc test. 
Locomotion was analysed using total turns completed during 1 h of exploration in the FMP Y-maze. All 
other data were analysed for normality using the Shapiro-Wilk test and screened for outliers using the 
ROUT outlier analysis (Q = 1%) and boxplot with Tukey whiskers. Outliers were removed from further 
analysis. Zone data from the novel tank diving test were analysed using two-way ANOVA followed 
Sidaks multiple comparison test, distance travelled in the novel tank, total turns in the FMP Y-maze, 
ELISA and qPCR data were analysed using t-test for normally distributed data and Mann-Whitney U test 
for non-normally distributed data. Results were considered significant when p ≤0.05.  
Due to a tracking issue with the software used, several fish were missing data from the behavioural tests. 
No data points were removed from ELISA or qPCR analysis due to small sample size.   
 
3.4 Results 
Juvenile disc1 mutants maintain anxiety response 
The disc1Y472 homozygous, point mutation results in the introduction of a premature stop codon located 
within the N-terminal domain of the disc1 gene (Fig. 1A). To understand the impact of this mutation on 
juvenile behaviour, we first analysed baseline anxiety responses using the novel tank diving test. The 
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juvenile disc1Y472 mutants showed indistinguishable behavioural response to wild type fish for the time 
spent in each zone (Two-way ANOVA, F(1,54) = 0.122, p = 0.72) (Fig. 1B) and distance travelled (Mann-
Whitney U = 40, n1 = n2 = 9, p = 0.983, two-tailed) (Fig. 1C). However, there was a significant difference 
in the number of entries into the top of the tank, with wild type fish making nearly 8 times as many 
entries into the top zone compared to disc1Y472 mutants (Mann-Whitney U = 18.50, n1 = n2 = 9, p = 
0.0490, two-tailed) (Fig. 1D). Thus, demonstrating a maintained anxiety response that in wild type fish, 
reduces over the course of the trial, permitting increased entries into the top zone. However, in 
discY472mutants the anxiety of a novel environment is not alleviated with time. However, there were no 

























Figure 1. A) (upper) Schematic of disc1 protein in zebrafish consisting of N-terminus, globular 
domain with a Tyr>Stop inserted as a point mutation at 472 amino acids (Y472) and a coiled-coil 
domain and C terminus, with a predicted protein length of 994 amino acids. (lower) Schematic of 
disc1 intron regions (red line) and 14 exon regions (blue rectangles). (B) Juvenile zebrafish in the 
novel tank diving test, showing time spent in the bottom, middle and top zones during 6 min of 
free exploration of controls and disc1Y472 mutants (Two-way ANOVA). There were no differences 
in time spent in the bottom of the tank (C) or distance travelled (D). However, there was a 
significant decrease in number of entries to the top zone made by disc1Y472 mutants compared to 
wild type controls (t-test) (E). Bars represent mean, error bar are mean ± SEM, * p ≤ 0.05. 
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Disc1 mutant juveniles demonstrate significantly altered cognitive function of WM and exploratory 
strategies.  
To assess cognitive processing, we used the FMP Y-maze to evaluate WM and exploration strategies 
after 1 h of free swimming in the maze. Frequency distribution was used to plot the percentage use of 
each tetragram sequence throughout the duration of the trial and identify specific search patterns (Fig. 
2A). Previous studies have highlighted two main strategies as susceptible to change related to WM 
processing; alternations (RLRL, LRLR) and repetitions (RRRR, LLLL) (see Part 1: Chpt 3) (Cleal, Fontana, et 
al., 2020). Further examination of these two strategies highlight substantial differences between disc1Y472 
mutants and wild type controls, with disc1Y472 fish demonstrating significant impairment of WM, as 
shown by a greater than 2-fold decrease in alternation use throughout the trial (LMM; F(1,72.01) = 41.22, 
p < 0.001) (Fig. 2B). Additionally, there was an increase in the use of repetitions by disc1Y472 mutants 
compared to wild type fish ((LMM; F(1,72.01) = 41.22, p < 0.000) (Fig. 2C). The overall search strategy was 
severely impacted by cognitive impairment, as the usual alternation dominant strategy was evident in 
wild types, but was completely diminished in disc1Y472 fish, ultimately resulting in almost equal use of 
each of the 16 tetragram sequences. Thus, demonstrating random exploration, instead of application of 
a specific search strategy. However, as with the novel tank diving test, there was no differences observed 



















Figure 2. Search strategy after 1 h of exploration in the FMP Y-maze. (A) Percentage use of each 
tetragram sequence by 2-month old zebrafish wild type controls v disc1Y472 mutants in the FMP 
Y-maze (controls, n = 5; disc1Y472, n = 10). Controls demonstrate a clear dominant use of 
alternations, which is not evident in disc1Y472 mutants. Percentage use of (B) alternations and (C) 
repetitions in controls compared to disc1Y472 mutants. (D) Locomotor activity was assessed using 
total turns. Normality was analysed using Shapiro-Wilk test. Tetragram data were log transformed 
and analysed using LMM followed by Bonferroni post-hoc test. Total turns were analysed using t-
test. The dashed line denotes chance performance (approximately 6.25%). Bars are mean, error 




Abnormal expression of genes critical to the normal functioning of the HPI axis in disc1 mutations  
Brain corticosteroid receptor balance has been discovered to be involved in plasticity and cognitive 
performance. Specifically glucocorticoids can influence memory, contextualization and motivational 
responses to environmental cues and experiences (de Kloet et al., 2018). Having identified altered 
anxiety responses and cognitive performance, we investigated how glucocorticoid pathways may be 
altered in disc1 mutants. Therefore, we analysed whole body cortisol levels following an acute stress, 
and expression levels of gr and drd5 which directly and indirectly (respectively) modulate glucocorticoid 
activity. An acute stress of 5 min net chasing, followed by 10 min of rest, which has previously been 
shown to result in peak cortisol levels following stress, did not provoke significant differences between 
wild type and disc1Y47f2 mutants (Mann-Whitney U = 8.00, n1 = n2 = 4, p >0.999, two-tailed) (Fig. 3A). 
However, a significant increase in gr mRNA expression (Mann-Whitney U = 0.00, n1 = n2 = 6, p = 0.002, 
two-tailed) (Fig. 3B) and slight decrease in drd5 mRNA expression (t-test; t = 2.57, df = 10, p = 0.028) 

































Figure 3. (A) Whole body cortisol following acute stress did not show any significant difference 
between controls and disc1Y472 mutants (n = 4 per group). Quantitative RT-PCR for disc1Y472 
mutants shows a 2-fold increase in gr (B) and significant decrease in drd5 (C) whole brain mRNA 
expression. All data were analysed for normality using Shapiro-Wilk test. Normally distributed 
data were analysed using t-test, non-normally distributed data were analysed using Mann-





In this study we report, for the first time, that zebrafish carrying a disc1 point mutation have severely 
impaired WM that generated random exploration over strategized exploration, which was evident from 
as early as 2 months-old. Although there was no overall effect on anxiety-like behaviour, supported by 
similar cortisol levels in both groups following acute stress, there was evidence that initial anxiety 
responses (to a novel environment) perpetuated for longer in disc1 mutants compared to wild type fish. 
This was shown by a significantly lowered number of transitions into the top zone by disc1Y472 mutants 
in the novel tank diving test. Further, we identified whole brain expression changes in two genes, gr and 
drd5, that play important roles in maintaining cognition and HPI axis activity, which may indicate a 
potential pathway responsible for aberrant behaviour in disc1 induced neuropsychiatric disorders, 
including SZ.  
Novelty tests are regularly used in animal models to assess anxiety responses (Harro, 2018; Lezak et al., 
2017; Maximino et al., 2010). The typical response of fish when introduced to a novel environment is to 
dive to the bottom of the tank. Following a short period of habituation the fish gradually begins to 
ascend into the top area of the tank, making multiple transitions between the different zones for the 
remainder of the trial (Cachat et al., 2010). Using the novel tank diving test, we assessed anxiety 
responses in wild type fish compared to disc1Y472 mutants, using time spent in each zone and number 
of transitions into the top zone as behavioural endpoints. We found that, overall, there was no difference 
in the time spent in each zone between wild types and disc1Y472 mutants. Although, on average control 
fish did not spend more time at the top, they did make a significantly greater number of entries into 
the top zone compared to disc1 mutants. Thus, demonstrating a reduction in anxiety-like behaviour as 
fish habituated to their environment. However, carriers of the disc1Y472 mutation made on average fewer 
than 5 transitions into the top zone compared to greater than 15 transitions made by wild type fish. The 
lack of transitions into the top zone is potentially reflective of a prolonged anxiety response.  
Previous studies in zebrafish have reported whole body cortisol levels that correlate well with 
findings in the novel tank diving test (Cachat et al., 2010; Maximino et al., 2010). We, therefore, 
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investigated cortisol levels in wild type and disc1 mutants following an acute stress. In line with our 
findings from the novel tank diving test, we found that there was no significant difference in cortisol 
levels between groups. Previous zebrafish studies using the disc1Y472 mutant line have investigated 
cortisol levels in larvae following acute stressors (alarm substance and sodium chloride) and although 
they reported differences between wild type stress response and baseline, they similarly do not report 
differences between wild type and disc1Y472 following stressor. Instead, stress reactivity differences are 
in comparison to basal levels of each group, not between groups (Eachus et al., 2017). These findings 
are in line with human studies investigating stress reactivity in patients with SZ. (Nugent et al., 2015) 
similarly reported no overall difference in salivary cortisol levels post-stress test, however, when dividing 
patients into groups of distress tolerance (completed the stress test) and intolerant (did not complete 
the stress test) they found prolonged cortisol reactivity that had not returned to baseline levels after 40 
min post-stress test in schizophrenic patients with distress intolerance (Nugent et al., 2015). Although 
we did not examine cortisol levels at multiple time points following the acute stress, we hypothesis that 
they would be reflective of our findings in the novel tank diving test and would be maintained for a 
longer period than wild type controls and warrants further investigation.  
Cognitive deficits are a hallmark of SZ and often present with moderate to severe impairments 
in patients and animal models (Ayhan et al., 2016; Keefe & Harvey, 2012). Deficits in cognitive functions, 
such as memory, executive function and attention have been demonstrated in early-onset SZ 
(development between childhood and early adulthood), which correlates with clinical severity and is 
comparable to adult-onset forms of the disorder, as those exhibiting early-onset cognitive deficits do 
not tend to show age-related improvements, as is associated with healthy peers (Frangou, 2009; Hollis, 
1995; Vyas et al., 2010). One of the most commonly reported cognitive deficiencies in SZ is WM and has 
been demonstrated in numerous animal models (Carless et al., 2011; Gamo et al., 2013; Kvajo et al., 
2008; Simen et al., 2009; Wang et al., 2019). However, as yet, no zebrafish model of SZ has examined 
differences in cognition. We therefore set out to assess WM abilities in mutant zebrafish carrying the 
disc1Y472  point mutation using the FMP Y-maze. Prior studies utilising the FMP Y-maze have reported a 
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specific exploration strategy whilst traversing the maze that is common to zebrafish, rodents and 
humans and is heavily dominated by use of alternations (RLRL+LRLR) (Cleal, Fontana, et al., 2020; 
Fontana, Cleal, & Parker, 2019; Fontana, Cleal, Clay, et al., 2019). Variations in this strategy have been 
triggered by blocking glutamatergic, cholinergic and dopaminergic receptors prior to exploration, all 
reducing use of alternations, however, only high doses of D1/D5 receptor antagonist caused a 
simultaneous down regulation of alternations and up regulation of repetitions (Cleal, Fontana, et al., 
2020). Here, we found that disc1Y472 mutants presented with severe WM impairments compared to wild 
type controls, demonstrating a total loss of the alternation based strategy and instead encompassing a 
completely random exploration pattern in which turn sequences were selected by chance. In addition 
to the deficit in alternation use, there was an increase in the use of repetitions (LLLL+RRRR) compared 
to controls. Prior studies by our group have shown increases in repetition strategies in zebrafish pre-
treated with a D1/D5 receptor antagonist, but not a D2/D3 receptor antagonist (Cleal, Fontana, et al., 
2020). These findings potentially suggest a role for disrupted dopaminergic signalling in altered 
cognitive performance in the FMP Y-maze.  
To further understand the molecular mechanisms underpinning the behavioural changes seen 
in disc1Y472 mutants, we analysed whole brain mRNA expression of gr and drd5. Glucocorticoids and 
their associated receptors play a critical role in modulating stress responses through HPA axis activation 
in humans and HPI activation in zebrafish (Derek Alsop & Vijayan, 2009; Aponte & Petrunich-Rutherford, 
2019; Ramamoorthy & Cidlowski, 2016; Wilson et al., 2013). Having already demonstrated that cortisol 
is not significantly upregulated following acute stress in disc1Y472 mutants, we further analysed the 
impact of this line on gr expression. We found a 2-fold increase in gr mRNA whole brain expression in 
disc1Y472 mutants compared to wild type controls. Our findings are at odds with other studies 
investigating GR regulation in SZ with many reporting a down regulation of GR mRNA expression in 
humans (Liu et al., 2020; Sinclair et al., 2011). However, rodent models of mild chronic stress have 
demonstrated greater than 2-fold increase in Gr mRNA expression in the prefrontal cortex (Wei et al., 
2016). If our findings of prolonged anxiety-like behaviour in the novel tank diving test is correlated with 
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prolonged cortisol elevation following stress, as shown in schizophrenic patients (Nugent et al., 2015), 
then this may act as a potential mechanism for causing the up-regulation of gr mRNA and warrants 
further investigation.  
Dopamine is a major factor in neuroendocrine function, cognition and psychosis (Lee et al., 2000). 
Dysregulation of the dopaminergic system has been heavily implicated in SZ (Dahoun et al., 2017; 
Kokkinou et al., 2020; Tost et al., 2010). Dopamine D1 (DRD1) and D2 (DRD2) receptors have been 
extensively studied in SZ, with many current antipsychotic medications acting as DRD2 antagonists and 
DRD1 implicated in the negative symptoms (Alfimova et al., 2013; McCutcheon et al., 2020; Price et al., 
2014; Takahashi et al., 2012). However, relatively little has been investigated in relation to DRD5 mostly 
notably due to the lack of specific ligands that can differentiate between DRD1 and DRD5 (Moraga-
Amaro et al., 2016). However, this receptor is worth further examination as DRD5 has been linked with 
regulating the HPA axis and GR expression and may provide an alternative mechanism by which 
neuropsychiatric disorders exert influence over cognitive domains (Perreault et al., 2013). Therefore, we 
have investigated whole brain mRNA expression of drd5 in disc1 mutant zebrafish. We found that drd5 
was significantly down-regulated compared to wild type controls. Previous studies investigating the 
effects of glucocorticoids on DRD5 found that high levels of circulating glucocorticoids down regulate 
DRD5 and disrupt the balance between DRD2 and DRD5 interaction in response to dopamine availability 
(Lee et al., 2000). Similar to the up-regulation of gr mRNA, altered cortisol levels could also cause the 
down-regulation of drd5 reported here. In addition to this, previous studies utilising knockdown and 
knockout models of Drd5 in rodents have demonstrated impaired WM performance, demonstrating a 
critical role for DRD5 in cognitive function, particularly WM (Carr et al., 2017; Moraga-Amaro et al., 
2016). However, it is worth noting that several studies have identified regional specific alterations in 
DRD5 expression (Bai et al., 2017), this combined with regional expression of GR in SZ (Sinclair et al., 
2011) may implicate localized effects of dysregulation of the dopaminergic and neuroendocrine systems 
that perpetuate adolescent stage cognitive deficits and altered anxiety responses that are commonly 




Here we demonstrate that disc1 mutant zebrafish, show maintained anxiety-like behaviour that is not 
alleviated by acclimatization to a novel environment, indicating altered anxiety response. Examination 
of cognitive performance in the FMP Y-maze reveals severe cognitive impairment, particularly in WM, 
indicating a complete loss of strategy formation, ultimately resulting in purely random exploration of 
the maze. Furthermore, upregulation of gr and downregulation of drd5 mRNA expression suggest 
possible mechanisms that may underpin anxiety and cognitive alterations in disc1Y472 mutants.  Together 
our data demonstrate a significant impact of disc1 mutation on normal behaviour and cognitive function 
in juvenile zebrafish, resembling findings in humans and rodents and implicate a role for the drd5 















4.1 General Discussion 
In the previous section we describe a new zebrafish slit-3 mutant line that exhibits a broad spectrum of 
cognitive, behavioural and biochemical abnormalities. With human GWAS data implicating aberrant 
SLIT-3 functioning as high risk for the development of SZ. We hypothesised that altered phenotypes in 
the slit-3 zebrafish model, represents SZ-like characteristics. To validate this hypothesis, we tested a 
well-known SZ-mutant line, disc1, and assessed central features of SZ, including cognitive function, 
anxiety responses and markers of HPI axis activation and regulation in both zebrafish models. Below is 
a description of their respective findings.  
 Slit-3 mutants tested in the FMP Y-maze demonstrated a significant down-regulation of the use 
of alternations, which has been extensively described throughout this thesis as pertaining to a reduction 
in WM performance. The same examination with disc1 mutants revealed a substantial inhibition of the 
alternation strategy, reducing their use to near chance selection, making the alternation-based strategy 
indistinguishable from all other tetragram strategies. This marks a significant deficit in WM performance 
in disc1 mutants compared to slit-3 mutants, and greater still compared to controls. Interestingly, such 
substantial reduction in the use of alternations has only previously been seen with zebrafish pre-treated 
with MK-801 and the D1 antagonist SCH-23390 (see Part 1: Chpt 3), potentially implicating the NMDA 
or D1 pathways as the underlying mechanisms in the disruption of WM performance. Additionally, both 
models showed up-regulation of stereotypic behaviours, as demonstrated by a significant increase in 
the use of repetitions compared to controls. The increase in stereotypic behaviours was greatest in slit-
3 mutants, which used this strategy at greater than chance levels, whilst disc1 mutants maintained low 
overall levels, but increased use compared to controls.  
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 Next we examined anxiety response to a novel environment, tested using the novel tank diving 
paradigm. Slit-3 mutants showed increased time spent at the bottom of the tank, indicating increased 
anxiety. This was accompanied by novelty-induced hyperlocomotion, described as such due to the lack 
of differences in locomotor activity after 1 h in the FMP Y-maze during which there is substantial 
habituation time, which may alleviate hyperlocomotor responses. Disc1 mutants showed no differences 
in time spent bottom dwelling or changes in locomotor activity. However, it is worth noting that disc1 
controls appeared to spend a substantial amount of time at the bottom, potentially resulting in ceiling 
effects that make it difficult to identify differences between control and mutant groups. This could 
potentially be a factor of age, as disc1 mutants were tested at 2-month old, whilst slit-3 mutants were 
tested as adults (6 months-old), and this could act as a confound when investigating anxiety behaviour.  
 Finally, we examined markers of HPI axis activation and regulation by analysing whole-body 
cortisol following acute stress and basal gr mRNA expression, respectively. Slit-3 mutants showed a 
decrease in whole-body cortisol following acute stress, but showed no differences in gr expression 
between mutants and controls. Disc1 mutants showed the complete inverse of these findings, with no 
differences in post stress cortisol levels compared to controls, but significant up-regulation of basal gr 
mRNA expression.  
 Combined these data describe two zebrafish lines that exhibit significant cognitive, behavioural 
and biochemical abnormalities compared to their respective controls. Similarities between cognitive 
deficits in disc1 mutants compared to MK-801 suggests robust replication of the cognitive symptoms 
associated with SZ. However, the slit-3 mutant line, despite showing lesser cognitive deficits, has greater 
dysregulation of the HPI axis, anxiety-like behaviours and stereotypies that are commonly described in 
SZ patients.  
 We conclude that further work is required to validate the role of slit-3 in SZ, however, this model 
does provide a transgenic zebrafish line with extensive neurological perturbations that are common to 
a range of psychiatric disorders, including SZ, and thus provides an alternative line for investigating 





5.1 Final Discussion 
The goal of this thesis was two-fold. To utilize zebrafish as an emerging model of complex disorders 
and to examine the cognitive symptomology associated with many neuropsychiatric conditions, as these 
can be life-long and significantly impact quality of life. Lack of progression in identifying clinically 
relevant therapeutic strategies over the last half a century has highlighted a need for a different 
approach and zebrafish offer such an alternative. The second aim was to design a non-invasive, robust, 
high throughput cognitive task that could demonstrate high translational relevance to clinical measures 
of disease. Part 1 of this thesis characterises and validates the FMP Y-maze as a clinically relevant 
cognitive task that can be used to assess cognitive function, particularly working memory and cognitive 
flexibility in model organisms ranging from flies, fish and rodents to humans.  
 Part 1 set out to validate the FMP Y-maze using pharmacological intervention to identify 
potential neurotransmitter systems critical to normal exploration of the maze. We identified 
glutamatergic and dopaminergic systems, particularly through D1-like receptors, and to a lesser extent 
cholinergic systems, as critical for the underlying working memory and executive functions required to 
strategically navigate the maze. Cross-species tests identified commonalities between vertebrate 
organisms in the way they naturally explore a novel, non-reinforced environment, and identified a 
dominant search strategy based on alternating left and right turns. Subsequent chapters set out to 
examine the applications and limitations of the FMP Y-maze, primarily using zebrafish, but integrating 
other models, such as rodents and humans to reaffirm the use of zebrafish for studying complex human 
disorders, but also to further validate the robustness of the FMP Y-maze. Ontogenetic evaluation of 
cognitive development, in tangent with examination of the developing neuroendocrine system, 
identified juvenile stages in zebrafish, similar to adolescent stages in humans, as a critical period of 
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increased vulnerability to stress-pathologies and onset of neuropsychiatric disorders.  Continued 
examination of maturing cognitive function identified deficits in working memory and cognitive 
flexibility in healthy ageing, the relevance of which was confirmed by examining a healthy human cohort 
using the virtual FMP Y-maze and replicating our findings from zebrafish. These two studies identify 
zebrafish as a model organism suitable to assessing cognition from larvae to ageing and have the 
additional benefit that all of these stages can be modelled in as little as two years. Finally, we used a 
genetic mouse model of AD to provide further validation of the FMP Y-maze and demonstrate its 
potential use as a cognitive task used for investigating neurodegenerative disorders.  
 Parts 2 & 3 focus on the original aim of the thesis and use zebrafish to investigate aspects of 
neuropsychiatric disorders that converge on aberrant cognitive processing. Part 2 investigates the long-
term effects of prenatal alcohol exposure on longitudinal cognitive deficits that could be identified in 
adulthood, despite only being exposed to a low concentration of drug. This highlights the sensitivity of 
the developing brain to environmental perturbations and long-term effects of early cognitive disruption. 
The negative consequences of prenatal drug exposure were in stark contrast to the next chapter which 
implicated chronic drug exposure regimens during adulthood with cognitive enhancing effects of 
nicotine and amphetamine on working memory performance in the FMP Y-maze. However, repeat 
exposure caused divergent effects of nicotine treated compared to amphetamine treated fish. Nicotine 
continued to exert pro-cognitive effects, enhancing working memory and maintaining cognitive 
flexibility. Amphetamine, on the other hand, demonstrated continued increases in use of alternations, 
but at the expensive of other strategies. Sensitizing effects of amphetamine resulted in the complete 
block of cognitive flexibility and potentially identified the first stages of drug-induced maladaptive 
behaviours. Thus, once again, demonstrating differences in the roles of the dopaminergic and 
cholinergic systems in influencing cognitive processes.  
Finally, Part 3 analyses two transgenic lines, modelling aspects of neuropsychiatric disorders, 
such as aberrant cognitive function, anxiety responses and dysregulation of the HPI axis. The first 
chapter aims to generate and characterise a new zebrafish mutant line with schizophrenia-like 
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phenotypes. CRISPR/Cas9 genome editing was used to generate a slit-3 mutant line. Behavioural and 
biochemical characterisation identified significant cognitive impairment in the FMP Y-maze, increased 
stereotypies, heighten anxiety responses and severe dysregulation of HPI axis activation in slit-3 
mutants. Previous studies had identified mutations in slit-3 with increased sensitivity to the rewarding 
effects of nicotine, found in humans and zebrafish. Additionally, GWAS studies have implicated SLIT-3 
as a high susceptibility gene for the development of schizophrenia. This information combined with our 
data identified slit-3 as a potential genetic link between the extremely high comorbidity of nicotine 
addiction in schizophrenic patients. Thus, having identified schizophrenia-like behaviours in slit-3 
mutant fish, we examined the impact of nicotine treatment on cognitive performance and anxiety 
responses and found that nicotine attenuated cognitive impairments and reduced anxiety, restoring fish 
to near control levels. To further this investigation, we tested another well-known anxiolytic drug, 
alcohol, to identify if responses to nicotine was due to the drugs anxiolytic effects or rewarding 
properties. We found that slit-3 mutants showed greater preference for the ethanol-paired cue than 
controls in the CPP, but had no effect on anxiety responses. Our data further identify a role for 
stimulation of the cholinergic system as a mechanism for enhancing cognitive performance both in 
health and disease as well as a role for reducing anxiety, without negatively impacting other domains 
such as cognitive flexibility.  
 
Future directions 
The global pandemic has had a huge impact on this work and resulted in much research left incomplete. 
However, the data that has been compiled paves the way for many future studies. Covid-19 has brought 
about unprecedented social isolation, future uncertainty, grave health issues and death and there is little 
doubt of the huge impact that this event will have on the short and long-term mental health of the 
global population. Understanding the molecular and neurophysiological mechanisms of 
neuropsychiatric disorders is even more critical than ever and so is the need to find effective therapeutic 
strategies to combat mental illness. The potential of the FMP Y-maze to bridge the gap between findings 
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in animal models and the clinic is exciting and requires more work to fully appreciate its potential. As 
such, future plans for human studies using the FMP Y-maze to investigate cognitive changes in people 
suffering with mild cognitive decline, schizophrenia, autism, depression and anxiety are already in place. 
Generation of new and improved genetic models of these disorders will allow direct comparisons of 
cognitive performance and potentially, increased success in finding effective therapeutic strategies. 
Being able to robustly translate findings from animal models to humans is going to prove imperative to 
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